{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "3664114e",
   "metadata": {},
   "source": [
    "# APIs\n",
    "\n",
    "Sample APIs: https://github.com/public-apis/public-apis\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "d37c60dd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Response [403]>"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import json\n",
    "import requests\n",
    "url = 'http://api.worldbank.org/v2/country/USA/indicator/NY.GDP.PCAP.CD?format=json&per_page=5000&source=2'\n",
    "r = requests.get(url)\n",
    "#j = r.json()\n",
    "r"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "9c990709",
   "metadata": {},
   "source": [
    "## API Example without API key: Currency conversion (JSON)\n",
    "\n",
    "See https://github.com/fawazahmed0/currency-api#readme for API documentation"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "13e29fa3",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "https://cdn.jsdelivr.net/gh/fawazahmed0/currency-api@1/latest/currencies/eur/usd.json\n",
      "{'date': '2023-03-21', 'usd': 1.071593}\n",
      "1 Euro is 1.071593 dollars\n"
     ]
    }
   ],
   "source": [
    "import requests\n",
    "\n",
    "from_currency = 'eur'\n",
    "to_currency = 'usd'\n",
    "base_url = 'https://cdn.jsdelivr.net/gh/fawazahmed0/currency-api@1/latest/currencies/'\n",
    "url = base_url + f'{from_currency}/{to_currency}.json'\n",
    "print(url)\n",
    "\n",
    "r = requests.get(url)\n",
    "j = r.json()\n",
    "\n",
    "print(j)\n",
    "\n",
    "print(f\"1 Euro is {j.get('usd')} dollars\")\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "5e2a7d36",
   "metadata": {},
   "source": [
    "## API Example without API key: Reddit stock sentiment API (JSON)\n",
    "\n",
    "https://tradestie.com/apps/reddit/api/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "id": "b2d29391",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "42\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[{'no_of_comments': 38,\n",
       "  'sentiment': 'Bullish',\n",
       "  'sentiment_score': 0.13,\n",
       "  'ticker': 'GME'},\n",
       " {'no_of_comments': 9,\n",
       "  'sentiment': 'Bullish',\n",
       "  'sentiment_score': 0.555,\n",
       "  'ticker': 'JP'},\n",
       " {'no_of_comments': 9,\n",
       "  'sentiment': 'Bearish',\n",
       "  'sentiment_score': -0.248,\n",
       "  'ticker': 'FRC'}]"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r2 = requests.get('https://tradestie.com/api/v1/apps/reddit')\n",
    "j2 = r2.json()\n",
    "print(len(j2))\n",
    "j2[:3]  # j2\n"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "d506bf1e",
   "metadata": {},
   "source": [
    "## API Example without API key: NIH NCBI Entrez Pubmed papers (XML)\n",
    "\n",
    "https://www.ncbi.nlm.nih.gov/home/develop/api/\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "22c9a08a",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=asthma[mesh]+AND+leukotrienes[mesh]+AND+2022[pdat]&usehistory=y'"
      ]
     },
     "execution_count": 3,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "db = 'pubmed'\n",
    "query = 'asthma[mesh]+AND+leukotrienes[mesh]+AND+2022[pdat]'\n",
    "\n",
    "#assemble the esearch URL\n",
    "base_url3 = 'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/'\n",
    "url3 = base_url3 + f'esearch.fcgi?db={db}&term={query}&usehistory=y'\n",
    "url3"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "id": "eb772aea",
   "metadata": {},
   "outputs": [],
   "source": [
    "r3 = requests.get(url3)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "id": "3e87d8d9",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'<?xml version=\"1.0\" encoding=\"UTF-8\" ?>\\n<!DOCTYPE eSearchResult PUBLIC \"-//NLM//DTD esearch 20060628//EN\" \"https://eutils.ncbi.nlm.nih.gov/eutils/dtd/20060628/esearch.dtd\">\\n<eSearchResult><Count>17</Count><RetMax>17</RetMax><RetStart>0</RetStart><QueryKey>1</QueryKey><WebEnv>MCID_641a9c175642d62875458113</WebEnv><IdList>\\n<Id>36184313</Id>\\n<Id>36130059</Id>\\n<Id>36126795</Id>\\n<Id>36115955</Id>\\n<Id>35917595</Id>\\n<Id>35850310</Id>\\n<Id>35720028</Id>\\n<Id>35527666</Id>\\n<Id>35451080</Id>\\n<Id>35410888</Id>\\n<Id>35227979</Id>\\n<Id>35226440</Id>\\n<Id>35026480</Id>\\n<Id>35026207</Id>\\n<Id>34954219</Id>\\n<Id>34376110</Id>\\n<Id>33973823</Id>\\n</IdList><TranslationSet><Translation>     <From>asthma[mesh]</From>     <To>\"asthma\"[MeSH Terms]</To>    </Translation><Translation>     <From>leukotrienes[mesh]</From>     <To>\"leukotrienes\"[MeSH Terms]</To>    </Translation></TranslationSet><QueryTranslation>\"asthma\"[MeSH Terms] AND \"leukotrienes\"[MeSH Terms] AND 2022/01/01:2022/12/31[Date - Publication]</QueryTranslation></eSearchResult>\\n'"
      ]
     },
     "execution_count": 5,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r3.text"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "id": "994e67e7",
   "metadata": {},
   "outputs": [],
   "source": [
    "from xml.etree import ElementTree\n",
    "\n",
    "tree = ElementTree.fromstring(r3.text)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "id": "3a43a4f0",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1 MCID_641a9c175642d62875458113\n"
     ]
    }
   ],
   "source": [
    "key = tree.find('QueryKey').text\n",
    "webenv = tree.find('WebEnv').text\n",
    "print(key, webenv)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "41fbfa8d",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&query_key=1&WebEnv=MCID_641a9c175642d62875458113&rettype=abstract&retmode=xml'"
      ]
     },
     "execution_count": 8,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "url4 = base_url3 + \\\n",
    "f'efetch.fcgi?db={db}&query_key={key}&WebEnv={webenv}&rettype=abstract&retmode=xml'\n",
    "url4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "id": "2f5de2c7",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<Response [200]>\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "'<?xml version=\"1.0\" ?>\\n<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2023//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd\">\\n<PubmedArticleSet>\\n<PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36184313</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>09</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-6825</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>151</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Updates on immune mechanisms in aspirin-exacerbated respiratory disease.</ArticleTitle><Pagination><StartPage>301</StartPage><EndPage>309</EndPage><MedlinePgn>301-309</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2022.08.021</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)01171-X</ELocationID><Abstract><AbstractText>Aspirin-exacerbated respiratory disease has fascinated and frustrated specialists in allergy/immunology, pulmonology, and otorhinolaryngology for decades. It generally develops in previously healthy young adults and is unremitting and challenging to treat. The classical triad of asthma, nasal polyposis, and pathognomonic respiratory reactions to aspirin and other cyclooxygenase-1 inhibitors is accompanied by high levels of mast cell activation, cysteinyl leukotriene production, platelet activation, and severe type 2 respiratory inflammation. The \"unbraking\" of mast cell activation and further cysteinyl leukotriene generation induced by cyclooxygenase-1 inhibition reflect an idiosyncratic dependency on cyclooxygenase-1-derived products, likely prostaglandin E<sub>2</sub>, to maintain a tenuous homeostasis. Although cysteinyl leukotrienes are clear disease effectors, little else was known about their cellular sources and targets, and the contributions from other mediators and type 2 respiratory inflammation effector cells to disease pathophysiology were unknown until recently. The applications of targeted biological therapies, single-cell genomics, and transgenic animal approaches have substantially advanced our understanding of aspirin-exacerbated respiratory disease pathogenesis and treatment and have also revealed disease heterogeneity. This review covers novel insights into the immunopathogenesis of aspirin-exacerbated respiratory disease from each of these lines of research, including the roles of lipid mediators, effector cell populations, and inflammatory cytokines, discusses unanswered questions regarding cause and pathogenesis, and considers potential future therapeutic options.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Laidlaw</LastName><ForeName>Tanya M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass. Electronic address: tlaidlaw@bwh.harvard.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Boyce</LastName><ForeName>Joshua A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 AI078908</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI136041</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI052353</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI095219</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>09</Month><Day>30</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI=\"D051545\">Cyclooxygenase 1</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051545\" MajorTopicYN=\"N\">Cyclooxygenase 1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">AERD</Keyword><Keyword MajorTopicYN=\"N\">CRSwNP</Keyword><Keyword MajorTopicYN=\"N\">leukotriene E4</Keyword><Keyword MajorTopicYN=\"N\">mast cells</Keyword><Keyword MajorTopicYN=\"N\">mechanisms</Keyword><Keyword MajorTopicYN=\"N\">prostaglandin E2</Keyword></KeywordList><CoiStatement><b>Conflict of Interest:</b> TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline and Sanofi-Genzyme, Novartis, and Regeneron. JA Boyce has served on the advisory boards of Sanofi-Genzyme, Siolta Therapeutics, and Third Harmonic Bio.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>6</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>8</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2024</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>10</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>10</Month><Day>2</Day><Hour>22</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36184313</ArticleId><ArticleId IdType=\"mid\">NIHMS1839874</ArticleId><ArticleId IdType=\"pmc\">PMC9905222</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jaci.2022.08.021</ArticleId><ArticleId IdType=\"pii\">S0091-6749(22)01171-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Inada M, Matsumoto C, Uematsu S, Akira S, Miyaura C. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J Immunol. 2006;177(3):1879&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16849500</ArticleId></ArticleIdList></Reference><Reference><Citation>Kay LJ, Yeo WW, Peachell PT. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol. 2006;147(7):707&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC1751511</ArticleId><ArticleId IdType=\"pubmed\">16432506</ArticleId></ArticleIdList></Reference><Reference><Citation>Maric J, Ravindran A, Mazzurana L, Bjorklund AK, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141(5):1761&#x2013;73 e6.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5929462</ArticleId><ArticleId IdType=\"pubmed\">29217133</ArticleId></ArticleIdList></Reference><Reference><Citation>Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005;96(6):1203&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16215982</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int. 2008;57(4):429&#x2013;36.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18797183</ArticleId></ArticleIdList></Reference><Reference><Citation>Roca-Ferrer J, Perez-Gonzalez M, Garcia-Garcia FJ, Pereda J, Pujols L, Alobid I, et al. Low Prostaglandin E(2) and Cyclooxygenase Expression in Nasal Mucosa Fibroblasts of Aspirin-Intolerant Asthmatics. Respirology. 2013.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23441755</ArticleId></ArticleIdList></Reference><Reference><Citation>Machado-Carvalho L, Martin M, Torres R, Gabasa M, Alobid I, Mullol J, et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1beta/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(1):99&#x2013;107.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26560040</ArticleId></ArticleIdList></Reference><Reference><Citation>Corrigan CJ, Napoli RL, Meng Q, Fang C, Wu H, Tochiki K, et al. Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol. 2012;129(6):1636&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22418066</ArticleId></ArticleIdList></Reference><Reference><Citation>Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol. 2006;117(2):312&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16461132</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN, Raby BA, Zhou X, Guo F, Thibault D, Baccarelli A, et al. Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. Am J Respir Cell Mol Biol. 2016;54(1):34&#x2013;40.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4742927</ArticleId><ArticleId IdType=\"pubmed\">26051534</ArticleId></ArticleIdList></Reference><Reference><Citation>Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8564100</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Laidlaw TM, Katz HR, Boyce JA. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013;110(42):16987&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3801005</ArticleId><ArticleId IdType=\"pubmed\">24085850</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JW, Drazen JM, McFadden ER Jr., Weller P, Corey EJ, Lewis RA, et al. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. JAMA. 1983;249(20):2814&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">6842792</ArticleId></ArticleIdList></Reference><Reference><Citation>Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143(5 Pt 1):1025&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1850964</ArticleId></ArticleIdList></Reference><Reference><Citation>Arm JP, O&#x2019;Hickey SP, Spur BW, Lee TH. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis. 1989;140(1):148&#x2013;53.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2546469</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol. 1994;94(6 Pt 1):1046&#x2013;56.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7798537</ArticleId></ArticleIdList></Reference><Reference><Citation>Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993;148(6 Pt 1):1447&#x2013;51.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8256883</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Fuentes DJ, Wang Y. Efficacy of Zileuton in Patients with Asthma and History of Aspirin Sensitivity: A Retrospective Analysis of Data from Two Phase 3 Studies. AAAAI: J Allergy Clin Immunol; 2017. p. AB384.</Citation></Reference><Reference><Citation>Bankova LG, Lai J, Yoshimoto E, Boyce JA, Austen KF, Kanaoka Y, et al. Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99. Proc Natl Acad Sci U S A. 2016;113(22):6242&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4896673</ArticleId><ArticleId IdType=\"pubmed\">27185938</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Cirka H, et al. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. J Immunol. 2018;200(3):915&#x2013;27.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5780246</ArticleId><ArticleId IdType=\"pubmed\">29282304</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12(3):679&#x2013;90.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6462243</ArticleId><ArticleId IdType=\"pubmed\">30664709</ArticleId></ArticleIdList></Reference><Reference><Citation>Bankova LG, Dwyer DF, Yoshimoto E, Ualiyeva S, McGinty JW, Raff H, et al. The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation. Sci Immunol. 2018;3(28).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6599626</ArticleId><ArticleId IdType=\"pubmed\">30291131</ArticleId></ArticleIdList></Reference><Reference><Citation>von MJ, Ji M, Liang HE, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. 2016;529(7585):221&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4830391</ArticleId><ArticleId IdType=\"pubmed\">26675736</ArticleId></ArticleIdList></Reference><Reference><Citation>Ualiyeva S, Lemire E, Aviles EC, Wong C, Boyd AA, Lai J, et al. Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation. Sci Immunol. 2021;6(66):eabj0474.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8750919</ArticleId><ArticleId IdType=\"pubmed\">34932383</ArticleId></ArticleIdList></Reference><Reference><Citation>Ualiyeva S, Hallen N, Kanaoka Y, Ledderose C, Matsumoto I, Junger WG, et al. Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2. Science Immunology. 2020;5(43):eaax7224.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7176051</ArticleId><ArticleId IdType=\"pubmed\">31953256</ArticleId></ArticleIdList></Reference><Reference><Citation>Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol. 2013;132(1):205&#x2013;13.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3704056</ArticleId><ArticleId IdType=\"pubmed\">23688412</ArticleId></ArticleIdList></Reference><Reference><Citation>von Moltke J, O&#x2019;Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214(1):27&#x2013;37.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5206504</ArticleId><ArticleId IdType=\"pubmed\">28011865</ArticleId></ArticleIdList></Reference><Reference><Citation>McGinty JW, Ting H-A, Billipp TE, Nadjsombati MS, Khan DM, Barrett NA, et al. Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity. Immunity. 2020;52(3):528&#x2013;41.e7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7469474</ArticleId><ArticleId IdType=\"pubmed\">32160525</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85(6 Pt 1):477&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11152169</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitson-Salazar A, Prussin C. Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease. Front Med (Lausanne). 2017;4:165.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5635264</ArticleId><ArticleId IdType=\"pubmed\">29057225</ArticleId></ArticleIdList></Reference><Reference><Citation>Maric J, Ravindran A, Mazzurana L, Van Acker A, Rao A, Kokkinou E, et al. Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation. J Allergy Clin Immunol. 2019;143(6):2202&#x2013;14 e5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30578872</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566&#x2013;76.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4860132</ArticleId><ArticleId IdType=\"pubmed\">26691435</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4289104</ArticleId><ArticleId IdType=\"pubmed\">25218285</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001;193(2):255&#x2013;61.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2193345</ArticleId><ArticleId IdType=\"pubmed\">11208866</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 2014;133(4):1184&#x2013;94.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3979107</ArticleId><ArticleId IdType=\"pubmed\">24388011</ArticleId></ArticleIdList></Reference><Reference><Citation>Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol. 2005;175(10):6531&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16272307</ArticleId></ArticleIdList></Reference><Reference><Citation>Price CPE, Guo A, Stevens WW, Cousens L, Vu TT, Suh LA, et al. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: a randomized controlled clinical trial. Clin Exp Allergy. 2022.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35524339</ArticleId></ArticleIdList></Reference><Reference><Citation>Gevaert P, Bachert C, Maspero JF, Cuevas M, Steele D, Acharya S, et al. Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER). J Allergy Clin Immunol. 2022;149(5):1675&#x2013;82 e3.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35094848</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN. Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor? J Allergy Clin Immunol. 2022;149(5):1587&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35304159</ArticleId></ArticleIdList></Reference><Reference><Citation>Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101(4):834&#x2013;46.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC508632</ArticleId><ArticleId IdType=\"pubmed\">9466979</ArticleId></ArticleIdList></Reference><Reference><Citation>Nasser SM, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med. 1996;153(1):90&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8542168</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Prussin C, Panettieri RA, Lee S, Ferguson BJ, Adappa ND, et al. Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size. Laryngoscope. 2019;129(2):E61&#x2013;E6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30284267</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsui C, Kajiwara K, Hayashi H, Ito J, Mita H, Ono E, et al. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, et al. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(3):720&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5568994</ArticleId><ArticleId IdType=\"pubmed\">28238741</ArticleId></ArticleIdList></Reference><Reference><Citation>Maclouf J, Murphy RC, Henson PM. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation of human neutrophil/platelet mixtures. Blood. 1990;76(9):1838&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2224131</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3335383</ArticleId><ArticleId IdType=\"pubmed\">22262771</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2018.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6286686</ArticleId><ArticleId IdType=\"pubmed\">29890239</ArticleId></ArticleIdList></Reference><Reference><Citation>Dwyer DF, Ordovas-Montanes J, Allon SJ, Buchheit KM, Vukovic M, Derakhshan T, et al. Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation. Sci Immunol. 2021;6(56).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8362933</ArticleId><ArticleId IdType=\"pubmed\">33637594</ArticleId></ArticleIdList></Reference><Reference><Citation>Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol. 2003;111(4):743&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12704352</ArticleId></ArticleIdList></Reference><Reference><Citation>Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, et al. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)]. Arerugi = [Allergy]. 1992;41(10):1515&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1482300</ArticleId></ArticleIdList></Reference><Reference><Citation>Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, et al. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma Immunol. 2001;87(2):146&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11527248</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, et al. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol. 1998;80(2):171&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">9494450</ArticleId></ArticleIdList></Reference><Reference><Citation>Eastman JJ, Cavagnero KJ, Deconde AS, Kim AS, Karta MR, Broide DH, et al. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(1):101&#x2013;8 e3.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5496786</ArticleId><ArticleId IdType=\"pubmed\">28279492</ArticleId></ArticleIdList></Reference><Reference><Citation>Salimi M, Stoger L, Liu W, Go S, Pavord I, Klenerman P, et al. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol. 2017;140(4):1090&#x2013;100 e11.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5624780</ArticleId><ArticleId IdType=\"pubmed\">28115217</ArticleId></ArticleIdList></Reference><Reference><Citation>Kupczyk M, Kurmanowska Z, Kuprys-Lipinska I, Bochenska-Marciniak M, Kuna P. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir Med. 2010;104(10):1404&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20452758</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchheit KM, Dwyer DF, Ordovas-Montanes J, Katz HR, Lewis E, Vukovic M, et al. IL-5Ralpha marks nasal polyp IgG4 and IgE-expressing cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7282948</ArticleId><ArticleId IdType=\"pubmed\">32199912</ArticleId></ArticleIdList></Reference><Reference><Citation>Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 2018;560(7720):649&#x2013;54.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6133715</ArticleId><ArticleId IdType=\"pubmed\">30135581</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens WW, Staudacher AG, Hulse KE, Carter RG, Winter DR, Kato A, et al. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7606335</ArticleId><ArticleId IdType=\"pubmed\">32371071</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, et al. PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell. 2017;171(3):628&#x2013;41 e26.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5683852</ArticleId><ArticleId IdType=\"pubmed\">29053969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagasaki T, Schuyler AJ, Zhao J, Samovich SN, Yamada K, Deng Y, et al. 15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation. J Clin Invest. 2022;132(1).</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8718153</ArticleId><ArticleId IdType=\"pubmed\">34762602</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326&#x2013;32.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7113089</ArticleId><ArticleId IdType=\"pubmed\">31830587</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Mitsui C, Nakatani E, Fukutomi Y, Kajiwara K, Watai K, et al. Omalizumab reduces cysteinyl leukotriene and 9alpha,11beta-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1585&#x2013;7.e4.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26559322</ArticleId></ArticleIdList></Reference><Reference><Citation>Lang DM, Aronica MA, Maierson ES, Wang XF, Vasas DC, Hazen SL. Omalizumab can inhibit respiratory reaction during aspirin desensitization. Ann Allergy Asthma Immunol. 2018;121(1):98&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29777744</ArticleId></ArticleIdList></Reference><Reference><Citation>Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2018;6(3):1045&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5997393</ArticleId><ArticleId IdType=\"pubmed\">29501519</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, et al. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148(2):574&#x2013;84.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9096876</ArticleId><ArticleId IdType=\"pubmed\">34144111</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin H, Barrett NA, Laidlaw T. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series. J Allergy Clin Immunol Pract. 2021;9(3):1384&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9255360</ArticleId><ArticleId IdType=\"pubmed\">32956852</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott WC, Cahill KN, Milne GL, Li P, Sheng Q, Huang LC, et al. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1318&#x2013;28 e5.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8035132</ArticleId><ArticleId IdType=\"pubmed\">33189729</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016;315(5):469&#x2013;79.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26836729</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Mullol J, Fan C, Zhang D, Amin N, Khan A, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462&#x2013;5 e1.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">30954643</ArticleId></ArticleIdList></Reference><Reference><Citation>Bavaro N, Gakpo D, Mittal A, Bensko JC, Laidlaw TM, Buchheit KM. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ralpha in a real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2910&#x2013;2 e1.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8277677</ArticleId><ArticleId IdType=\"pubmed\">33631410</ArticleId></ArticleIdList></Reference><Reference><Citation>Buchheit KM, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko JC, et al. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2022.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC9378638</ArticleId><ArticleId IdType=\"pubmed\">35460728</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel P, Bensko JC, Bhattacharyya N, Laidlaw TM, Buchheit KM. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2022;128(3):326&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8882131</ArticleId><ArticleId IdType=\"pubmed\">34863953</ArticleId></ArticleIdList></Reference><Reference><Citation>Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol. 2006;117(6):1446&#x2013;54.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">16751012</ArticleId></ArticleIdList></Reference><Reference><Citation>Mustafa SS, Vadamalai K. Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021;126(6):738&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33746062</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, et al. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway. J Immunol. 2015;195(8):3537&#x2013;45.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4592820</ArticleId><ArticleId IdType=\"pubmed\">26342029</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal immunology. 2019.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6462243</ArticleId><ArticleId IdType=\"pubmed\">30664709</ArticleId></ArticleIdList></Reference><Reference><Citation>Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021;384(19):1800&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33979488</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelsen SG, Agache IO, Soong W, Israel E, Chupp GL, Cheung DS, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021;148(3):790&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">33872652</ArticleId></ArticleIdList></Reference><Reference><Citation>Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. New England Journal of Medicine. 2021;385(18):1656&#x2013;68.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34706171</ArticleId></ArticleIdList></Reference><Reference><Citation>Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12532116</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, et al. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. Am J Respir Crit Care Med. 2019;200(6):704&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6775876</ArticleId><ArticleId IdType=\"pubmed\">30978291</ArticleId></ArticleIdList></Reference><Reference><Citation>Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">12421891</ArticleId></ArticleIdList></Reference><Reference><Citation>Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1999;160(1):291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10390414</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang JE, Ding D, Martin-Lazaro J, White A, Stevenson DD. Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2012;108(1):14&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22192959</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi H, Fukutomi Y, Mitsui C, Nakatani E, Watai K, Kamide Y, et al. Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers. J Allergy Clin Immunol Pract. 2018;6(1):116&#x2013;25 e3.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">28583479</ArticleId></ArticleIdList></Reference><Reference><Citation>Samter M, Beers RF, Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975&#x2013;83.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">5646829</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace S, Pergola C, Dehm F, Rossi A, Gerstmeier J, Troisi F, et al. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. J Clin Invest. 2017;127(8):3167&#x2013;76.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5531400</ArticleId><ArticleId IdType=\"pubmed\">28737505</ArticleId></ArticleIdList></Reference><Reference><Citation>Laffont S, Blanquart E, Savignac M, Cenac C, Laverny G, Metzger D, et al. Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med. 2017;214(6):1581&#x2013;92.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5461006</ArticleId><ArticleId IdType=\"pubmed\">28484078</ArticleId></ArticleIdList></Reference><Reference><Citation>Pace S, Rossi A, Krauth V, Dehm F, Troisi F, Bilancia R, et al. Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation. Sci Rep. 2017;7(1):3759.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5476623</ArticleId><ArticleId IdType=\"pubmed\">28630405</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolmert J, Gomez C, Balgoma D, Sjodin M, Bood J, Konradsen JR, et al. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation. Am J Respir Crit Care Med. 2020.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7781128</ArticleId><ArticleId IdType=\"pubmed\">32667261</ArticleId></ArticleIdList></Reference><Reference><Citation>Szczeklik A Aspirin-induced asthma as a viral disease. Clin Allergy. 1988;18(1):15&#x2013;20.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3127083</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaravinos A, Bizakis J, Spandidos DA. Prevalence of human papilloma virus and human herpes virus types 1&#x2013;7 in human nasal polyposis. J Med Virol. 2009;81(9):1613&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">19626617</ArticleId></ArticleIdList></Reference><Reference><Citation>Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy. 2010;65(11):1430&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20456313</ArticleId></ArticleIdList></Reference><Reference><Citation>Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607&#x2013;14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11295647</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2011;128(6):1198&#x2013;206 e1.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3384688</ArticleId><ArticleId IdType=\"pubmed\">21996343</ArticleId></ArticleIdList></Reference><Reference><Citation>Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2008;121(6):1385&#x2013;92, 92 e1&#x2013;2.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2802261</ArticleId><ArticleId IdType=\"pubmed\">18410958</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeffe JS, Seshadri S, Hamill KJ, Huang JH, Carter R, Suh L, et al. A role for anti-BP180 autoantibodies in chronic rhinosinusitis. Laryngoscope. 2013;123(9):2104&#x2013;11.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3813294</ArticleId><ArticleId IdType=\"pubmed\">24167818</ArticleId></ArticleIdList></Reference><Reference><Citation>Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21510141</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheong HS, Park SM, Kim MO, Park JS, Lee JY, Byun JY, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy. 2011;66(5):637&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">21121930</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128(9):E304&#x2013;E10.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6082743</ArticleId><ArticleId IdType=\"pubmed\">29417576</ArticleId></ArticleIdList></Reference><Reference><Citation>Tognetti A, Sarolidou G, Lasselin J, Lekander M, Olsson MJ, Lundstrom JN. Acute Systemic Experimental Inflammation Does Not Reduce Human Odor Identification Performance. Chem Senses. 2021;46.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8015794</ArticleId><ArticleId IdType=\"pubmed\">33537776</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36130059</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>01</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1545-4304</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>63</Volume><PubDate><Year>2023</Year><Month>Jan</Month><Day>20</Day></PubDate></JournalIssue><Title>Annual review of pharmacology and toxicology</Title><ISOAbbreviation>Annu Rev Pharmacol Toxicol</ISOAbbreviation></Journal><ArticleTitle>Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.</ArticleTitle><Pagination><StartPage>407</StartPage><EndPage>428</EndPage><MedlinePgn>407-428</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1146/annurev-pharmtox-051921-085014</ELocationID><Abstract><AbstractText>Leukotrienes are potent immune-regulating lipid mediators with patho-genic roles in inflammatory and allergic diseases, particularly asthma. These autacoids also contribute to low-grade inflammation, a hallmark of cardiovascular, neurodegenerative, metabolic, and tumor diseases. Biosynthesis of leukotrienes involves release and oxidative metabolism of arachidonic acid and proceeds via a set of cytosolic and integral membrane enzymes that are typically expressed by cells of the innate immune system. In activated cells, these enzymes traffic and assemble at the endoplasmic and perinuclear membrane, together comprising a biosynthetic complex. Here we describe recent advances in our molecular understanding of the protein components of the leukotriene-synthesizing enzyme machinery and also briefly touch upon the leukotriene receptors. Moreover, we discuss emerging opportunities for pharmacological intervention and development of new therapeutics.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Haeggstr&#xf6;m</LastName><ForeName>Jesper Z</ForeName><Initials>JZ</Initials><AffiliationInfo><Affiliation>Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, Sweden; email: jesper.haeggstrom@ki.se.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Newcomer</LastName><ForeName>Marcia E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA; email: newcomer@lsu.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>09</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Annu Rev Pharmacol Toxicol</MedlineTA><NlmUniqueID>7607088</NlmUniqueID><ISSNLinking>0362-1642</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"Y\">Leukotrienes</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">arachidonic acid</Keyword><Keyword MajorTopicYN=\"N\">endemic diseases</Keyword><Keyword MajorTopicYN=\"N\">inflammation</Keyword><Keyword MajorTopicYN=\"N\">leukotriene</Keyword><Keyword MajorTopicYN=\"N\">structure-based drug design</Keyword><Keyword MajorTopicYN=\"N\">therapeutics</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>9</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>1</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>14</Hour><Minute>43</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36130059</ArticleId><ArticleId IdType=\"doi\">10.1146/annurev-pharmtox-051921-085014</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36126795</PMID><DateCompleted><Year>2023</Year><Month>02</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>02</Month><Day>07</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-6825</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>151</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Feb</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.</ArticleTitle><Pagination><StartPage>310</StartPage><EndPage>313</EndPage><MedlinePgn>310-313</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2022.09.012</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)01215-5</ELocationID><Abstract><AbstractText>Aspirin-exacerbated respiratory disease (AERD) is associated with overproduction of proinflammatory cysteinyl leukotrienes (CysLTs), defective generation of anti-inflammatory prostaglandin E<sub>2</sub> (PGE<sub>2</sub>), and reduced expression of the EP2 receptor for PGE<sub>2</sub>. Reduced PGE<sub>2</sub> synthesis results from the downregulation of inducible COX-2. Because PGE<sub>2</sub> signaling via EP2 inhibits the 5-lipoxygenase/leukotriene C<sub>4</sub> synthase-dependent pathway, the deficient levels of both PGE<sub>2</sub> and EP2 likely contribute to the excessive baseline production of cysteinyl leukotrienes in patients with AERD compared with in patients with aspirin-tolerant asthma. The COX-2 pathway is regulated by an autocrine metabolic loop involving IL-1&#x3b2;, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE<sub>2</sub> prostaglandin E<sub>2</sub> synthase-1, and PGE<sub>2</sub>. Previous studies reported that this metabolic loop is dysregulated in patients with AERD. When the downexpressed EP2 receptor is normalized, the entire loop returns to its normal function. Cotreatment of airway cells from healthy subjects with IL-4 and IFN-&#x3b3; induces alterations in the metabolic loop similar to those seen in patients with AERD. In these patients, IL-4, which is produced in excess in airways of patients with AERD, likely contributes to the alteration of normal functioning of the autocrine metabolic loop involving IL-1&#x3b2;, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE<sub>2</sub> prostaglandin E<sub>2</sub> synthase-1, and PGE<sub>2</sub>. We hypothesized that by blocking IL-4 action, dupilumab normalizes EP2 expression and restores the normal functioning of the COX-2 pathway autocrine metabolic loop, thereby normalizing the synthesis of PGE<sub>2</sub> and restoring aspirin tolerance.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Picado</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain; Institut d\\'Investigacions Biom&#xe8;diques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biom&#xe9;dicas en Red de Enfermedades Respiratorias, Madrid, Spain. Electronic address: cpicado@ub.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mullol</LastName><ForeName>Joaquim</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d\\'Investigacions Biom&#xe8;diques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biom&#xe9;dicas en Red de Enfermedades Respiratorias, Madrid, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Roca-Ferrer</LastName><ForeName>Jordi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Institut d\\'Investigacions Biom&#xe8;diques August Pi I Sunyer, Barcelona, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance></Chemical><Chemical><RegistryNumber>420K487FSG</RegistryNumber><NameOfSubstance UI=\"C582203\">dupilumab</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.14.99.1</RegistryNumber><NameOfSubstance UI=\"D051546\">Cyclooxygenase 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>207137-56-2</RegistryNumber><NameOfSubstance UI=\"D015847\">Interleukin-4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical><Chemical><RegistryNumber>K7Q1JQR04M</RegistryNumber><NameOfSubstance UI=\"D015232\">Dinoprostone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 5.3.99.3</RegistryNumber><NameOfSubstance UI=\"D000071876\">Prostaglandin-E Synthases</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D058307\">Receptors, Prostaglandin E, EP2 Subtype</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D017472\">Receptors, Interleukin-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051546\" MajorTopicYN=\"N\">Cyclooxygenase 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015847\" MajorTopicYN=\"N\">Interleukin-4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015232\" MajorTopicYN=\"N\">Dinoprostone</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000071876\" MajorTopicYN=\"N\">Prostaglandin-E Synthases</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D058307\" MajorTopicYN=\"N\">Receptors, Prostaglandin E, EP2 Subtype</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017472\" MajorTopicYN=\"N\">Receptors, Interleukin-1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aspirin</Keyword><Keyword MajorTopicYN=\"N\">asthma</Keyword><Keyword MajorTopicYN=\"N\">dupilumab</Keyword><Keyword MajorTopicYN=\"N\">leukotriene</Keyword><Keyword MajorTopicYN=\"N\">nonsteroidal anti-inflammatory drug</Keyword><Keyword MajorTopicYN=\"N\">prostaglandin E(2)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>6</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>9</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2023</Year><Month>2</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>9</Month><Day>20</Day><Hour>19</Hour><Minute>24</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36126795</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jaci.2022.09.012</ArticleId><ArticleId IdType=\"pii\">S0091-6749(22)01215-5</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">36115955</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>20</Day></DateRevised><Article PubModel=\"Electronic\"><Journal><ISSN IssnType=\"Electronic\">2662-7671</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>22</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>17</Day></PubDate></JournalIssue><Title>BMC complementary medicine and therapies</Title><ISOAbbreviation>BMC Complement Med Ther</ISOAbbreviation></Journal><ArticleTitle>Edible algae (Ecklonia cava) bioprocessed with mycelia of shiitake (Lentinula edodes) mushrooms in liquid culture and its isolated fractions protect mice against allergic asthma.</ArticleTitle><Pagination><StartPage>242</StartPage><MedlinePgn>242</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">242</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12906-022-03705-y</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Ecklonia cava is an edible marine brown alga harvested from the ocean that is widely consumed in Asian countries as a health-promoting medicinal food The objective of the present study is to evaluate the anti-asthma mechanism of a new functional food produced by bioprocessing edible algae Ecklonia cava and shiitake Lentinula edodes mushroom mycelia and isolated fractions.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We used as series of methods, including high performance liquid chromatography, gas chromatography, cell assays, and an in vivo mouse assay to evaluate the asthma-inhibitory effect of Ecklonia cava bioprocessed (fermented) with Lentinula edodes shiitake mushroom mycelium and its isolated fractions in mast cells and in orally fed mice.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">The treatments inhibited the degranulation of RBL-2H3 cells and immunoglobulin E (IgE) production, suggesting anti-asthma effects in vitro. The in vitro anti-asthma effects in cells were confirmed in mice following the induction of asthma by alumina and chicken egg ovalbumin (OVA). Oral administration of the bioprocessed Ecklonia cava and purified fractions suppressed the induction of asthma and was accompanied by the inhibition of inflammation- and immune-related substances, including eotaxin; thymic stromal lymphopoietin (TSLP); OVA-specific IgE; leukotriene C<sub>4</sub> (LTC4); prostaglandin D2 (PGD<sub>2</sub>); and vascular cell adhesion molecule-1 (VCAM-1) in bronchoalveolar lavage fluid (BALF) and other fluids and organs. Th2 cytokines were reduced and Th1 cytokines were restored in serum, suggesting the asthma-induced inhibitory effect is regulated by the balance of the Th1/Th2 immune response. Serum levels of IL-10, a regulatory T cell (Treg) cytokine, were increased, further favoring reduced inflammation. Histology of lung tissues revealed that the treatment also reversed the thickening of the airway wall and the contraction and infiltration of bronchial and blood vessels and perialveolar inflammatory cells. The bioprocessed Ecklonia cava/mushroom mycelia new functional food showed the highest inhibition as compared with commercial algae and the fractions isolated from the bioprocessed product.</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">The in vitro cell and in vivo mouse assays demonstrate the potential value of the new bioprocessed formulation as an anti-inflammatory and anti-allergic combination of natural compounds against allergic asthma and might also ameliorate allergic manifestations of foods, drugs, and viral infections.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Kyung Hee</ForeName><Initials>KH</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jang</LastName><ForeName>Yeo Jin</ForeName><Initials>YJ</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Present address: Herbal Medicine Research Division, National Institute of Food &amp; Drug Safety Evaluation, Cheongju, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Hwang</LastName><ForeName>Woon Sang</ForeName><Initials>WS</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kwon</LastName><ForeName>Ki Sun</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lee</LastName><ForeName>Wha Young</ForeName><Initials>WY</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Jeanman</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kim</LastName><ForeName>Sung Phil</ForeName><Initials>SP</Initials><AffiliationInfo><Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea. spkim@strbiotech.co.kr.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Friedman</LastName><ForeName>Mendel</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>U.S. Department of Agriculture, Western Regional Research Center, Agricultural Research Services, Albany, CA, USA. mendel.friedman@usda.gov.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>09</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Complement Med Ther</MedlineTA><NlmUniqueID>101761232</NlmUniqueID><ISSNLinking>2662-7671</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018926\">Anti-Allergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018927\">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D019010\">Vascular Cell Adhesion Molecule-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>130068-27-8</RegistryNumber><NameOfSubstance UI=\"D016753\">Interleukin-10</NameOfSubstance></Chemical><Chemical><RegistryNumber>2CU6TT9V48</RegistryNumber><NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI=\"D007073\">Immunoglobulin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>9006-59-1</RegistryNumber><NameOfSubstance UI=\"D010047\">Ovalbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>LMI26O6933</RegistryNumber><NameOfSubstance UI=\"D000537\">Aluminum Oxide</NameOfSubstance></Chemical><Chemical><RegistryNumber>RXY07S6CZ2</RegistryNumber><NameOfSubstance UI=\"D015230\">Prostaglandin D2</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000363\" MajorTopicYN=\"Y\">Agaricales</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000537\" MajorTopicYN=\"N\">Aluminum Oxide</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018926\" MajorTopicYN=\"Y\">Anti-Allergic Agents</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018927\" MajorTopicYN=\"Y\">Anti-Asthmatic Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000893\" MajorTopicYN=\"N\">Anti-Inflammatory Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007073\" MajorTopicYN=\"N\">Immunoglobulin E</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016753\" MajorTopicYN=\"N\">Interleukin-10</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D025282\" MajorTopicYN=\"N\">Mycelium</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010047\" MajorTopicYN=\"N\">Ovalbumin</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D000459\" MajorTopicYN=\"Y\">Phaeophyta</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015230\" MajorTopicYN=\"N\">Prostaglandin D2</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D020942\" MajorTopicYN=\"Y\">Shiitake Mushrooms</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D019010\" MajorTopicYN=\"N\">Vascular Cell Adhesion Molecule-1</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Anti-asthma effect</Keyword><Keyword MajorTopicYN=\"N\">Bioassays</Keyword><Keyword MajorTopicYN=\"N\">Bioprocessed food, mast cells</Keyword><Keyword MajorTopicYN=\"N\">Bronchoalveolar lavage fluid</Keyword><Keyword MajorTopicYN=\"N\">Dietary interventions</Keyword><Keyword MajorTopicYN=\"N\">Ecklonia cava</Keyword><Keyword MajorTopicYN=\"N\">Edible algae</Keyword><Keyword MajorTopicYN=\"N\">Gas chromatography</Keyword><Keyword MajorTopicYN=\"N\">Histology</Keyword><Keyword MajorTopicYN=\"N\">Immunoglobulins, cytokines</Keyword><Keyword MajorTopicYN=\"N\">Lungs</Keyword><Keyword MajorTopicYN=\"N\">Mice</Keyword><Keyword MajorTopicYN=\"N\">Shiitake mushrooms</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>1</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>23</Hour><Minute>25</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>9</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">36115955</ArticleId><ArticleId IdType=\"pmc\">PMC9482293</ArticleId><ArticleId IdType=\"doi\">10.1186/s12906-022-03705-y</ArticleId><ArticleId IdType=\"pii\">10.1186/s12906-022-03705-y</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Beers MH. The Merck Manual of Diagnosis and Therapy. 18. Whitehouse Station: Merck Research Laboratories; 2006.</Citation></Reference><Reference><Citation>De La Cruz N, Hines JH, Shaw C, Appiah D. Geographic disparity in asthma hospitalizations: the role of race/ethnicity, socioeconomic status, and other factors. Cureus. 2021;13(11):e20015.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8631481</ArticleId><ArticleId IdType=\"pubmed\">34873552</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeebhay MF, Baatjies R. Occupational inhalant allergy in food handling occupations. Curr Opin Allergy Clin Immunol. 2021;22(2):64&#x2013;72. doi: 10.1097/ACI.0000000000000804.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/ACI.0000000000000804</ArticleId><ArticleId IdType=\"pubmed\">34923552</ArticleId></ArticleIdList></Reference><Reference><Citation>Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma surveillance - United States, 2006-2018. MMWR Surveill Summ. 2021;70(5):1&#x2013;32. doi: 10.15585/mmwr.ss7005a1.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.15585/mmwr.ss7005a1</ArticleId><ArticleId IdType=\"pmc\">PMC8480992</ArticleId><ArticleId IdType=\"pubmed\">34529643</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma V, Cowan DC. Obesity, inflammation, and severe asthma: an update. Curr Allergy Asthma Rep. 2021;21(12):46. doi: 10.1007/s11882-021-01024-9.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s11882-021-01024-9</ArticleId><ArticleId IdType=\"pmc\">PMC8684548</ArticleId><ArticleId IdType=\"pubmed\">34921631</ArticleId></ArticleIdList></Reference><Reference><Citation>Southerland VA, Anenberg SC, Harris M, Apte J, Hystad P, van Donkelaar A, Martin RV, Beyers M, Roy A. Assessing the distribution of air pollution health risks within cities: a neighborhood-scale analysis leveraging high-resolution data sets in the bay area, California. Environ Health Perspect. 2021;129(3):37006. doi: 10.1289/EHP7679.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1289/EHP7679</ArticleId><ArticleId IdType=\"pmc\">PMC8011332</ArticleId><ArticleId IdType=\"pubmed\">33787320</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Hwang J, Yadav D, An E-K, Kwak M, Lee PC-W, Jin J-O. Enhancement of immune checkpoint inhibitor-mediated anti-cancer immunity by intranasal treatment of Ecklonia cava fucoidan against metastatic lung cancer. Int J Mol Sci. 2021;22(17):9125. doi: 10.3390/ijms22179125.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22179125</ArticleId><ArticleId IdType=\"pmc\">PMC8431244</ArticleId><ArticleId IdType=\"pubmed\">34502035</ArticleId></ArticleIdList></Reference><Reference><Citation>Bocanegra A, Macho-Gonz&#xe1;lez A, Garcimart&#xed;n A, Bened&#xed; J, S&#xe1;nchez-Muniz FJ. Whole alga, algal extracts, and compounds as ingredients of functional foods: composition and action mechanism relationships in the prevention and treatment of type-2 diabetes mellitus. Int J Mol Sci. 2021;22(8):3816. doi: 10.3390/ijms22083816.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/ijms22083816</ArticleId><ArticleId IdType=\"pmc\">PMC8067684</ArticleId><ArticleId IdType=\"pubmed\">33917044</ArticleId></ArticleIdList></Reference><Reference><Citation>Jung J-I, Kim S, Baek S-M, Choi S-I, Kim G-H, Imm J-Y. Ecklonia cava extract exerts anti-inflammatory effect in human gingival fibroblasts and chronic periodontitis animal model by suppression of pro-inflammatory cytokines and chemokines. Foods. 2021;10(7):1656. doi: 10.3390/foods10071656.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/foods10071656</ArticleId><ArticleId IdType=\"pmc\">PMC8304037</ArticleId><ArticleId IdType=\"pubmed\">34359526</ArticleId></ArticleIdList></Reference><Reference><Citation>Shin HC, Kim SH, Park Y, Lee BH, Hwang HJ. Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial. Phytother Res. 2012;26(3):363&#x2013;368. doi: 10.1002/ptr.3559.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/ptr.3559</ArticleId><ArticleId IdType=\"pubmed\">21717516</ArticleId></ArticleIdList></Reference><Reference><Citation>Yun JW, Kim SH, Kim YS, You JR, Cho EY, Yoon JH, Kwon E, Yun IJ, Oh JH, Jang JJ, et al. Enzymatic extract from Ecklonia cava: acute and subchronic oral toxicity and genotoxicity studies. Regul Toxicol Pharmacol. 2018;92:46&#x2013;54. doi: 10.1016/j.yrtph.2017.10.034.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.yrtph.2017.10.034</ArticleId><ArticleId IdType=\"pubmed\">29108849</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J, Jung Y, Lee E, Jang S, Ryu DH, Kwon O, Hwang GS. Urinary metabolomic profiling analysis and evaluation of the effect of Ecklonia cava extract intake. Nutrients. 2020;12(5):1407. doi: 10.3390/nu12051407.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu12051407</ArticleId><ArticleId IdType=\"pmc\">PMC7285171</ArticleId><ArticleId IdType=\"pubmed\">32422870</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Lee SJ, Nam SH, Friedman M. Elm tree (Ulmus parvifolia) bark bioprocessed with mycelia of shiitake (Lentinus edodes) mushrooms in liquid culture: composition and mechanism of protection against allergic asthma in mice. J Agric Food Chem. 2016;64(4):773&#x2013;784. doi: 10.1021/acs.jafc.5b04972.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/acs.jafc.5b04972</ArticleId><ArticleId IdType=\"pubmed\">26807923</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against a Salmonella lipopolysaccharide-induced endotoxemia. J Agric Food Chem. 2013;61(46):10987&#x2013;10994. doi: 10.1021/jf403173k.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf403173k</ArticleId><ArticleId IdType=\"pubmed\">24200110</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Park SO. Fermentation of black rice with basidiomycetes mycelia and immune stimulating agent through bioconversion process. Patent Number 10&#x2013;2013-0077802, Republic of Korea, July 9 2013.</Citation></Reference><Reference><Citation>Chen Y, Xie M-Y, Nie S-P, Li C, Wang Y-X. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum. Food Chem. 2008;107(1):231&#x2013;241. doi: 10.1016/j.foodchem.2007.08.021.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.foodchem.2007.08.021</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J-H, Ko J-Y, Oh J-Y, Kim C-Y, Lee H-J, Kim J, Jeon Y-J. Preparative isolation and purification of phlorotannins from Ecklonia cava using centrifugal partition chromatography by one-step. Food Chem. 2014;158:433&#x2013;437. doi: 10.1016/j.foodchem.2014.02.112.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.foodchem.2014.02.112</ArticleId><ArticleId IdType=\"pubmed\">24731366</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y, Xie M-Y, Wang Y-X, Nie S-P, Li C. Analysis of the monosaccharide composition of purified polysaccharides in Ganoderma atrum by capillary gas chromatography. Phytochem Anal. 2009;20(6):503&#x2013;510. doi: 10.1002/pca.1153.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1002/pca.1153</ArticleId><ArticleId IdType=\"pubmed\">19743070</ArticleId></ArticleIdList></Reference><Reference><Citation>Goo HR, Choi JS, Na DH. Quantitative determination of major phlorotannins in Ecklonia stolonifera. Arch Pharm Res. 2010;33(4):539&#x2013;544. doi: 10.1007/s12272-010-0407-y.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1007/s12272-010-0407-y</ArticleId><ArticleId IdType=\"pubmed\">20422362</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeong HJ, Hong SH, Lee DJ, Park JH, Kim KS, Kim HM. Role of ca(2+) on TNF-&#x3b1; and IL-6 secretion from RBL-2H3 mast cells. Cell Signal. 2002;14(7):633&#x2013;639. doi: 10.1016/S0898-6568(02)00005-0.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/S0898-6568(02)00005-0</ArticleId><ArticleId IdType=\"pubmed\">11955956</ArticleId></ArticleIdList></Reference><Reference><Citation>Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53(10):849&#x2013;856. doi: 10.1136/thx.53.10.849.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/thx.53.10.849</ArticleId><ArticleId IdType=\"pmc\">PMC1745083</ArticleId><ArticleId IdType=\"pubmed\">10193371</ArticleId></ArticleIdList></Reference><Reference><Citation>Coomes SM, Kannan Y, Pelly VS, Entwistle LJ, Guidi R, Perez-Lloret J, Nikolov N, M&#xfc;ller W, Wilson MS. CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation. Mucosal Immunol. 2017;10(1):150&#x2013;161. doi: 10.1038/mi.2016.47.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1038/mi.2016.47</ArticleId><ArticleId IdType=\"pubmed\">27166557</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through up-regulation of the Th1 immune reaction. J Agric Food Chem. 2014;62(11):2384&#x2013;2391. doi: 10.1021/jf405223q.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf405223q</ArticleId><ArticleId IdType=\"pubmed\">24593132</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Lee SJ, Nam SH, Friedman M. Turmeric bioprocessed with mycelia from the shiitake culinary-medicinal mushroom Lentinus edodes (Agaricomycetes) protects mice against salmonellosis. Int J Med Mushrooms. 2017;19(4):363&#x2013;376. doi: 10.1615/IntJMedMushrooms.v19.i4.70.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1615/IntJMedMushrooms.v19.i4.70</ArticleId><ArticleId IdType=\"pubmed\">28605325</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Lee SJ, Nam SH, Friedman M. The composition of a bioprocessed shiitake (Lentinus edodes) mushroom mycelia and rice bran formulation and its antimicrobial effects against Salmonella enterica subsp. enterica serovar Typhimurium strain SL1344 in macrophage cells and in mice. BMC Complement Altern Med. 2018;18(1):322. doi: 10.1186/s12906-018-2365-8.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12906-018-2365-8</ArticleId><ArticleId IdType=\"pmc\">PMC6282263</ArticleId><ArticleId IdType=\"pubmed\">30518352</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Lee JR, Kwon KS, Jang YJ, Kim J, Yu KH, Lee SY, Friedman M. A bioprocessed black rice bran glutathione-enriched yeast extract protects rats and mice against alcohol-induced hangovers. Food Nutr Sci. 2021;12(03):223&#x2013;238.</Citation></Reference><Reference><Citation>Choi SP, Kang MY, Koh HJ, Nam SH, Friedman M. Antiallergic activities of pigmented rice bran extracts in cell assays. J Food Sci. 2007;72(9):S719&#x2013;S726. doi: 10.1111/j.1750-3841.2007.00562.x.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1750-3841.2007.00562.x</ArticleId><ArticleId IdType=\"pubmed\">18034759</ArticleId></ArticleIdList></Reference><Reference><Citation>Choi SP, Kim SP, Kang MY, Nam SH, Friedman M. Protective effects of black rice bran against chemically-induced inflammation of mouse skin. J Agric Food Chem. 2010;58(18):10007&#x2013;10015. doi: 10.1021/jf102224b.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf102224b</ArticleId><ArticleId IdType=\"pubmed\">20731354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SP, Yang JY, Kang MY, Park JC, Nam SH, Friedman M. Composition of liquid rice hull smoke and anti-inflammatory effects in mice. J Agric Food Chem. 2011;59(9):4570&#x2013;4581. doi: 10.1021/jf2003392.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf2003392</ArticleId><ArticleId IdType=\"pubmed\">21438497</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhawamai S, Lin SH, Hou YY, Chen YH. Thermal cooking changes the profile of phenolic compounds, but does not attenuate the anti-inflammatory activities of black rice. Food Nutr Res. 2016;60:32941. doi: 10.3402/fnr.v60.32941.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3402/fnr.v60.32941</ArticleId><ArticleId IdType=\"pmc\">PMC5031796</ArticleId><ArticleId IdType=\"pubmed\">27652685</ArticleId></ArticleIdList></Reference><Reference><Citation>Bovard D, van der Toorn M, Schlage WK, Constant S, Renggli K, Peitsch MC, Hoeng J. Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia. Biochem Biophys Rep. 2022;29:101187.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8673819</ArticleId><ArticleId IdType=\"pubmed\">34931176</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, An S. Plastic bronchitis associated with influenza a virus in children with asthma. J Int Med Res. 2021;49(12):3000605211065370.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8721730</ArticleId><ArticleId IdType=\"pubmed\">34939439</ArticleId></ArticleIdList></Reference><Reference><Citation>Torun &#x15e;, Kesim &#xc7;, S&#xfc;ner A, Botan Y&#x131;ld&#x131;r&#x131;m B, &#xd6;zen &#xd6;, Ak&#xe7;ay &#x15e;. Influenza viruses and SARS-CoV-2 in adult: \\'Similarities and differences\\'. Tuberk Toraks. 2021;69(4):458&#x2013;468. doi: 10.5578/tt.20219603.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.5578/tt.20219603</ArticleId><ArticleId IdType=\"pubmed\">34957739</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiocchi A, Bognanni A, Brozek J, Ebisawa M, Schunemann H, group WDg. World allergy organization (WAO) diagnosis and rationale for action against Cow\\'s Milk allergy (DRACMA) guidelines update - I - plan and definitions. World Allergy Organ J. 2022;15(1):100609. doi: 10.1016/j.waojou.2021.100609.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.waojou.2021.100609</ArticleId><ArticleId IdType=\"pmc\">PMC8818560</ArticleId><ArticleId IdType=\"pubmed\">35145603</ArticleId></ArticleIdList></Reference><Reference><Citation>Alghamdi R, Alshaier R, Alotaibi A, Almutairi A, Alotaibi G, Faqeeh A, Almalki A, AbdulMajed H. Immunotherapy effectiveness in treating peanut hypersensitivity: a systemic review. Cureus. 2022;14(2):e21832.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8896406</ArticleId><ArticleId IdType=\"pubmed\">35291522</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, He Z, Raghavan V. Soybean allergy: characteristics, mechanisms, detection and its reduction through novel food processing techniques. Crit Rev Food Sci Nutr. 2022. 10.1080/10408398.2022.2029345:1-14.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35075969</ArticleId></ArticleIdList></Reference><Reference><Citation>Brandon DL, Friedman M. Immunoassays of soy proteins. J Agric Food Chem. 2002;50(22):6635&#x2013;6642. doi: 10.1021/jf020186g.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1021/jf020186g</ArticleId><ArticleId IdType=\"pubmed\">12381163</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang P, Gao J, Che H, Xue W, Yang D. Molecular basis of IgE-mediated shrimp allergy and heat desensitization. Nutrients. 2021;13(10):3397. doi: 10.3390/nu13103397.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3390/nu13103397</ArticleId><ArticleId IdType=\"pmc\">PMC8540294</ArticleId><ArticleId IdType=\"pubmed\">34684397</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeboah-Korang A, Memon A, Patel N, Portocarrero-Castillo A, Osman A, Kleesattel D, et al. Impact of prior drug allergies on the risk, clinical features, and outcomes of idiosyncratic drug-induced liver injury in adults. Dig Dis Sci. 2022. 10.1007/s10620-022-07403-0.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35122190</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35917595</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1532-2823</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>184</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Prostaglandins, leukotrienes, and essential fatty acids</Title><ISOAbbreviation>Prostaglandins Leukot Essent Fatty Acids</ISOAbbreviation></Journal><ArticleTitle>Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.</ArticleTitle><Pagination><StartPage>102474</StartPage><MedlinePgn>102474</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.plefa.2022.102474</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0952-3278(22)00086-2</ELocationID><Abstract><AbstractText>Severe nasal polyposis and mucosal inflammation, in patients with chronic rhinosinusitis (CRS) may include a dysregulated eicosanoid profile, but a clinical role for eicosanoids in CRS with nasal polyps (NP; CRSwNP) remains to be elucidated. This study focused on assessing levels and clinical implications of inflammatory mediators in nasal secretions and urine from patients with different NP severity or Aspirin Exacerbated Respiratory Disease (AERD). Levels of leukotrienes E<sub>4</sub> and B<sub>4</sub>, prostaglandins D<sub>2</sub> and E<sub>2</sub> as well as 15(S)-hydroxyeicosatetraenoic acid were measured with enzyme immunoassays and cytokines with magnetic bead immunoassays. Patients with CRSwNP were subdivided based on NP score; CRSwNP-low (NP score &#x2264; 4, n&#xa0;=&#xa0;11) or CRSwNP-high (NP score &#x2265; 5, n&#xa0;=&#xa0;32) and compared to CRS without polyps (CRSsNP, n&#xa0;=&#xa0;12), CRSwNP-AERD (n&#xa0;=&#xa0;11) and individuals without CRS (n&#xa0;=&#xa0;25). Smell test score, fractional exhaled nitric oxide (FeNO), blood eosinophils and Sinonasal outcome test-22 were assessed as clinical markers. Leukotriene E<sub>4</sub>, prostaglandin D<sub>2</sub> and 15(S)-hydroxyeicosatetraenoic acid in nasal secretions correlated with NP score. Nasal leukotriene E<sub>4</sub> also correlated with FeNO and smell test score, with highest levels found in CRSwNP-AERD. Levels of prostaglandin D<sub>2</sub> in nasal secretion as well as urinary levels of the prostaglandin D<sub>2</sub> metabolite 11&#x3b2;-prostaglandin F<sub>2&#x3b1;</sub> differed between CRSNP-high and CRSwNP-low. Urinary 11&#x3b2;-prostaglandin F<sub>2&#x3b1;</sub> was associated with asthma comorbidity whereas a similar association with prostaglandin D<sub>2</sub> in nasal secretions was not observed. In conclusion, subdividing patients based on NP severity in combination with analysis of eicosanoids in non-invasively collected nasal secretions, may have clinical implications when assessing CRS disease severity.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Nordstr&#xf6;m</LastName><ForeName>Axel</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden. Electronic address: axel.nordstrom@shh.se.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jangard</LastName><ForeName>Mattias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Svedberg</LastName><ForeName>Marie</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Ryott</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Kumlin</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>07</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>Scotland</Country><MedlineTA>Prostaglandins Leukot Essent Fatty Acids</MedlineTA><NlmUniqueID>8802730</NlmUniqueID><ISSNLinking>0952-3278</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015777\">Eicosanoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011453\">Prostaglandins</NameOfSubstance></Chemical><Chemical><RegistryNumber>75715-89-8</RegistryNumber><NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName><QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015777\" MajorTopicYN=\"N\">Eicosanoids</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009298\" MajorTopicYN=\"Y\">Nasal Polyps</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D011453\" MajorTopicYN=\"N\">Prostaglandins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012220\" MajorTopicYN=\"Y\">Rhinitis</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012852\" MajorTopicYN=\"Y\">Sinusitis</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">AERD</Keyword><Keyword MajorTopicYN=\"N\">CRS</Keyword><Keyword MajorTopicYN=\"N\">Leukotriene</Keyword><Keyword MajorTopicYN=\"N\">Nasal polyp score</Keyword><Keyword MajorTopicYN=\"N\">Nasal secretions</Keyword><Keyword MajorTopicYN=\"N\">Prostaglandin</Keyword></KeywordList><CoiStatement>Declaration of Competing Interest None of the authors have any conflict of interest to declare.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>4</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>7</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>8</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>9</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>8</Month><Day>2</Day><Hour>18</Hour><Minute>13</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35917595</ArticleId><ArticleId IdType=\"doi\">10.1016/j.plefa.2022.102474</ArticleId><ArticleId IdType=\"pii\">S0952-3278(22)00086-2</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35850310</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>14</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1873-2968</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>203</Volume><PubDate><Year>2022</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Biochemical pharmacology</Title><ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation></Journal><ArticleTitle>Recent advances in function and structure of two leukotriene B<sub>4</sub> receptors: BLT1 and BLT2.</ArticleTitle><Pagination><StartPage>115178</StartPage><MedlinePgn>115178</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bcp.2022.115178</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0006-2952(22)00272-6</ELocationID><Abstract><AbstractText>Leukotriene B<sub>4</sub> (LTB<sub>4</sub>) is generated by the enzymatic oxidation of arachidonic acid, which is then released from the cell membrane and acts as a potent activator of leukocytes and other inflammatory cells. Numerous studies have demonstrated the physiological and pathophysiological significance of this lipid in various diseases. LTB<sub>4</sub> exerts its activities by binding to its specific G protein-coupled receptors (GPCRs): BLT1 and BLT2. In mouse disease models, treatment with BLT1 antagonists or BLT1 gene ablation attenuated various diseases, including bronchial asthma, arthritis, and psoriasis, whereas BLT2 deficiency exacerbated several diseases in the skin, cornea, and small intestine. Therefore, BLT1 inhibitors and BLT2 activators could be beneficial for the treatment of several inflammatory and immune disorders. As a result, attractive compounds targeting LTB<sub>4</sub> receptors have been developed by several pharmaceutical companies. This review aims to understand the potential of BLT1 and BLT2 as therapeutic targets for the treatment of various inflammatory diseases. In addition, recent topics are discussed with major focuses on the structure and post-translational modifications of BLT1 and BLT2. Collectively, current evidence on modulating LTB<sub>4</sub> receptor functions provides new strategies for the treatment of various diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Nakamura</LastName><ForeName>Motonao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Bioscience, Graduate school of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama 700-0005, Japan. Electronic address: moto-nakamura@ous.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Shimizu</LastName><ForeName>Takao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Lipid Signaling, National Center for Global Health and Medicine, Tokyo 162-8655, Japan; Institute of Microbial Chemistry, Tokyo 141-0021, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>07</Month><Day>16</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Biochem Pharmacol</MedlineTA><NlmUniqueID>0101032</NlmUniqueID><ISSNLinking>0006-2952</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018102\">Receptors, Leukotriene B4</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HGW4DR56D</RegistryNumber><NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007962\" MajorTopicYN=\"N\">Leukocytes</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011565\" MajorTopicYN=\"Y\">Psoriasis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018102\" MajorTopicYN=\"N\">Receptors, Leukotriene B4</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">BLT1</Keyword><Keyword MajorTopicYN=\"N\">BLT2</Keyword><Keyword MajorTopicYN=\"N\">Inflammation</Keyword><Keyword MajorTopicYN=\"N\">LTB(4) receptor</Keyword><Keyword MajorTopicYN=\"N\">Phosphorylation</Keyword><Keyword MajorTopicYN=\"N\">Posttranslational modification</Keyword><Keyword MajorTopicYN=\"N\">Structure</Keyword><Keyword MajorTopicYN=\"N\">leukotriene B(4)</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>5</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>7</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>7</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>8</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>7</Month><Day>19</Day><Hour>7</Hour><Minute>26</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35850310</ArticleId><ArticleId IdType=\"doi\">10.1016/j.bcp.2022.115178</ArticleId><ArticleId IdType=\"pii\">S0006-2952(22)00272-6</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35720028</PMID><DateCompleted><Year>2022</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1748-6718</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>2022</Volume><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Computational and mathematical methods in medicine</Title><ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation></Journal><ArticleTitle>Effect of Bairui Granule on Inflammatory Mediators in Induced Sputum, Leukotriene C4, and EOS in Peripheral Blood of Children with Cough Variant Asthma.</ArticleTitle><Pagination><StartPage>2657994</StartPage><MedlinePgn>2657994</MedlinePgn></Pagination><ELocationID EIdType=\"pii\" ValidYN=\"Y\">2657994</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1155/2022/2657994</ELocationID><Abstract><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To study the effect of Hanchuan Zupa granule combined with conventional western medicine in the treatment of children with bronchial asthma.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">98 cases in Fengrun District People\\'s Hospital of Tangshan City from June 2018 to February 2021 were selected. The control group was given oxygen therapy, antibiotics, and aerosol inhalation of quick acting <i>&#x3b2;</i> 2 receptor agonist, glucocorticoid, and other conventional western medicine treatment, while the observation group was treated with Bairui granule on the basis of the control group. The course of treatment of the two groups was 1 week.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">After treatment, the levels of sputum IL-4, IL-17, neu, and ECP in the two groups decreased, and the observation group was lower than the control group (<i>P</i> &lt; 0.05). The levels of EOS, CXCR4, LTB4, and SDF-1 in peripheral blood of the two groups were lower than those in the control group (<i>P</i> &lt; 0.05). The daytime cough, night cough, and TCM syndrome scores of the two groups were decreased, and the observation group was lower than the control group (<i>P</i> &lt; 0.05).</AbstractText><AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">Bairui granule combined with conventional western medicine in the treatment of children with bronchial asthma, the curative effect is worthy of affirmation, can effectively improve cough symptoms, reduce EOS, CXCR, LTB4, SDF-1 levels, inhibit airway inflammation, and has good clinical application value.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Yi Shen et al.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Shen</LastName><ForeName>Yi</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lu</LastName><ForeName>Min</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Xu</LastName><ForeName>Qiuyan</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liu</LastName><ForeName>Lu</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cheng</LastName><ForeName>Zhi</ForeName><Initials>Z</Initials><Identifier Source=\"ORCID\">0000-0003-1389-1546</Identifier><AffiliationInfo><Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Comput Math Methods Med</MedlineTA><NlmUniqueID>101277751</NlmUniqueID><ISSNLinking>1748-670X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018836\">Inflammation Mediators</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HGW4DR56D</RegistryNumber><NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance></Chemical><Chemical><RegistryNumber>2CU6TT9V48</RegistryNumber><NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003371\" MajorTopicYN=\"N\">Cough</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004804\" MajorTopicYN=\"N\">Eosinophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018836\" MajorTopicYN=\"N\">Inflammation Mediators</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D013183\" MajorTopicYN=\"Y\">Sputum</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2022</Year><Month>4</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>4</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>4</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>6</Month><Day>20</Day><Hour>3</Hour><Minute>37</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>6</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35720028</ArticleId><ArticleId IdType=\"pmc\">PMC9200585</ArticleId><ArticleId IdType=\"doi\">10.1155/2022/2657994</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Jian W., Shiwen L. The effect of montelukast sodium in adjuvant treatment of bronchial asthma in children and its effect on immune function and inflammatory cytokine levels. Chongqing Medicine . 2020;49(12):1979&#x2013;1983.</Citation></Reference><Reference><Citation>Chuanhe L., Jianguo H., Yunxiao S. A 20-year comparative study on the prevalence of childhood asthma in 16 cities in China. Chinese Journal of Practical Pediatrics . 2015;30(8):596&#x2013;600.</Citation></Reference><Reference><Citation>Yakun L., Ying Y., Xulei G. Epidemiological characteristics and influencing factors of allergic bronchial asthma in children aged 0-14 years in Daxing District, Beijing. Hebei Medicine . 2020;42(11):1739&#x2013;1742.</Citation></Reference><Reference><Citation>Xiaoyang W. Research progress in the treatment of bronchial asthma in children. International Journal Of Pediatrics . 2020;47(3):154.</Citation></Reference><Reference><Citation>Respiratory Group of Pediatrics Branch of Chinese Medical Association. Editorial Board of Chinese Journal of Pediatrics. Guidelines for the diagnosis and prevention of bronchial asthma in children (2016 edition) Chinese Journal of Pediatrics . 2016;54(3):167&#x2013;181.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">26957061</ArticleId></ArticleIdList></Reference><Reference><Citation>Pulmonary Diseases Branch of Chinese Society of Traditional Chinese Medicine. Expert consensus on diagnosis and treatment of bronchial asthma in traditional Chinese medicine (2012) Journal of Traditional Chinese Medicine . 2013;54(7):627&#x2013;629.</Citation></Reference><Reference><Citation>Hua W., Xiaoqing C. Research progress on the role of leukotrienes and their receptor antagonists in lung diseases. Chinese Journal of Women and Children\\'s Clinical Medicine (Electronic Edition) . 2017;13(2):234&#x2013;239.</Citation></Reference><Reference><Citation>Shotaro M., Shigetoshi K., Kenzo T., Miyata S. Association of comorbidities and medications with risk of asthma exacerbation in pediatric patients: a retrospective study using Japanese claims data. Scientific Reports . 2022;12:p. 5509.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8975995</ArticleId><ArticleId IdType=\"pubmed\">35365694</ArticleId></ArticleIdList></Reference><Reference><Citation>Simon C., Ewout S., Richard B., Pavord I. Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling. BMJ Open . 2022;12(4):p. e058215. doi: 10.1136/bmjopen-2021-058215.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmjopen-2021-058215</ArticleId><ArticleId IdType=\"pmc\">PMC8977743</ArticleId><ArticleId IdType=\"pubmed\">35365539</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan X., Bin C., Tian Z. The clinical characteristics of bronchial asthma and the research progress of new drugs. Food and Drugs . 2019;21(5):419&#x2013;420.</Citation></Reference><Reference><Citation>John O., Leung Donald Y. M. Asthma 2022--moving toward precision medicine. Annals of Allergy, Asthma &amp; Immunology . 2022;128(4):p. 343. doi: 10.1016/j.anai.2022.01.011.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.anai.2022.01.011</ArticleId><ArticleId IdType=\"pubmed\">35365251</ArticleId></ArticleIdList></Reference><Reference><Citation>Quint Jennifer K., Sofie A., Kocks Janwillem W. H. Short-acting &#x3b2;-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. The Journal of Allergy and Clinical Immunology: In Practice . 2022;10 doi: 10.1016/j.jaip.2022.02.047.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaip.2022.02.047</ArticleId><ArticleId IdType=\"pubmed\">35364341</ArticleId></ArticleIdList></Reference><Reference><Citation>Lixia L., Liming Z., Dan Z. Research progress of hypoxia-inducible factor 1 in the airway inflammation mechanism of bronchial asthma. International Journal of Respiration . 2020;40(8):613&#x2013;618.</Citation></Reference><Reference><Citation>Tong Y., Dajun J., Hailong Y. Research progress and clinical application of Uyghur medicine Bairui granules. New Chinese Medicine . 2019;51(4):42&#x2013;45.</Citation></Reference><Reference><Citation>Cong C., Jing H., Liu L. Discussion on the etiology, location and pathogenesis of bronchial asthma in traditional Chinese medicine. Hebei Journal of Traditional Chinese Medicine . 2019;41(5):775&#x2013;778.</Citation></Reference><Reference><Citation>Guihua X., Miaoyan S., Xiuming S. Clinical observation of Shegan Mahuang decoction in the treatment of cold asthma of bronchial asthma. Beijing Traditional Chinese Medicine . 2017;36(4):299&#x2013;302.</Citation></Reference><Reference><Citation>Zhenhua L., Qiong C., Jing W., Li X., He Y., Yu Q. Simulation-based training in asthma exacerbation for medical students: effect of prior exposure to simulation training on performance. BMC Medical Education . 2022;22(1):p. 223. doi: 10.1186/s12909-022-03300-2.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1186/s12909-022-03300-2</ArticleId><ArticleId IdType=\"pmc\">PMC8973632</ArticleId><ArticleId IdType=\"pubmed\">35361196</ArticleId></ArticleIdList></Reference><Reference><Citation>Teresa T., Jingqin Z., Emilie T., Zhang K., Gershon A. S., Licskai C. Is overreliance on short-acting &#x3b2;-agonists associated with health risks in the older asthma population? ERJ open research . 2022;8(1):00032&#x2013;02022. doi: 10.1183/23120541.00032-2022.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/23120541.00032-2022</ArticleId><ArticleId IdType=\"pmc\">PMC8958218</ArticleId><ArticleId IdType=\"pubmed\">35350274</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng W., Jinming L., Shaoshun L. Research progress of thyme grass. Chinese Pharmacist . 2006;9(1):1059&#x2013;1060.</Citation></Reference><Reference><Citation>YangYang Y., Xing Y. C., Chao G. Clinical efficacy and safety of removing blood stasis and removing phlegm in the treatment of epilepsy with cognitive impairment. Medicine (Baltimore) . 2021;100(47):p. e27929. doi: 10.1097/MD.0000000000027929.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/MD.0000000000027929</ArticleId><ArticleId IdType=\"pmc\">PMC8615331</ArticleId><ArticleId IdType=\"pubmed\">34964768</ArticleId></ArticleIdList></Reference><Reference><Citation>Qing-Yi Z., Yi S., Jing Z. Effectiveness of herb-partitioned moxibustion combined with electroacupuncture on polycystic ovary syndrome in patients with symptom pattern of kidney deficiency and phlegm-dampne. Journal of Traditional Chinese Medicine . 2021;41:985&#x2013;993.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">34939397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ge F., Yaxin W., Zhenqian Y., et al. Test-retest reliability of the coronary heart disease damp phlegm and blood stasis pattern questionnaire: results from a multicenter clinical trial. Evidence-based Complementary and Alternative Medicine . 2021;2021:6. doi: 10.1155/2021/6291301.6291301</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1155/2021/6291301</ArticleId><ArticleId IdType=\"pmc\">PMC8610670</ArticleId><ArticleId IdType=\"pubmed\">34824591</ArticleId></ArticleIdList></Reference><Reference><Citation>Long W., Jing L. Observation on the efficacy of nebulized inhalation of interferon &#x3b1;-1b combined with oral Bairui granules in the treatment of bronchiolitis. Journal of Traditional Chinese Medicine . 2017;45(3):62&#x2013;64.</Citation></Reference><Reference><Citation>Song P., Zeng L., Liang Z., Wang Q., Ou A. Clinical efficacy and safety of Chinese herbal medicine auxiliary therapy for childhood cough variant asthma: a systematic review and meta-analysis of 20 randomized controlled trials. Internal Medicine . 2016;55(16):2135&#x2013;2143. doi: 10.2169/internalmedicine.55.5546.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.2169/internalmedicine.55.5546</ArticleId><ArticleId IdType=\"pubmed\">27522988</ArticleId></ArticleIdList></Reference><Reference><Citation>Yingxia L., Qinghua H., Lijuan Z. Detection of serum IL-4, HIF-1&#x3b1;, IFN-&#x3b3;, VEGF levels in children with bronchial asthma and their clinical significance. Clinical Medicine Research and Practice . 2020;5(16):98&#x2013;100.</Citation></Reference><Reference><Citation>Zhongping W., Cuiping H., Ming L. Clinical study on the relationship between serum IL-35, IL-17 expression levels and 25-hydroxyvitamin D3 levels and asthma. China Maternal and Child Health Care . 2020;35(12):2231&#x2013;2234.</Citation></Reference><Reference><Citation>Junxiu P., Lei Z., Junli H. Expression and significance of ECP, 25-hydroxyvitamin D3, and M2 receptors in the acute exacerbation of bronchial asthma in children. Journal of Hainan Medical University . 2019;25(20):1566&#x2013;1570.</Citation></Reference><Reference><Citation>Xiaofang S., Ling J., Furong L. Changes and significance of serum LTB4, IL-17 levels and lung function in children with acute bronchial asthma. Journal of Clinical Research . 2019;36(6):1084&#x2013;1086.</Citation></Reference><Reference><Citation>Biwen M., Jie L., Jianghong W. The role of stromal cell-derived factor-1/CXC chemokine receptor 4 in airway inflammation and airway remodeling in bronchial asthmatic rats. Chinese tuberculosis He Respiratory Journal . 2015;38(1):39&#x2013;44.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">25791655</ArticleId></ArticleIdList></Reference><Reference><Citation>Wgealla M. M. A. M. A., Liang H., Chen R., et al. Amniotic fluid derived stem cells promote skin regeneration and alleviate scar formation through exosomal miRNA-146a-5p via targeting CXCR4. Journal of Cosmetic Dermatology . 2022;22</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35364624</ArticleId></ArticleIdList></Reference><Reference><Citation>Shristi P., Yinglong M. Mechanism of peptide agonist binding in CXCR4 chemokine receptor. Frontiers in molecular biosciences . 2022;9:p. 821055. doi: 10.3389/fmolb.2022.821055.</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fmolb.2022.821055</ArticleId><ArticleId IdType=\"pmc\">PMC8963245</ArticleId><ArticleId IdType=\"pubmed\">35359589</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsayed Reem Khaled M. E., Fareed K. A. A. Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression. Seminars in Cancer Biology . 2022</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">35346802</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35527666</PMID><DateCompleted><Year>2022</Year><Month>05</Month><Day>10</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>10</Day></DateRevised><Article PubModel=\"Electronic-eCollection\"><Journal><ISSN IssnType=\"Electronic\">1578-1267</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>50</Volume><Issue>3</Issue><PubDate><Year>2022</Year></PubDate></JournalIssue><Title>Allergologia et immunopathologia</Title><ISOAbbreviation>Allergol Immunopathol (Madr)</ISOAbbreviation></Journal><ArticleTitle>The comparative effect of Leukotriene receptor antagonist add on therapy and step up inhaled Corticosteroid in partially controlled asthma: An open-labeled randomized controlled trial.</ArticleTitle><Pagination><StartPage>125</StartPage><EndPage>131</EndPage><MedlinePgn>125-131</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.15586/aei.v50i3.553</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">No studies are comparing the impact of the add-on leukotriene-receptor antagonist (LTRA) with a step-up dose of inhaled corticosteroids (ICS) in partly controlled asthma patients with asthma control test (ACT) score &#x2c2; 23.</AbstractText><AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">To study the effect of LTRA add-on therapy in comparison to a step-up to medium dose of ICS in partially controlled asthma.</AbstractText><AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">An open-labeled randomized controlled trial was conducted in asthma subjects with partly controlled asthma who had been in regular receipt of low dose ICS. All subjects were assessed for asthma using ACT, daytime and nighttime symptoms, rate of relievers used, spirometry, and impulse oscillometry (IOS) at 3 and 6 months. Subjects were randomized to receive daily oral LTRA 10 mg or step-up medium dose of ICS.</AbstractText><AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Between June 2020 and January 2021, 50 participants were enrolled, all patients completing the study. After treatment, mean ACT scores were increased to more than 23 indicating well-controlled asthma in both groups, control being sustained throughout the whole 6-month study period (P &#x2c2; 0.001). Within each group, ACT scores were improved by a minimal clinical important difference (MCID) &#x2265; 3 points at 6 months, compared to baseline values. There were significant decreases in nighttime and daytime symptoms, and the numbers of rescue relievers used in 4 weeks in both groups compared to baseline (P &#x2c2; 0.001).</AbstractText><AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">LTRA add-on therapy in partially controlled asthma patients is comparable with step-up to medium dose of ICS/LABA as regards asthma control.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Ruenwilai</LastName><ForeName>Parinya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Theerakittikul</LastName><ForeName>Theerakorn</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; theerakorn.t@cmu.ac.th.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Chaiwong</LastName><ForeName>Warawut</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Phetsuk</LastName><ForeName>Nittaya</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pothirat</LastName><ForeName>Chaicharn</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Liwsrisakun</LastName><ForeName>Chalerm</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016449\">Randomized Controlled Trial</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>05</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>Singapore</Country><MedlineTA>Allergol Immunopathol (Madr)</MedlineTA><NlmUniqueID>0370073</NlmUniqueID><ISSNLinking>0301-0546</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000305\">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018927\">Anti-Asthmatic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D020024\">Leukotriene Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000280\" MajorTopicYN=\"N\">Administration, Inhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000305\" MajorTopicYN=\"N\">Adrenal Cortex Hormones</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D018927\" MajorTopicYN=\"Y\">Anti-Asthmatic Agents</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004359\" MajorTopicYN=\"N\">Drug Therapy, Combination</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D020024\" MajorTopicYN=\"N\">Leukotriene Antagonists</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">asthma control</Keyword><Keyword MajorTopicYN=\"N\">inhaled corticosteroids</Keyword><Keyword MajorTopicYN=\"N\">leukotriene-receptor antagonists</Keyword><Keyword MajorTopicYN=\"N\">lung function</Keyword></KeywordList><CoiStatement>The authors declare that there is no conflict of interest in this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>12</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>2</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>5</Month><Day>9</Day><Hour>3</Hour><Minute>16</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>5</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>5</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35527666</ArticleId><ArticleId IdType=\"doi\">10.15586/aei.v50i3.553</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>1. Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Pothirat C, et al. Survey of asthma control in Thailand. Respirology. 2004;9(3):373&#x2013;378. 10.1111/j.1440-1843.2004.00584.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1440-1843.2004.00584.x</ArticleId></ArticleIdList></Reference><Reference><Citation>2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. [Internet]. [Accessed 2018 Apr 10]. Available from: http://www.ginasthma.org</Citation><ArticleIdList><ArticleId IdType=\"doi\"/></ArticleIdList></Reference><Reference><Citation>3. Teeratakulpisarn J, Pairojkul S, Heng S. Survey of prevalence of asthma, Allergic rhinitis and eczema in schoolchildren from KhonKaen. An ISAAC (Study, International Study of Asthma and Allergic in Childhood). Asian Pac J. Allergy Immunol. 2000;18:4:187&#x2013;194.</Citation><ArticleIdList><ArticleId IdType=\"doi\"/></ArticleIdList></Reference><Reference><Citation>4. Murphy RC, Gij&#xf3;n MA. Biosynthesis and metabolism of leukotrienes. Biochem J. 2007.1;405(3):379&#x2013;395. 10.1042/BJ20070289</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1042/BJ20070289</ArticleId></ArticleIdList></Reference><Reference><Citation>5. L&#xf6;fdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319(7202):87&#x2013;90. 10.1136/bmj.319.7202.87</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1136/bmj.319.7202.87</ArticleId></ArticleIdList></Reference><Reference><Citation>6. Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019;15;199(12):1471&#x2013;1477. 10.1164/rccm.201810-1868CI</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1164/rccm.201810-1868CI</ArticleId></ArticleIdList></Reference><Reference><Citation>7. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Respir J. 2003;21(4):633&#x2013;636. 10.1183/09031936.03.00306302</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/09031936.03.00306302</ArticleId></ArticleIdList></Reference><Reference><Citation>8. Rogala B, Bo&#x17c;ek A, Gluck J. Is there a relationship between asthma and diabetes? J Asthma. 2020;57(12):1332&#x2013;1338. 10.1080/02770903.2019.1652642</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1080/02770903.2019.1652642</ArticleId></ArticleIdList></Reference><Reference><Citation>9. Niyatiwatchanchai N, Chaiwong W, Pothirat C. The validity and reliability of the Thai version of the asthma control test. Asian Pac J Allergy Immunol. 2021 J [Online ahead of print].</Citation><ArticleIdList><ArticleId IdType=\"doi\"/></ArticleIdList></Reference><Reference><Citation>10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319&#x2013;338. 10.1183/09031936.05.00034805</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/09031936.05.00034805</ArticleId></ArticleIdList></Reference><Reference><Citation>11. King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellac&#xe0; RL, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. 10.1183/13993003.00753-2019</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/13993003.00753-2019</ArticleId></ArticleIdList></Reference><Reference><Citation>12. Johansson SA, Dahl R. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma. Allergy. 1998;43:173&#x2013;178. 10.1111/j.1398-9995.1988.tb00415.x</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/j.1398-9995.1988.tb00415.x</ArticleId></ArticleIdList></Reference><Reference><Citation>13. Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162(2 Pt 1):578&#x2013;585. 10.1164/ajrccm.162.2.9905041</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1164/ajrccm.162.2.9905041</ArticleId></ArticleIdList></Reference><Reference><Citation>14. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158(11):1213&#x2013;1220. 10.1001/archinte.158.11.1213</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1001/archinte.158.11.1213</ArticleId></ArticleIdList></Reference><Reference><Citation>15. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J. 1997;10:646&#x2013;651.</Citation><ArticleIdList><ArticleId IdType=\"doi\"/></ArticleIdList></Reference><Reference><Citation>16. Bisgaard H, Loland L, Anhoj J. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med.1999;160:1227&#x2013;1231. 10.1164/ajrccm.160.4.9903004</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1164/ajrccm.160.4.9903004</ArticleId></ArticleIdList></Reference><Reference><Citation>17. Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry. Chest. 2020;157:1435&#x2013;1441. 10.1016/j.chest.2019.12.035</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.chest.2019.12.035</ArticleId></ArticleIdList></Reference><Reference><Citation>18. Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe (Sheff). 2015;11(1):57&#x2013;65. 10.1183/20734735.020514</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1183/20734735.020514</ArticleId></ArticleIdList></Reference><Reference><Citation>19. Shi Y, Aledia AS, Galant SP, George SC. Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children. J Allergy Clin Immunol. 2013;131(3):718&#x2013;723. 10.1016/j.jaci.2012.09.022</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2012.09.022</ArticleId></ArticleIdList></Reference><Reference><Citation>20. Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012;129(3):671&#x2013;678. 10.1016/j.jaci.2011.11.002</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.jaci.2011.11.002</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35451080</PMID><DateCompleted><Year>2022</Year><Month>08</Month><Day>09</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1398-9995</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>77</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Allergy</Title><ISOAbbreviation>Allergy</ISOAbbreviation></Journal><ArticleTitle>Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.</ArticleTitle><Pagination><StartPage>2549</StartPage><EndPage>2551</EndPage><MedlinePgn>2549-2551</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/all.15319</ELocationID><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>van der Burg</LastName><ForeName>Nicole</ForeName><Initials>N</Initials><Identifier Source=\"ORCID\">0000-0002-3369-6425</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stenberg</LastName><ForeName>Henning</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences Malm&#xf6;, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bjermer</LastName><ForeName>Leif</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Diamant</LastName><ForeName>Zuzana</ForeName><Initials>Z</Initials><Identifier Source=\"ORCID\">0000-0003-0133-0100</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology Immunology &amp; Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Tufvesson</LastName><ForeName>Ellen</ForeName><Initials>E</Initials><Identifier Source=\"ORCID\">0000-0002-4941-332X</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016422\">Letter</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>04</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Denmark</Country><MedlineTA>Allergy</MedlineTA><NlmUniqueID>7804028</NlmUniqueID><ISSNLinking>0105-4538</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D011453\">Prostaglandins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI=\"D003545\">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001985\" MajorTopicYN=\"N\">Bronchial Provocation Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001992\" MajorTopicYN=\"N\">Bronchoalveolar Lavage Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003545\" MajorTopicYN=\"N\">Cysteine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006967\" MajorTopicYN=\"Y\">Hypersensitivity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D011453\" MajorTopicYN=\"N\">Prostaglandins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007507\" MajorTopicYN=\"N\">Therapeutic Irrigation</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Bronchial lavage</Keyword><Keyword MajorTopicYN=\"N\">allergen bronchoprovocation test</Keyword><Keyword MajorTopicYN=\"N\">asthma</Keyword><Keyword MajorTopicYN=\"N\">cysteinyl-leukotriene pathway</Keyword><Keyword MajorTopicYN=\"N\">prostaglandin pathway</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest in relation to this work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>4</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>4</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>8</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>22</Day><Hour>7</Hour><Minute>5</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35451080</ArticleId><ArticleId IdType=\"pmc\">PMC9546403</ArticleId><ArticleId IdType=\"doi\">10.1111/all.15319</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019;25(1):121&#x2010;127. doi:10.1097/mcp.0000000000000544</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1097/mcp.0000000000000544</ArticleId><ArticleId IdType=\"pubmed\">30422894</ArticleId></ArticleIdList></Reference><Reference><Citation>Insuela DBR, Ferrero MR, Coutinho DDS, Martins MA, Carvalho VF. Could arachidonic acid&#x2010;derived pro&#x2010;resolving mediators be a new therapeutic strategy for asthma therapy? Front Immunol. 2020;11:580598. doi:10.3389/fimmu.2020.580598</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.3389/fimmu.2020.580598</ArticleId><ArticleId IdType=\"pmc\">PMC7755608</ArticleId><ArticleId IdType=\"pubmed\">33362766</ArticleId></ArticleIdList></Reference><Reference><Citation>Tufvesson E, Nihlberg K, Westergren&#x2010;Thorsson G, Bjermer L. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids. 2011;85(2):67&#x2010;73. doi:10.1016/j.plefa.2011.04.025</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1016/j.plefa.2011.04.025</ArticleId><ArticleId IdType=\"pubmed\">21596548</ArticleId></ArticleIdList></Reference><Reference><Citation>Stenberg H, Diamant Z, Ankerst J, Bjermer L, Tufvesson E. Small airway involvement in the late allergic response in asthma. Clin Exp Allergy. 2017;47(12):1555&#x2010;1565. doi:10.1111/cea.13036</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1111/cea.13036</ArticleId><ArticleId IdType=\"pubmed\">28940836</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Vyve T, Chanez P, Lacoste JY, Bousquet J, Michel FB, Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest. 1992;102(2):356&#x2010;361. doi:10.1378/chest.102.2.356</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1378/chest.102.2.356</ArticleId><ArticleId IdType=\"pubmed\">1643913</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh A, Yamamoto M, Kam SHY, et al. Gene&#x2010;metabolite expression in blood can discriminate allergen&#x2010;induced isolated early from dual asthmatic responses. PLoS One. 2013;8(7):e67907. doi:10.1371/journal.pone.0067907</Citation><ArticleIdList><ArticleId IdType=\"doi\">10.1371/journal.pone.0067907</ArticleId><ArticleId IdType=\"pmc\">PMC3699462</ArticleId><ArticleId IdType=\"pubmed\">23844124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\"><PMID Version=\"1\">35410888</PMID><DateCompleted><Year>2022</Year><Month>12</Month><Day>06</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>27</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1708-8267</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>70</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Journal of investigative medicine : the official publication of the American Federation for Clinical Research</Title><ISOAbbreviation>J Investig Med</ISOAbbreviation></Journal><ArticleTitle>Bronchodilatory effect of higenamine as antiallergic asthma treatment.</ArticleTitle><Pagination><StartPage>1753</StartPage><EndPage>1758</EndPage><MedlinePgn>1753-1758</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1136/jim-2021-002173</ELocationID><Abstract><AbstractText>Asthma is a complex airway disease that affects more than 350&#x2009;million humans worldwide. Allergic asthma symptoms are induced by Th2 immune response with the release of cytokines and allegro-inflammatory mediators that amplify the inflammatory response, airway hyper-responsiveness (AHR) and hyperproduction of mucus. Higenamine, as a chemical compound, is a &#x3b2;<sub>2</sub> adrenoreceptor agonist and can be used as bronchodilator in allergic asthma.BALB/c mice were allocated in four groups and then allergic asthma was induced in three groups. One of the asthmatic groups was treated with albuterol and other one was treated with higenamine. At least, methacholine challenge to determine the AHR, measurement of cytokines, total immunoglobulin E (IgE), LTB4 and LTC4 levels, evaluation of gene expression of Muc5ac, Muc5b, Agr2 and Arg1, and histopathological study were done.Higenamine treatment reduced AHR, interleukin (IL)-4, IL-13 levels, mRNA expression of MUC5ac, MUC5b, Arg1 and Agr2, goblet cell hyperplasia and mucus hypersecretion. Higenamine had no significant effect on IL-5, interferon-&#x3b3; (INF-&#x3b3;), IgE, LTB4, LTC4 levels and eosinophilic inflammation in lung tissue.Higenamine treatment controls asthma acute attack and breathlessness and can be used as asthma treatment with control of AHR and decrease of airflow obstruction and mucus hypersecretion and had allegro-immune-regulatory effect. But higenamine treatment had no notable effect on the inflammation and inflammatory factors.</AbstractText><CopyrightInformation>&#xa9; American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Du</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Hospital Infection Management, The Fourth People\\'s Hospital of Chengdu, Chengdu, Sichuan Province, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Mehrabi Nasab</LastName><ForeName>Entezar</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Athari</LastName><ForeName>Seyyed Shamsadin</ForeName><Initials>SS</Initials><Identifier Source=\"ORCID\">0000-0002-6355-6378</Identifier><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran (the Islamic Republic of).</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Qian</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of General Surgery, Yancheng No.1 Peoples\\'s Hospital, Yancheng, Jiangsu Province, China xuelinwuhengn@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>04</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Investig Med</MedlineTA><NlmUniqueID>9501229</NlmUniqueID><ISSNLinking>1081-5589</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018926\">Anti-Allergic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>H82Q2D5WA7</RegistryNumber><NameOfSubstance UI=\"C108128\">frovatriptan</NameOfSubstance></Chemical><Chemical><RegistryNumber>TBV5O16GAP</RegistryNumber><NameOfSubstance UI=\"C012348\">higenamine</NameOfSubstance></Chemical><Chemical><RegistryNumber>37341-29-0</RegistryNumber><NameOfSubstance UI=\"D007073\">Immunoglobulin E</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HGW4DR56D</RegistryNumber><NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance></Chemical><Chemical><RegistryNumber>2CU6TT9V48</RegistryNumber><NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D009088\">Mucoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C526445\">Agr2 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018926\" MajorTopicYN=\"Y\">Anti-Allergic Agents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007073\" MajorTopicYN=\"N\">Immunoglobulin E</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008168\" MajorTopicYN=\"N\">Lung</DescriptorName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D009088\" MajorTopicYN=\"N\">Mucoproteins</DescriptorName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012130\" MajorTopicYN=\"Y\">Respiratory Hypersensitivity</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">asthma</Keyword><Keyword MajorTopicYN=\"N\">respiratory system</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>11</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>4</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>12</Month><Day>6</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>5</Hour><Minute>29</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35410888</ArticleId><ArticleId IdType=\"doi\">10.1136/jim-2021-002173</ArticleId><ArticleId IdType=\"pii\">jim-2021-002173</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\"><PMID Version=\"1\">35227979</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>22</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>31</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1768-3254</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>233</Volume><PubDate><Year>2022</Year><Month>Apr</Month><Day>05</Day></PubDate></JournalIssue><Title>European journal of medicinal chemistry</Title><ISOAbbreviation>Eur J Med Chem</ISOAbbreviation></Journal><ArticleTitle>Discovery of dual-target ligands binding to beta2-adrenoceptor and cysteinyl-leukotriene receptor for the potential treatment of asthma from natural products derived DNA-encoded library.</ArticleTitle><Pagination><StartPage>114212</StartPage><MedlinePgn>114212</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.ejmech.2022.114212</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0223-5234(22)00114-3</ELocationID><Abstract><AbstractText>The design, synthesis, and discovery of dual-target compounds are considered as a promising strategy to develop new drugs with improved safety and efficacy compared with single-target drugs. This necessitates development of the methodologies that enable us to rapidly and accurately achieve the dual-target leads. Applying rosmarinic acid, 18&#x3b2;-glycyrrhetinic acid, rhein, and ferulic acid as template building blocks, we introduced the self-assembling DNA encoded technique to build the library containing 1,000 compounds. These compounds were screened by receptor chromatography with immobilized beta<sub>2</sub>-adrenoceptor (&#x3b2;<sub>2</sub>-AR) and cysteinyl-leukotriene receptor (CysLT), whereby we obtained a derivative of 18&#x3b2;-glycyrrhetinic acid (XC267) that specifically binds to the two receptors. In&#xa0;vitro assessment demonstrated the desired binding affinity of 6.57&#xa0;&#xd7;&#xa0;10<sup>4</sup>&#xa0;M<sup>-1</sup> to &#x3b2;<sub>2</sub>-AR, 2.82&#xa0;&#xd7;&#xa0;10<sup>4</sup>&#xa0;M<sup>-1</sup> to CysLT, and the dissociation rate constant of 7.52 s<sup>-1</sup> to &#x3b2;<sub>2</sub>-AR, 17.2 s<sup>-1</sup> to CysLT. Pharmacological examination with ovalbumin-induced mice demonstrated that XC267 significantly reduced the levels of IL-4, IL-13, and IgE after oral administration of 10&#xa0;mg/kg. By Western blot analysis, we observed an up-regulated expression of &#x3b2;<sub>2</sub>-AR and a blocked level of CysLT with a dose-dependent manner in pulmonary bronchial. Our results suggest XC627 is a potential candidate to treat asthma by simultaneously regulating the signaling pathway of the two receptors.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier Masson SAS. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Liang</LastName><ForeName>Qi</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zuo</LastName><ForeName>Haiyue</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Tian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yin</LastName><ForeName>Jiatai</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Huang</LastName><ForeName>Xiaomin</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Jing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Qian</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yin</LastName><ForeName>Guowei</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhao</LastName><ForeName>Xinfeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>College of Life Sciences, Northwest University, Xi\\'an, 710069, China. Electronic address: zhaoxf@nwu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>02</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Eur J Med Chem</MedlineTA><NlmUniqueID>0420510</NlmUniqueID><ISSNLinking>0223-5234</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D001688\">Biological Products</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D008024\">Ligands</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D018077\">Receptors, Leukotriene</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance></Chemical><Chemical><RegistryNumber>K848JZ4886</RegistryNumber><NameOfSubstance UI=\"D003545\">Cysteine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001688\" MajorTopicYN=\"Y\">Biological Products</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D003545\" MajorTopicYN=\"N\">Cysteine</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008024\" MajorTopicYN=\"N\">Ligands</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D018077\" MajorTopicYN=\"N\">Receptors, Leukotriene</DescriptorName><QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName><QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">DNA-Encoded library</Keyword><Keyword MajorTopicYN=\"N\">Drug discovery</Keyword><Keyword MajorTopicYN=\"N\">Natural products</Keyword><Keyword MajorTopicYN=\"N\">Receptor chromatography</Keyword></KeywordList><CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2022</Year><Month>2</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>2</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>5</Hour><Minute>49</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35227979</ArticleId><ArticleId IdType=\"doi\">10.1016/j.ejmech.2022.114212</ArticleId><ArticleId IdType=\"pii\">S0223-5234(22)00114-3</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35226440</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>13</Day></DateCompleted><DateRevised><Year>2022</Year><Month>05</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1897-9483</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>132</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>28</Day></PubDate></JournalIssue><Title>Polish archives of internal medicine</Title><ISOAbbreviation>Pol Arch Intern Med</ISOAbbreviation></Journal><ArticleTitle>Aspirin&#x2011;induced asthma: a still evolving area of basic and clinical research.</ArticleTitle><ELocationID EIdType=\"pii\" ValidYN=\"Y\">16219</ELocationID><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.20452/pamw.16219</ELocationID><Abstract><AbstractText>The first modern description of respiratory syndrome of aspirin hypersensitivity was published over half of the century ago, but the pathogenesis of the disease is still elusive. Just a few years after discovery how aspirin works, Andrew Szczeklik and his co&#x2011;workers described that asthmatics with aspirin hypersensitivity cross&#x2011;react to the whole class of nonsteroidal anti&#x2011;inflammatory drugs. It took rest of his life to seek for an answer on how this disease, nowadays referred to as N &#x2011;ERD, develops and how it can be treated. In the meantime, cysteinyl leukotrienes, leukotriene modifying drugs, and novel subpopulations of lymphocytes were discovered. This review on aspirin hypersensitivity documents a progress in our understanding of mechanisms of hypersensitivity to nonsteroidal anti&#x2011;inflammatory drugs. Current concepts about origin of the disease integrate advances in the field of allergology and inflammatory mechanisms of asthma. However, pharmacological inhibition of prostaglandin biosynthesis by nonsteroidal anti&#x2011;inflammatory drugs has a pivotal role in these investigations. Presented is a central role of prostaglandin E2 , a double&#x2011;faced lipid immunoregulatory mediator whose deficiency is related to the administration of an anti&#x2011;inflammatory drug. Discussed are cysteinyl leukotrienes, the most reliable biomarkers of aspirin hypersensitivity and cells of innate immunity capable of leukotrienes production. Involvement of blood platelets and recently described mucosal basophils are areas of ongoing studies in the disease. Aspirin hypersensitivity is an acquired condition; therefore, the search for genetic predisposition using classic association studies was inconclusive. There is a new hope to explain mechanisms of aspirin hypersensitivity by studies of innate lymphoid cells, which have a central role in the regulation of respiratory mucosa function in asthma.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Sanak</LastName><ForeName>Marek</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Division of Clinical Genetics and Molecular Biology, Department of Medicine, Jagiellonian University Medical College, Krak&#xf3;w, Poland. marek.sanak@uj.edu.pl</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>02</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Poland</Country><MedlineTA>Pol Arch Intern Med</MedlineTA><NlmUniqueID>101700960</NlmUniqueID><ISSNLinking>0032-3772</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000894\">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000894\" MajorTopicYN=\"N\">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000139\" MajorTopicYN=\"N\">chemically induced</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007113\" MajorTopicYN=\"N\">Immunity, Innate</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008214\" MajorTopicYN=\"N\">Lymphocytes</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>2</Month><Day>28</Day><Hour>14</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>3</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35226440</ArticleId><ArticleId IdType=\"doi\">10.20452/pamw.16219</ArticleId><ArticleId IdType=\"pii\">16219</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35026480</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>18</Day></DateCompleted><DateRevised><Year>2022</Year><Month>04</Month><Day>18</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1878-1519</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>299</Volume><PubDate><Year>2022</Year><Month>May</Month></PubDate></JournalIssue><Title>Respiratory physiology &amp; neurobiology</Title><ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>Ganoderma modulates allergic asthma pathologic features via anti-inflammatory effects.</ArticleTitle><Pagination><StartPage>103843</StartPage><MedlinePgn>103843</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.resp.2022.103843</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1569-9048(22)00002-7</ELocationID><Abstract><AbstractText>Ganoderma, a fungal genus, is a traditional medicine with immuno-modulating effects. Asthma is an inflammatory disease of airways, and the main trigger of asthma is allergic inflammation. In this study, the effects of Ganoderma (an anti-inflammatory agent) given via oral administration (G/O) or intraperitoneal injection (G/IP) on asthma was evaluated. Forty BALB/c mice were divided into four groups, including the control, OVA-challenge, OVA-challenge + G/O, and OVA-challenge + G/IP. To determine AHR, the MCh challenge test was done. The levels of IL-1&#x3b2;, -4, -5, -6, -8, -10, -12, -13, -17, -25, -33, -38, Cys-LT, LTB4, and hydroxyproline were measured. Finally, lung histopathology was evaluated to determine eosinophilic inflammation, goblet cell hyperplasia, and mucus hyper-secretion. Treatment with G/O and G/IP could significantly reduce the levels of IL-1&#x3b2;, -5, -6, -8, -17, -25, -33, and -38; the levels of IL-4 and IL-13 had no significant changes, but the levels of IL-10 and IL-12 were enhanced. The mice treated with G/O and G/IP showed decreased levels of Cys-LT, LTB4, peribronchial and perivascular inflammation, but no significant changes were observed in AHR, hydroxyproline level, goblet cell hyperplasia, and mucus hyper-secretion. Ganoderma can be applied as an immunomodulatory and anti-inflammatory agent for managing asthma.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022. Published by Elsevier B.V.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Yanfeng</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi\\'an City, 710077, People\\'s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Miaomiao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi\\'an City, 710077, People\\'s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Rui</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi\\'an City, 710077, People\\'s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Biyu</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi\\'an City, 710077, People\\'s Republic of China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Athari</LastName><ForeName>Seyyed Shamsadin</ForeName><Initials>SS</Initials><AffiliationInfo><Affiliation>Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wang</LastName><ForeName>Jinli</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi\\'an City, 710077, People\\'s Republic of China. Electronic address: wangjinli1980@sina.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>01</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Respir Physiol Neurobiol</MedlineTA><NlmUniqueID>101140022</NlmUniqueID><ISSNLinking>1569-9048</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HGW4DR56D</RegistryNumber><NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance></Chemical><Chemical><RegistryNumber>9006-59-1</RegistryNumber><NameOfSubstance UI=\"D010047\">Ovalbumin</NameOfSubstance></Chemical><Chemical><RegistryNumber>RMB44WO89X</RegistryNumber><NameOfSubstance UI=\"D006909\">Hydroxyproline</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D000893\" MajorTopicYN=\"N\">Anti-Inflammatory Agents</DescriptorName><QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001992\" MajorTopicYN=\"N\">Bronchoalveolar Lavage Fluid</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D032902\" MajorTopicYN=\"Y\">Ganoderma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006909\" MajorTopicYN=\"N\">Hydroxyproline</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006965\" MajorTopicYN=\"N\">Hyperplasia</DescriptorName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D008168\" MajorTopicYN=\"N\">Lung</DescriptorName><QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D010047\" MajorTopicYN=\"N\">Ovalbumin</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Airway</Keyword><Keyword MajorTopicYN=\"N\">Allergy</Keyword><Keyword MajorTopicYN=\"N\">Ganoderma</Keyword><Keyword MajorTopicYN=\"N\">Inflammation</Keyword><Keyword MajorTopicYN=\"N\">Traditional medicine</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>6</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2022</Year><Month>1</Month><Day>9</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>4</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>20</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35026480</ArticleId><ArticleId IdType=\"doi\">10.1016/j.resp.2022.103843</ArticleId><ArticleId IdType=\"pii\">S1569-9048(22)00002-7</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">35026207</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>12</Day></DateCompleted><DateRevised><Year>2022</Year><Month>09</Month><Day>15</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-6825</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>150</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>The Journal of allergy and clinical immunology</Title><ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation></Journal><ArticleTitle>Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index.</ArticleTitle><Pagination><StartPage>170</StartPage><EndPage>177.e6</EndPage><MedlinePgn>170-177.e6</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2021.12.787</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)00005-7</ELocationID><Abstract><AbstractText Label=\"BACKGROUND\">Patients with aspirin-exacerbated respiratory disease can experience severe reactions during aspirin challenge that are associated with high levels of mast cell mediators. The tissue source and clinical factors contributing to systemic mediator levels are unknown.</AbstractText><AbstractText Label=\"OBJECTIVE\">We sought to determine the concordance between respiratory tract and systemic inflammatory mediator levels and identify clinical factors associated with these mediators.</AbstractText><AbstractText Label=\"METHODS\">We performed an oral aspirin challenge in 30 subjects with aspirin-exacerbated respiratory disease. Respiratory symptoms and function, nasal mucosal fluid, blood, and urine were collected at baseline, at the onset of a respiratory reaction, and over a 3-hour observation period. Changes in nasal and systemic mediator levels were compared.</AbstractText><AbstractText Label=\"RESULTS\">Neither tryptase nor leukotriene E<sub>4</sub> levels in nasal fluid correlated with serum tryptase or urinary leukotriene E<sub>4</sub> levels at baseline or during reactions. We observed no association between the baseline or aspirin-induced change in nasal versus urinary leukotriene E<sub>4</sub> and serum tryptase levels. Body mass index inversely correlated with baseline and aspirin-induced urinary leukotriene E<sub>4</sub>, prostaglandin D<sub>2</sub> metabolite, and serum tryptase levels, as well as with aspirin-induced symptoms and respiratory function, but not with nasal mediators.</AbstractText><AbstractText Label=\"CONCLUSIONS\">The levels of nasal and systemic aspirin-induced mast cell products are discordant in aspirin-exacerbated respiratory disease. Systemically detected levels are likely derived from mast cells outside of the sinonasal cavity and do not accurately reflect upper respiratory tract production. Increased body mass index decreases systemic mast cell mediator production and reaction severity, supporting a contribution of metabolic regulation in aspirin-induced systemic reactions.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Cahill</LastName><ForeName>Katherine N</ForeName><Initials>KN</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: Katherine.cahill@vumc.org.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Wu</LastName><ForeName>Pingsheng</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Milne</LastName><ForeName>Ginger L</ForeName><Initials>GL</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Vanderbilt University, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Amin</LastName><ForeName>Taneem</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Singer</LastName><ForeName>Joseph</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Murphy</LastName><ForeName>Katherine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lewis</LastName><ForeName>Erin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gapko</LastName><ForeName>Deborah</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Boyce</LastName><ForeName>Joshua A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Buchheit</LastName><ForeName>Katherine M</ForeName><Initials>KM</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Laidlaw</LastName><ForeName>Tanya M</ForeName><Initials>TM</Initials><AffiliationInfo><Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women\\'s Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN=\"Y\"><Grant><GrantID>R01 HL128241</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U01 AI155299</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>T32 AI007306</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>U19 AI095219</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI078908</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 DK020593</GrantID><Acronym>DK</Acronym><Agency>NIDDK NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 HL136209</GrantID><Acronym>HL</Acronym><Agency>NHLBI NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R37 AI052353</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI136041</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>K23 AI118804</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2022</Year><Month>01</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Allergy Clin Immunol</MedlineTA><NlmUniqueID>1275002</NlmUniqueID><ISSNLinking>0091-6749</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>75715-89-8</RegistryNumber><NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.21.59</RegistryNumber><NameOfSubstance UI=\"D053802\">Tryptases</NameOfSubstance></Chemical><Chemical><RegistryNumber>R16CO5Y76E</RegistryNumber><NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName><QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015992\" MajorTopicYN=\"N\">Body Mass Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012137\" MajorTopicYN=\"N\">Respiratory System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D012852\" MajorTopicYN=\"Y\">Sinusitis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D053802\" MajorTopicYN=\"N\">Tryptases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Aspirin-exacerbated respiratory disease</Keyword><Keyword MajorTopicYN=\"N\">aspirin-induced reactions</Keyword><Keyword MajorTopicYN=\"N\">body mass index</Keyword><Keyword MajorTopicYN=\"N\">leukotrienes</Keyword><Keyword MajorTopicYN=\"N\">mast cells</Keyword><Keyword MajorTopicYN=\"N\">prostaglandins</Keyword></KeywordList><CoiStatement><b>Conflicts of Interest:</b> KN Cahill has severed on scientific advisory boards for Teva, GlaxoSmithKline, Blueprint Medicines, Regeneron, Genentech, Sanofi-Pasteur and reports personal fees from Novartis, Third Harmonic Bio, Ribon Therapeutics, and Verantos outside the submitted work. JA Boyce has served on scientific advisory boards for Sanofi and Regeneron. K Buchheit has served on scientific advisory boards for AstraZeneca, Sanofi-Genzyme, Regeneron, and GlaxoSmithKline. TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline, Sanofi-Genzyme, and Regeneron. P Wu, G Milne, T Amin, J Singer, K Murphy, E Lewis, and D Gapko have no conflicts.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>8</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pmc-release\"><Year>2023</Year><Month>7</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>7</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2022</Year><Month>1</Month><Day>13</Day><Hour>20</Hour><Minute>15</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">35026207</ArticleId><ArticleId IdType=\"mid\">NIHMS1770703</ArticleId><ArticleId IdType=\"pmc\">PMC9271535</ArticleId><ArticleId IdType=\"doi\">10.1016/j.jaci.2021.12.787</ArticleId><ArticleId IdType=\"pii\">S0091-6749(22)00005-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572&#x2013;5.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">8564100</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245&#x2013;52.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC4289104</ArticleId><ArticleId IdType=\"pubmed\">25218285</ArticleId></ArticleIdList></Reference><Reference><Citation>Cahill KN, Murphy K, Singer J, Israel E, Boyce JA, Laidlaw TM. Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(2):799&#x2013;803 e2.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6519056</ArticleId><ArticleId IdType=\"pubmed\">30339852</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyce JA. Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function. J Allergy Clin Immunol. 2019;144(4):875&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7735393</ArticleId><ArticleId IdType=\"pubmed\">31587797</ArticleId></ArticleIdList></Reference><Reference><Citation>White A, Ludington E, Mehra P, Stevenson DD, Simon RA. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol. 2006;97(5):688&#x2013;93.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">17165280</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang GX, Palumbo ML, Singer JI, Cahill KN, Laidlaw TM. Sinus surgery improves lower respiratory reactivity during aspirin desensitization for AERD. J Allergy Clin Immunol Pract. 2019.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC7110416</ArticleId><ArticleId IdType=\"pubmed\">30877073</ArticleId></ArticleIdList></Reference><Reference><Citation>Jerschow E, Edin ML, Chi Y, Hurst B, Abuzeid WM, Akbar NA, et al. Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2019;7(5):1580&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6511299</ArticleId><ArticleId IdType=\"pubmed\">30580047</ArticleId></ArticleIdList></Reference><Reference><Citation>Giouleka P, Papatheodorou G, Lyberopoulos P, Karakatsani A, Alchanatis M, Roussos C, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest. 2011;41(1):30&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">20825465</ArticleId></ArticleIdList></Reference><Reference><Citation>Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, et al. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes. 2012;61(9):2311&#x2013;9.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3425405</ArticleId><ArticleId IdType=\"pubmed\">22688342</ArticleId></ArticleIdList></Reference><Reference><Citation>Amorim NRT, Luna-Gomes T, Gama-Almeida M, Souza-Almeida G, Canetti C, Diaz BL, et al. Leptin Elicits LTC4 Synthesis by Eosinophils Mediated by Sequential Two-Step Autocrine Activation of CCR3 and PGD2 Receptors. Front Immunol. 2018;9:2139.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6160734</ArticleId><ArticleId IdType=\"pubmed\">30298073</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol. 2004;287(3):L497&#x2013;502.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">15145787</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol. 2002;168(8):4018&#x2013;24.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">11937559</ArticleId></ArticleIdList></Reference><Reference><Citation>Baek HS, Choi JH, Oh JW, Lee HB. Leptin and urinary leukotriene E4 and 9alpha,11beta-prostaglandin F2 release after exercise challenge. Ann Allergy Asthma Immunol. 2013;111(2):112&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">23886229</ArticleId></ArticleIdList></Reference><Reference><Citation>Karampatakis N, Karampatakis T, Galli-Tsinopoulou A, Kotanidou EP, Tsergouli K, Eboriadou-Petikopoulou M, et al. Impaired glucose metabolism and bronchial hyperresponsiveness in obese prepubertal asthmatic children. Pediatr Pulmonol. 2017;52(2):160&#x2013;6.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">27362543</ArticleId></ArticleIdList></Reference><Reference><Citation>Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol. 1999;104(3 Pt 1):559&#x2013;64.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">10482828</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(1):316&#x2013;24 e7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6286686</ArticleId><ArticleId IdType=\"pubmed\">29890239</ArticleId></ArticleIdList></Reference><Reference><Citation>Staso PJ, Wu P, Laidlaw TM, Cahill KN. Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC8222107</ArticleId><ArticleId IdType=\"pubmed\">33781934</ArticleId></ArticleIdList></Reference><Reference><Citation>Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790&#x2013;8.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC3335383</ArticleId><ArticleId IdType=\"pubmed\">22262771</ArticleId></ArticleIdList></Reference><Reference><Citation>Thwaites RS, Ito K, Chingono JMS, Coates M, Jarvis HC, Tunstall T, et al. Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis. J Infect Dis. 2017;215(8):1240&#x2013;4.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5441107</ArticleId><ArticleId IdType=\"pubmed\">28368490</ArticleId></ArticleIdList></Reference><Reference><Citation>Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51(11):3299&#x2013;305.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2952570</ArticleId><ArticleId IdType=\"pubmed\">20671299</ArticleId></ArticleIdList></Reference><Reference><Citation>Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol. 1994;14(3):190&#x2013;204.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">7929694</ArticleId></ArticleIdList></Reference><Reference><Citation>Protasiuk E, Olejnik M. Determination of Salicylic Acid in Feed Using LC-MS/MS. J Vet Res. 2018;62(3):303&#x2013;7.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6295987</ArticleId><ArticleId IdType=\"pubmed\">30584609</ArticleId></ArticleIdList></Reference><Reference><Citation>Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985;10(2):164&#x2013;77.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">3888490</ArticleId></ArticleIdList></Reference><Reference><Citation>Verboven K, Wouters K, Gaens K, Hansen D, Bijnen M, Wetzels S, et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep. 2018;8(1):4677.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC5856747</ArticleId><ArticleId IdType=\"pubmed\">29549282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelechowska P, Brzezinska-Blaszczyk E, Wiktorska M, Rozalska S, Wawrocki S, Kozlowska E, et al. Adipocytokines leptin and adiponectin function as mast cell activity modulators. Immunology. 2019;158(1):3&#x2013;18.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6700464</ArticleId><ArticleId IdType=\"pubmed\">31220342</ArticleId></ArticleIdList></Reference><Reference><Citation>Divoux A, Moutel S, Poitou C, Lacasa D, Veyrie N, Aissat A, et al. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J Clin Endocrinol Metab. 2012;97(9):E1677&#x2013;85.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">22745246</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelechowska P, Agier J, Kozlowska E, Brzezinska-Blaszczyk E. Mast cells participate in chronic low-grade inflammation within adipose tissue. Obes Rev. 2018;19(5):686&#x2013;97.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">29334696</ArticleId></ArticleIdList></Reference><Reference><Citation>Richelsen B Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47(3):171&#x2013;82.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">1475271</ArticleId></ArticleIdList></Reference><Reference><Citation>Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Paivarinta U, Moilanen T, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm. 2009;2009:345838.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC2726438</ArticleId><ArticleId IdType=\"pubmed\">19688109</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair P, Radford K, Fanat A, Janssen LJ, Peters-Golden M, Cox PG. The effects of leptin on airway smooth muscle responses. Am J Respir Cell Mol Biol. 2008;39(4):475&#x2013;81.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">18421018</ArticleId></ArticleIdList></Reference><Reference><Citation>Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol. 1988;82(4):654&#x2013;60.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">2844876</ArticleId></ArticleIdList></Reference><Reference><Citation>Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019;381(25):2440&#x2013;50.</Citation><ArticleIdList><ArticleId IdType=\"pubmed\">31851800</ArticleId></ArticleIdList></Reference><Reference><Citation>Lugogo N, Green CL, Agada N, Zhang S, Meghdadpour S, Zhou R, et al. Obesity&#x2019;s effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol. 2018;141(3):1096&#x2013;104.</Citation><ArticleIdList><ArticleId IdType=\"pmc\">PMC6076889</ArticleId><ArticleId IdType=\"pubmed\">28624608</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">34954219</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>16</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Print\">1098-8823</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>158</Volume><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Prostaglandins &amp; other lipid mediators</Title><ISOAbbreviation>Prostaglandins Other Lipid Mediat</ISOAbbreviation></Journal><ArticleTitle>Role of arachidonic acid lipoxygenase pathway in Asthma.</ArticleTitle><Pagination><StartPage>106609</StartPage><MedlinePgn>106609</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.prostaglandins.2021.106609</ELocationID><ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1098-8823(21)00084-8</ELocationID><Abstract><AbstractText>The arachidonic acid (AA) metabolism pathways play a key role in immunological response and inflammation diseases, such as asthma, etc. AA in cell membranes can be metabolized by lipoxygenases (LOXs) to a screen of bioactive substances that include leukotrienes (LTs), lipoxins (LXs), and eicosatetraenoic acids (ETEs), which are considered closely related to the pathophysiology of respiratory allergic disease. Studies also verified that drugs regulating AA LOXs pathway have better rehabilitative intervention for asthma. This review aims to summarize the physiological and pathophysiological importance of AA LOXs metabolism pathways in asthma and to discuss its prospects of therapeutic strategies.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Elsevier Inc. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Luo</LastName><ForeName>Yacan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Jin</LastName><ForeName>Minli</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lou</LastName><ForeName>Lejing</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Yang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Chengye</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Li</LastName><ForeName>Xi</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>The Affiliated Kangning Hospital of Wenzhou Medical University, Wenzhou, PR China.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Zhou</LastName><ForeName>Meixi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: 351070639@qq.com.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Cai</LastName><ForeName>Chang</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: WZFY2017@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>12</Month><Day>23</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Prostaglandins Other Lipid Mediat</MedlineTA><NlmUniqueID>9808648</NlmUniqueID><ISSNLinking>1098-8823</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D044045\">Lipoxins</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.-</RegistryNumber><NameOfSubstance UI=\"D001091\">Arachidonate Lipoxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.-</RegistryNumber><NameOfSubstance UI=\"D058945\">Lipoxygenases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.13.11.34</RegistryNumber><NameOfSubstance UI=\"D001094\">Arachidonate 5-Lipoxygenase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D001094\" MajorTopicYN=\"N\">Arachidonate 5-Lipoxygenase</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001091\" MajorTopicYN=\"N\">Arachidonate Lipoxygenases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D044045\" MajorTopicYN=\"Y\">Lipoxins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D058945\" MajorTopicYN=\"N\">Lipoxygenases</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">Airway inflammation</Keyword><Keyword MajorTopicYN=\"N\">Arachidonic acid</Keyword><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">Lipoxygenase</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"received\"><Year>2021</Year><Month>5</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus=\"revised\"><Year>2021</Year><Month>11</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus=\"accepted\"><Year>2021</Year><Month>12</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus=\"pubmed\"><Year>2021</Year><Month>12</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2021</Year><Month>12</Month><Day>26</Day><Hour>20</Hour><Minute>39</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">34954219</ArticleId><ArticleId IdType=\"doi\">10.1016/j.prostaglandins.2021.106609</ArticleId><ArticleId IdType=\"pii\">S1098-8823(21)00084-8</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\"><PMID Version=\"1\">34376110</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>14</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>26</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1532-4303</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>59</Volume><Issue>8</Issue><PubDate><Year>2022</Year><Month>Aug</Month></PubDate></JournalIssue><Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title><ISOAbbreviation>J Asthma</ISOAbbreviation></Journal><ArticleTitle>Inhaled corticosteroids\\' effects on biomarkers in exhaled breath condensate and blood in patients newly diagnosed with asthma who smoke.</ArticleTitle><Pagination><StartPage>1613</StartPage><EndPage>1620</EndPage><MedlinePgn>1613-1620</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1080/02770903.2021.1962341</ELocationID><Abstract><AbstractText Label=\"OBJECTIVE\">Exposure to cigarette smoke complicates the treatment and management of asthma through a variety of inflammatory effects. This study aimed to investigate the differences between newly diagnosed cases of asthma in smokers and nonsmokers in terms of localized and systemic biomarkers following treatment with inhaled corticosteroids (ICS) or ICS in combination with a long-acting &#x3b2;2 agonist (LABA).</AbstractText><AbstractText Label=\"METHODS\">Specimens of exhaled breath condensate (EBC) from newly diagnosed patients with asthma were used to quantify inflammation in the airways, while blood samples were used to assess systemic inflammation. In both samples, the levels of IL-6, LTB4, LTD4, and 8-isoprostane were measured and these were repeated after 3&#x2009;months of treatment with ICS or ICS&#x2009;+&#x2009;LABA.</AbstractText><AbstractText Label=\"RESULTS\">Of the 20 patients, 10 (50%) were nonsmokers with asthma (NSA) and 10 (50%) smokers with asthma (SA). There was no statistically significant difference in the blood or EBC levels of IL-6, LTB4, LTD4, or 8-isoprostane between the groups prior to treatment. Only the decrease in 8-isoprostane level in the EBC samples was found to be significantly greater in the NSA group after treatment (for smokers, the change was 2.91&#x2009;&#xb1;&#x2009;23.22, while for nonsmokers it was -22.72&#x2009;&#xb1;&#x2009;33.12, <i>p</i>&#x2009;=&#x2009;0.022). Post-treatment asthma control was significantly better in the NSA group (<i>p</i>&#x2009;=&#x2009;0.033).</AbstractText><AbstractText Label=\"CONCLUSION\">Monitoring the alterations in 8-isoprostane levels in EBC in patients with asthma who smoke may be helpful in deciding on therapeutic management and switching treatments. Asthma control was better in nonsmokers than in smokers.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Duman</LastName><ForeName>Berna</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Bezmi&#xe2;lem Vak&#x131;f University School of Medicine, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Borekci</LastName><ForeName>Sermin</ForeName><Initials>S</Initials><Identifier Source=\"ORCID\">0000-0002-0089-1312</Identifier><AffiliationInfo><Affiliation>Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Akdeniz</LastName><ForeName>Nilgun</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gazioglu</LastName><ForeName>Sema Bilgic</ForeName><Initials>SB</Initials><AffiliationInfo><Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Deniz</LastName><ForeName>Gunnur</ForeName><Initials>G</Initials><Identifier Source=\"ORCID\">0000-0002-0721-6213</Identifier><AffiliationInfo><Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Gemicioglu</LastName><ForeName>Bilun</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov\\'t</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>08</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Asthma</MedlineTA><NlmUniqueID>8106454</NlmUniqueID><ISSNLinking>0277-0903</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D000305\">Adrenal Cortex Hormones</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015850\">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>1HGW4DR56D</RegistryNumber><NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance></Chemical><Chemical><RegistryNumber>73836-78-9</RegistryNumber><NameOfSubstance UI=\"D017998\">Leukotriene D4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D000305\" MajorTopicYN=\"N\">Adrenal Cortex Hormones</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D001944\" MajorTopicYN=\"N\">Breath Tests</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D045853\" MajorTopicYN=\"N\">Exhalation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName><QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015850\" MajorTopicYN=\"N\">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D017998\" MajorTopicYN=\"N\">Leukotriene D4</DescriptorName><QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012907\" MajorTopicYN=\"N\">Smoking</DescriptorName><QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">8-isoprostane</Keyword><Keyword MajorTopicYN=\"N\">Asthma</Keyword><Keyword MajorTopicYN=\"N\">IL-6</Keyword><Keyword MajorTopicYN=\"N\">LTB4</Keyword><Keyword MajorTopicYN=\"N\">LTD4</Keyword><Keyword MajorTopicYN=\"N\">biomarkers</Keyword><Keyword MajorTopicYN=\"N\">exhaled breath condensate</Keyword><Keyword MajorTopicYN=\"N\">smoking</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2021</Year><Month>8</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>7</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2021</Year><Month>8</Month><Day>11</Day><Hour>5</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">34376110</ArticleId><ArticleId IdType=\"doi\">10.1080/02770903.2021.1962341</ArticleId></ArticleIdList></PubmedData></PubmedArticle><PubmedArticle><MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\"><PMID Version=\"1\">33973823</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>07</Day></DateRevised><Article PubModel=\"Print-Electronic\"><Journal><ISSN IssnType=\"Electronic\">1097-6817</ISSN><JournalIssue CitedMedium=\"Internet\"><Volume>166</Volume><Issue>2</Issue><PubDate><Year>2022</Year><Month>Feb</Month></PubDate></JournalIssue><Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title><ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation></Journal><ArticleTitle>Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.</ArticleTitle><Pagination><StartPage>224</StartPage><EndPage>232</EndPage><MedlinePgn>224-232</MedlinePgn></Pagination><ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/01945998211011060</ELocationID><Abstract><AbstractText Label=\"OBJECTIVE\">To provide a comprehensive state-of-the-art review of the emerging role of urine leukotriene E4 (uLTE4) as a biomarker in the diagnosis of chronic rhinosinusitis (CRS), aspirin-exacerbated respiratory disease (AERD), and asthma.</AbstractText><AbstractText Label=\"DATA SOURCES\">Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus.</AbstractText><AbstractText Label=\"REVIEW METHODS\">A state-of-the-art review was performed investigating the role of uLTE4 as a diagnostic biomarker, predictor of disease severity, and potential marker of selected therapeutic efficacy.</AbstractText><AbstractText Label=\"CONCLUSIONS\">uLTE4 has been shown to be a reliable and clinically relevant biomarker for CRS, AERD, and asthma. uLTE4 is helpful in ongoing efforts to better endotype patients with CRS and to predict disease severity.</AbstractText><AbstractText Label=\"IMPLICATIONS FOR PRACTICE\">Aside from being a diagnostic biomarker, uLTE4 is also able to differentiate aspirin-tolerant patients from patients with AERD and has been associated with objective disease severity in patients with CRS with nasal polyposis. uLTE4 levels have also been shown to predict response to medical therapy, particularly leukotriene-modifying agents.</AbstractText></Abstract><AuthorList CompleteYN=\"Y\"><Author ValidYN=\"Y\"><LastName>Choby</LastName><ForeName>Garret</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Low</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Levy</LastName><ForeName>Joshua M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Emory University, Atlanta, Georgia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Stokken</LastName><ForeName>Janalee K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Pinheiro-Neto</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Bartemes</LastName><ForeName>Kathy</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Marino</LastName><ForeName>Michael</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Han</LastName><ForeName>Joseph K</ForeName><Initials>JK</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Divekar</LastName><ForeName>Rohit</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>O\\'Brien</LastName><ForeName>Erin K</ForeName><Initials>EK</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN=\"Y\"><LastName>Lal</LastName><ForeName>Devyani</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI=\"D016428\">Journal Article</PublicationType><PublicationType UI=\"D016454\">Review</PublicationType></PublicationTypeList><ArticleDate DateType=\"Electronic\"><Year>2021</Year><Month>05</Month><Day>11</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Otolaryngol Head Neck Surg</MedlineTA><NlmUniqueID>8508176</NlmUniqueID><ISSNLinking>0194-5998</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>75715-89-8</RegistryNumber><NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI=\"D001249\" MajorTopicYN=\"N\">Asthma</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D055963\" MajorTopicYN=\"N\">Asthma, Aspirin-Induced</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName><QualifierName UI=\"Q000652\" MajorTopicYN=\"Y\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName><QualifierName UI=\"Q000652\" MajorTopicYN=\"Y\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012220\" MajorTopicYN=\"N\">Rhinitis</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading><MeshHeading><DescriptorName UI=\"D012852\" MajorTopicYN=\"N\">Sinusitis</DescriptorName><QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName><QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner=\"NOTNLM\"><Keyword MajorTopicYN=\"N\">AERD</Keyword><Keyword MajorTopicYN=\"N\">aspirin-exacerbated respiratory disease</Keyword><Keyword MajorTopicYN=\"N\">biomarker</Keyword><Keyword MajorTopicYN=\"N\">chronic rhinosinusitis</Keyword><Keyword MajorTopicYN=\"N\">endotype</Keyword><Keyword MajorTopicYN=\"N\">nasal polyps</Keyword><Keyword MajorTopicYN=\"N\">phenotype</Keyword><Keyword MajorTopicYN=\"N\">uLTE4</Keyword><Keyword MajorTopicYN=\"N\">urine leukotriene E4</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus=\"pubmed\"><Year>2021</Year><Month>5</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"medline\"><Year>2022</Year><Month>3</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus=\"entrez\"><Year>2021</Year><Month>5</Month><Day>11</Day><Hour>12</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType=\"pubmed\">33973823</ArticleId><ArticleId IdType=\"doi\">10.1177/01945998211011060</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>'"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r4 = requests.get(url4)\n",
    "print(r4)\n",
    "r4.text"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "fb1f60f5",
   "metadata": {},
   "source": [
    "### Aside: Pretty printing XML\n",
    "https://www.geeksforgeeks.org/pretty-printing-xml-in-python/"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "id": "0e9514ec",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" encoding=\"utf-8\"?>\n",
      "<!DOCTYPE PubmedArticleSet PUBLIC \"-//NLM//DTD PubMedArticle, 1st January 2023//EN\" \"https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd\">\n",
      "<PubmedArticleSet>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    36184313\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     02\n",
      "    </Month>\n",
      "    <Day>\n",
      "     07\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     02\n",
      "    </Month>\n",
      "    <Day>\n",
      "     09\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1097-6825\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       151\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       2\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2023\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Feb\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      The Journal of allergy and clinical immunology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      J Allergy Clin Immunol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Updates on immune mechanisms in aspirin-exacerbated respiratory disease.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      301\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      309\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      301-309\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.jaci.2022.08.021\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0091-6749(22)01171-X\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Aspirin-exacerbated respiratory disease has fascinated and frustrated specialists in allergy/immunology, pulmonology, and otorhinolaryngology for decades. It generally develops in previously healthy young adults and is unremitting and challenging to treat. The classical triad of asthma, nasal polyposis, and pathognomonic respiratory reactions to aspirin and other cyclooxygenase-1 inhibitors is accompanied by high levels of mast cell activation, cysteinyl leukotriene production, platelet activation, and severe type 2 respiratory inflammation. The \"unbraking\" of mast cell activation and further cysteinyl leukotriene generation induced by cyclooxygenase-1 inhibition reflect an idiosyncratic dependency on cyclooxygenase-1-derived products, likely prostaglandin E\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      , to maintain a tenuous homeostasis. Although cysteinyl leukotrienes are clear disease effectors, little else was known about their cellular sources and targets, and the contributions from other mediators and type 2 respiratory inflammation effector cells to disease pathophysiology were unknown until recently. The applications of targeted biological therapies, single-cell genomics, and transgenic animal approaches have substantially advanced our understanding of aspirin-exacerbated respiratory disease pathogenesis and treatment and have also revealed disease heterogeneity. This review covers novel insights into the immunopathogenesis of aspirin-exacerbated respiratory disease from each of these lines of research, including the roles of lipid mediators, effector cell populations, and inflammatory cytokines, discusses unanswered questions regarding cause and pathogenesis, and considers potential future therapeutic options.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Laidlaw\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Tanya M\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       TM\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass. Electronic address: tlaidlaw@bwh.harvard.edu.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Boyce\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joshua A\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JA\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <GrantList CompleteYN=\"Y\">\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 AI078908\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 AI136041\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R37 AI052353\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       U19 AI095219\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "    </GrantList>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      09\n",
      "     </Month>\n",
      "     <Day>\n",
      "      30\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     J Allergy Clin Immunol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     1275002\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0091-6749\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 1.14.99.1\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D051545\">\n",
      "      Cyclooxygenase 1\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      R16CO5Y76E\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C112381\">\n",
      "      cysteinyl-leukotriene\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051545\">\n",
      "      Cyclooxygenase 1\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     AERD\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     CRSwNP\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotriene E4\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     mast cells\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     mechanisms\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     prostaglandin E2\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    <b>\n",
      "     Conflict of Interest:\n",
      "    </b>\n",
      "    TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline and Sanofi-Genzyme, Novartis, and Regeneron. JA Boyce has served on the advisory boards of Sanofi-Genzyme, Siolta Therapeutics, and Third Harmonic Bio.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      3\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      10\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pmc-release\">\n",
      "     <Year>\n",
      "      2024\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      10\n",
      "     </Month>\n",
      "     <Day>\n",
      "      3\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2023\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      10\n",
      "     </Month>\n",
      "     <Day>\n",
      "      2\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      22\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      12\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     36184313\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"mid\">\n",
      "     NIHMS1839874\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pmc\">\n",
      "     PMC9905222\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.jaci.2022.08.021\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0091-6749(22)01171-X\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Inada M, Matsumoto C, Uematsu S, Akira S, Miyaura C. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J Immunol. 2006;177(3):1879–85.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16849500\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kay LJ, Yeo WW, Peachell PT. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol. 2006;147(7):707–13.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC1751511\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16432506\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Maric J, Ravindran A, Mazzurana L, Bjorklund AK, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141(5):1761–73 e6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5929462\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29217133\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005;96(6):1203–11.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16215982\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int. 2008;57(4):429–36.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       18797183\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Roca-Ferrer J, Perez-Gonzalez M, Garcia-Garcia FJ, Pereda J, Pujols L, Alobid I, et al. Low Prostaglandin E(2) and Cyclooxygenase Expression in Nasal Mucosa Fibroblasts of Aspirin-Intolerant Asthmatics. Respirology. 2013.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       23441755\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Machado-Carvalho L, Martin M, Torres R, Gabasa M, Alobid I, Mullol J, et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1beta/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(1):99–107.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26560040\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Corrigan CJ, Napoli RL, Meng Q, Fang C, Wu H, Tochiki K, et al. Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol. 2012;129(6):1636–46.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22418066\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol. 2006;117(2):312–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16461132\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN, Raby BA, Zhou X, Guo F, Thibault D, Baccarelli A, et al. Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. Am J Respir Cell Mol Biol. 2016;54(1):34–40.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4742927\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26051534\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572–5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       8564100\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Liu T, Laidlaw TM, Katz HR, Boyce JA. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013;110(42):16987–92.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3801005\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24085850\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Weiss JW, Drazen JM, McFadden ER Jr., Weller P, Corey EJ, Lewis RA, et al. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. JAMA. 1983;249(20):2814–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       6842792\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143(5 Pt 1):1025–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       1850964\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Arm JP, O’Hickey SP, Spur BW, Lee TH. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis. 1989;140(1):148–53.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       2546469\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol. 1994;94(6 Pt 1):1046–56.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       7798537\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993;148(6 Pt 1):1447–51.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       8256883\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Fuentes DJ, Wang Y. Efficacy of Zileuton in Patients with Asthma and History of Aspirin Sensitivity: A Retrospective Analysis of Data from Two Phase 3 Studies. AAAAI: J Allergy Clin Immunol; 2017. p. AB384.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bankova LG, Lai J, Yoshimoto E, Boyce JA, Austen KF, Kanaoka Y, et al. Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99. Proc Natl Acad Sci U S A. 2016;113(22):6242–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4896673\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       27185938\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Cirka H, et al. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. J Immunol. 2018;200(3):915–27.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5780246\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29282304\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12(3):679–90.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6462243\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30664709\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bankova LG, Dwyer DF, Yoshimoto E, Ualiyeva S, McGinty JW, Raff H, et al. The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation. Sci Immunol. 2018;3(28).\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6599626\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30291131\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      von MJ, Ji M, Liang HE, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. 2016;529(7585):221–5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4830391\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26675736\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ualiyeva S, Lemire E, Aviles EC, Wong C, Boyd AA, Lai J, et al. Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation. Sci Immunol. 2021;6(66):eabj0474.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8750919\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34932383\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ualiyeva S, Hallen N, Kanaoka Y, Ledderose C, Matsumoto I, Junger WG, et al. Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2. Science Immunology. 2020;5(43):eaax7224.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7176051\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       31953256\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol. 2013;132(1):205–13.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3704056\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       23688412\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      von Moltke J, O’Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214(1):27–37.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5206504\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28011865\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      McGinty JW, Ting H-A, Billipp TE, Nadjsombati MS, Khan DM, Barrett NA, et al. Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity. Immunity. 2020;52(3):528–41.e7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7469474\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32160525\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85(6 Pt 1):477–82.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11152169\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mitson-Salazar A, Prussin C. Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease. Front Med (Lausanne). 2017;4:165.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5635264\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29057225\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Maric J, Ravindran A, Mazzurana L, Van Acker A, Rao A, Kokkinou E, et al. Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation. J Allergy Clin Immunol. 2019;143(6):2202–14 e5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30578872\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566–76.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4860132\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26691435\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245–52.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4289104\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       25218285\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001;193(2):255–61.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC2193345\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11208866\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 2014;133(4):1184–94.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3979107\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24388011\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol. 2005;175(10):6531–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16272307\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Price CPE, Guo A, Stevens WW, Cousens L, Vu TT, Suh LA, et al. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: a randomized controlled clinical trial. Clin Exp Allergy. 2022.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35524339\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Gevaert P, Bachert C, Maspero JF, Cuevas M, Steele D, Acharya S, et al. Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER). J Allergy Clin Immunol. 2022;149(5):1675–82 e3.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35094848\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN. Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor? J Allergy Clin Immunol. 2022;149(5):1587–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35304159\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101(4):834–46.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC508632\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       9466979\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Nasser SM, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med. 1996;153(1):90–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       8542168\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Prussin C, Panettieri RA, Lee S, Ferguson BJ, Adappa ND, et al. Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size. Laryngoscope. 2019;129(2):E61–E6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30284267\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mitsui C, Kajiwara K, Hayashi H, Ito J, Mita H, Ono E, et al. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26194538\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, et al. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(3):720–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5568994\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28238741\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Maclouf J, Murphy RC, Henson PM. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation of human neutrophil/platelet mixtures. Blood. 1990;76(9):1838–44.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       2224131\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3335383\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22262771\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2018.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6286686\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29890239\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Dwyer DF, Ordovas-Montanes J, Allon SJ, Buchheit KM, Vukovic M, Derakhshan T, et al. Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation. Sci Immunol. 2021;6(56).\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8362933\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33637594\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol. 2003;111(4):743–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       12704352\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, et al. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)]. Arerugi = [Allergy]. 1992;41(10):1515–20.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       1482300\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, et al. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma Immunol. 2001;87(2):146–50.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11527248\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, et al. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol. 1998;80(2):171–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       9494450\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Eastman JJ, Cavagnero KJ, Deconde AS, Kim AS, Karta MR, Broide DH, et al. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(1):101–8 e3.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5496786\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28279492\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Salimi M, Stoger L, Liu W, Go S, Pavord I, Klenerman P, et al. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol. 2017;140(4):1090–100 e11.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5624780\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28115217\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kupczyk M, Kurmanowska Z, Kuprys-Lipinska I, Bochenska-Marciniak M, Kuna P. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir Med. 2010;104(10):1404–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20452758\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Buchheit KM, Dwyer DF, Ordovas-Montanes J, Katz HR, Lewis E, Vukovic M, et al. IL-5Ralpha marks nasal polyp IgG4 and IgE-expressing cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7282948\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32199912\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 2018;560(7720):649–54.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6133715\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30135581\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Stevens WW, Staudacher AG, Hulse KE, Carter RG, Winter DR, Kato A, et al. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7606335\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32371071\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, et al. PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell. 2017;171(3):628–41 e26.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5683852\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29053969\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Nagasaki T, Schuyler AJ, Zhao J, Samovich SN, Yamada K, Deng Y, et al. 15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation. J Clin Invest. 2022;132(1).\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8718153\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34762602\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326–32.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7113089\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       31830587\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Hayashi H, Mitsui C, Nakatani E, Fukutomi Y, Kajiwara K, Watai K, et al. Omalizumab reduces cysteinyl leukotriene and 9alpha,11beta-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1585–7.e4.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26559322\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Lang DM, Aronica MA, Maierson ES, Wang XF, Vasas DC, Hazen SL. Omalizumab can inhibit respiratory reaction during aspirin desensitization. Ann Allergy Asthma Immunol. 2018;121(1):98–104.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29777744\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2018;6(3):1045–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5997393\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29501519\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, et al. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148(2):574–84.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC9096876\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34144111\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Martin H, Barrett NA, Laidlaw T. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series. J Allergy Clin Immunol Pract. 2021;9(3):1384–5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC9255360\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32956852\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Scott WC, Cahill KN, Milne GL, Li P, Sheng Q, Huang LC, et al. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1318–28 e5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8035132\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33189729\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016;315(5):469–79.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26836729\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Mullol J, Fan C, Zhang D, Amin N, Khan A, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462–5 e1.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30954643\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bavaro N, Gakpo D, Mittal A, Bensko JC, Laidlaw TM, Buchheit KM. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ralpha in a real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2910–2 e1.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8277677\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33631410\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Buchheit KM, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko JC, et al. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2022.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC9378638\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35460728\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Patel P, Bensko JC, Bhattacharyya N, Laidlaw TM, Buchheit KM. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2022;128(3):326–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8882131\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34863953\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol. 2006;117(6):1446–54.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       16751012\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mustafa SS, Vadamalai K. Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021;126(6):738–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33746062\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, et al. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway. J Immunol. 2015;195(8):3537–45.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4592820\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26342029\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal immunology. 2019.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6462243\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30664709\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021;384(19):1800–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33979488\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kelsen SG, Agache IO, Soong W, Israel E, Chupp GL, Cheung DS, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021;148(3):790–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33872652\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. New England Journal of Medicine. 2021;385(18):1656–68.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34706171\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       12532116\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, et al. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. Am J Respir Crit Care Med. 2019;200(6):704–11.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6775876\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30978291\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       12421891\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1999;160(1):291–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       10390414\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Chang JE, Ding D, Martin-Lazaro J, White A, Stevenson DD. Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2012;108(1):14–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22192959\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Hayashi H, Fukutomi Y, Mitsui C, Nakatani E, Watai K, Kamide Y, et al. Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers. J Allergy Clin Immunol Pract. 2018;6(1):116–25 e3.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28583479\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Samter M, Beers RF, Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975–83.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       5646829\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Pace S, Pergola C, Dehm F, Rossi A, Gerstmeier J, Troisi F, et al. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. J Clin Invest. 2017;127(8):3167–76.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5531400\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28737505\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laffont S, Blanquart E, Savignac M, Cenac C, Laverny G, Metzger D, et al. Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med. 2017;214(6):1581–92.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5461006\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28484078\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Pace S, Rossi A, Krauth V, Dehm F, Troisi F, Bilancia R, et al. Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation. Sci Rep. 2017;7(1):3759.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5476623\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28630405\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kolmert J, Gomez C, Balgoma D, Sjodin M, Bood J, Konradsen JR, et al. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation. Am J Respir Crit Care Med. 2020.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7781128\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32667261\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Szczeklik A Aspirin-induced asthma as a viral disease. Clin Allergy. 1988;18(1):15–20.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       3127083\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zaravinos A, Bizakis J, Spandidos DA. Prevalence of human papilloma virus and human herpes virus types 1–7 in human nasal polyposis. J Med Virol. 2009;81(9):1613–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       19626617\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy. 2010;65(11):1430–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20456313\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607–14.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11295647\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2011;128(6):1198–206 e1.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3384688\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21996343\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2008;121(6):1385–92, 92 e1–2.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC2802261\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       18410958\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jeffe JS, Seshadri S, Hamill KJ, Huang JH, Carter R, Suh L, et al. A role for anti-BP180 autoantibodies in chronic rhinosinusitis. Laryngoscope. 2013;123(9):2104–11.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3813294\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24167818\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21510141\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cheong HS, Park SM, Kim MO, Park JS, Lee JY, Byun JY, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy. 2011;66(5):637–44.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21121930\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128(9):E304–E10.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6082743\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29417576\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tognetti A, Sarolidou G, Lasselin J, Lekander M, Olsson MJ, Lundstrom JN. Acute Systemic Experimental Inflammation Does Not Reduce Human Odor Identification Performance. Chem Senses. 2021;46.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8015794\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33537776\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    36130059\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     01\n",
      "    </Month>\n",
      "    <Day>\n",
      "     24\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     02\n",
      "    </Month>\n",
      "    <Day>\n",
      "     01\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1545-4304\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       63\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2023\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Jan\n",
      "       </Month>\n",
      "       <Day>\n",
      "        20\n",
      "       </Day>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Annual review of pharmacology and toxicology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Annu Rev Pharmacol Toxicol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      407\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      428\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      407-428\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1146/annurev-pharmtox-051921-085014\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Leukotrienes are potent immune-regulating lipid mediators with patho-genic roles in inflammatory and allergic diseases, particularly asthma. These autacoids also contribute to low-grade inflammation, a hallmark of cardiovascular, neurodegenerative, metabolic, and tumor diseases. Biosynthesis of leukotrienes involves release and oxidative metabolism of arachidonic acid and proceeds via a set of cytosolic and integral membrane enzymes that are typically expressed by cells of the innate immune system. In activated cells, these enzymes traffic and assemble at the endoplasmic and perinuclear membrane, together comprising a biosynthetic complex. Here we describe recent advances in our molecular understanding of the protein components of the leukotriene-synthesizing enzyme machinery and also briefly touch upon the leukotriene receptors. Moreover, we discuss emerging opportunities for pharmacological intervention and development of new therapeutics.\n",
      "     </AbstractText>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Haeggström\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jesper Z\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JZ\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, Sweden; email: jesper.haeggstrom@ki.se.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Newcomer\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Marcia E\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       ME\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA; email: newcomer@lsu.edu.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      09\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Annu Rev Pharmacol Toxicol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     7607088\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0362-1642\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     arachidonic acid\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     endemic diseases\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     inflammation\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotriene\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     structure-based drug design\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     therapeutics\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      22\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2023\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      25\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      14\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      43\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     36130059\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1146/annurev-pharmtox-051921-085014\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    36126795\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     02\n",
      "    </Month>\n",
      "    <Day>\n",
      "     07\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2023\n",
      "    </Year>\n",
      "    <Month>\n",
      "     02\n",
      "    </Month>\n",
      "    <Day>\n",
      "     07\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1097-6825\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       151\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       2\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2023\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Feb\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      The Journal of allergy and clinical immunology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      J Allergy Clin Immunol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      310\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      313\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      310-313\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.jaci.2022.09.012\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0091-6749(22)01215-5\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Aspirin-exacerbated respiratory disease (AERD) is associated with overproduction of proinflammatory cysteinyl leukotrienes (CysLTs), defective generation of anti-inflammatory prostaglandin E\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      (PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      ), and reduced expression of the EP2 receptor for PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      . Reduced PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      synthesis results from the downregulation of inducible COX-2. Because PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      signaling via EP2 inhibits the 5-lipoxygenase/leukotriene C\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      synthase-dependent pathway, the deficient levels of both PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      and EP2 likely contribute to the excessive baseline production of cysteinyl leukotrienes in patients with AERD compared with in patients with aspirin-tolerant asthma. The COX-2 pathway is regulated by an autocrine metabolic loop involving IL-1β, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      prostaglandin E\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      synthase-1, and PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      . Previous studies reported that this metabolic loop is dysregulated in patients with AERD. When the downexpressed EP2 receptor is normalized, the entire loop returns to its normal function. Cotreatment of airway cells from healthy subjects with IL-4 and IFN-γ induces alterations in the metabolic loop similar to those seen in patients with AERD. In these patients, IL-4, which is produced in excess in airways of patients with AERD, likely contributes to the alteration of normal functioning of the autocrine metabolic loop involving IL-1β, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      prostaglandin E\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      synthase-1, and PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      . We hypothesized that by blocking IL-4 action, dupilumab normalizes EP2 expression and restores the normal functioning of the COX-2 pathway autocrine metabolic loop, thereby normalizing the synthesis of PGE\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      and restoring aspirin tolerance.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Picado\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       César\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Madrid, Spain. Electronic address: cpicado@ub.edu.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Mullol\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joaquim\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Madrid, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Roca-Ferrer\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jordi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      09\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     J Allergy Clin Immunol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     1275002\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0091-6749\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      R16CO5Y76E\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      420K487FSG\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C582203\">\n",
      "      dupilumab\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 1.14.99.1\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D051546\">\n",
      "      Cyclooxygenase 2\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      207137-56-2\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015847\">\n",
      "      Interleukin-4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C112381\">\n",
      "      cysteinyl-leukotriene\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      K7Q1JQR04M\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015232\">\n",
      "      Dinoprostone\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 5.3.99.3\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000071876\">\n",
      "      Prostaglandin-E Synthases\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D058307\">\n",
      "      Receptors, Prostaglandin E, EP2 Subtype\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017472\">\n",
      "      Receptors, Interleukin-1\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051546\">\n",
      "      Cyclooxygenase 2\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015847\">\n",
      "      Interleukin-4\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015232\">\n",
      "      Dinoprostone\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000071876\">\n",
      "      Prostaglandin-E Synthases\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000235\">\n",
      "      genetics\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D058307\">\n",
      "      Receptors, Prostaglandin E, EP2 Subtype\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017472\">\n",
      "      Receptors, Interleukin-1\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Aspirin\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     dupilumab\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotriene\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     nonsteroidal anti-inflammatory drug\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     prostaglandin E(2)\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      18\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      29\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2023\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      20\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      19\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      24\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     36126795\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.jaci.2022.09.012\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0091-6749(22)01215-5\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    36115955\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     09\n",
      "    </Month>\n",
      "    <Day>\n",
      "     20\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     09\n",
      "    </Month>\n",
      "    <Day>\n",
      "     20\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      2662-7671\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       22\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       1\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Sep\n",
      "       </Month>\n",
      "       <Day>\n",
      "        17\n",
      "       </Day>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      BMC complementary medicine and therapies\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      BMC Complement Med Ther\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Edible algae (Ecklonia cava) bioprocessed with mycelia of shiitake (Lentinula edodes) mushrooms in liquid culture and its isolated fractions protect mice against allergic asthma.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      242\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      242\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     242\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1186/s12906-022-03705-y\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">\n",
      "      Ecklonia cava is an edible marine brown alga harvested from the ocean that is widely consumed in Asian countries as a health-promoting medicinal food The objective of the present study is to evaluate the anti-asthma mechanism of a new functional food produced by bioprocessing edible algae Ecklonia cava and shiitake Lentinula edodes mushroom mycelia and isolated fractions.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">\n",
      "      We used as series of methods, including high performance liquid chromatography, gas chromatography, cell assays, and an in vivo mouse assay to evaluate the asthma-inhibitory effect of Ecklonia cava bioprocessed (fermented) with Lentinula edodes shiitake mushroom mycelium and its isolated fractions in mast cells and in orally fed mice.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">\n",
      "      The treatments inhibited the degranulation of RBL-2H3 cells and immunoglobulin E (IgE) production, suggesting anti-asthma effects in vitro. The in vitro anti-asthma effects in cells were confirmed in mice following the induction of asthma by alumina and chicken egg ovalbumin (OVA). Oral administration of the bioprocessed Ecklonia cava and purified fractions suppressed the induction of asthma and was accompanied by the inhibition of inflammation- and immune-related substances, including eotaxin; thymic stromal lymphopoietin (TSLP); OVA-specific IgE; leukotriene C\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      (LTC4); prostaglandin D2 (PGD\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      ); and vascular cell adhesion molecule-1 (VCAM-1) in bronchoalveolar lavage fluid (BALF) and other fluids and organs. Th2 cytokines were reduced and Th1 cytokines were restored in serum, suggesting the asthma-induced inhibitory effect is regulated by the balance of the Th1/Th2 immune response. Serum levels of IL-10, a regulatory T cell (Treg) cytokine, were increased, further favoring reduced inflammation. Histology of lung tissues revealed that the treatment also reversed the thickening of the airway wall and the contraction and infiltration of bronchial and blood vessels and perialveolar inflammatory cells. The bioprocessed Ecklonia cava/mushroom mycelia new functional food showed the highest inhibition as compared with commercial algae and the fractions isolated from the bioprocessed product.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">\n",
      "      The in vitro cell and in vivo mouse assays demonstrate the potential value of the new bioprocessed formulation as an anti-inflammatory and anti-allergic combination of natural compounds against allergic asthma and might also ameliorate allergic manifestations of foods, drugs, and viral infections.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      © 2022. The Author(s).\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lee\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Kyung Hee\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       KH\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Jang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Yeo Jin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       YJ\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Present address: Herbal Medicine Research Division, National Institute of Food &amp; Drug Safety Evaluation, Cheongju, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Hwang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Woon Sang\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       WS\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Kwon\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Ki Sun\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       KS\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lee\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Wha Young\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       WY\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Kim\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jeanman\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Kim\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Sung Phil\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       SP\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        STR Biotech Co., Ltd., Chuncheon, Republic of Korea. spkim@strbiotech.co.kr.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Friedman\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Mendel\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        U.S. Department of Agriculture, Western Regional Research Center, Agricultural Research Services, Albany, CA, USA. mendel.friedman@usda.gov.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      09\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     England\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     BMC Complement Med Ther\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     101761232\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     2662-7671\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018926\">\n",
      "      Anti-Allergic Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018927\">\n",
      "      Anti-Asthmatic Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000893\">\n",
      "      Anti-Inflammatory Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D019010\">\n",
      "      Vascular Cell Adhesion Molecule-1\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      130068-27-8\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D016753\">\n",
      "      Interleukin-10\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      2CU6TT9V48\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      37341-29-0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007073\">\n",
      "      Immunoglobulin E\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      9006-59-1\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D010047\">\n",
      "      Ovalbumin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      LMI26O6933\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000537\">\n",
      "      Aluminum Oxide\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      RXY07S6CZ2\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015230\">\n",
      "      Prostaglandin D2\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D000363\">\n",
      "      Agaricales\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000537\">\n",
      "      Aluminum Oxide\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D018926\">\n",
      "      Anti-Allergic Agents\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D018927\">\n",
      "      Anti-Asthmatic Agents\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000893\">\n",
      "      Anti-Inflammatory Agents\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007073\">\n",
      "      Immunoglobulin E\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D016753\">\n",
      "      Interleukin-10\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051379\">\n",
      "      Mice\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008807\">\n",
      "      Mice, Inbred BALB C\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D025282\">\n",
      "      Mycelium\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D010047\">\n",
      "      Ovalbumin\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D000459\">\n",
      "      Phaeophyta\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015230\">\n",
      "      Prostaglandin D2\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D020942\">\n",
      "      Shiitake Mushrooms\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D019010\">\n",
      "      Vascular Cell Adhesion Molecule-1\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Anti-asthma effect\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Bioassays\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Bioprocessed food, mast cells\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Bronchoalveolar lavage fluid\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Dietary interventions\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Ecklonia cava\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Edible algae\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Gas chromatography\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Histology\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Immunoglobulins, cytokines\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Lungs\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Mice\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Shiitake mushrooms\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    The authors declare that they have no competing interests.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      5\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      23\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      25\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      18\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    epublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     36115955\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pmc\">\n",
      "     PMC9482293\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1186/s12906-022-03705-y\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     10.1186/s12906-022-03705-y\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Beers MH. The Merck Manual of Diagnosis and Therapy. 18. Whitehouse Station: Merck Research Laboratories; 2006.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      De La Cruz N, Hines JH, Shaw C, Appiah D. Geographic disparity in asthma hospitalizations: the role of race/ethnicity, socioeconomic status, and other factors. Cureus. 2021;13(11):e20015.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8631481\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34873552\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jeebhay MF, Baatjies R. Occupational inhalant allergy in food handling occupations. Curr Opin Allergy Clin Immunol. 2021;22(2):64–72. doi: 10.1097/ACI.0000000000000804.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1097/ACI.0000000000000804\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34923552\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma surveillance - United States, 2006-2018. MMWR Surveill Summ. 2021;70(5):1–32. doi: 10.15585/mmwr.ss7005a1.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.15585/mmwr.ss7005a1\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8480992\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34529643\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Sharma V, Cowan DC. Obesity, inflammation, and severe asthma: an update. Curr Allergy Asthma Rep. 2021;21(12):46. doi: 10.1007/s11882-021-01024-9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1007/s11882-021-01024-9\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8684548\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34921631\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Southerland VA, Anenberg SC, Harris M, Apte J, Hystad P, van Donkelaar A, Martin RV, Beyers M, Roy A. Assessing the distribution of air pollution health risks within cities: a neighborhood-scale analysis leveraging high-resolution data sets in the bay area, California. Environ Health Perspect. 2021;129(3):37006. doi: 10.1289/EHP7679.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1289/EHP7679\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8011332\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33787320\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zhang W, Hwang J, Yadav D, An E-K, Kwak M, Lee PC-W, Jin J-O. Enhancement of immune checkpoint inhibitor-mediated anti-cancer immunity by intranasal treatment of Ecklonia cava fucoidan against metastatic lung cancer. Int J Mol Sci. 2021;22(17):9125. doi: 10.3390/ijms22179125.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3390/ijms22179125\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8431244\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34502035\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bocanegra A, Macho-González A, Garcimartín A, Benedí J, Sánchez-Muniz FJ. Whole alga, algal extracts, and compounds as ingredients of functional foods: composition and action mechanism relationships in the prevention and treatment of type-2 diabetes mellitus. Int J Mol Sci. 2021;22(8):3816. doi: 10.3390/ijms22083816.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3390/ijms22083816\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8067684\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33917044\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jung J-I, Kim S, Baek S-M, Choi S-I, Kim G-H, Imm J-Y. Ecklonia cava extract exerts anti-inflammatory effect in human gingival fibroblasts and chronic periodontitis animal model by suppression of pro-inflammatory cytokines and chemokines. Foods. 2021;10(7):1656. doi: 10.3390/foods10071656.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3390/foods10071656\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8304037\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34359526\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Shin HC, Kim SH, Park Y, Lee BH, Hwang HJ. Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial. Phytother Res. 2012;26(3):363–368. doi: 10.1002/ptr.3559.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1002/ptr.3559\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21717516\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yun JW, Kim SH, Kim YS, You JR, Cho EY, Yoon JH, Kwon E, Yun IJ, Oh JH, Jang JJ, et al. Enzymatic extract from Ecklonia cava: acute and subchronic oral toxicity and genotoxicity studies. Regul Toxicol Pharmacol. 2018;92:46–54. doi: 10.1016/j.yrtph.2017.10.034.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.yrtph.2017.10.034\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29108849\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim J, Jung Y, Lee E, Jang S, Ryu DH, Kwon O, Hwang GS. Urinary metabolomic profiling analysis and evaluation of the effect of Ecklonia cava extract intake. Nutrients. 2020;12(5):1407. doi: 10.3390/nu12051407.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3390/nu12051407\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7285171\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       32422870\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Lee SJ, Nam SH, Friedman M. Elm tree (Ulmus parvifolia) bark bioprocessed with mycelia of shiitake (Lentinus edodes) mushrooms in liquid culture: composition and mechanism of protection against allergic asthma in mice. J Agric Food Chem. 2016;64(4):773–784. doi: 10.1021/acs.jafc.5b04972.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/acs.jafc.5b04972\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26807923\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against a Salmonella lipopolysaccharide-induced endotoxemia. J Agric Food Chem. 2013;61(46):10987–10994. doi: 10.1021/jf403173k.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/jf403173k\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24200110\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Lee SJ, Park SO. Fermentation of black rice with basidiomycetes mycelia and immune stimulating agent through bioconversion process. Patent Number 10–2013-0077802, Republic of Korea, July 9 2013.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Chen Y, Xie M-Y, Nie S-P, Li C, Wang Y-X. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum. Food Chem. 2008;107(1):231–241. doi: 10.1016/j.foodchem.2007.08.021.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.foodchem.2007.08.021\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Lee J-H, Ko J-Y, Oh J-Y, Kim C-Y, Lee H-J, Kim J, Jeon Y-J. Preparative isolation and purification of phlorotannins from Ecklonia cava using centrifugal partition chromatography by one-step. Food Chem. 2014;158:433–437. doi: 10.1016/j.foodchem.2014.02.112.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.foodchem.2014.02.112\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24731366\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Chen Y, Xie M-Y, Wang Y-X, Nie S-P, Li C. Analysis of the monosaccharide composition of purified polysaccharides in Ganoderma atrum by capillary gas chromatography. Phytochem Anal. 2009;20(6):503–510. doi: 10.1002/pca.1153.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1002/pca.1153\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       19743070\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Goo HR, Choi JS, Na DH. Quantitative determination of major phlorotannins in Ecklonia stolonifera. Arch Pharm Res. 2010;33(4):539–544. doi: 10.1007/s12272-010-0407-y.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1007/s12272-010-0407-y\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20422362\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jeong HJ, Hong SH, Lee DJ, Park JH, Kim KS, Kim HM. Role of ca(2+) on TNF-α and IL-6 secretion from RBL-2H3 mast cells. Cell Signal. 2002;14(7):633–639. doi: 10.1016/S0898-6568(02)00005-0.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/S0898-6568(02)00005-0\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11955956\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53(10):849–856. doi: 10.1136/thx.53.10.849.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1136/thx.53.10.849\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC1745083\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       10193371\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Coomes SM, Kannan Y, Pelly VS, Entwistle LJ, Guidi R, Perez-Lloret J, Nikolov N, Müller W, Wilson MS. CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation. Mucosal Immunol. 2017;10(1):150–161. doi: 10.1038/mi.2016.47.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1038/mi.2016.47\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       27166557\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through up-regulation of the Th1 immune reaction. J Agric Food Chem. 2014;62(11):2384–2391. doi: 10.1021/jf405223q.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/jf405223q\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       24593132\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Lee SJ, Nam SH, Friedman M. Turmeric bioprocessed with mycelia from the shiitake culinary-medicinal mushroom Lentinus edodes (Agaricomycetes) protects mice against salmonellosis. Int J Med Mushrooms. 2017;19(4):363–376. doi: 10.1615/IntJMedMushrooms.v19.i4.70.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1615/IntJMedMushrooms.v19.i4.70\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28605325\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Lee SJ, Nam SH, Friedman M. The composition of a bioprocessed shiitake (Lentinus edodes) mushroom mycelia and rice bran formulation and its antimicrobial effects against Salmonella enterica subsp. enterica serovar Typhimurium strain SL1344 in macrophage cells and in mice. BMC Complement Altern Med. 2018;18(1):322. doi: 10.1186/s12906-018-2365-8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1186/s12906-018-2365-8\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6282263\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30518352\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Lee JR, Kwon KS, Jang YJ, Kim J, Yu KH, Lee SY, Friedman M. A bioprocessed black rice bran glutathione-enriched yeast extract protects rats and mice against alcohol-induced hangovers. Food Nutr Sci. 2021;12(03):223–238.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Choi SP, Kang MY, Koh HJ, Nam SH, Friedman M. Antiallergic activities of pigmented rice bran extracts in cell assays. J Food Sci. 2007;72(9):S719–S726. doi: 10.1111/j.1750-3841.2007.00562.x.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1111/j.1750-3841.2007.00562.x\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       18034759\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Choi SP, Kim SP, Kang MY, Nam SH, Friedman M. Protective effects of black rice bran against chemically-induced inflammation of mouse skin. J Agric Food Chem. 2010;58(18):10007–10015. doi: 10.1021/jf102224b.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/jf102224b\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20731354\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Kim SP, Yang JY, Kang MY, Park JC, Nam SH, Friedman M. Composition of liquid rice hull smoke and anti-inflammatory effects in mice. J Agric Food Chem. 2011;59(9):4570–4581. doi: 10.1021/jf2003392.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/jf2003392\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21438497\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bhawamai S, Lin SH, Hou YY, Chen YH. Thermal cooking changes the profile of phenolic compounds, but does not attenuate the anti-inflammatory activities of black rice. Food Nutr Res. 2016;60:32941. doi: 10.3402/fnr.v60.32941.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3402/fnr.v60.32941\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5031796\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       27652685\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Bovard D, van der Toorn M, Schlage WK, Constant S, Renggli K, Peitsch MC, Hoeng J. Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia. Biochem Biophys Rep. 2022;29:101187.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8673819\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34931176\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wang Y, An S. Plastic bronchitis associated with influenza a virus in children with asthma. J Int Med Res. 2021;49(12):3000605211065370.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8721730\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34939439\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Torun Ş, Kesim Ç, Süner A, Botan Yıldırım B, Özen Ö, Akçay Ş. Influenza viruses and SARS-CoV-2 in adult: 'Similarities and differences'. Tuberk Toraks. 2021;69(4):458–468. doi: 10.5578/tt.20219603.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.5578/tt.20219603\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34957739\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Fiocchi A, Bognanni A, Brozek J, Ebisawa M, Schunemann H, group WDg. World allergy organization (WAO) diagnosis and rationale for action against Cow's Milk allergy (DRACMA) guidelines update - I - plan and definitions. World Allergy Organ J. 2022;15(1):100609. doi: 10.1016/j.waojou.2021.100609.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.waojou.2021.100609\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8818560\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35145603\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Alghamdi R, Alshaier R, Alotaibi A, Almutairi A, Alotaibi G, Faqeeh A, Almalki A, AbdulMajed H. Immunotherapy effectiveness in treating peanut hypersensitivity: a systemic review. Cureus. 2022;14(2):e21832.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8896406\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35291522\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wang J, He Z, Raghavan V. Soybean allergy: characteristics, mechanisms, detection and its reduction through novel food processing techniques. Crit Rev Food Sci Nutr. 2022. 10.1080/10408398.2022.2029345:1-14.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35075969\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Brandon DL, Friedman M. Immunoassays of soy proteins. J Agric Food Chem. 2002;50(22):6635–6642. doi: 10.1021/jf020186g.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1021/jf020186g\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       12381163\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zhang P, Gao J, Che H, Xue W, Yang D. Molecular basis of IgE-mediated shrimp allergy and heat desensitization. Nutrients. 2021;13(10):3397. doi: 10.3390/nu13103397.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3390/nu13103397\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8540294\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34684397\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yeboah-Korang A, Memon A, Patel N, Portocarrero-Castillo A, Osman A, Kleesattel D, et al. Impact of prior drug allergies on the risk, clinical features, and outcomes of idiosyncratic drug-induced liver injury in adults. Dig Dis Sci. 2022. 10.1007/s10620-022-07403-0.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35122190\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35917595\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     09\n",
      "    </Month>\n",
      "    <Day>\n",
      "     13\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     12\n",
      "    </Month>\n",
      "    <Day>\n",
      "     27\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1532-2823\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       184\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Sep\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Prostaglandins, leukotrienes, and essential fatty acids\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Prostaglandins Leukot Essent Fatty Acids\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      102474\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      102474\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.plefa.2022.102474\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0952-3278(22)00086-2\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Severe nasal polyposis and mucosal inflammation, in patients with chronic rhinosinusitis (CRS) may include a dysregulated eicosanoid profile, but a clinical role for eicosanoids in CRS with nasal polyps (NP; CRSwNP) remains to be elucidated. This study focused on assessing levels and clinical implications of inflammatory mediators in nasal secretions and urine from patients with different NP severity or Aspirin Exacerbated Respiratory Disease (AERD). Levels of leukotrienes E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      and B\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      , prostaglandins D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      and E\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      as well as 15(S)-hydroxyeicosatetraenoic acid were measured with enzyme immunoassays and cytokines with magnetic bead immunoassays. Patients with CRSwNP were subdivided based on NP score; CRSwNP-low (NP score ≤ 4, n = 11) or CRSwNP-high (NP score ≥ 5, n = 32) and compared to CRS without polyps (CRSsNP, n = 12), CRSwNP-AERD (n = 11) and individuals without CRS (n = 25). Smell test score, fractional exhaled nitric oxide (FeNO), blood eosinophils and Sinonasal outcome test-22 were assessed as clinical markers. Leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      , prostaglandin D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      and 15(S)-hydroxyeicosatetraenoic acid in nasal secretions correlated with NP score. Nasal leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      also correlated with FeNO and smell test score, with highest levels found in CRSwNP-AERD. Levels of prostaglandin D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      in nasal secretion as well as urinary levels of the prostaglandin D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      metabolite 11β-prostaglandin F\n",
      "      <sub>\n",
      "       2α\n",
      "      </sub>\n",
      "      differed between CRSNP-high and CRSwNP-low. Urinary 11β-prostaglandin F\n",
      "      <sub>\n",
      "       2α\n",
      "      </sub>\n",
      "      was associated with asthma comorbidity whereas a similar association with prostaglandin D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      in nasal secretions was not observed. In conclusion, subdividing patients based on NP severity in combination with analysis of eicosanoids in non-invasively collected nasal secretions, may have clinical implications when assessing CRS disease severity.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Nordström\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Axel\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       A\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden. Electronic address: axel.nordstrom@shh.se.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Jangard\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Mattias\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Svedberg\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Marie\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Ryott\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Michael\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Kumlin\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Maria\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      07\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     Scotland\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Prostaglandins Leukot Essent Fatty Acids\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     8802730\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0952-3278\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015777\">\n",
      "      Eicosanoids\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D011453\">\n",
      "      Prostaglandins\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      75715-89-8\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000150\">\n",
      "      complications\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D002908\">\n",
      "      Chronic Disease\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015777\">\n",
      "      Eicosanoids\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D009298\">\n",
      "      Nasal Polyps\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D011453\">\n",
      "      Prostaglandins\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D012220\">\n",
      "      Rhinitis\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D012852\">\n",
      "      Sinusitis\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     AERD\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     CRS\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Leukotriene\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Nasal polyp score\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Nasal secretions\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Prostaglandin\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    Declaration of Competing Interest None of the authors have any conflict of interest to declare.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      25\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      3\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      9\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      2\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      18\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      13\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35917595\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.plefa.2022.102474\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0952-3278(22)00086-2\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35850310\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     08\n",
      "    </Month>\n",
      "    <Day>\n",
      "     24\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     09\n",
      "    </Month>\n",
      "    <Day>\n",
      "     14\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1873-2968\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       203\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Sep\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Biochemical pharmacology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Biochem Pharmacol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Recent advances in function and structure of two leukotriene B\n",
      "     <sub>\n",
      "      4\n",
      "     </sub>\n",
      "     receptors: BLT1 and BLT2.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      115178\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      115178\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.bcp.2022.115178\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0006-2952(22)00272-6\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Leukotriene B\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      (LTB\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      ) is generated by the enzymatic oxidation of arachidonic acid, which is then released from the cell membrane and acts as a potent activator of leukocytes and other inflammatory cells. Numerous studies have demonstrated the physiological and pathophysiological significance of this lipid in various diseases. LTB\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      exerts its activities by binding to its specific G protein-coupled receptors (GPCRs): BLT1 and BLT2. In mouse disease models, treatment with BLT1 antagonists or BLT1 gene ablation attenuated various diseases, including bronchial asthma, arthritis, and psoriasis, whereas BLT2 deficiency exacerbated several diseases in the skin, cornea, and small intestine. Therefore, BLT1 inhibitors and BLT2 activators could be beneficial for the treatment of several inflammatory and immune disorders. As a result, attractive compounds targeting LTB\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      receptors have been developed by several pharmaceutical companies. This review aims to understand the potential of BLT1 and BLT2 as therapeutic targets for the treatment of various inflammatory diseases. In addition, recent topics are discussed with major focuses on the structure and post-translational modifications of BLT1 and BLT2. Collectively, current evidence on modulating LTB\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      receptor functions provides new strategies for the treatment of various diseases.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 Elsevier Inc. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Nakamura\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Motonao\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Bioscience, Graduate school of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama 700-0005, Japan. Electronic address: moto-nakamura@ous.ac.jp.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Shimizu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Takao\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       T\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Lipid Signaling, National Center for Global Health and Medicine, Tokyo 162-8655, Japan; Institute of Microbial Chemistry, Tokyo 141-0021, Japan.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      07\n",
      "     </Month>\n",
      "     <Day>\n",
      "      16\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     England\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Biochem Pharmacol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     0101032\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0006-2952\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018102\">\n",
      "      Receptors, Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      1HGW4DR56D\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007962\">\n",
      "      Leukocytes\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000235\">\n",
      "      genetics\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051379\">\n",
      "      Mice\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D011565\">\n",
      "      Psoriasis\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D018102\">\n",
      "      Receptors, Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000235\">\n",
      "      genetics\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     BLT1\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     BLT2\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Inflammation\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     LTB(4) receptor\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Phosphorylation\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Posttranslational modification\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Structure\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotriene B(4)\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      27\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      12\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      12\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      20\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      25\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      19\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      7\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      26\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35850310\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.bcp.2022.115178\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0006-2952(22)00272-6\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35720028\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     06\n",
      "    </Month>\n",
      "    <Day>\n",
      "     21\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     07\n",
      "    </Month>\n",
      "    <Day>\n",
      "     16\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Electronic-eCollection\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1748-6718\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       2022\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Computational and mathematical methods in medicine\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Comput Math Methods Med\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Effect of Bairui Granule on Inflammatory Mediators in Induced Sputum, Leukotriene C4, and EOS in Peripheral Blood of Children with Cough Variant Asthma.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      2657994\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      2657994\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     2657994\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1155/2022/2657994\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">\n",
      "      To study the effect of Hanchuan Zupa granule combined with conventional western medicine in the treatment of children with bronchial asthma.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">\n",
      "      98 cases in Fengrun District People's Hospital of Tangshan City from June 2018 to February 2021 were selected. The control group was given oxygen therapy, antibiotics, and aerosol inhalation of quick acting\n",
      "      <i>\n",
      "       β\n",
      "      </i>\n",
      "      2 receptor agonist, glucocorticoid, and other conventional western medicine treatment, while the observation group was treated with Bairui granule on the basis of the control group. The course of treatment of the two groups was 1 week.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">\n",
      "      After treatment, the levels of sputum IL-4, IL-17, neu, and ECP in the two groups decreased, and the observation group was lower than the control group (\n",
      "      <i>\n",
      "       P\n",
      "      </i>\n",
      "      &lt; 0.05). The levels of EOS, CXCR4, LTB4, and SDF-1 in peripheral blood of the two groups were lower than those in the control group (\n",
      "      <i>\n",
      "       P\n",
      "      </i>\n",
      "      &lt; 0.05). The daytime cough, night cough, and TCM syndrome scores of the two groups were decreased, and the observation group was lower than the control group (\n",
      "      <i>\n",
      "       P\n",
      "      </i>\n",
      "      &lt; 0.05).\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">\n",
      "      Bairui granule combined with conventional western medicine in the treatment of children with bronchial asthma, the curative effect is worthy of affirmation, can effectively improve cough symptoms, reduce EOS, CXCR, LTB4, SDF-1 levels, inhibit airway inflammation, and has good clinical application value.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 Yi Shen et al.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Shen\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Yi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Y\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Min\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Xu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Qiuyan\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Q\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Liu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Lu\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       L\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Cheng\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Zhi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Z\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0003-1389-1546\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      06\n",
      "     </Month>\n",
      "     <Day>\n",
      "      08\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Comput Math Methods Med\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     101277751\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     1748-670X\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018836\">\n",
      "      Inflammation Mediators\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      1HGW4DR56D\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      2CU6TT9V48\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D002648\">\n",
      "      Child\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D003371\">\n",
      "      Cough\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D004804\">\n",
      "      Eosinophils\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D018836\">\n",
      "      Inflammation Mediators\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D013183\">\n",
      "      Sputum\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <CoiStatement>\n",
      "    The authors declare that they have no conflicts of interest.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      24\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      29\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      20\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      3\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      37\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      22\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    epublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35720028\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pmc\">\n",
      "     PMC9200585\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1155/2022/2657994\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jian W., Shiwen L. The effect of montelukast sodium in adjuvant treatment of bronchial asthma in children and its effect on immune function and inflammatory cytokine levels. Chongqing Medicine . 2020;49(12):1979–1983.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Chuanhe L., Jianguo H., Yunxiao S. A 20-year comparative study on the prevalence of childhood asthma in 16 cities in China. Chinese Journal of Practical Pediatrics . 2015;30(8):596–600.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yakun L., Ying Y., Xulei G. Epidemiological characteristics and influencing factors of allergic bronchial asthma in children aged 0-14 years in Daxing District, Beijing. Hebei Medicine . 2020;42(11):1739–1742.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Xiaoyang W. Research progress in the treatment of bronchial asthma in children. International Journal Of Pediatrics . 2020;47(3):154.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Respiratory Group of Pediatrics Branch of Chinese Medical Association. Editorial Board of Chinese Journal of Pediatrics. Guidelines for the diagnosis and prevention of bronchial asthma in children (2016 edition) Chinese Journal of Pediatrics . 2016;54(3):167–181.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       26957061\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Pulmonary Diseases Branch of Chinese Society of Traditional Chinese Medicine. Expert consensus on diagnosis and treatment of bronchial asthma in traditional Chinese medicine (2012) Journal of Traditional Chinese Medicine . 2013;54(7):627–629.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Hua W., Xiaoqing C. Research progress on the role of leukotrienes and their receptor antagonists in lung diseases. Chinese Journal of Women and Children's Clinical Medicine (Electronic Edition) . 2017;13(2):234–239.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Shotaro M., Shigetoshi K., Kenzo T., Miyata S. Association of comorbidities and medications with risk of asthma exacerbation in pediatric patients: a retrospective study using Japanese claims data. Scientific Reports . 2022;12:p. 5509.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8975995\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35365694\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Simon C., Ewout S., Richard B., Pavord I. Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling. BMJ Open . 2022;12(4):p. e058215. doi: 10.1136/bmjopen-2021-058215.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1136/bmjopen-2021-058215\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8977743\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35365539\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tan X., Bin C., Tian Z. The clinical characteristics of bronchial asthma and the research progress of new drugs. Food and Drugs . 2019;21(5):419–420.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      John O., Leung Donald Y. M. Asthma 2022--moving toward precision medicine. Annals of Allergy, Asthma &amp; Immunology . 2022;128(4):p. 343. doi: 10.1016/j.anai.2022.01.011.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.anai.2022.01.011\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35365251\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Quint Jennifer K., Sofie A., Kocks Janwillem W. H. Short-acting β-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. The Journal of Allergy and Clinical Immunology: In Practice . 2022;10 doi: 10.1016/j.jaip.2022.02.047.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.jaip.2022.02.047\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35364341\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Lixia L., Liming Z., Dan Z. Research progress of hypoxia-inducible factor 1 in the airway inflammation mechanism of bronchial asthma. International Journal of Respiration . 2020;40(8):613–618.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tong Y., Dajun J., Hailong Y. Research progress and clinical application of Uyghur medicine Bairui granules. New Chinese Medicine . 2019;51(4):42–45.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cong C., Jing H., Liu L. Discussion on the etiology, location and pathogenesis of bronchial asthma in traditional Chinese medicine. Hebei Journal of Traditional Chinese Medicine . 2019;41(5):775–778.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Guihua X., Miaoyan S., Xiuming S. Clinical observation of Shegan Mahuang decoction in the treatment of cold asthma of bronchial asthma. Beijing Traditional Chinese Medicine . 2017;36(4):299–302.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zhenhua L., Qiong C., Jing W., Li X., He Y., Yu Q. Simulation-based training in asthma exacerbation for medical students: effect of prior exposure to simulation training on performance. BMC Medical Education . 2022;22(1):p. 223. doi: 10.1186/s12909-022-03300-2.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1186/s12909-022-03300-2\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8973632\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35361196\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Teresa T., Jingqin Z., Emilie T., Zhang K., Gershon A. S., Licskai C. Is overreliance on short-acting β-agonists associated with health risks in the older asthma population? ERJ open research . 2022;8(1):00032–02022. doi: 10.1183/23120541.00032-2022.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1183/23120541.00032-2022\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8958218\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35350274\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zheng W., Jinming L., Shaoshun L. Research progress of thyme grass. Chinese Pharmacist . 2006;9(1):1059–1060.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      YangYang Y., Xing Y. C., Chao G. Clinical efficacy and safety of removing blood stasis and removing phlegm in the treatment of epilepsy with cognitive impairment. Medicine (Baltimore) . 2021;100(47):p. e27929. doi: 10.1097/MD.0000000000027929.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1097/MD.0000000000027929\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8615331\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34964768\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Qing-Yi Z., Yi S., Jing Z. Effectiveness of herb-partitioned moxibustion combined with electroacupuncture on polycystic ovary syndrome in patients with symptom pattern of kidney deficiency and phlegm-dampne. Journal of Traditional Chinese Medicine . 2021;41:985–993.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34939397\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ge F., Yaxin W., Zhenqian Y., et al. Test-retest reliability of the coronary heart disease damp phlegm and blood stasis pattern questionnaire: results from a multicenter clinical trial. Evidence-based Complementary and Alternative Medicine . 2021;2021:6. doi: 10.1155/2021/6291301.6291301\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1155/2021/6291301\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8610670\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       34824591\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Long W., Jing L. Observation on the efficacy of nebulized inhalation of interferon α-1b combined with oral Bairui granules in the treatment of bronchiolitis. Journal of Traditional Chinese Medicine . 2017;45(3):62–64.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Song P., Zeng L., Liang Z., Wang Q., Ou A. Clinical efficacy and safety of Chinese herbal medicine auxiliary therapy for childhood cough variant asthma: a systematic review and meta-analysis of 20 randomized controlled trials. Internal Medicine . 2016;55(16):2135–2143. doi: 10.2169/internalmedicine.55.5546.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.2169/internalmedicine.55.5546\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       27522988\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Yingxia L., Qinghua H., Lijuan Z. Detection of serum IL-4, HIF-1α, IFN-γ, VEGF levels in children with bronchial asthma and their clinical significance. Clinical Medicine Research and Practice . 2020;5(16):98–100.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zhongping W., Cuiping H., Ming L. Clinical study on the relationship between serum IL-35, IL-17 expression levels and 25-hydroxyvitamin D3 levels and asthma. China Maternal and Child Health Care . 2020;35(12):2231–2234.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Junxiu P., Lei Z., Junli H. Expression and significance of ECP, 25-hydroxyvitamin D3, and M2 receptors in the acute exacerbation of bronchial asthma in children. Journal of Hainan Medical University . 2019;25(20):1566–1570.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Xiaofang S., Ling J., Furong L. Changes and significance of serum LTB4, IL-17 levels and lung function in children with acute bronchial asthma. Journal of Clinical Research . 2019;36(6):1084–1086.\n",
      "     </Citation>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Biwen M., Jie L., Jianghong W. The role of stromal cell-derived factor-1/CXC chemokine receptor 4 in airway inflammation and airway remodeling in bronchial asthmatic rats. Chinese tuberculosis He Respiratory Journal . 2015;38(1):39–44.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       25791655\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Wgealla M. M. A. M. A., Liang H., Chen R., et al. Amniotic fluid derived stem cells promote skin regeneration and alleviate scar formation through exosomal miRNA-146a-5p via targeting CXCR4. Journal of Cosmetic Dermatology . 2022;22\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35364624\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Shristi P., Yinglong M. Mechanism of peptide agonist binding in CXCR4 chemokine receptor. Frontiers in molecular biosciences . 2022;9:p. 821055. doi: 10.3389/fmolb.2022.821055.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3389/fmolb.2022.821055\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8963245\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35359589\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Alsayed Reem Khaled M. E., Fareed K. A. A. Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression. Seminars in Cancer Biology . 2022\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       35346802\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35527666\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     05\n",
      "    </Month>\n",
      "    <Day>\n",
      "     10\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     05\n",
      "    </Month>\n",
      "    <Day>\n",
      "     10\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Electronic-eCollection\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1578-1267\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       50\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       3\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Allergologia et immunopathologia\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Allergol Immunopathol (Madr)\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     The comparative effect of Leukotriene receptor antagonist add on therapy and step up inhaled Corticosteroid in partially controlled asthma: An open-labeled randomized controlled trial.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      125\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      131\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      125-131\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.15586/aei.v50i3.553\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">\n",
      "      No studies are comparing the impact of the add-on leukotriene-receptor antagonist (LTRA) with a step-up dose of inhaled corticosteroids (ICS) in partly controlled asthma patients with asthma control test (ACT) score ˂ 23.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">\n",
      "      To study the effect of LTRA add-on therapy in comparison to a step-up to medium dose of ICS in partially controlled asthma.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">\n",
      "      An open-labeled randomized controlled trial was conducted in asthma subjects with partly controlled asthma who had been in regular receipt of low dose ICS. All subjects were assessed for asthma using ACT, daytime and nighttime symptoms, rate of relievers used, spirometry, and impulse oscillometry (IOS) at 3 and 6 months. Subjects were randomized to receive daily oral LTRA 10 mg or step-up medium dose of ICS.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">\n",
      "      Between June 2020 and January 2021, 50 participants were enrolled, all patients completing the study. After treatment, mean ACT scores were increased to more than 23 indicating well-controlled asthma in both groups, control being sustained throughout the whole 6-month study period (P ˂ 0.001). Within each group, ACT scores were improved by a minimal clinical important difference (MCID) ≥ 3 points at 6 months, compared to baseline values. There were significant decreases in nighttime and daytime symptoms, and the numbers of rescue relievers used in 4 weeks in both groups compared to baseline (P ˂ 0.001).\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">\n",
      "      LTRA add-on therapy in partially controlled asthma patients is comparable with step-up to medium dose of ICS/LABA as regards asthma control.\n",
      "     </AbstractText>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Ruenwilai\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Parinya\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       P\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Theerakittikul\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Theerakorn\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       T\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; theerakorn.t@cmu.ac.th.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Chaiwong\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Warawut\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       W\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Phetsuk\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Nittaya\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       N\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Pothirat\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Chaicharn\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Liwsrisakun\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Chalerm\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016449\">\n",
      "      Randomized Controlled Trial\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      05\n",
      "     </Month>\n",
      "     <Day>\n",
      "      01\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     Singapore\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Allergol Immunopathol (Madr)\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     0370073\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0301-0546\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000305\">\n",
      "      Adrenal Cortex Hormones\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018927\">\n",
      "      Anti-Asthmatic Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D020024\">\n",
      "      Leukotriene Antagonists\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000280\">\n",
      "      Administration, Inhalation\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000305\">\n",
      "      Adrenal Cortex Hormones\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D018927\">\n",
      "      Anti-Asthmatic Agents\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D004359\">\n",
      "      Drug Therapy, Combination\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D020024\">\n",
      "      Leukotriene Antagonists\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     asthma control\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     inhaled corticosteroids\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotriene-receptor antagonists\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     lung function\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    The authors declare that there is no conflict of interest in this work.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      16\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      9\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      3\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      16\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      10\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    epublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35527666\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.15586/aei.v50i3.553\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      1. Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Pothirat C, et al. Survey of asthma control in Thailand. Respirology. 2004;9(3):373–378. 10.1111/j.1440-1843.2004.00584.x\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1111/j.1440-1843.2004.00584.x\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. [Internet]. [Accessed 2018 Apr 10]. Available from: http://www.ginasthma.org\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\"/>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      3. Teeratakulpisarn J, Pairojkul S, Heng S. Survey of prevalence of asthma, Allergic rhinitis and eczema in schoolchildren from KhonKaen. An ISAAC (Study, International Study of Asthma and Allergic in Childhood). Asian Pac J. Allergy Immunol. 2000;18:4:187–194.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\"/>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      4. Murphy RC, Gijón MA. Biosynthesis and metabolism of leukotrienes. Biochem J. 2007.1;405(3):379–395. 10.1042/BJ20070289\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1042/BJ20070289\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      5. Löfdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319(7202):87–90. 10.1136/bmj.319.7202.87\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1136/bmj.319.7202.87\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      6. Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019;15;199(12):1471–1477. 10.1164/rccm.201810-1868CI\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1164/rccm.201810-1868CI\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      7. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Respir J. 2003;21(4):633–636. 10.1183/09031936.03.00306302\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1183/09031936.03.00306302\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      8. Rogala B, Bożek A, Gluck J. Is there a relationship between asthma and diabetes? J Asthma. 2020;57(12):1332–1338. 10.1080/02770903.2019.1652642\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1080/02770903.2019.1652642\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      9. Niyatiwatchanchai N, Chaiwong W, Pothirat C. The validity and reliability of the Thai version of the asthma control test. Asian Pac J Allergy Immunol. 2021 J [Online ahead of print].\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\"/>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. 10.1183/09031936.05.00034805\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1183/09031936.05.00034805\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      11. King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellacà RL, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. 10.1183/13993003.00753-2019\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1183/13993003.00753-2019\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      12. Johansson SA, Dahl R. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma. Allergy. 1998;43:173–178. 10.1111/j.1398-9995.1988.tb00415.x\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1111/j.1398-9995.1988.tb00415.x\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      13. Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162(2 Pt 1):578–585. 10.1164/ajrccm.162.2.9905041\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1164/ajrccm.162.2.9905041\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      14. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158(11):1213–1220. 10.1001/archinte.158.11.1213\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1001/archinte.158.11.1213\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      15. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J. 1997;10:646–651.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\"/>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      16. Bisgaard H, Loland L, Anhoj J. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med.1999;160:1227–1231. 10.1164/ajrccm.160.4.9903004\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1164/ajrccm.160.4.9903004\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      17. Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry. Chest. 2020;157:1435–1441. 10.1016/j.chest.2019.12.035\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.chest.2019.12.035\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      18. Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe (Sheff). 2015;11(1):57–65. 10.1183/20734735.020514\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1183/20734735.020514\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      19. Shi Y, Aledia AS, Galant SP, George SC. Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children. J Allergy Clin Immunol. 2013;131(3):718–723. 10.1016/j.jaci.2012.09.022\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.jaci.2012.09.022\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      20. Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012;129(3):671–678. 10.1016/j.jaci.2011.11.002\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.jaci.2011.11.002\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35451080\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     08\n",
      "    </Month>\n",
      "    <Day>\n",
      "     09\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     10\n",
      "    </Month>\n",
      "    <Day>\n",
      "     15\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1398-9995\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       77\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       8\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Aug\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Allergy\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Allergy\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      2549\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      2551\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      2549-2551\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1111/all.15319\n",
      "    </ELocationID>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       van der Burg\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Nicole\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       N\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0002-3369-6425\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Stenberg\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Henning\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       H\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Bjermer\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Leif\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       L\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Diamant\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Zuzana\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Z\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0003-0133-0100\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Microbiology Immunology &amp; Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Tufvesson\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Ellen\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       E\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0002-4941-332X\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016422\">\n",
      "      Letter\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      04\n",
      "     </Month>\n",
      "     <Day>\n",
      "      28\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     Denmark\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Allergy\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     7804028\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0105-4538\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D011453\">\n",
      "      Prostaglandins\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C112381\">\n",
      "      cysteinyl-leukotriene\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      K848JZ4886\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D003545\">\n",
      "      Cysteine\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001985\">\n",
      "      Bronchial Provocation Tests\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001992\">\n",
      "      Bronchoalveolar Lavage Fluid\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D003545\">\n",
      "      Cysteine\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D006967\">\n",
      "      Hypersensitivity\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D011453\">\n",
      "      Prostaglandins\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007507\">\n",
      "      Therapeutic Irrigation\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Bronchial lavage\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     allergen bronchoprovocation test\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     cysteinyl-leukotriene pathway\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     prostaglandin pathway\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    The authors declare no conflict of interest in relation to this work.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      10\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      22\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      7\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      5\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35451080\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pmc\">\n",
      "     PMC9546403\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1111/all.15319\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019;25(1):121‐127. doi:10.1097/mcp.0000000000000544\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1097/mcp.0000000000000544\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30422894\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Insuela DBR, Ferrero MR, Coutinho DDS, Martins MA, Carvalho VF. Could arachidonic acid‐derived pro‐resolving mediators be a new therapeutic strategy for asthma therapy? Front Immunol. 2020;11:580598. doi:10.3389/fimmu.2020.580598\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.3389/fimmu.2020.580598\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7755608\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33362766\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Tufvesson E, Nihlberg K, Westergren‐Thorsson G, Bjermer L. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids. 2011;85(2):67‐73. doi:10.1016/j.plefa.2011.04.025\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1016/j.plefa.2011.04.025\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       21596548\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Stenberg H, Diamant Z, Ankerst J, Bjermer L, Tufvesson E. Small airway involvement in the late allergic response in asthma. Clin Exp Allergy. 2017;47(12):1555‐1565. doi:10.1111/cea.13036\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1111/cea.13036\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28940836\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Van Vyve T, Chanez P, Lacoste JY, Bousquet J, Michel FB, Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest. 1992;102(2):356‐361. doi:10.1378/chest.102.2.356\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1378/chest.102.2.356\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       1643913\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Singh A, Yamamoto M, Kam SHY, et al. Gene‐metabolite expression in blood can discriminate allergen‐induced isolated early from dual asthmatic responses. PLoS One. 2013;8(7):e67907. doi:10.1371/journal.pone.0067907\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"doi\">\n",
      "       10.1371/journal.pone.0067907\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3699462\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       23844124\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Curated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35410888\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     12\n",
      "    </Month>\n",
      "    <Day>\n",
      "     06\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     12\n",
      "    </Month>\n",
      "    <Day>\n",
      "     27\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1708-8267\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       70\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       8\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Dec\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Journal of investigative medicine : the official publication of the American Federation for Clinical Research\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      J Investig Med\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Bronchodilatory effect of higenamine as antiallergic asthma treatment.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      1753\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      1758\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      1753-1758\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1136/jim-2021-002173\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Asthma is a complex airway disease that affects more than 350 million humans worldwide. Allergic asthma symptoms are induced by Th2 immune response with the release of cytokines and allegro-inflammatory mediators that amplify the inflammatory response, airway hyper-responsiveness (AHR) and hyperproduction of mucus. Higenamine, as a chemical compound, is a β\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      adrenoreceptor agonist and can be used as bronchodilator in allergic asthma.BALB/c mice were allocated in four groups and then allergic asthma was induced in three groups. One of the asthmatic groups was treated with albuterol and other one was treated with higenamine. At least, methacholine challenge to determine the AHR, measurement of cytokines, total immunoglobulin E (IgE), LTB4 and LTC4 levels, evaluation of gene expression of Muc5ac, Muc5b, Agr2 and Arg1, and histopathological study were done.Higenamine treatment reduced AHR, interleukin (IL)-4, IL-13 levels, mRNA expression of MUC5ac, MUC5b, Arg1 and Agr2, goblet cell hyperplasia and mucus hypersecretion. Higenamine had no significant effect on IL-5, interferon-γ (INF-γ), IgE, LTB4, LTC4 levels and eosinophilic inflammation in lung tissue.Higenamine treatment controls asthma acute attack and breathlessness and can be used as asthma treatment with control of AHR and decrease of airflow obstruction and mucus hypersecretion and had allegro-immune-regulatory effect. But higenamine treatment had no notable effect on the inflammation and inflammatory factors.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      © American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Du\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jing\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Hospital Infection Management, The Fourth People's Hospital of Chengdu, Chengdu, Sichuan Province, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Mehrabi Nasab\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Entezar\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       E\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of).\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Athari\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Seyyed Shamsadin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       SS\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0002-6355-6378\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran (the Islamic Republic of).\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Qian\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Linlin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       L\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of General Surgery, Yancheng No.1 Peoples's Hospital, Yancheng, Jiangsu Province, China xuelinwuhengn@sina.com.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      04\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     England\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     J Investig Med\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     9501229\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     1081-5589\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018926\">\n",
      "      Anti-Allergic Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      H82Q2D5WA7\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C108128\">\n",
      "      frovatriptan\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      TBV5O16GAP\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C012348\">\n",
      "      higenamine\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      37341-29-0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007073\">\n",
      "      Immunoglobulin E\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      1HGW4DR56D\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      2CU6TT9V48\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D009088\">\n",
      "      Mucoproteins\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C526445\">\n",
      "      Agr2 protein, mouse\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051379\">\n",
      "      Mice\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D018926\">\n",
      "      Anti-Allergic Agents\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D004195\">\n",
      "      Disease Models, Animal\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007073\">\n",
      "      Immunoglobulin E\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017997\">\n",
      "      Leukotriene C4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008168\">\n",
      "      Lung\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008807\">\n",
      "      Mice, Inbred BALB C\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D009088\">\n",
      "      Mucoproteins\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D012130\">\n",
      "      Respiratory Hypersensitivity\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     respiratory system\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    Competing interests: None declared.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      11\n",
      "     </Month>\n",
      "     <Day>\n",
      "      5\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      13\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      6\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      12\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      5\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      29\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35410888\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1136/jim-2021-002173\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     jim-2021-002173\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Curated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35227979\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     03\n",
      "    </Month>\n",
      "    <Day>\n",
      "     22\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     05\n",
      "    </Month>\n",
      "    <Day>\n",
      "     31\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1768-3254\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       233\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Apr\n",
      "       </Month>\n",
      "       <Day>\n",
      "        05\n",
      "       </Day>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      European journal of medicinal chemistry\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Eur J Med Chem\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Discovery of dual-target ligands binding to beta2-adrenoceptor and cysteinyl-leukotriene receptor for the potential treatment of asthma from natural products derived DNA-encoded library.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      114212\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      114212\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.ejmech.2022.114212\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0223-5234(22)00114-3\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      The design, synthesis, and discovery of dual-target compounds are considered as a promising strategy to develop new drugs with improved safety and efficacy compared with single-target drugs. This necessitates development of the methodologies that enable us to rapidly and accurately achieve the dual-target leads. Applying rosmarinic acid, 18β-glycyrrhetinic acid, rhein, and ferulic acid as template building blocks, we introduced the self-assembling DNA encoded technique to build the library containing 1,000 compounds. These compounds were screened by receptor chromatography with immobilized beta\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      -adrenoceptor (β\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      -AR) and cysteinyl-leukotriene receptor (CysLT), whereby we obtained a derivative of 18β-glycyrrhetinic acid (XC267) that specifically binds to the two receptors. In vitro assessment demonstrated the desired binding affinity of 6.57 × 10\n",
      "      <sup>\n",
      "       4\n",
      "      </sup>\n",
      "      M\n",
      "      <sup>\n",
      "       -1\n",
      "      </sup>\n",
      "      to β\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      -AR, 2.82 × 10\n",
      "      <sup>\n",
      "       4\n",
      "      </sup>\n",
      "      M\n",
      "      <sup>\n",
      "       -1\n",
      "      </sup>\n",
      "      to CysLT, and the dissociation rate constant of 7.52 s\n",
      "      <sup>\n",
      "       -1\n",
      "      </sup>\n",
      "      to β\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      -AR, 17.2 s\n",
      "      <sup>\n",
      "       -1\n",
      "      </sup>\n",
      "      to CysLT. Pharmacological examination with ovalbumin-induced mice demonstrated that XC267 significantly reduced the levels of IL-4, IL-13, and IgE after oral administration of 10 mg/kg. By Western blot analysis, we observed an up-regulated expression of β\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      -AR and a blocked level of CysLT with a dose-dependent manner in pulmonary bronchial. Our results suggest XC627 is a potential candidate to treat asthma by simultaneously regulating the signaling pathway of the two receptors.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 Elsevier Masson SAS. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Liang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Qi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Q\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Zuo\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Haiyue\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       H\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Yang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Tian\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       T\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Yin\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jiatai\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Huang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Xiaomin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       X\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Wang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jing\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Li\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Qian\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Q\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Yin\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Guowei\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       G\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Zhao\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Xinfeng\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       X\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        College of Life Sciences, Northwest University, Xi'an, 710069, China. Electronic address: zhaoxf@nwu.edu.cn.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      02\n",
      "     </Month>\n",
      "     <Day>\n",
      "      21\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     France\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Eur J Med Chem\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     0420510\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0223-5234\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001688\">\n",
      "      Biological Products\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D008024\">\n",
      "      Ligands\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D018077\">\n",
      "      Receptors, Leukotriene\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"C112381\">\n",
      "      cysteinyl-leukotriene\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      K848JZ4886\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D003545\">\n",
      "      Cysteine\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001688\">\n",
      "      Biological Products\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D003545\">\n",
      "      Cysteine\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008024\">\n",
      "      Ligands\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051379\">\n",
      "      Mice\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D018077\">\n",
      "      Receptors, Leukotriene\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000235\">\n",
      "      genetics\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000378\">\n",
      "      metabolism\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015398\">\n",
      "      Signal Transduction\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     DNA-Encoded library\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Drug discovery\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Natural products\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Receptor chromatography\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      16\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      18\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      2\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      5\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      49\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35227979\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.ejmech.2022.114212\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0223-5234(22)00114-3\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35226440\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     04\n",
      "    </Month>\n",
      "    <Day>\n",
      "     13\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     05\n",
      "    </Month>\n",
      "    <Day>\n",
      "     16\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1897-9483\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       132\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       2\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Feb\n",
      "       </Month>\n",
      "       <Day>\n",
      "        28\n",
      "       </Day>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Polish archives of internal medicine\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Pol Arch Intern Med\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Aspirin‑induced asthma: a still evolving area of basic and clinical research.\n",
      "    </ArticleTitle>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     16219\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.20452/pamw.16219\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      The first modern description of respiratory syndrome of aspirin hypersensitivity was published over half of the century ago, but the pathogenesis of the disease is still elusive. Just a few years after discovery how aspirin works, Andrew Szczeklik and his co‑workers described that asthmatics with aspirin hypersensitivity cross‑react to the whole class of nonsteroidal anti‑inflammatory drugs. It took rest of his life to seek for an answer on how this disease, nowadays referred to as N ‑ERD, develops and how it can be treated. In the meantime, cysteinyl leukotrienes, leukotriene modifying drugs, and novel subpopulations of lymphocytes were discovered. This review on aspirin hypersensitivity documents a progress in our understanding of mechanisms of hypersensitivity to nonsteroidal anti‑inflammatory drugs. Current concepts about origin of the disease integrate advances in the field of allergology and inflammatory mechanisms of asthma. However, pharmacological inhibition of prostaglandin biosynthesis by nonsteroidal anti‑inflammatory drugs has a pivotal role in these investigations. Presented is a central role of prostaglandin E2 , a double‑faced lipid immunoregulatory mediator whose deficiency is related to the administration of an anti‑inflammatory drug. Discussed are cysteinyl leukotrienes, the most reliable biomarkers of aspirin hypersensitivity and cells of innate immunity capable of leukotrienes production. Involvement of blood platelets and recently described mucosal basophils are areas of ongoing studies in the disease. Aspirin hypersensitivity is an acquired condition; therefore, the search for genetic predisposition using classic association studies was inconclusive. There is a new hope to explain mechanisms of aspirin hypersensitivity by studies of innate lymphoid cells, which have a central role in the regulation of respiratory mucosa function in asthma.\n",
      "     </AbstractText>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Sanak\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Marek\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Clinical Genetics and Molecular Biology, Department of Medicine, Jagiellonian University Medical College, Kraków, Poland. marek.sanak@uj.edu.pl\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      02\n",
      "     </Month>\n",
      "     <Day>\n",
      "      28\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     Poland\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Pol Arch Intern Med\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     101700960\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0032-3772\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000894\">\n",
      "      Anti-Inflammatory Agents, Non-Steroidal\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      R16CO5Y76E\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000894\">\n",
      "      Anti-Inflammatory Agents, Non-Steroidal\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000139\">\n",
      "      chemically induced\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007113\">\n",
      "      Immunity, Innate\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008214\">\n",
      "      Lymphocytes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      2\n",
      "     </Month>\n",
      "     <Day>\n",
      "      28\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      14\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      26\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35226440\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.20452/pamw.16219\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     16219\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35026480\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     04\n",
      "    </Month>\n",
      "    <Day>\n",
      "     18\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     04\n",
      "    </Month>\n",
      "    <Day>\n",
      "     18\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1878-1519\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       299\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        May\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Respiratory physiology &amp; neurobiology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Respir Physiol Neurobiol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Ganoderma modulates allergic asthma pathologic features via anti-inflammatory effects.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      103843\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      103843\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.resp.2022.103843\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S1569-9048(22)00002-7\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      Ganoderma, a fungal genus, is a traditional medicine with immuno-modulating effects. Asthma is an inflammatory disease of airways, and the main trigger of asthma is allergic inflammation. In this study, the effects of Ganoderma (an anti-inflammatory agent) given via oral administration (G/O) or intraperitoneal injection (G/IP) on asthma was evaluated. Forty BALB/c mice were divided into four groups, including the control, OVA-challenge, OVA-challenge + G/O, and OVA-challenge + G/IP. To determine AHR, the MCh challenge test was done. The levels of IL-1β, -4, -5, -6, -8, -10, -12, -13, -17, -25, -33, -38, Cys-LT, LTB4, and hydroxyproline were measured. Finally, lung histopathology was evaluated to determine eosinophilic inflammation, goblet cell hyperplasia, and mucus hyper-secretion. Treatment with G/O and G/IP could significantly reduce the levels of IL-1β, -5, -6, -8, -17, -25, -33, and -38; the levels of IL-4 and IL-13 had no significant changes, but the levels of IL-10 and IL-12 were enhanced. The mice treated with G/O and G/IP showed decreased levels of Cys-LT, LTB4, peribronchial and perivascular inflammation, but no significant changes were observed in AHR, hydroxyproline level, goblet cell hyperplasia, and mucus hyper-secretion. Ganoderma can be applied as an immunomodulatory and anti-inflammatory agent for managing asthma.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022. Published by Elsevier B.V.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Li\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Yanfeng\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Y\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Li\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Miaomiao\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Wang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Rui\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       R\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Wang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Biyu\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       B\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Athari\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Seyyed Shamsadin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       SS\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Wang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Jinli\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China. Electronic address: wangjinli1980@sina.com.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      01\n",
      "     </Month>\n",
      "     <Day>\n",
      "      10\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     Netherlands\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Respir Physiol Neurobiol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     101140022\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     1569-9048\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000893\">\n",
      "      Anti-Inflammatory Agents\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      1HGW4DR56D\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      9006-59-1\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D010047\">\n",
      "      Ovalbumin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      RMB44WO89X\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D006909\">\n",
      "      Hydroxyproline\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000818\">\n",
      "      Animals\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000893\">\n",
      "      Anti-Inflammatory Agents\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000494\">\n",
      "      pharmacology\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001992\">\n",
      "      Bronchoalveolar Lavage Fluid\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D016207\">\n",
      "      Cytokines\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D004195\">\n",
      "      Disease Models, Animal\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D032902\">\n",
      "      Ganoderma\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006909\">\n",
      "      Hydroxyproline\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006965\">\n",
      "      Hyperplasia\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008168\">\n",
      "      Lung\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000473\">\n",
      "      pathology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D051379\">\n",
      "      Mice\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D008807\">\n",
      "      Mice, Inbred BALB C\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D010047\">\n",
      "      Ovalbumin\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Airway\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Allergy\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Ganoderma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Inflammation\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Traditional medicine\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      6\n",
      "     </Month>\n",
      "     <Day>\n",
      "      10\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      10\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      9\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      4\n",
      "     </Month>\n",
      "     <Day>\n",
      "      19\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      13\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      20\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      20\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35026480\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.resp.2022.103843\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S1569-9048(22)00002-7\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    35026207\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     07\n",
      "    </Month>\n",
      "    <Day>\n",
      "     12\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     09\n",
      "    </Month>\n",
      "    <Day>\n",
      "     15\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1097-6825\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       150\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       1\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Jul\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      The Journal of allergy and clinical immunology\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      J Allergy Clin Immunol\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      170\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      177.e6\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      170-177.e6\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.jaci.2021.12.787\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S0091-6749(22)00005-7\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"BACKGROUND\">\n",
      "      Patients with aspirin-exacerbated respiratory disease can experience severe reactions during aspirin challenge that are associated with high levels of mast cell mediators. The tissue source and clinical factors contributing to systemic mediator levels are unknown.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"OBJECTIVE\">\n",
      "      We sought to determine the concordance between respiratory tract and systemic inflammatory mediator levels and identify clinical factors associated with these mediators.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"METHODS\">\n",
      "      We performed an oral aspirin challenge in 30 subjects with aspirin-exacerbated respiratory disease. Respiratory symptoms and function, nasal mucosal fluid, blood, and urine were collected at baseline, at the onset of a respiratory reaction, and over a 3-hour observation period. Changes in nasal and systemic mediator levels were compared.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"RESULTS\">\n",
      "      Neither tryptase nor leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      levels in nasal fluid correlated with serum tryptase or urinary leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      levels at baseline or during reactions. We observed no association between the baseline or aspirin-induced change in nasal versus urinary leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      and serum tryptase levels. Body mass index inversely correlated with baseline and aspirin-induced urinary leukotriene E\n",
      "      <sub>\n",
      "       4\n",
      "      </sub>\n",
      "      , prostaglandin D\n",
      "      <sub>\n",
      "       2\n",
      "      </sub>\n",
      "      metabolite, and serum tryptase levels, as well as with aspirin-induced symptoms and respiratory function, but not with nasal mediators.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSIONS\">\n",
      "      The levels of nasal and systemic aspirin-induced mast cell products are discordant in aspirin-exacerbated respiratory disease. Systemically detected levels are likely derived from mast cells outside of the sinonasal cavity and do not accurately reflect upper respiratory tract production. Increased body mass index decreases systemic mast cell mediator production and reaction severity, supporting a contribution of metabolic regulation in aspirin-induced systemic reactions.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Cahill\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Katherine N\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       KN\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: Katherine.cahill@vumc.org.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Wu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Pingsheng\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       P\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Milne\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Ginger L\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       GL\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Pharmacology, Vanderbilt University, Nashville, Tenn.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Amin\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Taneem\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       T\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Singer\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joseph\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       J\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Murphy\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Katherine\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       K\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lewis\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Erin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       E\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Gapko\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Deborah\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       D\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Boyce\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joshua A\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JA\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Buchheit\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Katherine M\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       KM\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Laidlaw\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Tanya M\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       TM\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <GrantList CompleteYN=\"Y\">\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 HL128241\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       HL\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NHLBI NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       U01 AI155299\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       T32 AI007306\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       U19 AI095219\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 AI078908\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       P30 DK020593\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       DK\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIDDK NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 HL136209\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       HL\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NHLBI NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R37 AI052353\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       R01 AI136041\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "     <Grant>\n",
      "      <GrantID>\n",
      "       K23 AI118804\n",
      "      </GrantID>\n",
      "      <Acronym>\n",
      "       AI\n",
      "      </Acronym>\n",
      "      <Agency>\n",
      "       NIAID NIH HHS\n",
      "      </Agency>\n",
      "      <Country>\n",
      "       United States\n",
      "      </Country>\n",
      "     </Grant>\n",
      "    </GrantList>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D052061\">\n",
      "      Research Support, N.I.H., Extramural\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      01\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     J Allergy Clin Immunol\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     1275002\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0091-6749\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      75715-89-8\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 3.4.21.59\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D053802\">\n",
      "      Tryptases\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      R16CO5Y76E\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001241\">\n",
      "      Aspirin\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000009\">\n",
      "      adverse effects\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015992\">\n",
      "      Body Mass Index\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D012137\">\n",
      "      Respiratory System\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D012852\">\n",
      "      Sinusitis\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D053802\">\n",
      "      Tryptases\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Aspirin-exacerbated respiratory disease\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     aspirin-induced reactions\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     body mass index\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     leukotrienes\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     mast cells\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     prostaglandins\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "   <CoiStatement>\n",
      "    <b>\n",
      "     Conflicts of Interest:\n",
      "    </b>\n",
      "    KN Cahill has severed on scientific advisory boards for Teva, GlaxoSmithKline, Blueprint Medicines, Regeneron, Genentech, Sanofi-Pasteur and reports personal fees from Novartis, Third Harmonic Bio, Ribon Therapeutics, and Verantos outside the submitted work. JA Boyce has served on scientific advisory boards for Sanofi and Regeneron. K Buchheit has served on scientific advisory boards for AstraZeneca, Sanofi-Genzyme, Regeneron, and GlaxoSmithKline. TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline, Sanofi-Genzyme, and Regeneron. P Wu, G Milne, T Amin, J Singer, K Murphy, E Lewis, and D Gapko have no conflicts.\n",
      "   </CoiStatement>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      25\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      11\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      29\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pmc-release\">\n",
      "     <Year>\n",
      "      2023\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      1\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      1\n",
      "     </Month>\n",
      "     <Day>\n",
      "      13\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      20\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      15\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     35026207\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"mid\">\n",
      "     NIHMS1770703\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pmc\">\n",
      "     PMC9271535\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.jaci.2021.12.787\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S0091-6749(22)00005-7\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "   <ReferenceList>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572–5.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       8564100\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245–52.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC4289104\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       25218285\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Cahill KN, Murphy K, Singer J, Israel E, Boyce JA, Laidlaw TM. Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(2):799–803 e2.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6519056\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30339852\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Boyce JA. Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function. J Allergy Clin Immunol. 2019;144(4):875–81.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7735393\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       31587797\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      White A, Ludington E, Mehra P, Stevenson DD, Simon RA. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol. 2006;97(5):688–93.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       17165280\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Huang GX, Palumbo ML, Singer JI, Cahill KN, Laidlaw TM. Sinus surgery improves lower respiratory reactivity during aspirin desensitization for AERD. J Allergy Clin Immunol Pract. 2019.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC7110416\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30877073\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Jerschow E, Edin ML, Chi Y, Hurst B, Abuzeid WM, Akbar NA, et al. Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2019;7(5):1580–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6511299\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30580047\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Giouleka P, Papatheodorou G, Lyberopoulos P, Karakatsani A, Alchanatis M, Roussos C, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest. 2011;41(1):30–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20825465\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, et al. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes. 2012;61(9):2311–9.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3425405\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22688342\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Amorim NRT, Luna-Gomes T, Gama-Almeida M, Souza-Almeida G, Canetti C, Diaz BL, et al. Leptin Elicits LTC4 Synthesis by Eosinophils Mediated by Sequential Two-Step Autocrine Activation of CCR3 and PGD2 Receptors. Front Immunol. 2018;9:2139.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6160734\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30298073\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol. 2004;287(3):L497–502.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       15145787\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol. 2002;168(8):4018–24.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       11937559\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Baek HS, Choi JH, Oh JW, Lee HB. Leptin and urinary leukotriene E4 and 9alpha,11beta-prostaglandin F2 release after exercise challenge. Ann Allergy Asthma Immunol. 2013;111(2):112–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       23886229\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Karampatakis N, Karampatakis T, Galli-Tsinopoulou A, Kotanidou EP, Tsergouli K, Eboriadou-Petikopoulou M, et al. Impaired glucose metabolism and bronchial hyperresponsiveness in obese prepubertal asthmatic children. Pediatr Pulmonol. 2017;52(2):160–6.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       27362543\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol. 1999;104(3 Pt 1):559–64.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       10482828\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(1):316–24 e7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6286686\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29890239\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Staso PJ, Wu P, Laidlaw TM, Cahill KN. Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC8222107\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       33781934\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790–8.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC3335383\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22262771\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Thwaites RS, Ito K, Chingono JMS, Coates M, Jarvis HC, Tunstall T, et al. Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis. J Infect Dis. 2017;215(8):1240–4.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5441107\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28368490\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51(11):3299–305.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC2952570\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       20671299\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol. 1994;14(3):190–204.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       7929694\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Protasiuk E, Olejnik M. Determination of Salicylic Acid in Feed Using LC-MS/MS. J Vet Res. 2018;62(3):303–7.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6295987\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       30584609\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985;10(2):164–77.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       3888490\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Verboven K, Wouters K, Gaens K, Hansen D, Bijnen M, Wetzels S, et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep. 2018;8(1):4677.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC5856747\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29549282\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zelechowska P, Brzezinska-Blaszczyk E, Wiktorska M, Rozalska S, Wawrocki S, Kozlowska E, et al. Adipocytokines leptin and adiponectin function as mast cell activity modulators. Immunology. 2019;158(1):3–18.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6700464\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       31220342\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Divoux A, Moutel S, Poitou C, Lacasa D, Veyrie N, Aissat A, et al. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J Clin Endocrinol Metab. 2012;97(9):E1677–85.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       22745246\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Zelechowska P, Agier J, Kozlowska E, Brzezinska-Blaszczyk E. Mast cells participate in chronic low-grade inflammation within adipose tissue. Obes Rev. 2018;19(5):686–97.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       29334696\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Richelsen B Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47(3):171–82.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       1475271\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Paivarinta U, Moilanen T, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm. 2009;2009:345838.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC2726438\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       19688109\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Nair P, Radford K, Fanat A, Janssen LJ, Peters-Golden M, Cox PG. The effects of leptin on airway smooth muscle responses. Am J Respir Cell Mol Biol. 2008;39(4):475–81.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       18421018\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol. 1988;82(4):654–60.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       2844876\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019;381(25):2440–50.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       31851800\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "    <Reference>\n",
      "     <Citation>\n",
      "      Lugogo N, Green CL, Agada N, Zhang S, Meghdadpour S, Zhou R, et al. Obesity’s effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol. 2018;141(3):1096–104.\n",
      "     </Citation>\n",
      "     <ArticleIdList>\n",
      "      <ArticleId IdType=\"pmc\">\n",
      "       PMC6076889\n",
      "      </ArticleId>\n",
      "      <ArticleId IdType=\"pubmed\">\n",
      "       28624608\n",
      "      </ArticleId>\n",
      "     </ArticleIdList>\n",
      "    </Reference>\n",
      "   </ReferenceList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    34954219\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     03\n",
      "    </Month>\n",
      "    <Day>\n",
      "     16\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     03\n",
      "    </Month>\n",
      "    <Day>\n",
      "     16\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Print\">\n",
      "      1098-8823\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       158\n",
      "      </Volume>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Feb\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Prostaglandins &amp; other lipid mediators\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Prostaglandins Other Lipid Mediat\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Role of arachidonic acid lipoxygenase pathway in Asthma.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      106609\n",
      "     </StartPage>\n",
      "     <MedlinePgn>\n",
      "      106609\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1016/j.prostaglandins.2021.106609\n",
      "    </ELocationID>\n",
      "    <ELocationID EIdType=\"pii\" ValidYN=\"Y\">\n",
      "     S1098-8823(21)00084-8\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText>\n",
      "      The arachidonic acid (AA) metabolism pathways play a key role in immunological response and inflammation diseases, such as asthma, etc. AA in cell membranes can be metabolized by lipoxygenases (LOXs) to a screen of bioactive substances that include leukotrienes (LTs), lipoxins (LXs), and eicosatetraenoic acids (ETEs), which are considered closely related to the pathophysiology of respiratory allergic disease. Studies also verified that drugs regulating AA LOXs pathway have better rehabilitative intervention for asthma. This review aims to summarize the physiological and pathophysiological importance of AA LOXs metabolism pathways in asthma and to discuss its prospects of therapeutic strategies.\n",
      "     </AbstractText>\n",
      "     <CopyrightInformation>\n",
      "      Copyright © 2021 Elsevier Inc. All rights reserved.\n",
      "     </CopyrightInformation>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Luo\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Yacan\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       Y\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Jin\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Minli\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lou\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Lejing\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       L\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Yang\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Song\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       S\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Li\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Chengye\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Li\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Xi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       X\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        The Affiliated Kangning Hospital of Wenzhou Medical University, Wenzhou, PR China.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Zhou\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Meixi\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: 351070639@qq.com.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Cai\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Chang\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: WZFY2017@163.com.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      23\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     United States\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Prostaglandins Other Lipid Mediat\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     9808648\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     1098-8823\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D044045\">\n",
      "      Lipoxins\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 1.13.11.-\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001091\">\n",
      "      Arachidonate Lipoxygenases\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 1.13.11.-\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D058945\">\n",
      "      Lipoxygenases\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      EC 1.13.11.34\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D001094\">\n",
      "      Arachidonate 5-Lipoxygenase\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001094\">\n",
      "      Arachidonate 5-Lipoxygenase\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001091\">\n",
      "      Arachidonate Lipoxygenases\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015289\">\n",
      "      Leukotrienes\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D044045\">\n",
      "      Lipoxins\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D058945\">\n",
      "      Lipoxygenases\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Airway inflammation\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Arachidonic acid\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Lipoxygenase\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"received\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      7\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"revised\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      11\n",
      "     </Month>\n",
      "     <Day>\n",
      "      15\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"accepted\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      27\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      17\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      12\n",
      "     </Month>\n",
      "     <Day>\n",
      "      26\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      20\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      39\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     34954219\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1016/j.prostaglandins.2021.106609\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"pii\">\n",
      "     S1098-8823(21)00084-8\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation IndexingMethod=\"Automated\" Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    34376110\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     07\n",
      "    </Month>\n",
      "    <Day>\n",
      "     14\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     07\n",
      "    </Month>\n",
      "    <Day>\n",
      "     26\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1532-4303\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       59\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       8\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Aug\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      The Journal of asthma : official journal of the Association for the Care of Asthma\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      J Asthma\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Inhaled corticosteroids' effects on biomarkers in exhaled breath condensate and blood in patients newly diagnosed with asthma who smoke.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      1613\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      1620\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      1613-1620\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1080/02770903.2021.1962341\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"OBJECTIVE\">\n",
      "      Exposure to cigarette smoke complicates the treatment and management of asthma through a variety of inflammatory effects. This study aimed to investigate the differences between newly diagnosed cases of asthma in smokers and nonsmokers in terms of localized and systemic biomarkers following treatment with inhaled corticosteroids (ICS) or ICS in combination with a long-acting β2 agonist (LABA).\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"METHODS\">\n",
      "      Specimens of exhaled breath condensate (EBC) from newly diagnosed patients with asthma were used to quantify inflammation in the airways, while blood samples were used to assess systemic inflammation. In both samples, the levels of IL-6, LTB4, LTD4, and 8-isoprostane were measured and these were repeated after 3 months of treatment with ICS or ICS + LABA.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"RESULTS\">\n",
      "      Of the 20 patients, 10 (50%) were nonsmokers with asthma (NSA) and 10 (50%) smokers with asthma (SA). There was no statistically significant difference in the blood or EBC levels of IL-6, LTB4, LTD4, or 8-isoprostane between the groups prior to treatment. Only the decrease in 8-isoprostane level in the EBC samples was found to be significantly greater in the NSA group after treatment (for smokers, the change was 2.91 ± 23.22, while for nonsmokers it was -22.72 ± 33.12,\n",
      "      <i>\n",
      "       p\n",
      "      </i>\n",
      "      = 0.022). Post-treatment asthma control was significantly better in the NSA group (\n",
      "      <i>\n",
      "       p\n",
      "      </i>\n",
      "      = 0.033).\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSION\">\n",
      "      Monitoring the alterations in 8-isoprostane levels in EBC in patients with asthma who smoke may be helpful in deciding on therapeutic management and switching treatments. Asthma control was better in nonsmokers than in smokers.\n",
      "     </AbstractText>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Duman\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Berna\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       B\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Bezmiâlem Vakıf University School of Medicine, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Borekci\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Sermin\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       S\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0002-0089-1312\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Akdeniz\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Nilgun\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       N\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Gazioglu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Sema Bilgic\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       SB\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Deniz\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Gunnur\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       G\n",
      "      </Initials>\n",
      "      <Identifier Source=\"ORCID\">\n",
      "       0000-0002-0721-6213\n",
      "      </Identifier>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Gemicioglu\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Bilun\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       B\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D013485\">\n",
      "      Research Support, Non-U.S. Gov't\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      08\n",
      "     </Month>\n",
      "     <Day>\n",
      "      14\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     England\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     J Asthma\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     8106454\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0277-0903\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D000305\">\n",
      "      Adrenal Cortex Hormones\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015415\">\n",
      "      Biomarkers\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015850\">\n",
      "      Interleukin-6\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      1HGW4DR56D\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      73836-78-9\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017998\">\n",
      "      Leukotriene D4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D000305\">\n",
      "      Adrenal Cortex Hormones\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"Y\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000175\">\n",
      "      diagnosis\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015415\">\n",
      "      Biomarkers\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001944\">\n",
      "      Breath Tests\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D045853\">\n",
      "      Exhalation\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007249\">\n",
      "      Inflammation\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000188\">\n",
      "      drug therapy\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015850\">\n",
      "      Interleukin-6\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D007975\">\n",
      "      Leukotriene B4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017998\">\n",
      "      Leukotriene D4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000627\">\n",
      "      therapeutic use\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D012907\">\n",
      "      Smoking\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000453\">\n",
      "      epidemiology\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     8-isoprostane\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     Asthma\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     IL-6\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     LTB4\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     LTD4\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     biomarkers\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     exhaled breath condensate\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     smoking\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      12\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      7\n",
      "     </Month>\n",
      "     <Day>\n",
      "      15\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      8\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      5\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      30\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     34376110\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1080/02770903.2021.1962341\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      " <PubmedArticle>\n",
      "  <MedlineCitation Owner=\"NLM\" Status=\"MEDLINE\">\n",
      "   <PMID Version=\"1\">\n",
      "    33973823\n",
      "   </PMID>\n",
      "   <DateCompleted>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     03\n",
      "    </Month>\n",
      "    <Day>\n",
      "     07\n",
      "    </Day>\n",
      "   </DateCompleted>\n",
      "   <DateRevised>\n",
      "    <Year>\n",
      "     2022\n",
      "    </Year>\n",
      "    <Month>\n",
      "     03\n",
      "    </Month>\n",
      "    <Day>\n",
      "     07\n",
      "    </Day>\n",
      "   </DateRevised>\n",
      "   <Article PubModel=\"Print-Electronic\">\n",
      "    <Journal>\n",
      "     <ISSN IssnType=\"Electronic\">\n",
      "      1097-6817\n",
      "     </ISSN>\n",
      "     <JournalIssue CitedMedium=\"Internet\">\n",
      "      <Volume>\n",
      "       166\n",
      "      </Volume>\n",
      "      <Issue>\n",
      "       2\n",
      "      </Issue>\n",
      "      <PubDate>\n",
      "       <Year>\n",
      "        2022\n",
      "       </Year>\n",
      "       <Month>\n",
      "        Feb\n",
      "       </Month>\n",
      "      </PubDate>\n",
      "     </JournalIssue>\n",
      "     <Title>\n",
      "      Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery\n",
      "     </Title>\n",
      "     <ISOAbbreviation>\n",
      "      Otolaryngol Head Neck Surg\n",
      "     </ISOAbbreviation>\n",
      "    </Journal>\n",
      "    <ArticleTitle>\n",
      "     Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.\n",
      "    </ArticleTitle>\n",
      "    <Pagination>\n",
      "     <StartPage>\n",
      "      224\n",
      "     </StartPage>\n",
      "     <EndPage>\n",
      "      232\n",
      "     </EndPage>\n",
      "     <MedlinePgn>\n",
      "      224-232\n",
      "     </MedlinePgn>\n",
      "    </Pagination>\n",
      "    <ELocationID EIdType=\"doi\" ValidYN=\"Y\">\n",
      "     10.1177/01945998211011060\n",
      "    </ELocationID>\n",
      "    <Abstract>\n",
      "     <AbstractText Label=\"OBJECTIVE\">\n",
      "      To provide a comprehensive state-of-the-art review of the emerging role of urine leukotriene E4 (uLTE4) as a biomarker in the diagnosis of chronic rhinosinusitis (CRS), aspirin-exacerbated respiratory disease (AERD), and asthma.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"DATA SOURCES\">\n",
      "      Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"REVIEW METHODS\">\n",
      "      A state-of-the-art review was performed investigating the role of uLTE4 as a diagnostic biomarker, predictor of disease severity, and potential marker of selected therapeutic efficacy.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"CONCLUSIONS\">\n",
      "      uLTE4 has been shown to be a reliable and clinically relevant biomarker for CRS, AERD, and asthma. uLTE4 is helpful in ongoing efforts to better endotype patients with CRS and to predict disease severity.\n",
      "     </AbstractText>\n",
      "     <AbstractText Label=\"IMPLICATIONS FOR PRACTICE\">\n",
      "      Aside from being a diagnostic biomarker, uLTE4 is also able to differentiate aspirin-tolerant patients from patients with AERD and has been associated with objective disease severity in patients with CRS with nasal polyposis. uLTE4 levels have also been shown to predict response to medical therapy, particularly leukotriene-modifying agents.\n",
      "     </AbstractText>\n",
      "    </Abstract>\n",
      "    <AuthorList CompleteYN=\"Y\">\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Choby\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Garret\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       G\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Low\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Christopher M\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       CM\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Levy\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joshua M\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JM\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Emory University, Atlanta, Georgia, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Stokken\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Janalee K\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JK\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Pinheiro-Neto\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Carlos\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       C\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Bartemes\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Kathy\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       K\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Marino\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Michael\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       M\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Han\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Joseph K\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       JK\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Divekar\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Rohit\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       R\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       O'Brien\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Erin K\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       EK\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "     <Author ValidYN=\"Y\">\n",
      "      <LastName>\n",
      "       Lal\n",
      "      </LastName>\n",
      "      <ForeName>\n",
      "       Devyani\n",
      "      </ForeName>\n",
      "      <Initials>\n",
      "       D\n",
      "      </Initials>\n",
      "      <AffiliationInfo>\n",
      "       <Affiliation>\n",
      "        Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.\n",
      "       </Affiliation>\n",
      "      </AffiliationInfo>\n",
      "     </Author>\n",
      "    </AuthorList>\n",
      "    <Language>\n",
      "     eng\n",
      "    </Language>\n",
      "    <PublicationTypeList>\n",
      "     <PublicationType UI=\"D016428\">\n",
      "      Journal Article\n",
      "     </PublicationType>\n",
      "     <PublicationType UI=\"D016454\">\n",
      "      Review\n",
      "     </PublicationType>\n",
      "    </PublicationTypeList>\n",
      "    <ArticleDate DateType=\"Electronic\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      05\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "    </ArticleDate>\n",
      "   </Article>\n",
      "   <MedlineJournalInfo>\n",
      "    <Country>\n",
      "     England\n",
      "    </Country>\n",
      "    <MedlineTA>\n",
      "     Otolaryngol Head Neck Surg\n",
      "    </MedlineTA>\n",
      "    <NlmUniqueID>\n",
      "     8508176\n",
      "    </NlmUniqueID>\n",
      "    <ISSNLinking>\n",
      "     0194-5998\n",
      "    </ISSNLinking>\n",
      "   </MedlineJournalInfo>\n",
      "   <ChemicalList>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      0\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D015415\">\n",
      "      Biomarkers\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "    <Chemical>\n",
      "     <RegistryNumber>\n",
      "      75715-89-8\n",
      "     </RegistryNumber>\n",
      "     <NameOfSubstance UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </NameOfSubstance>\n",
      "    </Chemical>\n",
      "   </ChemicalList>\n",
      "   <CitationSubset>\n",
      "    IM\n",
      "   </CitationSubset>\n",
      "   <MeshHeadingList>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D001249\">\n",
      "      Asthma\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"Y\" UI=\"Q000175\">\n",
      "      diagnosis\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D055963\">\n",
      "      Asthma, Aspirin-Induced\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000175\">\n",
      "      diagnosis\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D015415\">\n",
      "      Biomarkers\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"Y\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D002908\">\n",
      "      Chronic Disease\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D006801\">\n",
      "      Humans\n",
      "     </DescriptorName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D017999\">\n",
      "      Leukotriene E4\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"Y\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D012220\">\n",
      "      Rhinitis\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"Y\" UI=\"Q000175\">\n",
      "      diagnosis\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "    <MeshHeading>\n",
      "     <DescriptorName MajorTopicYN=\"N\" UI=\"D012852\">\n",
      "      Sinusitis\n",
      "     </DescriptorName>\n",
      "     <QualifierName MajorTopicYN=\"Y\" UI=\"Q000175\">\n",
      "      diagnosis\n",
      "     </QualifierName>\n",
      "     <QualifierName MajorTopicYN=\"N\" UI=\"Q000652\">\n",
      "      urine\n",
      "     </QualifierName>\n",
      "    </MeshHeading>\n",
      "   </MeshHeadingList>\n",
      "   <KeywordList Owner=\"NOTNLM\">\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     AERD\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     aspirin-exacerbated respiratory disease\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     biomarker\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     chronic rhinosinusitis\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     endotype\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     nasal polyps\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     phenotype\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     uLTE4\n",
      "    </Keyword>\n",
      "    <Keyword MajorTopicYN=\"N\">\n",
      "     urine leukotriene E4\n",
      "    </Keyword>\n",
      "   </KeywordList>\n",
      "  </MedlineCitation>\n",
      "  <PubmedData>\n",
      "   <History>\n",
      "    <PubMedPubDate PubStatus=\"pubmed\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      12\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"medline\">\n",
      "     <Year>\n",
      "      2022\n",
      "     </Year>\n",
      "     <Month>\n",
      "      3\n",
      "     </Month>\n",
      "     <Day>\n",
      "      8\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      6\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      0\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "    <PubMedPubDate PubStatus=\"entrez\">\n",
      "     <Year>\n",
      "      2021\n",
      "     </Year>\n",
      "     <Month>\n",
      "      5\n",
      "     </Month>\n",
      "     <Day>\n",
      "      11\n",
      "     </Day>\n",
      "     <Hour>\n",
      "      12\n",
      "     </Hour>\n",
      "     <Minute>\n",
      "      12\n",
      "     </Minute>\n",
      "    </PubMedPubDate>\n",
      "   </History>\n",
      "   <PublicationStatus>\n",
      "    ppublish\n",
      "   </PublicationStatus>\n",
      "   <ArticleIdList>\n",
      "    <ArticleId IdType=\"pubmed\">\n",
      "     33973823\n",
      "    </ArticleId>\n",
      "    <ArticleId IdType=\"doi\">\n",
      "     10.1177/01945998211011060\n",
      "    </ArticleId>\n",
      "   </ArticleIdList>\n",
      "  </PubmedData>\n",
      " </PubmedArticle>\n",
      "</PubmedArticleSet>\n"
     ]
    }
   ],
   "source": [
    "from bs4 import BeautifulSoup\n",
    "  \n",
    "soup = BeautifulSoup(r4.text, \"xml\")\n",
    "print(soup.prettify())"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "id": "54d58933",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<?xml version=\"1.0\" ?>\n",
      "<!DOCTYPE PubmedArticleSet\n",
      "  PUBLIC '-//NLM//DTD PubMedArticle, 1st January 2023//EN'\n",
      "  'https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd'>\n",
      "<PubmedArticleSet>\n",
      "\t\n",
      "\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">36184313</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t<Day>07</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t<Day>09</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1097-6825</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>151</Volume>\n",
      "\t\t\t\t\t\t<Issue>2</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t\t\t<Month>Feb</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>The Journal of allergy and clinical immunology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Updates on immune mechanisms in aspirin-exacerbated respiratory disease.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>301</StartPage>\n",
      "\t\t\t\t\t<EndPage>309</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>301-309</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2022.08.021</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)01171-X</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tAspirin-exacerbated respiratory disease has fascinated and frustrated specialists in allergy/immunology, pulmonology, and otorhinolaryngology for decades. It generally develops in previously healthy young adults and is unremitting and challenging to treat. The classical triad of asthma, nasal polyposis, and pathognomonic respiratory reactions to aspirin and other cyclooxygenase-1 inhibitors is accompanied by high levels of mast cell activation, cysteinyl leukotriene production, platelet activation, and severe type 2 respiratory inflammation. The &quot;unbraking&quot; of mast cell activation and further cysteinyl leukotriene generation induced by cyclooxygenase-1 inhibition reflect an idiosyncratic dependency on cyclooxygenase-1-derived products, likely prostaglandin E\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t, to maintain a tenuous homeostasis. Although cysteinyl leukotrienes are clear disease effectors, little else was known about their cellular sources and targets, and the contributions from other mediators and type 2 respiratory inflammation effector cells to disease pathophysiology were unknown until recently. The applications of targeted biological therapies, single-cell genomics, and transgenic animal approaches have substantially advanced our understanding of aspirin-exacerbated respiratory disease pathogenesis and treatment and have also revealed disease heterogeneity. This review covers novel insights into the immunopathogenesis of aspirin-exacerbated respiratory disease from each of these lines of research, including the roles of lipid mediators, effector cell populations, and inflammatory cytokines, discusses unanswered questions regarding cause and pathogenesis, and considers potential future therapeutic options.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Laidlaw</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Tanya M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>TM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass. Electronic address: tlaidlaw@bwh.harvard.edu.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Boyce</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joshua A</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JA</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medicine, the Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Harvard Medical School, Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<GrantList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 AI078908</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 AI136041</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R37 AI052353</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>U19 AI095219</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t</GrantList>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t\t<Day>30</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>J Allergy Clin Immunol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>1275002</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0091-6749</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 1.14.99.1</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D051545\">Cyclooxygenase 1</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>R16CO5Y76E</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051545\" MajorTopicYN=\"N\">Cyclooxygenase 1</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">AERD</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">CRSwNP</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotriene E4</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">mast cells</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">mechanisms</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">prostaglandin E2</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>\n",
      "\t\t\t\t<b>Conflict of Interest:</b>\n",
      "\t\t\t\t TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline and Sanofi-Genzyme, Novartis, and Regeneron. JA Boyce has served on the advisory boards of Sanofi-Genzyme, Siolta Therapeutics, and Third Harmonic Bio.\n",
      "\t\t\t</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>3</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>10</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pmc-release\">\n",
      "\t\t\t\t\t<Year>2024</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>10</Month>\n",
      "\t\t\t\t\t<Day>3</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>10</Month>\n",
      "\t\t\t\t\t<Day>2</Day>\n",
      "\t\t\t\t\t<Hour>22</Hour>\n",
      "\t\t\t\t\t<Minute>12</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">36184313</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"mid\">NIHMS1839874</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC9905222</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaci.2022.08.021</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0091-6749(22)01171-X</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Inada M, Matsumoto C, Uematsu S, Akira S, Miyaura C. Membrane-bound prostaglandin E synthase-1-mediated prostaglandin E2 production by osteoblast plays a critical role in lipopolysaccharide-induced bone loss associated with inflammation. J Immunol. 2006;177(3):1879–85.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16849500</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kay LJ, Yeo WW, Peachell PT. Prostaglandin E2 activates EP2 receptors to inhibit human lung mast cell degranulation. Br J Pharmacol. 2006;147(7):707–13.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC1751511</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16432506</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Maric J, Ravindran A, Mazzurana L, Bjorklund AK, Van Acker A, Rao A, et al. Prostaglandin E2 suppresses human group 2 innate lymphoid cell function. J Allergy Clin Immunol. 2018;141(5):1761–73 e6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5929462</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29217133</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Brock TG. Regulating leukotriene synthesis: the role of nuclear 5-lipoxygenase. J Cell Biochem. 2005;96(6):1203–11.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16215982</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yoshimura T, Yoshikawa M, Otori N, Haruna S, Moriyama H. Correlation between the prostaglandin D(2)/E(2) ratio in nasal polyps and the recalcitrant pathophysiology of chronic rhinosinusitis associated with bronchial asthma. Allergol Int. 2008;57(4):429–36.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">18797183</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Roca-Ferrer J, Perez-Gonzalez M, Garcia-Garcia FJ, Pereda J, Pujols L, Alobid I, et al. Low Prostaglandin E(2) and Cyclooxygenase Expression in Nasal Mucosa Fibroblasts of Aspirin-Intolerant Asthmatics. Respirology. 2013.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23441755</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Machado-Carvalho L, Martin M, Torres R, Gabasa M, Alobid I, Mullol J, et al. Low E-prostanoid 2 receptor levels and deficient induction of the IL-1beta/IL-1 type I receptor/COX-2 pathway: Vicious circle in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(1):99–107.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26560040</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Corrigan CJ, Napoli RL, Meng Q, Fang C, Wu H, Tochiki K, et al. Reduced expression of the prostaglandin E2 receptor E-prostanoid 2 on bronchial mucosal leukocytes in patients with aspirin-sensitive asthma. J Allergy Clin Immunol. 2012;129(6):1636–46.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22418066</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ying S, Meng Q, Scadding G, Parikh A, Corrigan CJ, Lee TH. Aspirin-sensitive rhinosinusitis is associated with reduced E-prostanoid 2 receptor expression on nasal mucosal inflammatory cells. J Allergy Clin Immunol. 2006;117(2):312–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16461132</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN, Raby BA, Zhou X, Guo F, Thibault D, Baccarelli A, et al. Impaired E Prostanoid2 Expression and Resistance to Prostaglandin E2 in Nasal Polyp Fibroblasts from Subjects with Aspirin-Exacerbated Respiratory Disease. Am J Respir Cell Mol Biol. 2016;54(1):34–40.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4742927</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26051534</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572–5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">8564100</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu T, Laidlaw TM, Katz HR, Boyce JA. Prostaglandin E2 deficiency causes a phenotype of aspirin sensitivity that depends on platelets and cysteinyl leukotrienes. Proc Natl Acad Sci U S A. 2013;110(42):16987–92.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3801005</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24085850</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Weiss JW, Drazen JM, McFadden ER Jr., Weller P, Corey EJ, Lewis RA, et al. Airway constriction in normal humans produced by inhalation of leukotriene D. Potency, time course, and effect of aspirin therapy. JAMA. 1983;249(20):2814–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">6842792</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Christie PE, Tagari P, Ford-Hutchinson AW, Charlesson S, Chee P, Arm JP, et al. Urinary leukotriene E4 concentrations increase after aspirin challenge in aspirin-sensitive asthmatic subjects. Am Rev Respir Dis. 1991;143(5 Pt 1):1025–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">1850964</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Arm JP, O’Hickey SP, Spur BW, Lee TH. Airway responsiveness to histamine and leukotriene E4 in subjects with aspirin-induced asthma. Am Rev Respir Dis. 1989;140(1):148–53.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">2546469</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Rubin P, Cohn J, et al. Direct evidence for a role of the mast cell in the nasal response to aspirin in aspirin-sensitive asthma. J Allergy Clin Immunol. 1994;94(6 Pt 1):1046–56.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">7798537</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Israel E, Fischer AR, Rosenberg MA, Lilly CM, Callery JC, Shapiro J, et al. The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin. Am Rev Respir Dis. 1993;148(6 Pt 1):1447–51.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">8256883</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Fuentes DJ, Wang Y. Efficacy of Zileuton in Patients with Asthma and History of Aspirin Sensitivity: A Retrospective Analysis of Data from Two Phase 3 Studies. AAAAI: J Allergy Clin Immunol; 2017. p. AB384.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bankova LG, Lai J, Yoshimoto E, Boyce JA, Austen KF, Kanaoka Y, et al. Leukotriene E4 elicits respiratory epithelial cell mucin release through the G-protein-coupled receptor, GPR99. Proc Natl Acad Sci U S A. 2016;113(22):6242–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4896673</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27185938</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu T, Barrett NA, Kanaoka Y, Yoshimoto E, Garofalo D, Cirka H, et al. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity. J Immunol. 2018;200(3):915–27.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5780246</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29282304</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal Immunol. 2019;12(3):679–90.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6462243</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30664709</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bankova LG, Dwyer DF, Yoshimoto E, Ualiyeva S, McGinty JW, Raff H, et al. The cysteinyl leukotriene 3 receptor regulates expansion of IL-25-producing airway brush cells leading to type 2 inflammation. Sci Immunol. 2018;3(28).</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6599626</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30291131</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>von MJ, Ji M, Liang HE, Locksley RM. Tuft-cell-derived IL-25 regulates an intestinal ILC2-epithelial response circuit. Nature. 2016;529(7585):221–5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4830391</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26675736</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ualiyeva S, Lemire E, Aviles EC, Wong C, Boyd AA, Lai J, et al. Tuft cell-produced cysteinyl leukotrienes and IL-25 synergistically initiate lung type 2 inflammation. Sci Immunol. 2021;6(66):eabj0474.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8750919</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34932383</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ualiyeva S, Hallen N, Kanaoka Y, Ledderose C, Matsumoto I, Junger WG, et al. Airway brush cells generate cysteinyl leukotrienes through the ATP sensor P2Y2. Science Immunology. 2020;5(43):eaax7224.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7176051</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31953256</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Doherty TA, Khorram N, Lund S, Mehta AK, Croft M, Broide DH. Lung type 2 innate lymphoid cells express cysteinyl leukotriene receptor 1, which regulates TH2 cytokine production. J Allergy Clin Immunol. 2013;132(1):205–13.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3704056</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23688412</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>von Moltke J, O’Leary CE, Barrett NA, Kanaoka Y, Austen KF, Locksley RM. Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med. 2017;214(1):27–37.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5206504</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28011865</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>McGinty JW, Ting H-A, Billipp TE, Nadjsombati MS, Khan DM, Barrett NA, et al. Tuft-Cell-Derived Leukotrienes Drive Rapid Anti-helminth Immunity in the Small Intestine but Are Dispensable for Anti-protist Immunity. Immunity. 2020;52(3):528–41.e7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7469474</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32160525</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Stevenson DD, Simon RA, Mathison DA, Christiansen SC. Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics. Ann Allergy Asthma Immunol. 2000;85(6 Pt 1):477–82.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11152169</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mitson-Salazar A, Prussin C. Pathogenic Effector Th2 Cells in Allergic Eosinophilic Inflammatory Disease. Front Med (Lausanne). 2017;4:165.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5635264</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29057225</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Maric J, Ravindran A, Mazzurana L, Van Acker A, Rao A, Kokkinou E, et al. Cytokine-induced endogenous production of prostaglandin D2 is essential for human group 2 innate lymphoid cell activation. J Allergy Clin Immunol. 2019;143(6):2202–14 e5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30578872</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, et al. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1566–76.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4860132</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26691435</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D2: A dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245–52.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4289104</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25218285</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, et al. Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils, and basophils via seven-transmembrane receptor CRTH2. J Exp Med. 2001;193(2):255–61.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC2193345</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11208866</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Xue L, Salimi M, Panse I, Mjosberg JM, McKenzie AN, Spits H, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 2014;133(4):1184–94.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3979107</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24388011</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Xue L, Gyles SL, Wettey FR, Gazi L, Townsend E, Hunter MG, et al. Prostaglandin D2 causes preferential induction of proinflammatory Th2 cytokine production through an action on chemoattractant receptor-like molecule expressed on Th2 cells. J Immunol. 2005;175(10):6531–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16272307</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Price CPE, Guo A, Stevens WW, Cousens L, Vu TT, Suh LA, et al. Efficacy of an oral CRTH2 antagonist (AZD1981) in the treatment of chronic rhinosinusitis with nasal polyps in adults: a randomized controlled clinical trial. Clin Exp Allergy. 2022.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35524339</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Gevaert P, Bachert C, Maspero JF, Cuevas M, Steele D, Acharya S, et al. Phase 3b randomized controlled trial of fevipiprant in patients with nasal polyposis with asthma (THUNDER). J Allergy Clin Immunol. 2022;149(5):1675–82 e3.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35094848</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN. Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD2 receptor? J Allergy Clin Immunol. 2022;149(5):1587–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35304159</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cowburn AS, Sladek K, Soja J, Adamek L, Nizankowska E, Szczeklik A, et al. Overexpression of leukotriene C4 synthase in bronchial biopsies from patients with aspirin-intolerant asthma. J Clin Invest. 1998;101(4):834–46.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC508632</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">9466979</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nasser SM, Pfister R, Christie PE, Sousa AR, Barker J, Schmitz-Schumann M, et al. Inflammatory cell populations in bronchial biopsies from aspirin-sensitive asthmatic subjects. Am J Respir Crit Care Med. 1996;153(1):90–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">8542168</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Prussin C, Panettieri RA, Lee S, Ferguson BJ, Adappa ND, et al. Dexpramipexole depletes blood and tissue eosinophils in nasal polyps with no change in polyp size. Laryngoscope. 2019;129(2):E61–E6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30284267</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mitsui C, Kajiwara K, Hayashi H, Ito J, Mita H, Ono E, et al. Platelet activation markers overexpressed specifically in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26194538</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Takahashi T, Kato A, Berdnikovs S, Stevens WW, Suh LA, Norton JE, et al. Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(3):720–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5568994</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28238741</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Maclouf J, Murphy RC, Henson PM. Transcellular biosynthesis of sulfidopeptide leukotrienes during receptor-mediated stimulation of human neutrophil/platelet mixtures. Blood. 1990;76(9):1838–44.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">2224131</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3335383</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22262771</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2018.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6286686</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29890239</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Dwyer DF, Ordovas-Montanes J, Allon SJ, Buchheit KM, Vukovic M, Derakhshan T, et al. Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammation. Sci Immunol. 2021;6(56).</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8362933</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33637594</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bochenek G, Nagraba K, Nizankowska E, Szczeklik A. A controlled study of 9alpha,11beta-PGF2 (a prostaglandin D2 metabolite) in plasma and urine of patients with bronchial asthma and healthy controls after aspirin challenge. J Allergy Clin Immunol. 2003;111(4):743–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">12704352</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Imokawa S, Sato A, Taniguchi M, Toyoshima M, Nakazawa K, Hayakawa H, et al. [Sodium cromoglycate nebulized solution has an acute bronchodilative effect in patients with aspirin-intolerant asthma (AIA)]. Arerugi = [Allergy]. 1992;41(10):1515–20.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">1482300</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Amayasu H, Nakabayashi M, Akahori K, Ishizaki Y, Shoji T, Nakagawa H, et al. Cromolyn sodium suppresses eosinophilic inflammation in patients with aspirin-intolerant asthma. Ann Allergy Asthma Immunol. 2001;87(2):146–50.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11527248</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yoshida S, Amayasu H, Sakamoto H, Onuma K, Shoji T, Nakagawa H, et al. Cromolyn sodium prevents bronchoconstriction and urinary LTE4 excretion in aspirin-induced asthma. Ann Allergy Asthma Immunol. 1998;80(2):171–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">9494450</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Eastman JJ, Cavagnero KJ, Deconde AS, Kim AS, Karta MR, Broide DH, et al. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2017;140(1):101–8 e3.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5496786</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28279492</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Salimi M, Stoger L, Liu W, Go S, Pavord I, Klenerman P, et al. Cysteinyl leukotriene E4 activates human group 2 innate lymphoid cells and enhances the effect of prostaglandin D2 and epithelial cytokines. J Allergy Clin Immunol. 2017;140(4):1090–100 e11.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5624780</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28115217</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kupczyk M, Kurmanowska Z, Kuprys-Lipinska I, Bochenska-Marciniak M, Kuna P. Mediators of inflammation in nasal lavage from aspirin intolerant patients after aspirin challenge. Respir Med. 2010;104(10):1404–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20452758</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Buchheit KM, Dwyer DF, Ordovas-Montanes J, Katz HR, Lewis E, Vukovic M, et al. IL-5Ralpha marks nasal polyp IgG4 and IgE-expressing cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7282948</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32199912</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ordovas-Montanes J, Dwyer DF, Nyquist SK, Buchheit KM, Vukovic M, Deb C, et al. Allergic inflammatory memory in human respiratory epithelial progenitor cells. Nature. 2018;560(7720):649–54.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6133715</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30135581</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Stevens WW, Staudacher AG, Hulse KE, Carter RG, Winter DR, Kato A, et al. Activation of the 15-lipoxygenase pathway in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7606335</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32371071</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wenzel SE, Tyurina YY, Zhao J, St Croix CM, Dar HH, Mao G, et al. PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Cell. 2017;171(3):628–41 e26.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5683852</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29053969</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nagasaki T, Schuyler AJ, Zhao J, Samovich SN, Yamada K, Deng Y, et al. 15LO1 dictates glutathione redox changes in asthmatic airway epithelium to worsen type 2 inflammation. J Clin Invest. 2022;132(1).</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8718153</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34762602</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Buchheit KM. Biologics in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2020;124(4):326–32.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7113089</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31830587</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hayashi H, Mitsui C, Nakatani E, Fukutomi Y, Kajiwara K, Watai K, et al. Omalizumab reduces cysteinyl leukotriene and 9alpha,11beta-prostaglandin F2 overproduction in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2016;137(5):1585–7.e4.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26559322</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lang DM, Aronica MA, Maierson ES, Wang XF, Vasas DC, Hazen SL. Omalizumab can inhibit respiratory reaction during aspirin desensitization. Ann Allergy Asthma Immunol. 2018;121(1):98–104.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29777744</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tuttle KL, Buchheit KM, Laidlaw TM, Cahill KN. A retrospective analysis of mepolizumab in subjects with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2018;6(3):1045–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5997393</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29501519</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, et al. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148(2):574–84.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC9096876</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34144111</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Martin H, Barrett NA, Laidlaw T. Mepolizumab does not prevent all aspirin-induced reactions in patients with aspirin-exacerbated respiratory disease: A case series. J Allergy Clin Immunol Pract. 2021;9(3):1384–5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC9255360</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32956852</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Scott WC, Cahill KN, Milne GL, Li P, Sheng Q, Huang LC, et al. Inflammatory heterogeneity in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1318–28 e5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8035132</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33189729</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bachert C, Mannent L, Naclerio RM, Mullol J, Ferguson BJ, Gevaert P, et al. Effect of Subcutaneous Dupilumab on Nasal Polyp Burden in Patients With Chronic Sinusitis and Nasal Polyposis: A Randomized Clinical Trial. JAMA. 2016;315(5):469–79.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26836729</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Mullol J, Fan C, Zhang D, Amin N, Khan A, et al. Dupilumab improves nasal polyp burden and asthma control in patients with CRSwNP and AERD. J Allergy Clin Immunol Pract. 2019;7(7):2462–5 e1.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30954643</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bavaro N, Gakpo D, Mittal A, Bensko JC, Laidlaw TM, Buchheit KM. Efficacy of dupilumab in patients with aspirin-exacerbated respiratory disease and previous inadequate response to anti-IL-5 or anti-IL-5Ralpha in a real-world setting. J Allergy Clin Immunol Pract. 2021;9(7):2910–2 e1.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8277677</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33631410</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Buchheit KM, Sohail A, Hacker J, Maurer R, Gakpo D, Bensko JC, et al. Rapid and sustained effect of dupilumab on clinical and mechanistic outcomes in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2022.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC9378638</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35460728</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Patel P, Bensko JC, Bhattacharyya N, Laidlaw TM, Buchheit KM. Dupilumab as an adjunct to surgery in patients with aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2022;128(3):326–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8882131</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34863953</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Trudeau J, Hu H, Chibana K, Chu HW, Westcott JY, Wenzel SE. Selective downregulation of prostaglandin E2-related pathways by the Th2 cytokine IL-13. J Allergy Clin Immunol. 2006;117(6):1446–54.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">16751012</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mustafa SS, Vadamalai K. Dupilumab increases aspirin tolerance in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021;126(6):738–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33746062</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu T, Kanaoka Y, Barrett NA, Feng C, Garofalo D, Lai J, et al. Aspirin-Exacerbated Respiratory Disease Involves a Cysteinyl Leukotriene-Driven IL-33-Mediated Mast Cell Activation Pathway. J Immunol. 2015;195(8):3537–45.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4592820</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26342029</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Liu T, Barrett NA, Kanaoka Y, Buchheit K, Laidlaw TM, Garofalo D, et al. Cysteinyl leukotriene receptor 2 drives lung immunopathology through a platelet and high mobility box 1-dependent mechanism. Mucosal immunology. 2019.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6462243</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30664709</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Menzies-Gow A, Corren J, Bourdin A, Chupp G, Israel E, Wechsler ME, et al. Tezepelumab in Adults and Adolescents with Severe, Uncontrolled Asthma. N Engl J Med. 2021;384(19):1800–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33979488</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kelsen SG, Agache IO, Soong W, Israel E, Chupp GL, Cheung DS, et al. Astegolimab (anti-ST2) efficacy and safety in adults with severe asthma: A randomized clinical trial. J Allergy Clin Immunol. 2021;148(3):790–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33872652</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wechsler ME, Ruddy MK, Pavord ID, Israel E, Rabe KF, Ford LB, et al. Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma. New England Journal of Medicine. 2021;385(18):1656–68.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34706171</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Berges-Gimeno MP, Simon RA, Stevenson DD. Long-term treatment with aspirin desensitization in asthmatic patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2003;111(1):180–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">12532116</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN, Cui J, Kothari P, Murphy K, Raby BA, Singer J, et al. Unique Effect of Aspirin Therapy on Biomarkers in Aspirin-exacerbated Respiratory Disease. A Prospective Trial. Am J Respir Crit Care Med. 2019;200(6):704–11.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6775876</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30978291</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">12421891</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Picado C, Fernandez-Morata JC, Juan M, Roca-Ferrer J, Fuentes M, Xaubet A, et al. Cyclooxygenase-2 mRNA is downexpressed in nasal polyps from aspirin-sensitive asthmatics. Am J Respir Crit Care Med. 1999;160(1):291–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10390414</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chang JE, Ding D, Martin-Lazaro J, White A, Stevenson DD. Smoking, environmental tobacco smoke, and aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2012;108(1):14–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22192959</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hayashi H, Fukutomi Y, Mitsui C, Nakatani E, Watai K, Kamide Y, et al. Smoking Cessation as a Possible Risk Factor for the Development of Aspirin-Exacerbated Respiratory Disease in Smokers. J Allergy Clin Immunol Pract. 2018;6(1):116–25 e3.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28583479</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Samter M, Beers RF, Jr. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975–83.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">5646829</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pace S, Pergola C, Dehm F, Rossi A, Gerstmeier J, Troisi F, et al. Androgen-mediated sex bias impairs efficiency of leukotriene biosynthesis inhibitors in males. J Clin Invest. 2017;127(8):3167–76.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5531400</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28737505</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laffont S, Blanquart E, Savignac M, Cenac C, Laverny G, Metzger D, et al. Androgen signaling negatively controls group 2 innate lymphoid cells. J Exp Med. 2017;214(6):1581–92.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5461006</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28484078</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pace S, Rossi A, Krauth V, Dehm F, Troisi F, Bilancia R, et al. Sex differences in prostaglandin biosynthesis in neutrophils during acute inflammation. Sci Rep. 2017;7(1):3759.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5476623</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28630405</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kolmert J, Gomez C, Balgoma D, Sjodin M, Bood J, Konradsen JR, et al. Urinary Leukotriene E4 and Prostaglandin D2 Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type-2 Inflammation. Am J Respir Crit Care Med. 2020.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7781128</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32667261</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Szczeklik A Aspirin-induced asthma as a viral disease. Clin Allergy. 1988;18(1):15–20.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">3127083</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zaravinos A, Bizakis J, Spandidos DA. Prevalence of human papilloma virus and human herpes virus types 1–7 in human nasal polyposis. J Med Virol. 2009;81(9):1613–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">19626617</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sachse F, Becker K, von Eiff C, Metze D, Rudack C. Staphylococcus aureus invades the epithelium in nasal polyposis and induces IL-6 in nasal epithelial cells in vitro. Allergy. 2010;65(11):1430–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20456313</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bachert C, Gevaert P, Holtappels G, Johansson SG, van Cauwenberge P. Total and specific IgE in nasal polyps is related to local eosinophilic inflammation. J Allergy Clin Immunol. 2001;107(4):607–14.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11295647</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tan BK, Li QZ, Suh L, Kato A, Conley DB, Chandra RK, et al. Evidence for intranasal antinuclear autoantibodies in patients with chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2011;128(6):1198–206 e1.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3384688</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21996343</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kato A, Peters A, Suh L, Carter R, Harris KE, Chandra R, et al. Evidence of a role for B cell-activating factor of the TNF family in the pathogenesis of chronic rhinosinusitis with nasal polyps. J Allergy Clin Immunol. 2008;121(6):1385–92, 92 e1–2.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC2802261</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">18410958</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jeffe JS, Seshadri S, Hamill KJ, Huang JH, Carter R, Suh L, et al. A role for anti-BP180 autoantibodies in chronic rhinosinusitis. Laryngoscope. 2013;123(9):2104–11.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3813294</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24167818</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mendelsohn D, Jeremic G, Wright ED, Rotenberg BW. Revision rates after endoscopic sinus surgery: a recurrence analysis. Ann Otol Rhinol Laryngol. 2011;120(3):162–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21510141</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cheong HS, Park SM, Kim MO, Park JS, Lee JY, Byun JY, et al. Genome-wide methylation profile of nasal polyps: relation to aspirin hypersensitivity in asthmatics. Allergy. 2011;66(5):637–44.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21121930</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wu J, Chandra RK, Li P, Hull BP, Turner JH. Olfactory and middle meatal cytokine levels correlate with olfactory function in chronic rhinosinusitis. Laryngoscope. 2018;128(9):E304–E10.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6082743</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29417576</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tognetti A, Sarolidou G, Lasselin J, Lekander M, Olsson MJ, Lundstrom JN. Acute Systemic Experimental Inflammation Does Not Reduce Human Odor Identification Performance. Chem Senses. 2021;46.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8015794</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33537776</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">36130059</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>01</Month>\n",
      "\t\t\t\t<Day>24</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t<Day>01</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1545-4304</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>63</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t\t\t<Month>Jan</Month>\n",
      "\t\t\t\t\t\t\t<Day>20</Day>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Annual review of pharmacology and toxicology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Annu Rev Pharmacol Toxicol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>407</StartPage>\n",
      "\t\t\t\t\t<EndPage>428</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>407-428</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1146/annurev-pharmtox-051921-085014</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>Leukotrienes are potent immune-regulating lipid mediators with patho-genic roles in inflammatory and allergic diseases, particularly asthma. These autacoids also contribute to low-grade inflammation, a hallmark of cardiovascular, neurodegenerative, metabolic, and tumor diseases. Biosynthesis of leukotrienes involves release and oxidative metabolism of arachidonic acid and proceeds via a set of cytosolic and integral membrane enzymes that are typically expressed by cells of the innate immune system. In activated cells, these enzymes traffic and assemble at the endoplasmic and perinuclear membrane, together comprising a biosynthetic complex. Here we describe recent advances in our molecular understanding of the protein components of the leukotriene-synthesizing enzyme machinery and also briefly touch upon the leukotriene receptors. Moreover, we discuss emerging opportunities for pharmacological intervention and development of new therapeutics.</AbstractText>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Haeggström</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jesper Z</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JZ</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medical Biochemistry and Biophysics, Division of Chemistry 2, Karolinska Institutet, Stockholm, Sweden; email: jesper.haeggstrom@ki.se.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Newcomer</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Marcia E</ForeName>\n",
      "\t\t\t\t\t\t<Initials>ME</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Biological Sciences, Louisiana State University, Baton Rouge, Louisiana, USA; email: newcomer@lsu.edu.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>Annu Rev Pharmacol Toxicol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>7607088</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0362-1642</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"Y\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">arachidonic acid</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">endemic diseases</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">inflammation</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotriene</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">structure-based drug design</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">therapeutics</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>22</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>25</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t\t<Hour>14</Hour>\n",
      "\t\t\t\t\t<Minute>43</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">36130059</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1146/annurev-pharmtox-051921-085014</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">36126795</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t<Day>07</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t<Day>07</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1097-6825</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>151</Volume>\n",
      "\t\t\t\t\t\t<Issue>2</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t\t\t<Month>Feb</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>The Journal of allergy and clinical immunology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>310</StartPage>\n",
      "\t\t\t\t\t<EndPage>313</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>310-313</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2022.09.012</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)01215-5</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tAspirin-exacerbated respiratory disease (AERD) is associated with overproduction of proinflammatory cysteinyl leukotrienes (CysLTs), defective generation of anti-inflammatory prostaglandin E\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t (PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t), and reduced expression of the EP2 receptor for PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t. Reduced PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t synthesis results from the downregulation of inducible COX-2. Because PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t signaling via EP2 inhibits the 5-lipoxygenase/leukotriene C\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t synthase-dependent pathway, the deficient levels of both PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t and EP2 likely contribute to the excessive baseline production of cysteinyl leukotrienes in patients with AERD compared with in patients with aspirin-tolerant asthma. The COX-2 pathway is regulated by an autocrine metabolic loop involving IL-1β, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t prostaglandin E\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t synthase-1, and PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t. Previous studies reported that this metabolic loop is dysregulated in patients with AERD. When the downexpressed EP2 receptor is normalized, the entire loop returns to its normal function. Cotreatment of airway cells from healthy subjects with IL-4 and IFN-γ induces alterations in the metabolic loop similar to those seen in patients with AERD. In these patients, IL-4, which is produced in excess in airways of patients with AERD, likely contributes to the alteration of normal functioning of the autocrine metabolic loop involving IL-1β, IL-1 receptor type I, EP2, COX-2, membrane-bound PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t prostaglandin E\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t synthase-1, and PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t. We hypothesized that by blocking IL-4 action, dupilumab normalizes EP2 expression and restores the normal functioning of the COX-2 pathway autocrine metabolic loop, thereby normalizing the synthesis of PGE\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t and restoring aspirin tolerance.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Picado</LastName>\n",
      "\t\t\t\t\t\t<ForeName>César</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory Diseases, Hospital Clinic, University of Barcelona, Barcelona, Spain; Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Madrid, Spain. Electronic address: cpicado@ub.edu.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Mullol</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joaquim</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Centro de Investigaciones Biomédicas en Red de Enfermedades Respiratorias, Madrid, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Roca-Ferrer</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jordi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Institut d'Investigacions Biomèdiques August Pi I Sunyer, Barcelona, Spain; Rhinology Unit and Smell Clinic, ENT Department, Hospital Clinic Barcelona, Barcelona, Spain.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>J Allergy Clin Immunol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>1275002</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0091-6749</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>R16CO5Y76E</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>420K487FSG</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C582203\">dupilumab</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 1.14.99.1</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D051546\">Cyclooxygenase 2</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>207137-56-2</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015847\">Interleukin-4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>K7Q1JQR04M</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015232\">Dinoprostone</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 5.3.99.3</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000071876\">Prostaglandin-E Synthases</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D058307\">Receptors, Prostaglandin E, EP2 Subtype</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017472\">Receptors, Interleukin-1</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051546\" MajorTopicYN=\"N\">Cyclooxygenase 2</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015847\" MajorTopicYN=\"N\">Interleukin-4</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015232\" MajorTopicYN=\"N\">Dinoprostone</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000071876\" MajorTopicYN=\"N\">Prostaglandin-E Synthases</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D058307\" MajorTopicYN=\"N\">Receptors, Prostaglandin E, EP2 Subtype</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017472\" MajorTopicYN=\"N\">Receptors, Interleukin-1</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Aspirin</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">dupilumab</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotriene</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">nonsteroidal anti-inflammatory drug</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">prostaglandin E(2)</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>18</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>29</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>20</Day>\n",
      "\t\t\t\t\t<Hour>19</Hour>\n",
      "\t\t\t\t\t<Minute>24</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">36126795</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaci.2022.09.012</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0091-6749(22)01215-5</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">36115955</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t<Day>20</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t<Day>20</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">2662-7671</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>22</Volume>\n",
      "\t\t\t\t\t\t<Issue>1</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Sep</Month>\n",
      "\t\t\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>BMC complementary medicine and therapies</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>BMC Complement Med Ther</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Edible algae (Ecklonia cava) bioprocessed with mycelia of shiitake (Lentinula edodes) mushrooms in liquid culture and its isolated fractions protect mice against allergic asthma.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>242</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>242</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">242</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1186/s12906-022-03705-y</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">Ecklonia cava is an edible marine brown alga harvested from the ocean that is widely consumed in Asian countries as a health-promoting medicinal food The objective of the present study is to evaluate the anti-asthma mechanism of a new functional food produced by bioprocessing edible algae Ecklonia cava and shiitake Lentinula edodes mushroom mycelia and isolated fractions.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">We used as series of methods, including high performance liquid chromatography, gas chromatography, cell assays, and an in vivo mouse assay to evaluate the asthma-inhibitory effect of Ecklonia cava bioprocessed (fermented) with Lentinula edodes shiitake mushroom mycelium and its isolated fractions in mast cells and in orally fed mice.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">\n",
      "\t\t\t\t\t\tThe treatments inhibited the degranulation of RBL-2H3 cells and immunoglobulin E (IgE) production, suggesting anti-asthma effects in vitro. The in vitro anti-asthma effects in cells were confirmed in mice following the induction of asthma by alumina and chicken egg ovalbumin (OVA). Oral administration of the bioprocessed Ecklonia cava and purified fractions suppressed the induction of asthma and was accompanied by the inhibition of inflammation- and immune-related substances, including eotaxin; thymic stromal lymphopoietin (TSLP); OVA-specific IgE; leukotriene C\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t (LTC4); prostaglandin D2 (PGD\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t); and vascular cell adhesion molecule-1 (VCAM-1) in bronchoalveolar lavage fluid (BALF) and other fluids and organs. Th2 cytokines were reduced and Th1 cytokines were restored in serum, suggesting the asthma-induced inhibitory effect is regulated by the balance of the Th1/Th2 immune response. Serum levels of IL-10, a regulatory T cell (Treg) cytokine, were increased, further favoring reduced inflammation. Histology of lung tissues revealed that the treatment also reversed the thickening of the airway wall and the contraction and infiltration of bronchial and blood vessels and perialveolar inflammatory cells. The bioprocessed Ecklonia cava/mushroom mycelia new functional food showed the highest inhibition as compared with commercial algae and the fractions isolated from the bioprocessed product.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">The in vitro cell and in vivo mouse assays demonstrate the potential value of the new bioprocessed formulation as an anti-inflammatory and anti-allergic combination of natural compounds against allergic asthma and might also ameliorate allergic manifestations of foods, drugs, and viral infections.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>© 2022. The Author(s).</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lee</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Kyung Hee</ForeName>\n",
      "\t\t\t\t\t\t<Initials>KH</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Jang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Yeo Jin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>YJ</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Present address: Herbal Medicine Research Division, National Institute of Food &amp; Drug Safety Evaluation, Cheongju, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Hwang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Woon Sang</ForeName>\n",
      "\t\t\t\t\t\t<Initials>WS</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Kwon</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Ki Sun</ForeName>\n",
      "\t\t\t\t\t\t<Initials>KS</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lee</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Wha Young</ForeName>\n",
      "\t\t\t\t\t\t<Initials>WY</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Kim</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jeanman</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Kim</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Sung Phil</ForeName>\n",
      "\t\t\t\t\t\t<Initials>SP</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>STR Biotech Co., Ltd., Chuncheon, Republic of Korea. spkim@strbiotech.co.kr.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Friedman</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Mendel</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>U.S. Department of Agriculture, Western Regional Research Center, Agricultural Research Services, Albany, CA, USA. mendel.friedman@usda.gov.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>England</Country>\n",
      "\t\t\t\t<MedlineTA>BMC Complement Med Ther</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>101761232</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>2662-7671</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018926\">Anti-Allergic Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018927\">Anti-Asthmatic Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D019010\">Vascular Cell Adhesion Molecule-1</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>130068-27-8</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D016753\">Interleukin-10</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>2CU6TT9V48</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>37341-29-0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007073\">Immunoglobulin E</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>9006-59-1</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D010047\">Ovalbumin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>LMI26O6933</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000537\">Aluminum Oxide</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>RXY07S6CZ2</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015230\">Prostaglandin D2</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000363\" MajorTopicYN=\"Y\">Agaricales</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000537\" MajorTopicYN=\"N\">Aluminum Oxide</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018926\" MajorTopicYN=\"Y\">Anti-Allergic Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018927\" MajorTopicYN=\"Y\">Anti-Asthmatic Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000893\" MajorTopicYN=\"N\">Anti-Inflammatory Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007073\" MajorTopicYN=\"N\">Immunoglobulin E</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D016753\" MajorTopicYN=\"N\">Interleukin-10</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D025282\" MajorTopicYN=\"N\">Mycelium</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D010047\" MajorTopicYN=\"N\">Ovalbumin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000459\" MajorTopicYN=\"Y\">Phaeophyta</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015230\" MajorTopicYN=\"N\">Prostaglandin D2</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D020942\" MajorTopicYN=\"Y\">Shiitake Mushrooms</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D019010\" MajorTopicYN=\"N\">Vascular Cell Adhesion Molecule-1</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Anti-asthma effect</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Bioassays</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Bioprocessed food, mast cells</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Bronchoalveolar lavage fluid</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Dietary interventions</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Ecklonia cava</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Edible algae</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Gas chromatography</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Histology</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Immunoglobulins, cytokines</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Lungs</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Mice</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Shiitake mushrooms</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>The authors declare that they have no competing interests.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t\t<Hour>23</Hour>\n",
      "\t\t\t\t\t<Minute>25</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>18</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>epublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">36115955</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC9482293</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1186/s12906-022-03705-y</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">10.1186/s12906-022-03705-y</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Beers MH. The Merck Manual of Diagnosis and Therapy. 18. Whitehouse Station: Merck Research Laboratories; 2006.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>De La Cruz N, Hines JH, Shaw C, Appiah D. Geographic disparity in asthma hospitalizations: the role of race/ethnicity, socioeconomic status, and other factors. Cureus. 2021;13(11):e20015.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8631481</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34873552</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jeebhay MF, Baatjies R. Occupational inhalant allergy in food handling occupations. Curr Opin Allergy Clin Immunol. 2021;22(2):64–72. doi: 10.1097/ACI.0000000000000804.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1097/ACI.0000000000000804</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34923552</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pate CA, Zahran HS, Qin X, Johnson C, Hummelman E, Malilay J. Asthma surveillance - United States, 2006-2018. MMWR Surveill Summ. 2021;70(5):1–32. doi: 10.15585/mmwr.ss7005a1.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.15585/mmwr.ss7005a1</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8480992</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34529643</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sharma V, Cowan DC. Obesity, inflammation, and severe asthma: an update. Curr Allergy Asthma Rep. 2021;21(12):46. doi: 10.1007/s11882-021-01024-9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s11882-021-01024-9</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8684548</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34921631</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Southerland VA, Anenberg SC, Harris M, Apte J, Hystad P, van Donkelaar A, Martin RV, Beyers M, Roy A. Assessing the distribution of air pollution health risks within cities: a neighborhood-scale analysis leveraging high-resolution data sets in the bay area, California. Environ Health Perspect. 2021;129(3):37006. doi: 10.1289/EHP7679.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1289/EHP7679</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8011332</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33787320</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhang W, Hwang J, Yadav D, An E-K, Kwak M, Lee PC-W, Jin J-O. Enhancement of immune checkpoint inhibitor-mediated anti-cancer immunity by intranasal treatment of Ecklonia cava fucoidan against metastatic lung cancer. Int J Mol Sci. 2021;22(17):9125. doi: 10.3390/ijms22179125.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/ijms22179125</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8431244</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34502035</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bocanegra A, Macho-González A, Garcimartín A, Benedí J, Sánchez-Muniz FJ. Whole alga, algal extracts, and compounds as ingredients of functional foods: composition and action mechanism relationships in the prevention and treatment of type-2 diabetes mellitus. Int J Mol Sci. 2021;22(8):3816. doi: 10.3390/ijms22083816.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/ijms22083816</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8067684</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33917044</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jung J-I, Kim S, Baek S-M, Choi S-I, Kim G-H, Imm J-Y. Ecklonia cava extract exerts anti-inflammatory effect in human gingival fibroblasts and chronic periodontitis animal model by suppression of pro-inflammatory cytokines and chemokines. Foods. 2021;10(7):1656. doi: 10.3390/foods10071656.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/foods10071656</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8304037</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34359526</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shin HC, Kim SH, Park Y, Lee BH, Hwang HJ. Effects of 12-week oral supplementation of Ecklonia cava polyphenols on anthropometric and blood lipid parameters in overweight Korean individuals: a double-blind randomized clinical trial. Phytother Res. 2012;26(3):363–368. doi: 10.1002/ptr.3559.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1002/ptr.3559</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21717516</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yun JW, Kim SH, Kim YS, You JR, Cho EY, Yoon JH, Kwon E, Yun IJ, Oh JH, Jang JJ, et al. Enzymatic extract from Ecklonia cava: acute and subchronic oral toxicity and genotoxicity studies. Regul Toxicol Pharmacol. 2018;92:46–54. doi: 10.1016/j.yrtph.2017.10.034.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.yrtph.2017.10.034</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29108849</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim J, Jung Y, Lee E, Jang S, Ryu DH, Kwon O, Hwang GS. Urinary metabolomic profiling analysis and evaluation of the effect of Ecklonia cava extract intake. Nutrients. 2020;12(5):1407. doi: 10.3390/nu12051407.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/nu12051407</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7285171</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">32422870</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Lee SJ, Nam SH, Friedman M. Elm tree (Ulmus parvifolia) bark bioprocessed with mycelia of shiitake (Lentinus edodes) mushrooms in liquid culture: composition and mechanism of protection against allergic asthma in mice. J Agric Food Chem. 2016;64(4):773–784. doi: 10.1021/acs.jafc.5b04972.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/acs.jafc.5b04972</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26807923</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against a Salmonella lipopolysaccharide-induced endotoxemia. J Agric Food Chem. 2013;61(46):10987–10994. doi: 10.1021/jf403173k.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/jf403173k</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24200110</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lee SJ, Park SO. Fermentation of black rice with basidiomycetes mycelia and immune stimulating agent through bioconversion process. Patent Number 10–2013-0077802, Republic of Korea, July 9 2013.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chen Y, Xie M-Y, Nie S-P, Li C, Wang Y-X. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum. Food Chem. 2008;107(1):231–241. doi: 10.1016/j.foodchem.2007.08.021.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.foodchem.2007.08.021</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lee J-H, Ko J-Y, Oh J-Y, Kim C-Y, Lee H-J, Kim J, Jeon Y-J. Preparative isolation and purification of phlorotannins from Ecklonia cava using centrifugal partition chromatography by one-step. Food Chem. 2014;158:433–437. doi: 10.1016/j.foodchem.2014.02.112.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.foodchem.2014.02.112</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24731366</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chen Y, Xie M-Y, Wang Y-X, Nie S-P, Li C. Analysis of the monosaccharide composition of purified polysaccharides in Ganoderma atrum by capillary gas chromatography. Phytochem Anal. 2009;20(6):503–510. doi: 10.1002/pca.1153.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1002/pca.1153</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">19743070</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Goo HR, Choi JS, Na DH. Quantitative determination of major phlorotannins in Ecklonia stolonifera. Arch Pharm Res. 2010;33(4):539–544. doi: 10.1007/s12272-010-0407-y.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1007/s12272-010-0407-y</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20422362</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jeong HJ, Hong SH, Lee DJ, Park JH, Kim KS, Kim HM. Role of ca(2+) on TNF-α and IL-6 secretion from RBL-2H3 mast cells. Cell Signal. 2002;14(7):633–639. doi: 10.1016/S0898-6568(02)00005-0.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/S0898-6568(02)00005-0</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11955956</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Temelkovski J, Hogan SP, Shepherd DP, Foster PS, Kumar RK. An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen. Thorax. 1998;53(10):849–856. doi: 10.1136/thx.53.10.849.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1136/thx.53.10.849</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC1745083</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10193371</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Coomes SM, Kannan Y, Pelly VS, Entwistle LJ, Guidi R, Perez-Lloret J, Nikolov N, Müller W, Wilson MS. CD4+ Th2 cells are directly regulated by IL-10 during allergic airway inflammation. Mucosal Immunol. 2017;10(1):150–161. doi: 10.1038/mi.2016.47.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1038/mi.2016.47</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27166557</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Park SO, Lee SJ, Nam SH, Friedman M. A polysaccharide isolated from the liquid culture of Lentinus edodes (shiitake) mushroom mycelia containing black rice bran protects mice against salmonellosis through up-regulation of the Th1 immune reaction. J Agric Food Chem. 2014;62(11):2384–2391. doi: 10.1021/jf405223q.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/jf405223q</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">24593132</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Lee SJ, Nam SH, Friedman M. Turmeric bioprocessed with mycelia from the shiitake culinary-medicinal mushroom Lentinus edodes (Agaricomycetes) protects mice against salmonellosis. Int J Med Mushrooms. 2017;19(4):363–376. doi: 10.1615/IntJMedMushrooms.v19.i4.70.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1615/IntJMedMushrooms.v19.i4.70</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28605325</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Lee SJ, Nam SH, Friedman M. The composition of a bioprocessed shiitake (Lentinus edodes) mushroom mycelia and rice bran formulation and its antimicrobial effects against Salmonella enterica subsp. enterica serovar Typhimurium strain SL1344 in macrophage cells and in mice. BMC Complement Altern Med. 2018;18(1):322. doi: 10.1186/s12906-018-2365-8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1186/s12906-018-2365-8</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6282263</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30518352</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Lee JR, Kwon KS, Jang YJ, Kim J, Yu KH, Lee SY, Friedman M. A bioprocessed black rice bran glutathione-enriched yeast extract protects rats and mice against alcohol-induced hangovers. Food Nutr Sci. 2021;12(03):223–238.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Choi SP, Kang MY, Koh HJ, Nam SH, Friedman M. Antiallergic activities of pigmented rice bran extracts in cell assays. J Food Sci. 2007;72(9):S719–S726. doi: 10.1111/j.1750-3841.2007.00562.x.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/j.1750-3841.2007.00562.x</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">18034759</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Choi SP, Kim SP, Kang MY, Nam SH, Friedman M. Protective effects of black rice bran against chemically-induced inflammation of mouse skin. J Agric Food Chem. 2010;58(18):10007–10015. doi: 10.1021/jf102224b.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/jf102224b</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20731354</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Kim SP, Yang JY, Kang MY, Park JC, Nam SH, Friedman M. Composition of liquid rice hull smoke and anti-inflammatory effects in mice. J Agric Food Chem. 2011;59(9):4570–4581. doi: 10.1021/jf2003392.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/jf2003392</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21438497</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bhawamai S, Lin SH, Hou YY, Chen YH. Thermal cooking changes the profile of phenolic compounds, but does not attenuate the anti-inflammatory activities of black rice. Food Nutr Res. 2016;60:32941. doi: 10.3402/fnr.v60.32941.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3402/fnr.v60.32941</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5031796</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27652685</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Bovard D, van der Toorn M, Schlage WK, Constant S, Renggli K, Peitsch MC, Hoeng J. Iota-carrageenan extracted from red algae is a potent inhibitor of SARS-CoV-2 infection in reconstituted human airway epithelia. Biochem Biophys Rep. 2022;29:101187.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8673819</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34931176</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wang Y, An S. Plastic bronchitis associated with influenza a virus in children with asthma. J Int Med Res. 2021;49(12):3000605211065370.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8721730</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34939439</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Torun Ş, Kesim Ç, Süner A, Botan Yıldırım B, Özen Ö, Akçay Ş. Influenza viruses and SARS-CoV-2 in adult: 'Similarities and differences'. Tuberk Toraks. 2021;69(4):458–468. doi: 10.5578/tt.20219603.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.5578/tt.20219603</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34957739</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Fiocchi A, Bognanni A, Brozek J, Ebisawa M, Schunemann H, group WDg. World allergy organization (WAO) diagnosis and rationale for action against Cow's Milk allergy (DRACMA) guidelines update - I - plan and definitions. World Allergy Organ J. 2022;15(1):100609. doi: 10.1016/j.waojou.2021.100609.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.waojou.2021.100609</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8818560</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35145603</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Alghamdi R, Alshaier R, Alotaibi A, Almutairi A, Alotaibi G, Faqeeh A, Almalki A, AbdulMajed H. Immunotherapy effectiveness in treating peanut hypersensitivity: a systemic review. Cureus. 2022;14(2):e21832.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8896406</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35291522</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wang J, He Z, Raghavan V. Soybean allergy: characteristics, mechanisms, detection and its reduction through novel food processing techniques. Crit Rev Food Sci Nutr. 2022. 10.1080/10408398.2022.2029345:1-14.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35075969</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Brandon DL, Friedman M. Immunoassays of soy proteins. J Agric Food Chem. 2002;50(22):6635–6642. doi: 10.1021/jf020186g.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1021/jf020186g</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">12381163</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhang P, Gao J, Che H, Xue W, Yang D. Molecular basis of IgE-mediated shrimp allergy and heat desensitization. Nutrients. 2021;13(10):3397. doi: 10.3390/nu13103397.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3390/nu13103397</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8540294</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34684397</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yeboah-Korang A, Memon A, Patel N, Portocarrero-Castillo A, Osman A, Kleesattel D, et al. Impact of prior drug allergies on the risk, clinical features, and outcomes of idiosyncratic drug-induced liver injury in adults. Dig Dis Sci. 2022. 10.1007/s10620-022-07403-0.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35122190</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35917595</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t<Day>13</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t<Day>27</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1532-2823</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>184</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Sep</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Prostaglandins, leukotrienes, and essential fatty acids</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Prostaglandins Leukot Essent Fatty Acids</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Levels of eicosanoids in nasal secretions associated with nasal polyp severity in chronic rhinosinusitis.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>102474</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>102474</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.plefa.2022.102474</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0952-3278(22)00086-2</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tSevere nasal polyposis and mucosal inflammation, in patients with chronic rhinosinusitis (CRS) may include a dysregulated eicosanoid profile, but a clinical role for eicosanoids in CRS with nasal polyps (NP; CRSwNP) remains to be elucidated. This study focused on assessing levels and clinical implications of inflammatory mediators in nasal secretions and urine from patients with different NP severity or Aspirin Exacerbated Respiratory Disease (AERD). Levels of leukotrienes E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t and B\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t, prostaglandins D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t and E\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t as well as 15(S)-hydroxyeicosatetraenoic acid were measured with enzyme immunoassays and cytokines with magnetic bead immunoassays. Patients with CRSwNP were subdivided based on NP score; CRSwNP-low (NP score ≤ 4, n = 11) or CRSwNP-high (NP score ≥ 5, n = 32) and compared to CRS without polyps (CRSsNP, n = 12), CRSwNP-AERD (n = 11) and individuals without CRS (n = 25). Smell test score, fractional exhaled nitric oxide (FeNO), blood eosinophils and Sinonasal outcome test-22 were assessed as clinical markers. Leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t, prostaglandin D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t and 15(S)-hydroxyeicosatetraenoic acid in nasal secretions correlated with NP score. Nasal leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t also correlated with FeNO and smell test score, with highest levels found in CRSwNP-AERD. Levels of prostaglandin D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t in nasal secretion as well as urinary levels of the prostaglandin D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t metabolite 11β-prostaglandin F\n",
      "\t\t\t\t\t\t<sub>2α</sub>\n",
      "\t\t\t\t\t\t differed between CRSNP-high and CRSwNP-low. Urinary 11β-prostaglandin F\n",
      "\t\t\t\t\t\t<sub>2α</sub>\n",
      "\t\t\t\t\t\t was associated with asthma comorbidity whereas a similar association with prostaglandin D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t in nasal secretions was not observed. In conclusion, subdividing patients based on NP severity in combination with analysis of eicosanoids in non-invasively collected nasal secretions, may have clinical implications when assessing CRS disease severity.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Nordström</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Axel</ForeName>\n",
      "\t\t\t\t\t\t<Initials>A</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden. Electronic address: axel.nordstrom@shh.se.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Jangard</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Mattias</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Svedberg</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Marie</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Ryott</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Michael</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otorhinolaryngology, Sophiahemmet Hospital, Stockholm, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Kumlin</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Maria</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Health Promotion Science, Sophiahemmet University, Stockholm, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>Scotland</Country>\n",
      "\t\t\t\t<MedlineTA>Prostaglandins Leukot Essent Fatty Acids</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>8802730</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0952-3278</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015777\">Eicosanoids</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D011453\">Prostaglandins</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>75715-89-8</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000150\" MajorTopicYN=\"N\">complications</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015777\" MajorTopicYN=\"N\">Eicosanoids</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D009298\" MajorTopicYN=\"Y\">Nasal Polyps</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D011453\" MajorTopicYN=\"N\">Prostaglandins</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012220\" MajorTopicYN=\"Y\">Rhinitis</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012852\" MajorTopicYN=\"Y\">Sinusitis</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">AERD</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">CRS</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Leukotriene</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Nasal polyp score</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Nasal secretions</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Prostaglandin</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>Declaration of Competing Interest None of the authors have any conflict of interest to declare.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>25</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>3</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>9</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>2</Day>\n",
      "\t\t\t\t\t<Hour>18</Hour>\n",
      "\t\t\t\t\t<Minute>13</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35917595</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.plefa.2022.102474</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0952-3278(22)00086-2</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35850310</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>08</Month>\n",
      "\t\t\t\t<Day>24</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t<Day>14</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1873-2968</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>203</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Sep</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Biochemical pharmacology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Biochem Pharmacol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>\n",
      "\t\t\t\t\tRecent advances in function and structure of two leukotriene B\n",
      "\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t receptors: BLT1 and BLT2.\n",
      "\t\t\t\t</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>115178</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>115178</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.bcp.2022.115178</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0006-2952(22)00272-6</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tLeukotriene B\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t (LTB\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t) is generated by the enzymatic oxidation of arachidonic acid, which is then released from the cell membrane and acts as a potent activator of leukocytes and other inflammatory cells. Numerous studies have demonstrated the physiological and pathophysiological significance of this lipid in various diseases. LTB\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t exerts its activities by binding to its specific G protein-coupled receptors (GPCRs): BLT1 and BLT2. In mouse disease models, treatment with BLT1 antagonists or BLT1 gene ablation attenuated various diseases, including bronchial asthma, arthritis, and psoriasis, whereas BLT2 deficiency exacerbated several diseases in the skin, cornea, and small intestine. Therefore, BLT1 inhibitors and BLT2 activators could be beneficial for the treatment of several inflammatory and immune disorders. As a result, attractive compounds targeting LTB\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t receptors have been developed by several pharmaceutical companies. This review aims to understand the potential of BLT1 and BLT2 as therapeutic targets for the treatment of various inflammatory diseases. In addition, recent topics are discussed with major focuses on the structure and post-translational modifications of BLT1 and BLT2. Collectively, current evidence on modulating LTB\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t receptor functions provides new strategies for the treatment of various diseases.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 Elsevier Inc. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Nakamura</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Motonao</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Bioscience, Graduate school of Life Science, Okayama University of Science, 1-1 Ridai-cho, Kita-ku, Okayama 700-0005, Japan. Electronic address: moto-nakamura@ous.ac.jp.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Shimizu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Takao</ForeName>\n",
      "\t\t\t\t\t\t<Initials>T</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Lipid Signaling, National Center for Global Health and Medicine, Tokyo 162-8655, Japan; Institute of Microbial Chemistry, Tokyo 141-0021, Japan.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t\t<Day>16</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>England</Country>\n",
      "\t\t\t\t<MedlineTA>Biochem Pharmacol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>0101032</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0006-2952</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018102\">Receptors, Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>1HGW4DR56D</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007962\" MajorTopicYN=\"N\">Leukocytes</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D011565\" MajorTopicYN=\"Y\">Psoriasis</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018102\" MajorTopicYN=\"N\">Receptors, Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">BLT1</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">BLT2</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Inflammation</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">LTB(4) receptor</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Phosphorylation</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Posttranslational modification</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Structure</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotriene B(4)</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>27</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>12</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>12</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>20</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>25</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>19</Day>\n",
      "\t\t\t\t\t<Hour>7</Hour>\n",
      "\t\t\t\t\t<Minute>26</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35850310</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.bcp.2022.115178</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0006-2952(22)00272-6</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35720028</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>06</Month>\n",
      "\t\t\t\t<Day>21</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t<Day>16</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Electronic-eCollection\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1748-6718</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>2022</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Computational and mathematical methods in medicine</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Comput Math Methods Med</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Effect of Bairui Granule on Inflammatory Mediators in Induced Sputum, Leukotriene C4, and EOS in Peripheral Blood of Children with Cough Variant Asthma.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>2657994</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>2657994</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">2657994</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1155/2022/2657994</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"OBJECTIVE\" NlmCategory=\"UNASSIGNED\">To study the effect of Hanchuan Zupa granule combined with conventional western medicine in the treatment of children with bronchial asthma.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"METHODS\" NlmCategory=\"UNASSIGNED\">\n",
      "\t\t\t\t\t\t98 cases in Fengrun District People's Hospital of Tangshan City from June 2018 to February 2021 were selected. The control group was given oxygen therapy, antibiotics, and aerosol inhalation of quick acting \n",
      "\t\t\t\t\t\t<i>β</i>\n",
      "\t\t\t\t\t\t 2 receptor agonist, glucocorticoid, and other conventional western medicine treatment, while the observation group was treated with Bairui granule on the basis of the control group. The course of treatment of the two groups was 1 week.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"RESULTS\" NlmCategory=\"UNASSIGNED\">\n",
      "\t\t\t\t\t\tAfter treatment, the levels of sputum IL-4, IL-17, neu, and ECP in the two groups decreased, and the observation group was lower than the control group (\n",
      "\t\t\t\t\t\t<i>P</i>\n",
      "\t\t\t\t\t\t &lt; 0.05). The levels of EOS, CXCR4, LTB4, and SDF-1 in peripheral blood of the two groups were lower than those in the control group (\n",
      "\t\t\t\t\t\t<i>P</i>\n",
      "\t\t\t\t\t\t &lt; 0.05). The daytime cough, night cough, and TCM syndrome scores of the two groups were decreased, and the observation group was lower than the control group (\n",
      "\t\t\t\t\t\t<i>P</i>\n",
      "\t\t\t\t\t\t &lt; 0.05).\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSION\" NlmCategory=\"UNASSIGNED\">Bairui granule combined with conventional western medicine in the treatment of children with bronchial asthma, the curative effect is worthy of affirmation, can effectively improve cough symptoms, reduce EOS, CXCR, LTB4, SDF-1 levels, inhibit airway inflammation, and has good clinical application value.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 Yi Shen et al.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Shen</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Yi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Y</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Min</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Xu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Qiuyan</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Q</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Liu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Lu</ForeName>\n",
      "\t\t\t\t\t\t<Initials>L</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Cheng</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Zhi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Z</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0003-1389-1546</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Paediatrics, The Affiliated Suzhou Science &amp;Technology Town Hospital of Nanjing Medical University, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>06</Month>\n",
      "\t\t\t\t\t<Day>08</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>Comput Math Methods Med</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>101277751</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>1748-670X</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018836\">Inflammation Mediators</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>1HGW4DR56D</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>2CU6TT9V48</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D002648\" MajorTopicYN=\"N\">Child</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D003371\" MajorTopicYN=\"N\">Cough</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D004804\" MajorTopicYN=\"N\">Eosinophils</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018836\" MajorTopicYN=\"N\">Inflammation Mediators</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D013183\" MajorTopicYN=\"Y\">Sputum</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<CoiStatement>The authors declare that they have no conflicts of interest.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>24</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>29</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>20</Day>\n",
      "\t\t\t\t\t<Hour>3</Hour>\n",
      "\t\t\t\t\t<Minute>37</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>22</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>epublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35720028</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC9200585</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1155/2022/2657994</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jian W., Shiwen L. The effect of montelukast sodium in adjuvant treatment of bronchial asthma in children and its effect on immune function and inflammatory cytokine levels. Chongqing Medicine . 2020;49(12):1979–1983.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Chuanhe L., Jianguo H., Yunxiao S. A 20-year comparative study on the prevalence of childhood asthma in 16 cities in China. Chinese Journal of Practical Pediatrics . 2015;30(8):596–600.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yakun L., Ying Y., Xulei G. Epidemiological characteristics and influencing factors of allergic bronchial asthma in children aged 0-14 years in Daxing District, Beijing. Hebei Medicine . 2020;42(11):1739–1742.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Xiaoyang W. Research progress in the treatment of bronchial asthma in children. International Journal Of Pediatrics . 2020;47(3):154.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Respiratory Group of Pediatrics Branch of Chinese Medical Association. Editorial Board of Chinese Journal of Pediatrics. Guidelines for the diagnosis and prevention of bronchial asthma in children (2016 edition) Chinese Journal of Pediatrics . 2016;54(3):167–181.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">26957061</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Pulmonary Diseases Branch of Chinese Society of Traditional Chinese Medicine. Expert consensus on diagnosis and treatment of bronchial asthma in traditional Chinese medicine (2012) Journal of Traditional Chinese Medicine . 2013;54(7):627–629.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Hua W., Xiaoqing C. Research progress on the role of leukotrienes and their receptor antagonists in lung diseases. Chinese Journal of Women and Children's Clinical Medicine (Electronic Edition) . 2017;13(2):234–239.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shotaro M., Shigetoshi K., Kenzo T., Miyata S. Association of comorbidities and medications with risk of asthma exacerbation in pediatric patients: a retrospective study using Japanese claims data. Scientific Reports . 2022;12:p. 5509.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8975995</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35365694</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Simon C., Ewout S., Richard B., Pavord I. Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling. BMJ Open . 2022;12(4):p. e058215. doi: 10.1136/bmjopen-2021-058215.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1136/bmjopen-2021-058215</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8977743</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35365539</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tan X., Bin C., Tian Z. The clinical characteristics of bronchial asthma and the research progress of new drugs. Food and Drugs . 2019;21(5):419–420.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>John O., Leung Donald Y. M. Asthma 2022--moving toward precision medicine. Annals of Allergy, Asthma &amp; Immunology . 2022;128(4):p. 343. doi: 10.1016/j.anai.2022.01.011.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.anai.2022.01.011</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35365251</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Quint Jennifer K., Sofie A., Kocks Janwillem W. H. Short-acting β-agonist exposure and severe asthma exacerbations: SABINA findings from Europe and North America. The Journal of Allergy and Clinical Immunology: In Practice . 2022;10 doi: 10.1016/j.jaip.2022.02.047.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaip.2022.02.047</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35364341</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lixia L., Liming Z., Dan Z. Research progress of hypoxia-inducible factor 1 in the airway inflammation mechanism of bronchial asthma. International Journal of Respiration . 2020;40(8):613–618.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tong Y., Dajun J., Hailong Y. Research progress and clinical application of Uyghur medicine Bairui granules. New Chinese Medicine . 2019;51(4):42–45.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cong C., Jing H., Liu L. Discussion on the etiology, location and pathogenesis of bronchial asthma in traditional Chinese medicine. Hebei Journal of Traditional Chinese Medicine . 2019;41(5):775–778.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Guihua X., Miaoyan S., Xiuming S. Clinical observation of Shegan Mahuang decoction in the treatment of cold asthma of bronchial asthma. Beijing Traditional Chinese Medicine . 2017;36(4):299–302.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhenhua L., Qiong C., Jing W., Li X., He Y., Yu Q. Simulation-based training in asthma exacerbation for medical students: effect of prior exposure to simulation training on performance. BMC Medical Education . 2022;22(1):p. 223. doi: 10.1186/s12909-022-03300-2.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1186/s12909-022-03300-2</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8973632</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35361196</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Teresa T., Jingqin Z., Emilie T., Zhang K., Gershon A. S., Licskai C. Is overreliance on short-acting β-agonists associated with health risks in the older asthma population? ERJ open research . 2022;8(1):00032–02022. doi: 10.1183/23120541.00032-2022.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1183/23120541.00032-2022</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8958218</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35350274</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zheng W., Jinming L., Shaoshun L. Research progress of thyme grass. Chinese Pharmacist . 2006;9(1):1059–1060.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>YangYang Y., Xing Y. C., Chao G. Clinical efficacy and safety of removing blood stasis and removing phlegm in the treatment of epilepsy with cognitive impairment. Medicine (Baltimore) . 2021;100(47):p. e27929. doi: 10.1097/MD.0000000000027929.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1097/MD.0000000000027929</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8615331</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34964768</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Qing-Yi Z., Yi S., Jing Z. Effectiveness of herb-partitioned moxibustion combined with electroacupuncture on polycystic ovary syndrome in patients with symptom pattern of kidney deficiency and phlegm-dampne. Journal of Traditional Chinese Medicine . 2021;41:985–993.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34939397</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ge F., Yaxin W., Zhenqian Y., et al. Test-retest reliability of the coronary heart disease damp phlegm and blood stasis pattern questionnaire: results from a multicenter clinical trial. Evidence-based Complementary and Alternative Medicine . 2021;2021:6. doi: 10.1155/2021/6291301.6291301</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1155/2021/6291301</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8610670</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">34824591</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Long W., Jing L. Observation on the efficacy of nebulized inhalation of interferon α-1b combined with oral Bairui granules in the treatment of bronchiolitis. Journal of Traditional Chinese Medicine . 2017;45(3):62–64.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Song P., Zeng L., Liang Z., Wang Q., Ou A. Clinical efficacy and safety of Chinese herbal medicine auxiliary therapy for childhood cough variant asthma: a systematic review and meta-analysis of 20 randomized controlled trials. Internal Medicine . 2016;55(16):2135–2143. doi: 10.2169/internalmedicine.55.5546.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.2169/internalmedicine.55.5546</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27522988</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Yingxia L., Qinghua H., Lijuan Z. Detection of serum IL-4, HIF-1α, IFN-γ, VEGF levels in children with bronchial asthma and their clinical significance. Clinical Medicine Research and Practice . 2020;5(16):98–100.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zhongping W., Cuiping H., Ming L. Clinical study on the relationship between serum IL-35, IL-17 expression levels and 25-hydroxyvitamin D3 levels and asthma. China Maternal and Child Health Care . 2020;35(12):2231–2234.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Junxiu P., Lei Z., Junli H. Expression and significance of ECP, 25-hydroxyvitamin D3, and M2 receptors in the acute exacerbation of bronchial asthma in children. Journal of Hainan Medical University . 2019;25(20):1566–1570.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Xiaofang S., Ling J., Furong L. Changes and significance of serum LTB4, IL-17 levels and lung function in children with acute bronchial asthma. Journal of Clinical Research . 2019;36(6):1084–1086.</Citation>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Biwen M., Jie L., Jianghong W. The role of stromal cell-derived factor-1/CXC chemokine receptor 4 in airway inflammation and airway remodeling in bronchial asthmatic rats. Chinese tuberculosis He Respiratory Journal . 2015;38(1):39–44.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25791655</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Wgealla M. M. A. M. A., Liang H., Chen R., et al. Amniotic fluid derived stem cells promote skin regeneration and alleviate scar formation through exosomal miRNA-146a-5p via targeting CXCR4. Journal of Cosmetic Dermatology . 2022;22</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35364624</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Shristi P., Yinglong M. Mechanism of peptide agonist binding in CXCR4 chemokine receptor. Frontiers in molecular biosciences . 2022;9:p. 821055. doi: 10.3389/fmolb.2022.821055.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fmolb.2022.821055</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8963245</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35359589</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Alsayed Reem Khaled M. E., Fareed K. A. A. Epigenetic regulation of CXCR4 signaling in cancer pathogenesis and progression. Seminars in Cancer Biology . 2022</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">35346802</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35527666</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t<Day>10</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t<Day>10</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Electronic-eCollection\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1578-1267</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>50</Volume>\n",
      "\t\t\t\t\t\t<Issue>3</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Allergologia et immunopathologia</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Allergol Immunopathol (Madr)</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>The comparative effect of Leukotriene receptor antagonist add on therapy and step up inhaled Corticosteroid in partially controlled asthma: An open-labeled randomized controlled trial.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>125</StartPage>\n",
      "\t\t\t\t\t<EndPage>131</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>125-131</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.15586/aei.v50i3.553</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"BACKGROUND\" NlmCategory=\"BACKGROUND\">No studies are comparing the impact of the add-on leukotriene-receptor antagonist (LTRA) with a step-up dose of inhaled corticosteroids (ICS) in partly controlled asthma patients with asthma control test (ACT) score ˂ 23.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"OBJECTIVE\" NlmCategory=\"OBJECTIVE\">To study the effect of LTRA add-on therapy in comparison to a step-up to medium dose of ICS in partially controlled asthma.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"METHODS\" NlmCategory=\"METHODS\">An open-labeled randomized controlled trial was conducted in asthma subjects with partly controlled asthma who had been in regular receipt of low dose ICS. All subjects were assessed for asthma using ACT, daytime and nighttime symptoms, rate of relievers used, spirometry, and impulse oscillometry (IOS) at 3 and 6 months. Subjects were randomized to receive daily oral LTRA 10 mg or step-up medium dose of ICS.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"RESULTS\" NlmCategory=\"RESULTS\">Between June 2020 and January 2021, 50 participants were enrolled, all patients completing the study. After treatment, mean ACT scores were increased to more than 23 indicating well-controlled asthma in both groups, control being sustained throughout the whole 6-month study period (P ˂ 0.001). Within each group, ACT scores were improved by a minimal clinical important difference (MCID) ≥ 3 points at 6 months, compared to baseline values. There were significant decreases in nighttime and daytime symptoms, and the numbers of rescue relievers used in 4 weeks in both groups compared to baseline (P ˂ 0.001).</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSIONS\" NlmCategory=\"CONCLUSIONS\">LTRA add-on therapy in partially controlled asthma patients is comparable with step-up to medium dose of ICS/LABA as regards asthma control.</AbstractText>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Ruenwilai</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Parinya</ForeName>\n",
      "\t\t\t\t\t\t<Initials>P</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Theerakittikul</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Theerakorn</ForeName>\n",
      "\t\t\t\t\t\t<Initials>T</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; theerakorn.t@cmu.ac.th.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Chaiwong</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Warawut</ForeName>\n",
      "\t\t\t\t\t\t<Initials>W</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Phetsuk</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Nittaya</ForeName>\n",
      "\t\t\t\t\t\t<Initials>N</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Pothirat</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Chaicharn</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Liwsrisakun</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Chalerm</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Pulmonary, Critical Care and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016449\">Randomized Controlled Trial</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t\t<Day>01</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>Singapore</Country>\n",
      "\t\t\t\t<MedlineTA>Allergol Immunopathol (Madr)</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>0370073</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0301-0546</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000305\">Adrenal Cortex Hormones</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018927\">Anti-Asthmatic Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D020024\">Leukotriene Antagonists</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000280\" MajorTopicYN=\"N\">Administration, Inhalation</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000305\" MajorTopicYN=\"N\">Adrenal Cortex Hormones</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018927\" MajorTopicYN=\"Y\">Anti-Asthmatic Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D004359\" MajorTopicYN=\"N\">Drug Therapy, Combination</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D020024\" MajorTopicYN=\"N\">Leukotriene Antagonists</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">asthma control</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">inhaled corticosteroids</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotriene-receptor antagonists</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">lung function</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>The authors declare that there is no conflict of interest in this work.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>16</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>9</Day>\n",
      "\t\t\t\t\t<Hour>3</Hour>\n",
      "\t\t\t\t\t<Minute>16</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>10</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>epublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35527666</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.15586/aei.v50i3.553</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>1. Boonsawat W, Charoenphan P, Kiatboonsri S, Wongtim S, Viriyachaiyo V, Pothirat C, et al. Survey of asthma control in Thailand. Respirology. 2004;9(3):373–378. 10.1111/j.1440-1843.2004.00584.x</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/j.1440-1843.2004.00584.x</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2020. [Internet]. [Accessed 2018 Apr 10]. Available from: http://www.ginasthma.org</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\"/>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>3. Teeratakulpisarn J, Pairojkul S, Heng S. Survey of prevalence of asthma, Allergic rhinitis and eczema in schoolchildren from KhonKaen. An ISAAC (Study, International Study of Asthma and Allergic in Childhood). Asian Pac J. Allergy Immunol. 2000;18:4:187–194.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\"/>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>4. Murphy RC, Gijón MA. Biosynthesis and metabolism of leukotrienes. Biochem J. 2007.1;405(3):379–395. 10.1042/BJ20070289</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1042/BJ20070289</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>5. Löfdahl CG, Reiss TF, Leff JA, Israel E, Noonan MJ, Finn AF, et al. Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. BMJ. 1999;319(7202):87–90. 10.1136/bmj.319.7202.87</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1136/bmj.319.7202.87</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>6. Beasley R, Harper J, Bird G, Maijers I, Weatherall M, Pavord ID. Inhaled Corticosteroid Therapy in Adult Asthma. Time for a New Therapeutic Dose Terminology. Am J Respir Crit Care Med. 2019;15;199(12):1471–1477. 10.1164/rccm.201810-1868CI</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1164/rccm.201810-1868CI</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>7. Sim D, Griffiths A, Armstrong D, Clarke C, Rodda C, Freezer N. Adrenal suppression from high-dose inhaled fluticasone propionate in children with asthma. Eur Respir J. 2003;21(4):633–636. 10.1183/09031936.03.00306302</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1183/09031936.03.00306302</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>8. Rogala B, Bożek A, Gluck J. Is there a relationship between asthma and diabetes? J Asthma. 2020;57(12):1332–1338. 10.1080/02770903.2019.1652642</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1080/02770903.2019.1652642</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>9. Niyatiwatchanchai N, Chaiwong W, Pothirat C. The validity and reliability of the Thai version of the asthma control test. Asian Pac J Allergy Immunol. 2021 J [Online ahead of print].</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\"/>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>10. Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319–338. 10.1183/09031936.05.00034805</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1183/09031936.05.00034805</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>11. King GG, Bates J, Berger KI, Calverley P, de Melo PL, Dellacà RL, et al. Technical standards for respiratory oscillometry. Eur Respir J. 2020;55(2):1900753. 10.1183/13993003.00753-2019</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1183/13993003.00753-2019</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>12. Johansson SA, Dahl R. A double-blind dose-response study of budesonide by inhalation in patients with bronchial asthma. Allergy. 1998;43:173–178. 10.1111/j.1398-9995.1988.tb00415.x</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/j.1398-9995.1988.tb00415.x</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>13. Virchow JC Jr, Prasse A, Naya I, Summerton L, Harris A. Zafirlukast improves asthma control in patients receiving high-dose inhaled corticosteroids. Am J Respir Crit Care Med. 2000;162(2 Pt 1):578–585. 10.1164/ajrccm.162.2.9905041</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1164/ajrccm.162.2.9905041</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>14. Reiss TF, Chervinsky P, Dockhorn RJ, Shingo S, Seidenberg B, Edwards TB. Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group. Arch Intern Med. 1998;158(11):1213–1220. 10.1001/archinte.158.11.1213</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1001/archinte.158.11.1213</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>15. Santanello NC, Barber BL, Reiss TF, Friedman BS, Juniper EF, Zhang J. Measurement characteristics of two asthma symptom diary scales for use in clinical trials. Eur Respir J. 1997;10:646–651.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\"/>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>16. Bisgaard H, Loland L, Anhoj J. NO in exhaled air of asthmatic children is reduced by the leukotriene receptor antagonist montelukast. Am J Respir Crit Care Med.1999;160:1227–1231. 10.1164/ajrccm.160.4.9903004</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1164/ajrccm.160.4.9903004</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>17. Cottee AM, Seccombe LM, Thamrin C, King GG, Peters MJ, Farah CS. Bronchodilator Response Assessed by the Forced Oscillation Technique Identifies Poor Asthma Control With Greater Sensitivity Than Spirometry. Chest. 2020;157:1435–1441. 10.1016/j.chest.2019.12.035</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.chest.2019.12.035</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>18. Brashier B, Salvi S. Measuring lung function using sound waves: role of the forced oscillation technique and impulse oscillometry system. Breathe (Sheff). 2015;11(1):57–65. 10.1183/20734735.020514</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1183/20734735.020514</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>19. Shi Y, Aledia AS, Galant SP, George SC. Peripheral airway impairment measured by oscillometry predicts loss of asthma control in children. J Allergy Clin Immunol. 2013;131(3):718–723. 10.1016/j.jaci.2012.09.022</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaci.2012.09.022</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>20. Shi Y, Aledia AS, Tatavoosian AV, Vijayalakshmi S, Galant SP, George SC. Relating small airways to asthma control by using impulse oscillometry in children. J Allergy Clin Immunol. 2012;129(3):671–678. 10.1016/j.jaci.2011.11.002</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaci.2011.11.002</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35451080</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>08</Month>\n",
      "\t\t\t\t<Day>09</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>10</Month>\n",
      "\t\t\t\t<Day>15</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1398-9995</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>77</Volume>\n",
      "\t\t\t\t\t\t<Issue>8</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Aug</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Allergy</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Allergy</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Cysteinyl-leukotriene and prostaglandin pathways in bronchial versus alveolar lavage in allergic asthmatics.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>2549</StartPage>\n",
      "\t\t\t\t\t<EndPage>2551</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>2549-2551</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1111/all.15319</ELocationID>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>van der Burg</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Nicole</ForeName>\n",
      "\t\t\t\t\t\t<Initials>N</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0002-3369-6425</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Stenberg</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Henning</ForeName>\n",
      "\t\t\t\t\t\t<Initials>H</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Center for Primary Health Care Research, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Bjermer</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Leif</ForeName>\n",
      "\t\t\t\t\t\t<Initials>L</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Diamant</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Zuzana</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Z</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0003-0133-0100</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Microbiology Immunology &amp; Transplantation, KU Leuven, Catholic University of Leuven, Leuven, Belgium.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Tufvesson</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Ellen</ForeName>\n",
      "\t\t\t\t\t\t<Initials>E</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0002-4941-332X</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Clinical Sciences Lund, Respiratory Medicine and Allergology, Lund University, Lund, Sweden.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016422\">Letter</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>04</Month>\n",
      "\t\t\t\t\t<Day>28</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>Denmark</Country>\n",
      "\t\t\t\t<MedlineTA>Allergy</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>7804028</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0105-4538</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D011453\">Prostaglandins</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>K848JZ4886</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D003545\">Cysteine</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001985\" MajorTopicYN=\"N\">Bronchial Provocation Tests</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001992\" MajorTopicYN=\"N\">Bronchoalveolar Lavage Fluid</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D003545\" MajorTopicYN=\"N\">Cysteine</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006967\" MajorTopicYN=\"Y\">Hypersensitivity</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D011453\" MajorTopicYN=\"N\">Prostaglandins</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007507\" MajorTopicYN=\"N\">Therapeutic Irrigation</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Bronchial lavage</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">allergen bronchoprovocation test</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">cysteinyl-leukotriene pathway</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">prostaglandin pathway</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>The authors declare no conflict of interest in relation to this work.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>10</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>22</Day>\n",
      "\t\t\t\t\t<Hour>7</Hour>\n",
      "\t\t\t\t\t<Minute>5</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35451080</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC9546403</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1111/all.15319</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Diamant Z, Aalders W, Parulekar A, Bjermer L, Hanania NA. Targeting lipid mediators in asthma: time for reappraisal. Curr Opin Pulm Med. 2019;25(1):121‐127. doi:10.1097/mcp.0000000000000544</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1097/mcp.0000000000000544</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30422894</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Insuela DBR, Ferrero MR, Coutinho DDS, Martins MA, Carvalho VF. Could arachidonic acid‐derived pro‐resolving mediators be a new therapeutic strategy for asthma therapy? Front Immunol. 2020;11:580598. doi:10.3389/fimmu.2020.580598</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.3389/fimmu.2020.580598</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7755608</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33362766</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Tufvesson E, Nihlberg K, Westergren‐Thorsson G, Bjermer L. Leukotriene receptors are differently expressed in fibroblast from peripheral versus central airways in asthmatics and healthy controls. Prostaglandins Leukot Essent Fatty Acids. 2011;85(2):67‐73. doi:10.1016/j.plefa.2011.04.025</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.plefa.2011.04.025</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">21596548</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Stenberg H, Diamant Z, Ankerst J, Bjermer L, Tufvesson E. Small airway involvement in the late allergic response in asthma. Clin Exp Allergy. 2017;47(12):1555‐1565. doi:10.1111/cea.13036</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1111/cea.13036</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28940836</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Van Vyve T, Chanez P, Lacoste JY, Bousquet J, Michel FB, Godard P. Comparison between bronchial and alveolar samples of bronchoalveolar lavage fluid in asthma. Chest. 1992;102(2):356‐361. doi:10.1378/chest.102.2.356</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1378/chest.102.2.356</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">1643913</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Singh A, Yamamoto M, Kam SHY, et al. Gene‐metabolite expression in blood can discriminate allergen‐induced isolated early from dual asthmatic responses. PLoS One. 2013;8(7):e67907. doi:10.1371/journal.pone.0067907</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"doi\">10.1371/journal.pone.0067907</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3699462</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23844124</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\">\n",
      "\t\t\t<PMID Version=\"1\">35410888</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t<Day>06</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t<Day>27</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1708-8267</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>70</Volume>\n",
      "\t\t\t\t\t\t<Issue>8</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Dec</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Journal of investigative medicine : the official publication of the American Federation for Clinical Research</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>J Investig Med</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Bronchodilatory effect of higenamine as antiallergic asthma treatment.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>1753</StartPage>\n",
      "\t\t\t\t\t<EndPage>1758</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>1753-1758</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1136/jim-2021-002173</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tAsthma is a complex airway disease that affects more than 350 million humans worldwide. Allergic asthma symptoms are induced by Th2 immune response with the release of cytokines and allegro-inflammatory mediators that amplify the inflammatory response, airway hyper-responsiveness (AHR) and hyperproduction of mucus. Higenamine, as a chemical compound, is a β\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t adrenoreceptor agonist and can be used as bronchodilator in allergic asthma.BALB/c mice were allocated in four groups and then allergic asthma was induced in three groups. One of the asthmatic groups was treated with albuterol and other one was treated with higenamine. At least, methacholine challenge to determine the AHR, measurement of cytokines, total immunoglobulin E (IgE), LTB4 and LTC4 levels, evaluation of gene expression of Muc5ac, Muc5b, Agr2 and Arg1, and histopathological study were done.Higenamine treatment reduced AHR, interleukin (IL)-4, IL-13 levels, mRNA expression of MUC5ac, MUC5b, Arg1 and Agr2, goblet cell hyperplasia and mucus hypersecretion. Higenamine had no significant effect on IL-5, interferon-γ (INF-γ), IgE, LTB4, LTC4 levels and eosinophilic inflammation in lung tissue.Higenamine treatment controls asthma acute attack and breathlessness and can be used as asthma treatment with control of AHR and decrease of airflow obstruction and mucus hypersecretion and had allegro-immune-regulatory effect. But higenamine treatment had no notable effect on the inflammation and inflammatory factors.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>© American Federation for Medical Research 2022. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Du</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jing</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Hospital Infection Management, The Fourth People's Hospital of Chengdu, Chengdu, Sichuan Province, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Mehrabi Nasab</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Entezar</ForeName>\n",
      "\t\t\t\t\t\t<Initials>E</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran (the Islamic Republic of).</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Athari</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Seyyed Shamsadin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>SS</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0002-6355-6378</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran (the Islamic Republic of).</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Qian</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Linlin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>L</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of General Surgery, Yancheng No.1 Peoples's Hospital, Yancheng, Jiangsu Province, China xuelinwuhengn@sina.com.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>04</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>England</Country>\n",
      "\t\t\t\t<MedlineTA>J Investig Med</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>9501229</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>1081-5589</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018926\">Anti-Allergic Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>H82Q2D5WA7</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C108128\">frovatriptan</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>TBV5O16GAP</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C012348\">higenamine</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>37341-29-0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007073\">Immunoglobulin E</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>1HGW4DR56D</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>2CU6TT9V48</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017997\">Leukotriene C4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D009088\">Mucoproteins</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C526445\">Agr2 protein, mouse</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018926\" MajorTopicYN=\"Y\">Anti-Allergic Agents</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007073\" MajorTopicYN=\"N\">Immunoglobulin E</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017997\" MajorTopicYN=\"N\">Leukotriene C4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008168\" MajorTopicYN=\"N\">Lung</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D009088\" MajorTopicYN=\"N\">Mucoproteins</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012130\" MajorTopicYN=\"Y\">Respiratory Hypersensitivity</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">respiratory system</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>Competing interests: None declared.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>11</Month>\n",
      "\t\t\t\t\t<Day>5</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>13</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>6</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>12</Day>\n",
      "\t\t\t\t\t<Hour>5</Hour>\n",
      "\t\t\t\t\t<Minute>29</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35410888</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1136/jim-2021-002173</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">jim-2021-002173</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Curated\">\n",
      "\t\t\t<PMID Version=\"1\">35227979</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t<Day>22</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t<Day>31</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1768-3254</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>233</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Apr</Month>\n",
      "\t\t\t\t\t\t\t<Day>05</Day>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>European journal of medicinal chemistry</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Eur J Med Chem</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Discovery of dual-target ligands binding to beta2-adrenoceptor and cysteinyl-leukotriene receptor for the potential treatment of asthma from natural products derived DNA-encoded library.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>114212</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>114212</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.ejmech.2022.114212</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0223-5234(22)00114-3</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>\n",
      "\t\t\t\t\t\tThe design, synthesis, and discovery of dual-target compounds are considered as a promising strategy to develop new drugs with improved safety and efficacy compared with single-target drugs. This necessitates development of the methodologies that enable us to rapidly and accurately achieve the dual-target leads. Applying rosmarinic acid, 18β-glycyrrhetinic acid, rhein, and ferulic acid as template building blocks, we introduced the self-assembling DNA encoded technique to build the library containing 1,000 compounds. These compounds were screened by receptor chromatography with immobilized beta\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t-adrenoceptor (β\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t-AR) and cysteinyl-leukotriene receptor (CysLT), whereby we obtained a derivative of 18β-glycyrrhetinic acid (XC267) that specifically binds to the two receptors. In vitro assessment demonstrated the desired binding affinity of 6.57 × 10\n",
      "\t\t\t\t\t\t<sup>4</sup>\n",
      "\t\t\t\t\t\t M\n",
      "\t\t\t\t\t\t<sup>-1</sup>\n",
      "\t\t\t\t\t\t to β\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t-AR, 2.82 × 10\n",
      "\t\t\t\t\t\t<sup>4</sup>\n",
      "\t\t\t\t\t\t M\n",
      "\t\t\t\t\t\t<sup>-1</sup>\n",
      "\t\t\t\t\t\t to CysLT, and the dissociation rate constant of 7.52 s\n",
      "\t\t\t\t\t\t<sup>-1</sup>\n",
      "\t\t\t\t\t\t to β\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t-AR, 17.2 s\n",
      "\t\t\t\t\t\t<sup>-1</sup>\n",
      "\t\t\t\t\t\t to CysLT. Pharmacological examination with ovalbumin-induced mice demonstrated that XC267 significantly reduced the levels of IL-4, IL-13, and IgE after oral administration of 10 mg/kg. By Western blot analysis, we observed an up-regulated expression of β\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t-AR and a blocked level of CysLT with a dose-dependent manner in pulmonary bronchial. Our results suggest XC627 is a potential candidate to treat asthma by simultaneously regulating the signaling pathway of the two receptors.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 Elsevier Masson SAS. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Liang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Qi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Q</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Zuo</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Haiyue</ForeName>\n",
      "\t\t\t\t\t\t<Initials>H</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Yang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Tian</ForeName>\n",
      "\t\t\t\t\t\t<Initials>T</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Yin</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jiatai</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Huang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Xiaomin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>X</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jing</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Li</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Qian</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Q</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Yin</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Guowei</ForeName>\n",
      "\t\t\t\t\t\t<Initials>G</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Scientific Research Center, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen, China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Zhao</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Xinfeng</ForeName>\n",
      "\t\t\t\t\t\t<Initials>X</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>College of Life Sciences, Northwest University, Xi'an, 710069, China. Electronic address: zhaoxf@nwu.edu.cn.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t\t<Day>21</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>France</Country>\n",
      "\t\t\t\t<MedlineTA>Eur J Med Chem</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>0420510</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0223-5234</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001688\">Biological Products</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D008024\">Ligands</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D018077\">Receptors, Leukotriene</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"C112381\">cysteinyl-leukotriene</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>K848JZ4886</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D003545\">Cysteine</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001688\" MajorTopicYN=\"Y\">Biological Products</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D003545\" MajorTopicYN=\"N\">Cysteine</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008024\" MajorTopicYN=\"N\">Ligands</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D018077\" MajorTopicYN=\"N\">Receptors, Leukotriene</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000235\" MajorTopicYN=\"N\">genetics</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000378\" MajorTopicYN=\"N\">metabolism</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015398\" MajorTopicYN=\"N\">Signal Transduction</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">DNA-Encoded library</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Drug discovery</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Natural products</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Receptor chromatography</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>16</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>18</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>2</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t\t<Hour>5</Hour>\n",
      "\t\t\t\t\t<Minute>49</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35227979</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.ejmech.2022.114212</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0223-5234(22)00114-3</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35226440</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>04</Month>\n",
      "\t\t\t\t<Day>13</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t<Day>16</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1897-9483</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>132</Volume>\n",
      "\t\t\t\t\t\t<Issue>2</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Feb</Month>\n",
      "\t\t\t\t\t\t\t<Day>28</Day>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Polish archives of internal medicine</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Pol Arch Intern Med</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Aspirin‑induced asthma: a still evolving area of basic and clinical research.</ArticleTitle>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">16219</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.20452/pamw.16219</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>The first modern description of respiratory syndrome of aspirin hypersensitivity was published over half of the century ago, but the pathogenesis of the disease is still elusive. Just a few years after discovery how aspirin works, Andrew Szczeklik and his co‑workers described that asthmatics with aspirin hypersensitivity cross‑react to the whole class of nonsteroidal anti‑inflammatory drugs. It took rest of his life to seek for an answer on how this disease, nowadays referred to as N ‑ERD, develops and how it can be treated. In the meantime, cysteinyl leukotrienes, leukotriene modifying drugs, and novel subpopulations of lymphocytes were discovered. This review on aspirin hypersensitivity documents a progress in our understanding of mechanisms of hypersensitivity to nonsteroidal anti‑inflammatory drugs. Current concepts about origin of the disease integrate advances in the field of allergology and inflammatory mechanisms of asthma. However, pharmacological inhibition of prostaglandin biosynthesis by nonsteroidal anti‑inflammatory drugs has a pivotal role in these investigations. Presented is a central role of prostaglandin E2 , a double‑faced lipid immunoregulatory mediator whose deficiency is related to the administration of an anti‑inflammatory drug. Discussed are cysteinyl leukotrienes, the most reliable biomarkers of aspirin hypersensitivity and cells of innate immunity capable of leukotrienes production. Involvement of blood platelets and recently described mucosal basophils are areas of ongoing studies in the disease. Aspirin hypersensitivity is an acquired condition; therefore, the search for genetic predisposition using classic association studies was inconclusive. There is a new hope to explain mechanisms of aspirin hypersensitivity by studies of innate lymphoid cells, which have a central role in the regulation of respiratory mucosa function in asthma.</AbstractText>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Sanak</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Marek</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Clinical Genetics and Molecular Biology, Department of Medicine, Jagiellonian University Medical College, Kraków, Poland. marek.sanak@uj.edu.pl</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>02</Month>\n",
      "\t\t\t\t\t<Day>28</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>Poland</Country>\n",
      "\t\t\t\t<MedlineTA>Pol Arch Intern Med</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>101700960</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0032-3772</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000894\">Anti-Inflammatory Agents, Non-Steroidal</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>R16CO5Y76E</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000894\" MajorTopicYN=\"N\">Anti-Inflammatory Agents, Non-Steroidal</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000139\" MajorTopicYN=\"N\">chemically induced</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007113\" MajorTopicYN=\"N\">Immunity, Innate</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008214\" MajorTopicYN=\"N\">Lymphocytes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>2</Month>\n",
      "\t\t\t\t\t<Day>28</Day>\n",
      "\t\t\t\t\t<Hour>14</Hour>\n",
      "\t\t\t\t\t<Minute>26</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35226440</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.20452/pamw.16219</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">16219</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35026480</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>04</Month>\n",
      "\t\t\t\t<Day>18</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>04</Month>\n",
      "\t\t\t\t<Day>18</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1878-1519</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>299</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>May</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Respiratory physiology &amp; neurobiology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Respir Physiol Neurobiol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Ganoderma modulates allergic asthma pathologic features via anti-inflammatory effects.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>103843</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>103843</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.resp.2022.103843</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1569-9048(22)00002-7</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>Ganoderma, a fungal genus, is a traditional medicine with immuno-modulating effects. Asthma is an inflammatory disease of airways, and the main trigger of asthma is allergic inflammation. In this study, the effects of Ganoderma (an anti-inflammatory agent) given via oral administration (G/O) or intraperitoneal injection (G/IP) on asthma was evaluated. Forty BALB/c mice were divided into four groups, including the control, OVA-challenge, OVA-challenge + G/O, and OVA-challenge + G/IP. To determine AHR, the MCh challenge test was done. The levels of IL-1β, -4, -5, -6, -8, -10, -12, -13, -17, -25, -33, -38, Cys-LT, LTB4, and hydroxyproline were measured. Finally, lung histopathology was evaluated to determine eosinophilic inflammation, goblet cell hyperplasia, and mucus hyper-secretion. Treatment with G/O and G/IP could significantly reduce the levels of IL-1β, -5, -6, -8, -17, -25, -33, and -38; the levels of IL-4 and IL-13 had no significant changes, but the levels of IL-10 and IL-12 were enhanced. The mice treated with G/O and G/IP showed decreased levels of Cys-LT, LTB4, peribronchial and perivascular inflammation, but no significant changes were observed in AHR, hydroxyproline level, goblet cell hyperplasia, and mucus hyper-secretion. Ganoderma can be applied as an immunomodulatory and anti-inflammatory agent for managing asthma.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022. Published by Elsevier B.V.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Li</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Yanfeng</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Y</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Li</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Miaomiao</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Rui</ForeName>\n",
      "\t\t\t\t\t\t<Initials>R</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Biyu</ForeName>\n",
      "\t\t\t\t\t\t<Initials>B</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Athari</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Seyyed Shamsadin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>SS</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Jinli</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Traditional Chinese Medicine, Xidian Group Hospital, Xi'an City, 710077, People's Republic of China. Electronic address: wangjinli1980@sina.com.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>01</Month>\n",
      "\t\t\t\t\t<Day>10</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>Netherlands</Country>\n",
      "\t\t\t\t<MedlineTA>Respir Physiol Neurobiol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>101140022</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>1569-9048</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000893\">Anti-Inflammatory Agents</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D016207\">Cytokines</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>1HGW4DR56D</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>9006-59-1</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D010047\">Ovalbumin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>RMB44WO89X</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D006909\">Hydroxyproline</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000818\" MajorTopicYN=\"N\">Animals</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000893\" MajorTopicYN=\"N\">Anti-Inflammatory Agents</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000494\" MajorTopicYN=\"N\">pharmacology</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001992\" MajorTopicYN=\"N\">Bronchoalveolar Lavage Fluid</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D016207\" MajorTopicYN=\"N\">Cytokines</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D004195\" MajorTopicYN=\"N\">Disease Models, Animal</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D032902\" MajorTopicYN=\"Y\">Ganoderma</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006909\" MajorTopicYN=\"N\">Hydroxyproline</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006965\" MajorTopicYN=\"N\">Hyperplasia</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008168\" MajorTopicYN=\"N\">Lung</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000473\" MajorTopicYN=\"N\">pathology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D051379\" MajorTopicYN=\"N\">Mice</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D008807\" MajorTopicYN=\"N\">Mice, Inbred BALB C</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D010047\" MajorTopicYN=\"N\">Ovalbumin</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Airway</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Allergy</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Ganoderma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Inflammation</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Traditional medicine</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>6</Month>\n",
      "\t\t\t\t\t<Day>10</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>10</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>9</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>4</Month>\n",
      "\t\t\t\t\t<Day>19</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>13</Day>\n",
      "\t\t\t\t\t<Hour>20</Hour>\n",
      "\t\t\t\t\t<Minute>20</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35026480</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.resp.2022.103843</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S1569-9048(22)00002-7</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">35026207</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t<Day>12</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>09</Month>\n",
      "\t\t\t\t<Day>15</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1097-6825</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>150</Volume>\n",
      "\t\t\t\t\t\t<Issue>1</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Jul</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>The Journal of allergy and clinical immunology</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>J Allergy Clin Immunol</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Mediator production and severity of aspirin-induced respiratory reactions: Impact of sampling site and body mass index.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>170</StartPage>\n",
      "\t\t\t\t\t<EndPage>177.e6</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>170-177.e6</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.jaci.2021.12.787</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S0091-6749(22)00005-7</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"BACKGROUND\">Patients with aspirin-exacerbated respiratory disease can experience severe reactions during aspirin challenge that are associated with high levels of mast cell mediators. The tissue source and clinical factors contributing to systemic mediator levels are unknown.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"OBJECTIVE\">We sought to determine the concordance between respiratory tract and systemic inflammatory mediator levels and identify clinical factors associated with these mediators.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"METHODS\">We performed an oral aspirin challenge in 30 subjects with aspirin-exacerbated respiratory disease. Respiratory symptoms and function, nasal mucosal fluid, blood, and urine were collected at baseline, at the onset of a respiratory reaction, and over a 3-hour observation period. Changes in nasal and systemic mediator levels were compared.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"RESULTS\">\n",
      "\t\t\t\t\t\tNeither tryptase nor leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t levels in nasal fluid correlated with serum tryptase or urinary leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t levels at baseline or during reactions. We observed no association between the baseline or aspirin-induced change in nasal versus urinary leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t and serum tryptase levels. Body mass index inversely correlated with baseline and aspirin-induced urinary leukotriene E\n",
      "\t\t\t\t\t\t<sub>4</sub>\n",
      "\t\t\t\t\t\t, prostaglandin D\n",
      "\t\t\t\t\t\t<sub>2</sub>\n",
      "\t\t\t\t\t\t metabolite, and serum tryptase levels, as well as with aspirin-induced symptoms and respiratory function, but not with nasal mediators.\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSIONS\">The levels of nasal and systemic aspirin-induced mast cell products are discordant in aspirin-exacerbated respiratory disease. Systemically detected levels are likely derived from mast cells outside of the sinonasal cavity and do not accurately reflect upper respiratory tract production. Increased body mass index decreases systemic mast cell mediator production and reaction severity, supporting a contribution of metabolic regulation in aspirin-induced systemic reactions.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2022 American Academy of Allergy, Asthma &amp; Immunology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Cahill</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Katherine N</ForeName>\n",
      "\t\t\t\t\t\t<Initials>KN</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: Katherine.cahill@vumc.org.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Wu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Pingsheng</ForeName>\n",
      "\t\t\t\t\t\t<Initials>P</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Milne</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Ginger L</ForeName>\n",
      "\t\t\t\t\t\t<Initials>GL</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Pharmacology, Vanderbilt University, Nashville, Tenn.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Amin</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Taneem</ForeName>\n",
      "\t\t\t\t\t\t<Initials>T</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Medicine, Division of Allergy, Pulmonary and Critical Care Medicine, Vanderbilt University Medical Center, Nashville, Tenn.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Singer</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joseph</ForeName>\n",
      "\t\t\t\t\t\t<Initials>J</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Murphy</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Katherine</ForeName>\n",
      "\t\t\t\t\t\t<Initials>K</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lewis</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Erin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>E</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Gapko</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Deborah</ForeName>\n",
      "\t\t\t\t\t\t<Initials>D</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Boyce</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joshua A</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JA</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Buchheit</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Katherine M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>KM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Laidlaw</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Tanya M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>TM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergy and Clinical Immunology, Brigham and Women's Hospital, Boston, Mass; Jeff and Penny Vinik Center for Translational Immunology Research, Boston, Mass; Harvard Medical School, Boston, Mass.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<GrantList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 HL128241</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>HL</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NHLBI NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>U01 AI155299</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>T32 AI007306</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>U19 AI095219</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 AI078908</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>P30 DK020593</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>DK</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIDDK NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 HL136209</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>HL</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NHLBI NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R37 AI052353</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>R01 AI136041</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t\t<Grant>\n",
      "\t\t\t\t\t\t<GrantID>K23 AI118804</GrantID>\n",
      "\t\t\t\t\t\t<Acronym>AI</Acronym>\n",
      "\t\t\t\t\t\t<Agency>NIAID NIH HHS</Agency>\n",
      "\t\t\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t\t</Grant>\n",
      "\t\t\t\t</GrantList>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D052061\">Research Support, N.I.H., Extramural</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>01</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>J Allergy Clin Immunol</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>1275002</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0091-6749</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>75715-89-8</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 3.4.21.59</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D053802\">Tryptases</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>R16CO5Y76E</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001241\">Aspirin</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001241\" MajorTopicYN=\"N\">Aspirin</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000009\" MajorTopicYN=\"N\">adverse effects</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"Y\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015992\" MajorTopicYN=\"N\">Body Mass Index</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012137\" MajorTopicYN=\"N\">Respiratory System</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012852\" MajorTopicYN=\"Y\">Sinusitis</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D053802\" MajorTopicYN=\"N\">Tryptases</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Aspirin-exacerbated respiratory disease</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">aspirin-induced reactions</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">body mass index</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">leukotrienes</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">mast cells</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">prostaglandins</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t\t<CoiStatement>\n",
      "\t\t\t\t<b>Conflicts of Interest:</b>\n",
      "\t\t\t\t KN Cahill has severed on scientific advisory boards for Teva, GlaxoSmithKline, Blueprint Medicines, Regeneron, Genentech, Sanofi-Pasteur and reports personal fees from Novartis, Third Harmonic Bio, Ribon Therapeutics, and Verantos outside the submitted work. JA Boyce has served on scientific advisory boards for Sanofi and Regeneron. K Buchheit has served on scientific advisory boards for AstraZeneca, Sanofi-Genzyme, Regeneron, and GlaxoSmithKline. TM Laidlaw has served on scientific advisory boards for GlaxoSmithKline, Sanofi-Genzyme, and Regeneron. P Wu, G Milne, T Amin, J Singer, K Murphy, E Lewis, and D Gapko have no conflicts.\n",
      "\t\t\t</CoiStatement>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>25</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>11</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>29</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pmc-release\">\n",
      "\t\t\t\t\t<Year>2023</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>1</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>1</Month>\n",
      "\t\t\t\t\t<Day>13</Day>\n",
      "\t\t\t\t\t<Hour>20</Hour>\n",
      "\t\t\t\t\t<Minute>15</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">35026207</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"mid\">NIHMS1770703</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pmc\">PMC9271535</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.jaci.2021.12.787</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S0091-6749(22)00005-7</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t\t<ReferenceList>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Sestini P, Armetti L, Gambaro G, Pieroni MG, Refini RM, Sala A, et al. Inhaled PGE2 prevents aspirin-induced bronchoconstriction and urinary LTE4 excretion in aspirin-sensitive asthma. Am J Respir Crit Care Med. 1996;153(2):572–5.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">8564100</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN, Bensko JC, Boyce JA, Laidlaw TM. Prostaglandin D(2): a dominant mediator of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2015;135(1):245–52.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC4289104</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">25218285</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Cahill KN, Murphy K, Singer J, Israel E, Boyce JA, Laidlaw TM. Plasma tryptase elevation during aspirin-induced reactions in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(2):799–803 e2.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6519056</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30339852</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Boyce JA. Aspirin sensitivity: Lessons in the regulation (and dysregulation) of mast cell function. J Allergy Clin Immunol. 2019;144(4):875–81.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7735393</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31587797</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>White A, Ludington E, Mehra P, Stevenson DD, Simon RA. Effect of leukotriene modifier drugs on the safety of oral aspirin challenges. Ann Allergy Asthma Immunol. 2006;97(5):688–93.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">17165280</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Huang GX, Palumbo ML, Singer JI, Cahill KN, Laidlaw TM. Sinus surgery improves lower respiratory reactivity during aspirin desensitization for AERD. J Allergy Clin Immunol Pract. 2019.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC7110416</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30877073</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Jerschow E, Edin ML, Chi Y, Hurst B, Abuzeid WM, Akbar NA, et al. Sinus Surgery Is Associated with a Decrease in Aspirin-Induced Reaction Severity in Patients with Aspirin Exacerbated Respiratory Disease. J Allergy Clin Immunol Pract. 2019;7(5):1580–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6511299</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30580047</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Giouleka P, Papatheodorou G, Lyberopoulos P, Karakatsani A, Alchanatis M, Roussos C, et al. Body mass index is associated with leukotriene inflammation in asthmatics. Eur J Clin Invest. 2011;41(1):30–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20825465</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mothe-Satney I, Filloux C, Amghar H, Pons C, Bourlier V, Galitzky J, et al. Adipocytes secrete leukotrienes: contribution to obesity-associated inflammation and insulin resistance in mice. Diabetes. 2012;61(9):2311–9.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3425405</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22688342</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Amorim NRT, Luna-Gomes T, Gama-Almeida M, Souza-Almeida G, Canetti C, Diaz BL, et al. Leptin Elicits LTC4 Synthesis by Eosinophils Mediated by Sequential Two-Step Autocrine Activation of CCR3 and PGD2 Receptors. Front Immunol. 2018;9:2139.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6160734</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30298073</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mancuso P, Canetti C, Gottschalk A, Tithof PK, Peters-Golden M. Leptin augments alveolar macrophage leukotriene synthesis by increasing phospholipase activity and enhancing group IVC iPLA2 (cPLA2gamma) protein expression. Am J Physiol Lung Cell Mol Physiol. 2004;287(3):L497–502.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">15145787</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Mancuso P, Gottschalk A, Phare SM, Peters-Golden M, Lukacs NW, Huffnagle GB. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J Immunol. 2002;168(8):4018–24.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">11937559</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Baek HS, Choi JH, Oh JW, Lee HB. Leptin and urinary leukotriene E4 and 9alpha,11beta-prostaglandin F2 release after exercise challenge. Ann Allergy Asthma Immunol. 2013;111(2):112–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">23886229</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Karampatakis N, Karampatakis T, Galli-Tsinopoulou A, Kotanidou EP, Tsergouli K, Eboriadou-Petikopoulou M, et al. Impaired glucose metabolism and bronchial hyperresponsiveness in obese prepubertal asthmatic children. Pediatr Pulmonol. 2017;52(2):160–6.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">27362543</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Daffern PJ, Muilenburg D, Hugli TE, Stevenson DD. Association of urinary leukotriene E4 excretion during aspirin challenges with severity of respiratory responses. J Allergy Clin Immunol. 1999;104(3 Pt 1):559–64.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">10482828</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Cahill KN, Cardet JC, Murphy K, Cui J, Dioneda B, et al. A trial of type 12 purinergic (P2Y12) receptor inhibition with prasugrel identifies a potentially distinct endotype of patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2019;143(1):316–24 e7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6286686</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29890239</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Staso PJ, Wu P, Laidlaw TM, Cahill KN. Scoring tool for systemic symptoms during aspirin challenge detects mediator production in aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2021.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC8222107</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">33781934</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Laidlaw TM, Kidder MS, Bhattacharyya N, Xing W, Shen S, Milne GL, et al. Cysteinyl leukotriene overproduction in aspirin-exacerbated respiratory disease is driven by platelet-adherent leukocytes. Blood. 2012;119(16):3790–8.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC3335383</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22262771</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Thwaites RS, Ito K, Chingono JMS, Coates M, Jarvis HC, Tunstall T, et al. Nasosorption as a Minimally Invasive Sampling Procedure: Mucosal Viral Load and Inflammation in Primary RSV Bronchiolitis. J Infect Dis. 2017;215(8):1240–4.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5441107</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28368490</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Quehenberger O, Armando AM, Brown AH, Milne SB, Myers DS, Merrill AH, et al. Lipidomics reveals a remarkable diversity of lipids in human plasma. J Lipid Res. 2010;51(11):3299–305.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC2952570</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">20671299</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Schwartz LB, Bradford TR, Rouse C, Irani AM, Rasp G, Van der Zwan JK, et al. Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis. J Clin Immunol. 1994;14(3):190–204.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">7929694</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Protasiuk E, Olejnik M. Determination of Salicylic Acid in Feed Using LC-MS/MS. J Vet Res. 2018;62(3):303–7.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6295987</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">30584609</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Needs CJ, Brooks PM. Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet. 1985;10(2):164–77.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">3888490</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Verboven K, Wouters K, Gaens K, Hansen D, Bijnen M, Wetzels S, et al. Abdominal subcutaneous and visceral adipocyte size, lipolysis and inflammation relate to insulin resistance in male obese humans. Sci Rep. 2018;8(1):4677.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC5856747</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29549282</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zelechowska P, Brzezinska-Blaszczyk E, Wiktorska M, Rozalska S, Wawrocki S, Kozlowska E, et al. Adipocytokines leptin and adiponectin function as mast cell activity modulators. Immunology. 2019;158(1):3–18.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6700464</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31220342</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Divoux A, Moutel S, Poitou C, Lacasa D, Veyrie N, Aissat A, et al. Mast cells in human adipose tissue: link with morbid obesity, inflammatory status, and diabetes. J Clin Endocrinol Metab. 2012;97(9):E1677–85.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">22745246</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Zelechowska P, Agier J, Kozlowska E, Brzezinska-Blaszczyk E. Mast cells participate in chronic low-grade inflammation within adipose tissue. Obes Rev. 2018;19(5):686–97.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">29334696</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Richelsen B Release and effects of prostaglandins in adipose tissue. Prostaglandins Leukot Essent Fatty Acids. 1992;47(3):171–82.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">1475271</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Paivarinta U, Moilanen T, et al. Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage--mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm. 2009;2009:345838.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC2726438</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">19688109</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Nair P, Radford K, Fanat A, Janssen LJ, Peters-Golden M, Cox PG. The effects of leptin on airway smooth muscle responses. Am J Respir Cell Mol Biol. 2008;39(4):475–81.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">18421018</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Arm JP, Spur BW, Lee TH. The effects of inhaled leukotriene E4 on the airway responsiveness to histamine in subjects with asthma and normal subjects. J Allergy Clin Immunol. 1988;82(4):654–60.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">2844876</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Ward ZJ, Bleich SN, Cradock AL, Barrett JL, Giles CM, Flax C, et al. Projected U.S. State-Level Prevalence of Adult Obesity and Severe Obesity. N Engl J Med. 2019;381(25):2440–50.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">31851800</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t\t<Reference>\n",
      "\t\t\t\t\t<Citation>Lugogo N, Green CL, Agada N, Zhang S, Meghdadpour S, Zhou R, et al. Obesity’s effect on asthma extends to diagnostic criteria. J Allergy Clin Immunol. 2018;141(3):1096–104.</Citation>\n",
      "\t\t\t\t\t<ArticleIdList>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pmc\">PMC6076889</ArticleId>\n",
      "\t\t\t\t\t\t<ArticleId IdType=\"pubmed\">28624608</ArticleId>\n",
      "\t\t\t\t\t</ArticleIdList>\n",
      "\t\t\t\t</Reference>\n",
      "\t\t\t</ReferenceList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">34954219</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t<Day>16</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t<Day>16</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Print\">1098-8823</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>158</Volume>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Feb</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Prostaglandins &amp; other lipid mediators</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Prostaglandins Other Lipid Mediat</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Role of arachidonic acid lipoxygenase pathway in Asthma.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>106609</StartPage>\n",
      "\t\t\t\t\t<MedlinePgn>106609</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1016/j.prostaglandins.2021.106609</ELocationID>\n",
      "\t\t\t\t<ELocationID EIdType=\"pii\" ValidYN=\"Y\">S1098-8823(21)00084-8</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText>The arachidonic acid (AA) metabolism pathways play a key role in immunological response and inflammation diseases, such as asthma, etc. AA in cell membranes can be metabolized by lipoxygenases (LOXs) to a screen of bioactive substances that include leukotrienes (LTs), lipoxins (LXs), and eicosatetraenoic acids (ETEs), which are considered closely related to the pathophysiology of respiratory allergic disease. Studies also verified that drugs regulating AA LOXs pathway have better rehabilitative intervention for asthma. This review aims to summarize the physiological and pathophysiological importance of AA LOXs metabolism pathways in asthma and to discuss its prospects of therapeutic strategies.</AbstractText>\n",
      "\t\t\t\t\t<CopyrightInformation>Copyright © 2021 Elsevier Inc. All rights reserved.</CopyrightInformation>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Luo</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Yacan</ForeName>\n",
      "\t\t\t\t\t\t<Initials>Y</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Jin</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Minli</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lou</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Lejing</ForeName>\n",
      "\t\t\t\t\t\t<Initials>L</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Yang</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Song</ForeName>\n",
      "\t\t\t\t\t\t<Initials>S</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Li</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Chengye</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Li</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Xi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>X</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>The Affiliated Kangning Hospital of Wenzhou Medical University, Wenzhou, PR China.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Zhou</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Meixi</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: 351070639@qq.com.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Cai</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Chang</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, 325000, Zhejiang Province, PR China. Electronic address: WZFY2017@163.com.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>23</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>United States</Country>\n",
      "\t\t\t\t<MedlineTA>Prostaglandins Other Lipid Mediat</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>9808648</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>1098-8823</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015289\">Leukotrienes</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D044045\">Lipoxins</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 1.13.11.-</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001091\">Arachidonate Lipoxygenases</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 1.13.11.-</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D058945\">Lipoxygenases</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>EC 1.13.11.34</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D001094\">Arachidonate 5-Lipoxygenase</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001094\" MajorTopicYN=\"N\">Arachidonate 5-Lipoxygenase</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001091\" MajorTopicYN=\"N\">Arachidonate Lipoxygenases</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015289\" MajorTopicYN=\"N\">Leukotrienes</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D044045\" MajorTopicYN=\"Y\">Lipoxins</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D058945\" MajorTopicYN=\"N\">Lipoxygenases</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Airway inflammation</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Arachidonic acid</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Lipoxygenase</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"received\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>7</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"revised\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>11</Month>\n",
      "\t\t\t\t\t<Day>15</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"accepted\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>27</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>17</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>12</Month>\n",
      "\t\t\t\t\t<Day>26</Day>\n",
      "\t\t\t\t\t<Hour>20</Hour>\n",
      "\t\t\t\t\t<Minute>39</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">34954219</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1016/j.prostaglandins.2021.106609</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"pii\">S1098-8823(21)00084-8</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\" IndexingMethod=\"Automated\">\n",
      "\t\t\t<PMID Version=\"1\">34376110</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t<Day>14</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>07</Month>\n",
      "\t\t\t\t<Day>26</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1532-4303</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>59</Volume>\n",
      "\t\t\t\t\t\t<Issue>8</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Aug</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>The Journal of asthma : official journal of the Association for the Care of Asthma</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>J Asthma</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Inhaled corticosteroids' effects on biomarkers in exhaled breath condensate and blood in patients newly diagnosed with asthma who smoke.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>1613</StartPage>\n",
      "\t\t\t\t\t<EndPage>1620</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>1613-1620</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1080/02770903.2021.1962341</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"OBJECTIVE\">Exposure to cigarette smoke complicates the treatment and management of asthma through a variety of inflammatory effects. This study aimed to investigate the differences between newly diagnosed cases of asthma in smokers and nonsmokers in terms of localized and systemic biomarkers following treatment with inhaled corticosteroids (ICS) or ICS in combination with a long-acting β2 agonist (LABA).</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"METHODS\">Specimens of exhaled breath condensate (EBC) from newly diagnosed patients with asthma were used to quantify inflammation in the airways, while blood samples were used to assess systemic inflammation. In both samples, the levels of IL-6, LTB4, LTD4, and 8-isoprostane were measured and these were repeated after 3 months of treatment with ICS or ICS + LABA.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"RESULTS\">\n",
      "\t\t\t\t\t\tOf the 20 patients, 10 (50%) were nonsmokers with asthma (NSA) and 10 (50%) smokers with asthma (SA). There was no statistically significant difference in the blood or EBC levels of IL-6, LTB4, LTD4, or 8-isoprostane between the groups prior to treatment. Only the decrease in 8-isoprostane level in the EBC samples was found to be significantly greater in the NSA group after treatment (for smokers, the change was 2.91 ± 23.22, while for nonsmokers it was -22.72 ± 33.12, \n",
      "\t\t\t\t\t\t<i>p</i>\n",
      "\t\t\t\t\t\t = 0.022). Post-treatment asthma control was significantly better in the NSA group (\n",
      "\t\t\t\t\t\t<i>p</i>\n",
      "\t\t\t\t\t\t = 0.033).\n",
      "\t\t\t\t\t</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSION\">Monitoring the alterations in 8-isoprostane levels in EBC in patients with asthma who smoke may be helpful in deciding on therapeutic management and switching treatments. Asthma control was better in nonsmokers than in smokers.</AbstractText>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Duman</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Berna</ForeName>\n",
      "\t\t\t\t\t\t<Initials>B</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Bezmiâlem Vakıf University School of Medicine, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Borekci</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Sermin</ForeName>\n",
      "\t\t\t\t\t\t<Initials>S</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0002-0089-1312</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Akdeniz</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Nilgun</ForeName>\n",
      "\t\t\t\t\t\t<Initials>N</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Gazioglu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Sema Bilgic</ForeName>\n",
      "\t\t\t\t\t\t<Initials>SB</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Deniz</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Gunnur</ForeName>\n",
      "\t\t\t\t\t\t<Initials>G</Initials>\n",
      "\t\t\t\t\t\t<Identifier Source=\"ORCID\">0000-0002-0721-6213</Identifier>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Immunology, Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Gemicioglu</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Bilun</ForeName>\n",
      "\t\t\t\t\t\t<Initials>B</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Pulmonary Diseases, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Turkey.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D013485\">Research Support, Non-U.S. Gov't</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>08</Month>\n",
      "\t\t\t\t\t<Day>14</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>England</Country>\n",
      "\t\t\t\t<MedlineTA>J Asthma</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>8106454</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0277-0903</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D000305\">Adrenal Cortex Hormones</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015850\">Interleukin-6</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>1HGW4DR56D</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D007975\">Leukotriene B4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>73836-78-9</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017998\">Leukotriene D4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D000305\" MajorTopicYN=\"N\">Adrenal Cortex Hormones</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"Y\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001944\" MajorTopicYN=\"N\">Breath Tests</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D045853\" MajorTopicYN=\"N\">Exhalation</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007249\" MajorTopicYN=\"N\">Inflammation</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000188\" MajorTopicYN=\"N\">drug therapy</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015850\" MajorTopicYN=\"N\">Interleukin-6</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D007975\" MajorTopicYN=\"N\">Leukotriene B4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017998\" MajorTopicYN=\"N\">Leukotriene D4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000627\" MajorTopicYN=\"N\">therapeutic use</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012907\" MajorTopicYN=\"N\">Smoking</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000453\" MajorTopicYN=\"N\">epidemiology</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">8-isoprostane</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">Asthma</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">IL-6</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">LTB4</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">LTD4</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">biomarkers</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">exhaled breath condensate</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">smoking</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>12</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>7</Month>\n",
      "\t\t\t\t\t<Day>15</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>8</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t\t<Hour>5</Hour>\n",
      "\t\t\t\t\t<Minute>30</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">34376110</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1080/02770903.2021.1962341</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "\t<PubmedArticle>\n",
      "\t\t<MedlineCitation Status=\"MEDLINE\" Owner=\"NLM\">\n",
      "\t\t\t<PMID Version=\"1\">33973823</PMID>\n",
      "\t\t\t<DateCompleted>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t<Day>07</Day>\n",
      "\t\t\t</DateCompleted>\n",
      "\t\t\t<DateRevised>\n",
      "\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t<Month>03</Month>\n",
      "\t\t\t\t<Day>07</Day>\n",
      "\t\t\t</DateRevised>\n",
      "\t\t\t<Article PubModel=\"Print-Electronic\">\n",
      "\t\t\t\t<Journal>\n",
      "\t\t\t\t\t<ISSN IssnType=\"Electronic\">1097-6817</ISSN>\n",
      "\t\t\t\t\t<JournalIssue CitedMedium=\"Internet\">\n",
      "\t\t\t\t\t\t<Volume>166</Volume>\n",
      "\t\t\t\t\t\t<Issue>2</Issue>\n",
      "\t\t\t\t\t\t<PubDate>\n",
      "\t\t\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t\t\t<Month>Feb</Month>\n",
      "\t\t\t\t\t\t</PubDate>\n",
      "\t\t\t\t\t</JournalIssue>\n",
      "\t\t\t\t\t<Title>Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery</Title>\n",
      "\t\t\t\t\t<ISOAbbreviation>Otolaryngol Head Neck Surg</ISOAbbreviation>\n",
      "\t\t\t\t</Journal>\n",
      "\t\t\t\t<ArticleTitle>Urine Leukotriene E4: Implications as a Biomarker in Chronic Rhinosinusitis.</ArticleTitle>\n",
      "\t\t\t\t<Pagination>\n",
      "\t\t\t\t\t<StartPage>224</StartPage>\n",
      "\t\t\t\t\t<EndPage>232</EndPage>\n",
      "\t\t\t\t\t<MedlinePgn>224-232</MedlinePgn>\n",
      "\t\t\t\t</Pagination>\n",
      "\t\t\t\t<ELocationID EIdType=\"doi\" ValidYN=\"Y\">10.1177/01945998211011060</ELocationID>\n",
      "\t\t\t\t<Abstract>\n",
      "\t\t\t\t\t<AbstractText Label=\"OBJECTIVE\">To provide a comprehensive state-of-the-art review of the emerging role of urine leukotriene E4 (uLTE4) as a biomarker in the diagnosis of chronic rhinosinusitis (CRS), aspirin-exacerbated respiratory disease (AERD), and asthma.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"DATA SOURCES\">Ovid MEDLINE(R), Ovid EMBASE, Ovid Cochrane Central Register of Controlled Trials, Ovid Cochrane Database of Systematic Reviews, and Scopus.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"REVIEW METHODS\">A state-of-the-art review was performed investigating the role of uLTE4 as a diagnostic biomarker, predictor of disease severity, and potential marker of selected therapeutic efficacy.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"CONCLUSIONS\">uLTE4 has been shown to be a reliable and clinically relevant biomarker for CRS, AERD, and asthma. uLTE4 is helpful in ongoing efforts to better endotype patients with CRS and to predict disease severity.</AbstractText>\n",
      "\t\t\t\t\t<AbstractText Label=\"IMPLICATIONS FOR PRACTICE\">Aside from being a diagnostic biomarker, uLTE4 is also able to differentiate aspirin-tolerant patients from patients with AERD and has been associated with objective disease severity in patients with CRS with nasal polyposis. uLTE4 levels have also been shown to predict response to medical therapy, particularly leukotriene-modifying agents.</AbstractText>\n",
      "\t\t\t\t</Abstract>\n",
      "\t\t\t\t<AuthorList CompleteYN=\"Y\">\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Choby</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Garret</ForeName>\n",
      "\t\t\t\t\t\t<Initials>G</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Low</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Christopher M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>CM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Levy</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joshua M</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JM</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Emory University, Atlanta, Georgia, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Stokken</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Janalee K</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JK</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Pinheiro-Neto</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Carlos</ForeName>\n",
      "\t\t\t\t\t\t<Initials>C</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Bartemes</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Kathy</ForeName>\n",
      "\t\t\t\t\t\t<Initials>K</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Marino</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Michael</ForeName>\n",
      "\t\t\t\t\t\t<Initials>M</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Han</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Joseph K</ForeName>\n",
      "\t\t\t\t\t\t<Initials>JK</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Eastern Virginia Medical School, Norfolk, Virginia, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Divekar</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Rohit</ForeName>\n",
      "\t\t\t\t\t\t<Initials>R</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Division of Allergic Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>O'Brien</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Erin K</ForeName>\n",
      "\t\t\t\t\t\t<Initials>EK</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t\t<Author ValidYN=\"Y\">\n",
      "\t\t\t\t\t\t<LastName>Lal</LastName>\n",
      "\t\t\t\t\t\t<ForeName>Devyani</ForeName>\n",
      "\t\t\t\t\t\t<Initials>D</Initials>\n",
      "\t\t\t\t\t\t<AffiliationInfo>\n",
      "\t\t\t\t\t\t\t<Affiliation>Department of Otolaryngology-Head &amp; Neck Surgery, Mayo Clinic, Scottsdale, Arizona, USA.</Affiliation>\n",
      "\t\t\t\t\t\t</AffiliationInfo>\n",
      "\t\t\t\t\t</Author>\n",
      "\t\t\t\t</AuthorList>\n",
      "\t\t\t\t<Language>eng</Language>\n",
      "\t\t\t\t<PublicationTypeList>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016428\">Journal Article</PublicationType>\n",
      "\t\t\t\t\t<PublicationType UI=\"D016454\">Review</PublicationType>\n",
      "\t\t\t\t</PublicationTypeList>\n",
      "\t\t\t\t<ArticleDate DateType=\"Electronic\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>05</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t</ArticleDate>\n",
      "\t\t\t</Article>\n",
      "\t\t\t<MedlineJournalInfo>\n",
      "\t\t\t\t<Country>England</Country>\n",
      "\t\t\t\t<MedlineTA>Otolaryngol Head Neck Surg</MedlineTA>\n",
      "\t\t\t\t<NlmUniqueID>8508176</NlmUniqueID>\n",
      "\t\t\t\t<ISSNLinking>0194-5998</ISSNLinking>\n",
      "\t\t\t</MedlineJournalInfo>\n",
      "\t\t\t<ChemicalList>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>0</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D015415\">Biomarkers</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t\t<Chemical>\n",
      "\t\t\t\t\t<RegistryNumber>75715-89-8</RegistryNumber>\n",
      "\t\t\t\t\t<NameOfSubstance UI=\"D017999\">Leukotriene E4</NameOfSubstance>\n",
      "\t\t\t\t</Chemical>\n",
      "\t\t\t</ChemicalList>\n",
      "\t\t\t<CitationSubset>IM</CitationSubset>\n",
      "\t\t\t<MeshHeadingList>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D001249\" MajorTopicYN=\"N\">Asthma</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D055963\" MajorTopicYN=\"N\">Asthma, Aspirin-Induced</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000175\" MajorTopicYN=\"N\">diagnosis</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D015415\" MajorTopicYN=\"N\">Biomarkers</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"Y\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D002908\" MajorTopicYN=\"N\">Chronic Disease</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D006801\" MajorTopicYN=\"N\">Humans</DescriptorName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D017999\" MajorTopicYN=\"N\">Leukotriene E4</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"Y\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012220\" MajorTopicYN=\"N\">Rhinitis</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t\t<MeshHeading>\n",
      "\t\t\t\t\t<DescriptorName UI=\"D012852\" MajorTopicYN=\"N\">Sinusitis</DescriptorName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000175\" MajorTopicYN=\"Y\">diagnosis</QualifierName>\n",
      "\t\t\t\t\t<QualifierName UI=\"Q000652\" MajorTopicYN=\"N\">urine</QualifierName>\n",
      "\t\t\t\t</MeshHeading>\n",
      "\t\t\t</MeshHeadingList>\n",
      "\t\t\t<KeywordList Owner=\"NOTNLM\">\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">AERD</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">aspirin-exacerbated respiratory disease</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">biomarker</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">chronic rhinosinusitis</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">endotype</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">nasal polyps</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">phenotype</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">uLTE4</Keyword>\n",
      "\t\t\t\t<Keyword MajorTopicYN=\"N\">urine leukotriene E4</Keyword>\n",
      "\t\t\t</KeywordList>\n",
      "\t\t</MedlineCitation>\n",
      "\t\t<PubmedData>\n",
      "\t\t\t<History>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"pubmed\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>12</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"medline\">\n",
      "\t\t\t\t\t<Year>2022</Year>\n",
      "\t\t\t\t\t<Month>3</Month>\n",
      "\t\t\t\t\t<Day>8</Day>\n",
      "\t\t\t\t\t<Hour>6</Hour>\n",
      "\t\t\t\t\t<Minute>0</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t\t<PubMedPubDate PubStatus=\"entrez\">\n",
      "\t\t\t\t\t<Year>2021</Year>\n",
      "\t\t\t\t\t<Month>5</Month>\n",
      "\t\t\t\t\t<Day>11</Day>\n",
      "\t\t\t\t\t<Hour>12</Hour>\n",
      "\t\t\t\t\t<Minute>12</Minute>\n",
      "\t\t\t\t</PubMedPubDate>\n",
      "\t\t\t</History>\n",
      "\t\t\t<PublicationStatus>ppublish</PublicationStatus>\n",
      "\t\t\t<ArticleIdList>\n",
      "\t\t\t\t<ArticleId IdType=\"pubmed\">33973823</ArticleId>\n",
      "\t\t\t\t<ArticleId IdType=\"doi\">10.1177/01945998211011060</ArticleId>\n",
      "\t\t\t</ArticleIdList>\n",
      "\t\t</PubmedData>\n",
      "\t</PubmedArticle>\n",
      "</PubmedArticleSet>\n",
      "\n"
     ]
    }
   ],
   "source": [
    "import xml.dom.minidom\n",
    "  \n",
    "xml = xml.dom.minidom.parseString(r4.content)\n",
    "\n",
    "print(xml.toprettyxml() )"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "35836df4",
   "metadata": {},
   "source": [
    "### Extracting Data from XML"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "009d95d3",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Element PubmedArticleSet at 0x7f9b2b06bcc0>"
      ]
     },
     "execution_count": 12,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from lxml import etree\n",
    "\n",
    "tree4 = etree.XML(r4.content)\n",
    "tree4"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "id": "d6a73a2f",
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "- Updates on immune mechanisms in aspirin-exacerbated respiratory disease.\n",
      "- Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.\n",
      "- Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.\n"
     ]
    }
   ],
   "source": [
    "for title in tree4.xpath('//Article/ArticleTitle/text()')[:3] :\n",
    "    print('-', title)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "id": "2401094f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<Element Article at 0x7f9b2bd2c1c0>\n",
      "- Updates on immune mechanisms in aspirin-exacerbated respiratory disease.\n",
      "  -  Tanya M Laidlaw\n",
      "  -  Joshua A Boyce\n",
      "<Element Article at 0x7f9b2bd2d800>\n",
      "- Structures of Leukotriene Biosynthetic Enzymes and Development of New Therapeutics.\n",
      "  -  Jesper Z Haeggström\n",
      "  -  Marcia E Newcomer\n",
      "<Element Article at 0x7f9b2bd2d980>\n",
      "- Mechanisms by which dupilumab normalizes eicosanoid metabolism and restores aspirin-tolerance in AERD: A hypothesis.\n",
      "  -  César Picado\n",
      "  -  Joaquim Mullol\n",
      "  -  Jordi Roca-Ferrer\n"
     ]
    }
   ],
   "source": [
    "for a in tree4.xpath('//Article')[:3] :\n",
    "    print(a)\n",
    "    print('-', a.find('ArticleTitle').text)\n",
    "    # print('-', a.xpath('AuthorList/Author'))\n",
    "    for au in a.xpath('AuthorList/Author'):\n",
    "        print('  - ' , au.find('ForeName').text, au.find('LastName').text )"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "7fc2ae8c",
   "metadata": {},
   "source": [
    "## API Example with API Key: Geocode"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "id": "4fc00278",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'Los%20Angeles'"
      ]
     },
     "execution_count": 15,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import requests\n",
    "import json\n",
    "# api_key = '<top secret>'\n",
    "with open('opencage.key') as f:\n",
    "    api_key = f.read()\n",
    "# print(api_key)\n",
    "\n",
    "location_name = 'Los Angeles'\n",
    "enc_loc = requests.utils.quote(location_name)\n",
    "enc_loc"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "id": "ce70782d",
   "metadata": {},
   "outputs": [],
   "source": [
    "base_url = 'https://api.opencagedata.com/geocode/v1/json'\n",
    "url = f'{base_url}?q={enc_loc}&key={api_key}'\n",
    "# url"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "id": "8a79a5f6",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "b'{\"documentation\":\"https://opencagedata.com/api\",\"licenses\":[{\"name\":\"see attribution guide\",\"url\":\"https://opencagedata.com/credits\"}],\"rate\":{\"limit\":2500,\"remaining\":2492,\"reset\":1679529600},\"results\":[{\"annotations\":{\"DMS\":{\"lat\":\"34\\\\u00b0 3\\' 13.28724\\'\\' N\",\"lng\":\"118\\\\u00b0 14\\' 33.95760\\'\\' W\"},\"FIPS\":{\"county\":\"06037\",\"state\":\"06\"},\"MGRS\":\"11SLT8530268805\",\"Maidenhead\":\"DM04vb02uv\",\"Mercator\":{\"x\":-13162724.501,\"y\":4012087.536},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=207359#map=17/34.05369/-118.24277\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/34.05369/-118.24277&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=34.05369&mlon=-118.24277#map=17/34.05369/-118.24277\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"NORTHERN_AMERICA\":\"021\",\"US\":\"840\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"MEDC\"]},\"callingcode\":1,\"currency\":{\"alternate_symbols\":[\"US$\"],\"decimal_mark\":\".\",\"disambiguate_symbol\":\"US$\",\"html_entity\":\"$\",\"iso_code\":\"USD\",\"iso_numeric\":\"840\",\"name\":\"United States Dollar\",\"smallest_denomination\":1,\"subunit\":\"Cent\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\",\"},\"flag\":\"\\\\ud83c\\\\uddfa\\\\ud83c\\\\uddf8\",\"geohash\":\"9q5ctr61pu56cc11s98x\",\"qibla\":23.86,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"mph\"},\"sun\":{\"rise\":{\"apparent\":1679493300,\"astronomical\":1679488260,\"civil\":1679491800,\"nautical\":1679490060},\"set\":{\"apparent\":1679450700,\"astronomical\":1679455740,\"civil\":1679452200,\"nautical\":1679453940}},\"timezone\":{\"name\":\"America/Los_Angeles\",\"now_in_dst\":1,\"offset_sec\":-25200,\"offset_string\":\"-0700\",\"short_name\":\"PDT\"},\"what3words\":{\"words\":\"bless.fork.sober\"},\"wikidata\":\"Q65\"},\"bounds\":{\"northeast\":{\"lat\":34.337306,\"lng\":-118.1552947},\"southwest\":{\"lat\":33.659541,\"lng\":-118.6681779}},\"components\":{\"ISO_3166-1_alpha-2\":\"US\",\"ISO_3166-1_alpha-3\":\"USA\",\"ISO_3166-2\":[\"US-CA\"],\"_category\":\"place\",\"_type\":\"city\",\"city\":\"Los Angeles\",\"continent\":\"North America\",\"country\":\"United States\",\"country_code\":\"us\",\"county\":\"Los Angeles County\",\"state\":\"California\",\"state_code\":\"CA\"},\"confidence\":1,\"formatted\":\"Los Angeles, California, United States of America\",\"geometry\":{\"lat\":34.0536909,\"lng\":-118.242766}},{\"annotations\":{\"DMS\":{\"lat\":\"34\\\\u00b0 4\\' 15.15972\\'\\' N\",\"lng\":\"118\\\\u00b0 26\\' 48.66252\\'\\' W\"},\"FIPS\":{\"county\":\"06037\",\"state\":\"06\"},\"MGRS\":\"11SLT6649270959\",\"Maidenhead\":\"DM04sb67ja\",\"Mercator\":{\"x\":-13185443.107,\"y\":4014386.372},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?way=807458549#map=17/34.07088/-118.44685\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/34.07088/-118.44685&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=34.07088&mlon=-118.44685#map=17/34.07088/-118.44685\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"NORTHERN_AMERICA\":\"021\",\"US\":\"840\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"MEDC\"]},\"callingcode\":1,\"currency\":{\"alternate_symbols\":[\"US$\"],\"decimal_mark\":\".\",\"disambiguate_symbol\":\"US$\",\"html_entity\":\"$\",\"iso_code\":\"USD\",\"iso_numeric\":\"840\",\"name\":\"United States Dollar\",\"smallest_denomination\":1,\"subunit\":\"Cent\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\",\"},\"flag\":\"\\\\ud83c\\\\uddfa\\\\ud83c\\\\uddf8\",\"geohash\":\"9q5cbdmthrfwr4b8t39y\",\"qibla\":23.65,\"roadinfo\":{\"drive_on\":\"right\",\"road\":\"Hilgard Avenue\",\"speed_in\":\"mph\"},\"sun\":{\"rise\":{\"apparent\":1679493300,\"astronomical\":1679488320,\"civil\":1679491860,\"nautical\":1679490060},\"set\":{\"apparent\":1679450760,\"astronomical\":1679455800,\"civil\":1679452260,\"nautical\":1679454000}},\"timezone\":{\"name\":\"America/Los_Angeles\",\"now_in_dst\":1,\"offset_sec\":-25200,\"offset_string\":\"-0700\",\"short_name\":\"PDT\"},\"what3words\":{\"words\":\"stir.clean.wrong\"},\"wikidata\":\"Q174710\"},\"bounds\":{\"northeast\":{\"lat\":34.0780784,\"lng\":-118.4374163},\"southwest\":{\"lat\":34.0637597,\"lng\":-118.455411}},\"components\":{\"ISO_3166-1_alpha-2\":\"US\",\"ISO_3166-1_alpha-3\":\"USA\",\"ISO_3166-2\":[\"US-CA\"],\"_category\":\"education\",\"_type\":\"university\",\"city\":\"Los Angeles\",\"continent\":\"North America\",\"country\":\"United States\",\"country_code\":\"us\",\"county\":\"Los Angeles County\",\"postcode\":\"90095\",\"road\":\"Hilgard Avenue\",\"state\":\"California\",\"state_code\":\"CA\",\"suburb\":\"Westwood\",\"university\":\"University of California, Los Angeles\"},\"confidence\":8,\"formatted\":\"University of California, Los Angeles, Hilgard Avenue, Los Angeles, CA 90095, United States of America\",\"geometry\":{\"lat\":34.0708777,\"lng\":-118.4468507}},{\"annotations\":{\"DMS\":{\"lat\":\"34\\\\u00b0 18\\' 55.82592\\'\\' N\",\"lng\":\"118\\\\u00b0 12\\' 34.85160\\'\\' W\"},\"FIPS\":{\"county\":\"06037\",\"state\":\"06\"},\"MGRS\":\"11SLT8870097802\",\"Maidenhead\":\"DM04vh45ur\",\"Mercator\":{\"x\":-13159041.496,\"y\":4047158.133},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=396479#map=17/34.31551/-118.20968\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/34.31551/-118.20968&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=34.31551&mlon=-118.20968#map=17/34.31551/-118.20968\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"NORTHERN_AMERICA\":\"021\",\"US\":\"840\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"MEDC\"]},\"callingcode\":1,\"currency\":{\"alternate_symbols\":[\"US$\"],\"decimal_mark\":\".\",\"disambiguate_symbol\":\"US$\",\"html_entity\":\"$\",\"iso_code\":\"USD\",\"iso_numeric\":\"840\",\"name\":\"United States Dollar\",\"smallest_denomination\":1,\"subunit\":\"Cent\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\",\"},\"flag\":\"\\\\ud83c\\\\uddfa\\\\ud83c\\\\uddf8\",\"geohash\":\"9q5gnnfq6f1mbeh74cgn\",\"qibla\":23.83,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"mph\"},\"sun\":{\"rise\":{\"apparent\":1679493240,\"astronomical\":1679488260,\"civil\":1679491740,\"nautical\":1679490000},\"set\":{\"apparent\":1679450700,\"astronomical\":1679455740,\"civil\":1679452200,\"nautical\":1679454000}},\"timezone\":{\"name\":\"America/Los_Angeles\",\"now_in_dst\":1,\"offset_sec\":-25200,\"offset_string\":\"-0700\",\"short_name\":\"PDT\"},\"what3words\":{\"words\":\"prime.link.tables\"},\"wikidata\":\"Q104994\"},\"bounds\":{\"northeast\":{\"lat\":34.8233121,\"lng\":-117.64627},\"southwest\":{\"lat\":32.75004,\"lng\":-118.9517221}},\"components\":{\"ISO_3166-1_alpha-2\":\"US\",\"ISO_3166-1_alpha-3\":\"USA\",\"ISO_3166-2\":[\"US-CA\"],\"_category\":\"place\",\"_type\":\"county\",\"continent\":\"North America\",\"country\":\"United States\",\"country_code\":\"us\",\"county\":\"Los Angeles County\",\"state\":\"California\",\"state_code\":\"CA\"},\"confidence\":1,\"formatted\":\"Los Angeles County, California, United States of America\",\"geometry\":{\"lat\":34.3155072,\"lng\":-118.209681}},{\"annotations\":{\"DMS\":{\"lat\":\"9\\\\u00b0 23\\' 24.23004\\'\\' N\",\"lng\":\"75\\\\u00b0 14\\' 20.12244\\'\\' W\"},\"MGRS\":\"18PVR7376737985\",\"Maidenhead\":\"FJ29jj13ho\",\"Mercator\":{\"x\":-8375558.589,\"y\":1043041.346},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=3487764#map=17/9.39006/-75.23892\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/9.39006/-75.23892&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=9.39006&mlon=-75.23892#map=17/9.39006/-75.23892\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CO\":\"170\",\"LATIN_AMERICA\":\"419\",\"SOUTH_AMERICA\":\"005\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":57,\"currency\":{\"alternate_symbols\":[\"COL$\"],\"decimal_mark\":\",\",\"disambiguate_symbol\":\"COL$\",\"html_entity\":\"&#36;\",\"iso_code\":\"COP\",\"iso_numeric\":\"170\",\"name\":\"Colombian Peso\",\"smallest_denomination\":20,\"subunit\":\"Centavo\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\".\"},\"flag\":\"\\\\ud83c\\\\udde8\\\\ud83c\\\\uddf4\",\"geohash\":\"d3dmrvktn4bbczyucq1m\",\"qibla\":63.27,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679483100,\"astronomical\":1679478960,\"civil\":1679481840,\"nautical\":1679480400},\"set\":{\"apparent\":1679526660,\"astronomical\":1679444400,\"civil\":1679527920,\"nautical\":1679529360}},\"timezone\":{\"name\":\"America/Bogota\",\"now_in_dst\":0,\"offset_sec\":-18000,\"offset_string\":\"-0500\",\"short_name\":\"-05\"},\"what3words\":{\"words\":\"stepfather.spanned.colossus\"}},\"bounds\":{\"northeast\":{\"lat\":9.4022923,\"lng\":-75.2213977},\"southwest\":{\"lat\":9.3778767,\"lng\":-75.2594562}},\"components\":{\"ISO_3166-1_alpha-2\":\"CO\",\"ISO_3166-1_alpha-3\":\"COL\",\"ISO_3166-2\":[\"CO-SUC\"],\"_category\":\"place\",\"_type\":\"neighbourhood\",\"city_district\":\"Los Angeles\",\"continent\":\"South America\",\"country\":\"Colombia\",\"country_code\":\"co\",\"state\":\"Sucre\",\"state_code\":\"SUC\",\"state_district\":\"Montes de Mar\\\\u00eda\",\"town\":\"Los Palmitos\"},\"confidence\":7,\"formatted\":\"Los Angeles, Los Palmitos, Montes de Mar\\\\u00eda, Colombia\",\"geometry\":{\"lat\":9.3900639,\"lng\":-75.2389229}},{\"annotations\":{\"DMS\":{\"lat\":\"37\\\\u00b0 28\\' 14.68380\\'\\' S\",\"lng\":\"72\\\\u00b0 21\\' 6.06960\\'\\' W\"},\"MGRS\":\"18HYD3419749610\",\"Maidenhead\":\"FF32tm77ta\",\"Mercator\":{\"x\":-8054152.844,\"y\":-4478930.466},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=1658515#map=17/-37.47075/-72.35169\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/-37.47075/-72.35169&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=-37.47075&mlon=-72.35169#map=17/-37.47075/-72.35169\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CL\":\"152\",\"LATIN_AMERICA\":\"419\",\"SOUTH_AMERICA\":\"005\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":56,\"currency\":{\"alternate_symbols\":[],\"decimal_mark\":\",\",\"disambiguate_symbol\":\"CLP\",\"html_entity\":\"&#36;\",\"iso_code\":\"CLP\",\"iso_numeric\":\"152\",\"name\":\"Chilean Peso\",\"smallest_denomination\":1,\"subunit\":\"Peso\",\"subunit_to_unit\":1,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\".\"},\"flag\":\"\\\\ud83c\\\\udde8\\\\ud83c\\\\uddf1\",\"geohash\":\"63kdcdej5db8wcbccz46\",\"qibla\":84.96,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679482500,\"astronomical\":1679477280,\"civil\":1679480940,\"nautical\":1679479140},\"set\":{\"apparent\":1679525820,\"astronomical\":1679444640,\"civil\":1679527380,\"nautical\":1679529180}},\"timezone\":{\"name\":\"America/Santiago\",\"now_in_dst\":1,\"offset_sec\":-10800,\"offset_string\":\"-0300\",\"short_name\":\"-03\"},\"what3words\":{\"words\":\"analysis.possibly.flicked\"},\"wikidata\":\"Q16910\"},\"bounds\":{\"northeast\":{\"lat\":-37.1785281,\"lng\":-72.03901},\"southwest\":{\"lat\":-37.6629358,\"lng\":-72.6836424}},\"components\":{\"ISO_3166-1_alpha-2\":\"CL\",\"ISO_3166-1_alpha-3\":\"CHL\",\"ISO_3166-2\":[\"CL-BI\"],\"_category\":\"place\",\"_type\":\"city\",\"city\":\"Los \\\\u00c1ngeles\",\"continent\":\"South America\",\"country\":\"Chile\",\"country_code\":\"cl\",\"county\":\"Provincia de B\\\\u00edo-B\\\\u00edo\",\"state\":\"Biob\\\\u00edo Region\"},\"confidence\":1,\"formatted\":\"Los \\\\u00c1ngeles, Provincia de B\\\\u00edo-B\\\\u00edo, Chile\",\"geometry\":{\"lat\":-37.4707455,\"lng\":-72.351686}},{\"annotations\":{\"DMS\":{\"lat\":\"8\\\\u00b0 31\\' 27.00228\\'\\' N\",\"lng\":\"82\\\\u00b0 11\\' 39.06888\\'\\' W\"},\"MGRS\":\"17PLK6856642449\",\"Maidenhead\":\"EJ88vm65qt\",\"Mercator\":{\"x\":-9149814.905,\"y\":946096.718},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=11025613#map=17/8.52417/-82.19419\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/8.52417/-82.19419&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=8.52417&mlon=-82.19419#map=17/8.52417/-82.19419\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CENTRAL_AMERICA\":\"013\",\"LATIN_AMERICA\":\"419\",\"PA\":\"591\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":507,\"currency\":{\"alternate_symbols\":[\"US$\"],\"decimal_mark\":\".\",\"disambiguate_symbol\":\"US$\",\"html_entity\":\"$\",\"iso_code\":\"USD\",\"iso_numeric\":\"840\",\"name\":\"United States Dollar\",\"smallest_denomination\":1,\"subunit\":\"Cent\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\",\"},\"flag\":\"\\\\ud83c\\\\uddf5\\\\ud83c\\\\udde6\",\"geohash\":\"d1t83xu0beuyq9j6xvb0\",\"qibla\":61.17,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679484780,\"astronomical\":1679480640,\"civil\":1679483520,\"nautical\":1679482080},\"set\":{\"apparent\":1679528280,\"astronomical\":1679446080,\"civil\":1679529540,\"nautical\":1679444640}},\"timezone\":{\"name\":\"America/Panama\",\"now_in_dst\":0,\"offset_sec\":-18000,\"offset_string\":\"-0500\",\"short_name\":\"EST\"},\"what3words\":{\"words\":\"mimes.unblinking.overnights\"},\"wikidata\":\"Q20991006\"},\"bounds\":{\"northeast\":{\"lat\":8.5744293,\"lng\":-82.1248326},\"southwest\":{\"lat\":8.4737289,\"lng\":-82.2441543}},\"components\":{\"ISO_3166-1_alpha-2\":\"PA\",\"ISO_3166-1_alpha-3\":\"PAN\",\"ISO_3166-2\":[\"PA-4\"],\"_category\":\"place\",\"_type\":\"city\",\"city\":\"Los Angeles\",\"continent\":\"North America\",\"country\":\"Panama\",\"country_code\":\"pa\",\"county\":\"Distrito Gualaca\",\"state\":\"Chiriqu\\\\u00ed\"},\"confidence\":6,\"formatted\":\"Los Angeles, Distrito Gualaca, Panama\",\"geometry\":{\"lat\":8.5241673,\"lng\":-82.1941858}},{\"annotations\":{\"DMS\":{\"lat\":\"4\\\\u00b0 48\\' 3.20184\\'\\' N\",\"lng\":\"75\\\\u00b0 41\\' 29.38776\\'\\' W\"},\"MGRS\":\"18NVL2332030693\",\"Maidenhead\":\"FJ24dt72af\",\"Mercator\":{\"x\":-8425938.857,\"y\":531485.466},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=7752593#map=17/4.80089/-75.69150\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/4.80089/-75.69150&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=4.80089&mlon=-75.69150#map=17/4.80089/-75.69150\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CO\":\"170\",\"LATIN_AMERICA\":\"419\",\"SOUTH_AMERICA\":\"005\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":57,\"currency\":{\"alternate_symbols\":[\"COL$\"],\"decimal_mark\":\",\",\"disambiguate_symbol\":\"COL$\",\"html_entity\":\"&#36;\",\"iso_code\":\"COP\",\"iso_numeric\":\"170\",\"name\":\"Colombian Peso\",\"smallest_denomination\":20,\"subunit\":\"Centavo\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\".\"},\"flag\":\"\\\\ud83c\\\\udde8\\\\ud83c\\\\uddf4\",\"geohash\":\"d2f5m9gphq9kqpw9xrk9\",\"qibla\":64.68,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679483220,\"astronomical\":1679479080,\"civil\":1679481960,\"nautical\":1679480520},\"set\":{\"apparent\":1679526720,\"astronomical\":1679444460,\"civil\":1679527980,\"nautical\":1679529420}},\"timezone\":{\"name\":\"America/Bogota\",\"now_in_dst\":0,\"offset_sec\":-18000,\"offset_string\":\"-0500\",\"short_name\":\"-05\"},\"what3words\":{\"words\":\"unscrew.sourced.exposing\"}},\"bounds\":{\"northeast\":{\"lat\":4.8050146,\"lng\":-75.6898823},\"southwest\":{\"lat\":4.7967815,\"lng\":-75.6939554}},\"components\":{\"ISO_3166-1_alpha-2\":\"CO\",\"ISO_3166-1_alpha-3\":\"COL\",\"ISO_3166-2\":[\"CO-RIS\"],\"_category\":\"place\",\"_type\":\"neighbourhood\",\"borough\":\"Universidad\",\"city\":\"Perimetro Urbano Pereira\",\"continent\":\"South America\",\"country\":\"Colombia\",\"country_code\":\"co\",\"municipality\":\"Pereira\",\"region\":\"RAP Eje Cafetero\",\"state\":\"Risaralda\",\"state_code\":\"RIS\",\"state_district\":\"AMCO, Area Metropolitana Centro Occidente\",\"suburb\":\"Los Angeles\"},\"confidence\":9,\"formatted\":\"Los Angeles, Perimetro Urbano Pereira, AMCO, Area Metropolitana Centro Occidente, Colombia\",\"geometry\":{\"lat\":4.8008894,\"lng\":-75.6914966}},{\"annotations\":{\"DMS\":{\"lat\":\"13\\\\u00b0 15\\' 1.24992\\'\\' N\",\"lng\":\"86\\\\u00b0 1\\' 13.03860\\'\\' W\"},\"MGRS\":\"16PFV0613865028\",\"Maidenhead\":\"EK63xg70nc\",\"Mercator\":{\"x\":-9575734.714,\"y\":1478560.655},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?node=10034935559#map=17/13.25035/-86.02029\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/13.25035/-86.02029&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=13.25035&mlon=-86.02029#map=17/13.25035/-86.02029\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CENTRAL_AMERICA\":\"013\",\"LATIN_AMERICA\":\"419\",\"NI\":\"558\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":505,\"currency\":{\"alternate_symbols\":[],\"decimal_mark\":\".\",\"disambiguate_symbol\":\"NIO$\",\"html_entity\":\"\",\"iso_code\":\"NIO\",\"iso_numeric\":\"558\",\"name\":\"Nicaraguan C\\\\u00f3rdoba\",\"smallest_denomination\":5,\"subunit\":\"Centavo\",\"subunit_to_unit\":100,\"symbol\":\"C$\",\"symbol_first\":1,\"thousands_separator\":\",\"},\"flag\":\"\\\\ud83c\\\\uddf3\\\\ud83c\\\\uddee\",\"geohash\":\"d46g6s1uvgxzz4z5gwhd\",\"qibla\":57.51,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679485680,\"astronomical\":1679481420,\"civil\":1679484420,\"nautical\":1679482920},\"set\":{\"apparent\":1679529240,\"astronomical\":1679447100,\"civil\":1679444100,\"nautical\":1679445600}},\"timezone\":{\"name\":\"America/Managua\",\"now_in_dst\":0,\"offset_sec\":-21600,\"offset_string\":\"-0600\",\"short_name\":\"CST\"},\"what3words\":{\"words\":\"unbolt.ungoverned.unsuited\"}},\"bounds\":{\"northeast\":{\"lat\":14.2503472,\"lng\":-85.0202885},\"southwest\":{\"lat\":12.2503472,\"lng\":-87.0202885}},\"components\":{\"ISO_3166-1_alpha-2\":\"NI\",\"ISO_3166-1_alpha-3\":\"NIC\",\"ISO_3166-2\":[\"NI-JI\"],\"_category\":\"road\",\"_type\":\"road\",\"continent\":\"North America\",\"country\":\"Nicaragua\",\"country_code\":\"ni\",\"municipality\":\"Jinotega (Municipio)\",\"place\":\"Los Angeles\",\"postcode\":\"65000\",\"state\":\"Jinotega\",\"state_code\":\"JI\"},\"confidence\":1,\"formatted\":\"Los Angeles, Jinotega, Nicaragua\",\"geometry\":{\"lat\":13.2503472,\"lng\":-86.0202885}},{\"annotations\":{\"DMS\":{\"lat\":\"2\\\\u00b0 24\\' 58.35888\\'\\' N\",\"lng\":\"76\\\\u00b0 55\\' 2.29872\\'\\' W\"},\"MGRS\":\"18NTH8680067215\",\"Maidenhead\":\"FJ12mj99wv\",\"Mercator\":{\"x\":-8562395.248,\"y\":267251.044},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?node=6042263237#map=17/2.41621/-76.91731\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/2.41621/-76.91731&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=2.41621&mlon=-76.91731#map=17/2.41621/-76.91731\"},\"UN_M49\":{\"regions\":{\"AMERICAS\":\"019\",\"CO\":\"170\",\"LATIN_AMERICA\":\"419\",\"SOUTH_AMERICA\":\"005\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"LEDC\"]},\"callingcode\":57,\"currency\":{\"alternate_symbols\":[\"COL$\"],\"decimal_mark\":\",\",\"disambiguate_symbol\":\"COL$\",\"html_entity\":\"&#36;\",\"iso_code\":\"COP\",\"iso_numeric\":\"170\",\"name\":\"Colombian Peso\",\"smallest_denomination\":20,\"subunit\":\"Centavo\",\"subunit_to_unit\":100,\"symbol\":\"$\",\"symbol_first\":1,\"thousands_separator\":\".\"},\"flag\":\"\\\\ud83c\\\\udde8\\\\ud83c\\\\uddf4\",\"geohash\":\"d23m9xye2yk6c6by1ysp\",\"qibla\":65.29,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679483520,\"astronomical\":1679479440,\"civil\":1679482260,\"nautical\":1679480880},\"set\":{\"apparent\":1679527020,\"astronomical\":1679444700,\"civil\":1679528280,\"nautical\":1679443260}},\"timezone\":{\"name\":\"America/Bogota\",\"now_in_dst\":0,\"offset_sec\":-18000,\"offset_string\":\"-0500\",\"short_name\":\"-05\"},\"what3words\":{\"words\":\"uncoil.bras.drooped\"}},\"bounds\":{\"northeast\":{\"lat\":2.4562108,\"lng\":-76.8773052},\"southwest\":{\"lat\":2.3762108,\"lng\":-76.9573052}},\"components\":{\"ISO_3166-1_alpha-2\":\"CO\",\"ISO_3166-1_alpha-3\":\"COL\",\"ISO_3166-2\":[\"CO-CAU\"],\"_category\":\"place\",\"_type\":\"city\",\"continent\":\"South America\",\"country\":\"Colombia\",\"country_code\":\"co\",\"county\":\"El Tambo\",\"state\":\"Cauca\",\"state_code\":\"CAU\",\"state_district\":\"Centro\",\"town\":\"Los Angeles\"},\"confidence\":7,\"formatted\":\"Los Angeles, El Tambo, Colombia\",\"geometry\":{\"lat\":2.4162108,\"lng\":-76.9173052}},{\"annotations\":{\"DMS\":{\"lat\":\"40\\\\u00b0 21\\' 22.39812\\'\\' N\",\"lng\":\"3\\\\u00b0 41\\' 58.69968\\'\\' W\"},\"MGRS\":\"30TVK4059067530\",\"Maidenhead\":\"IN80di65bl\",\"Mercator\":{\"x\":-411841.907,\"y\":4890169.008},\"NUTS\":{\"NUTS0\":{\"code\":\"ES\"},\"NUTS1\":{\"code\":\"ES3\"},\"NUTS2\":{\"code\":\"ES30\"},\"NUTS3\":{\"code\":\"ES300\"}},\"OSM\":{\"edit_url\":\"https://www.openstreetmap.org/edit?relation=9235998#map=17/40.35622/-3.69964\",\"note_url\":\"https://www.openstreetmap.org/note/new#map=17/40.35622/-3.69964&layers=N\",\"url\":\"https://www.openstreetmap.org/?mlat=40.35622&mlon=-3.69964#map=17/40.35622/-3.69964\"},\"UN_M49\":{\"regions\":{\"ES\":\"724\",\"EUROPE\":\"150\",\"SOUTHERN_EUROPE\":\"039\",\"WORLD\":\"001\"},\"statistical_groupings\":[\"MEDC\"]},\"callingcode\":34,\"currency\":{\"alternate_symbols\":[],\"decimal_mark\":\",\",\"html_entity\":\"\\\\u20ac\",\"iso_code\":\"EUR\",\"iso_numeric\":\"978\",\"name\":\"Euro\",\"smallest_denomination\":1,\"subunit\":\"Cent\",\"subunit_to_unit\":100,\"symbol\":\"\\\\u20ac\",\"symbol_first\":0,\"thousands_separator\":\".\"},\"flag\":\"\\\\ud83c\\\\uddea\\\\ud83c\\\\uddf8\",\"geohash\":\"ezjmefdh00vr7tye4qmm\",\"qibla\":103.91,\"roadinfo\":{\"drive_on\":\"right\",\"speed_in\":\"km/h\"},\"sun\":{\"rise\":{\"apparent\":1679465820,\"astronomical\":1679460300,\"civil\":1679464140,\"nautical\":1679462280},\"set\":{\"apparent\":1679509680,\"astronomical\":1679515140,\"civil\":1679511300,\"nautical\":1679513220}},\"timezone\":{\"name\":\"Europe/Madrid\",\"now_in_dst\":0,\"offset_sec\":3600,\"offset_string\":\"+0100\",\"short_name\":\"CET\"},\"what3words\":{\"words\":\"basher.spooned.clean\"},\"wikidata\":\"Q390462\"},\"bounds\":{\"northeast\":{\"lat\":40.3645348,\"lng\":-3.6930263},\"southwest\":{\"lat\":40.3456815,\"lng\":-3.7070704}},\"components\":{\"ISO_3166-1_alpha-2\":\"ES\",\"ISO_3166-1_alpha-3\":\"ESP\",\"ISO_3166-2\":[\"ES-MD\"],\"_category\":\"place\",\"_type\":\"neighbourhood\",\"city\":\"Madrid\",\"continent\":\"Europe\",\"country\":\"Spain\",\"country_code\":\"es\",\"county\":\"\\\\u00c1rea metropolitana de Madrid y Corredor del Henares\",\"political_union\":\"European Union\",\"postcode\":\"28041\",\"quarter\":\"Los \\\\u00c1ngeles\",\"state\":\"Madrid\",\"suburb\":\"Villaverde\"},\"confidence\":8,\"formatted\":\"28041 Madrid, Spain\",\"geometry\":{\"lat\":40.3562217,\"lng\":-3.6996388}}],\"status\":{\"code\":200,\"message\":\"OK\"},\"stay_informed\":{\"blog\":\"https://blog.opencagedata.com\",\"mastodon\":\"https://en.osm.town/@opencage\",\"twitter\":\"https://twitter.com/OpenCage\"},\"thanks\":\"For using an OpenCage API\",\"timestamp\":{\"created_http\":\"Wed, 22 Mar 2023 06:11:38 GMT\",\"created_unix\":1679465498},\"total_results\":10}'"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "r = requests.get(url)\n",
    "r.content"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "id": "f839232b",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'documentation': 'https://opencagedata.com/api',\n",
       " 'licenses': [{'name': 'see attribution guide',\n",
       "   'url': 'https://opencagedata.com/credits'}],\n",
       " 'rate': {'limit': 2500, 'remaining': 2492, 'reset': 1679529600},\n",
       " 'results': [{'annotations': {'DMS': {'lat': \"34° 3' 13.28724'' N\",\n",
       "     'lng': \"118° 14' 33.95760'' W\"},\n",
       "    'FIPS': {'county': '06037', 'state': '06'},\n",
       "    'MGRS': '11SLT8530268805',\n",
       "    'Maidenhead': 'DM04vb02uv',\n",
       "    'Mercator': {'x': -13162724.501, 'y': 4012087.536},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=207359#map=17/34.05369/-118.24277',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/34.05369/-118.24277&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=34.05369&mlon=-118.24277#map=17/34.05369/-118.24277'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'NORTHERN_AMERICA': '021',\n",
       "      'US': '840',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['MEDC']},\n",
       "    'callingcode': 1,\n",
       "    'currency': {'alternate_symbols': ['US$'],\n",
       "     'decimal_mark': '.',\n",
       "     'disambiguate_symbol': 'US$',\n",
       "     'html_entity': '$',\n",
       "     'iso_code': 'USD',\n",
       "     'iso_numeric': '840',\n",
       "     'name': 'United States Dollar',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Cent',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': ','},\n",
       "    'flag': '🇺🇸',\n",
       "    'geohash': '9q5ctr61pu56cc11s98x',\n",
       "    'qibla': 23.86,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'mph'},\n",
       "    'sun': {'rise': {'apparent': 1679493300,\n",
       "      'astronomical': 1679488260,\n",
       "      'civil': 1679491800,\n",
       "      'nautical': 1679490060},\n",
       "     'set': {'apparent': 1679450700,\n",
       "      'astronomical': 1679455740,\n",
       "      'civil': 1679452200,\n",
       "      'nautical': 1679453940}},\n",
       "    'timezone': {'name': 'America/Los_Angeles',\n",
       "     'now_in_dst': 1,\n",
       "     'offset_sec': -25200,\n",
       "     'offset_string': '-0700',\n",
       "     'short_name': 'PDT'},\n",
       "    'what3words': {'words': 'bless.fork.sober'},\n",
       "    'wikidata': 'Q65'},\n",
       "   'bounds': {'northeast': {'lat': 34.337306, 'lng': -118.1552947},\n",
       "    'southwest': {'lat': 33.659541, 'lng': -118.6681779}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'US',\n",
       "    'ISO_3166-1_alpha-3': 'USA',\n",
       "    'ISO_3166-2': ['US-CA'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'city',\n",
       "    'city': 'Los Angeles',\n",
       "    'continent': 'North America',\n",
       "    'country': 'United States',\n",
       "    'country_code': 'us',\n",
       "    'county': 'Los Angeles County',\n",
       "    'state': 'California',\n",
       "    'state_code': 'CA'},\n",
       "   'confidence': 1,\n",
       "   'formatted': 'Los Angeles, California, United States of America',\n",
       "   'geometry': {'lat': 34.0536909, 'lng': -118.242766}},\n",
       "  {'annotations': {'DMS': {'lat': \"34° 4' 15.15972'' N\",\n",
       "     'lng': \"118° 26' 48.66252'' W\"},\n",
       "    'FIPS': {'county': '06037', 'state': '06'},\n",
       "    'MGRS': '11SLT6649270959',\n",
       "    'Maidenhead': 'DM04sb67ja',\n",
       "    'Mercator': {'x': -13185443.107, 'y': 4014386.372},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?way=807458549#map=17/34.07088/-118.44685',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/34.07088/-118.44685&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=34.07088&mlon=-118.44685#map=17/34.07088/-118.44685'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'NORTHERN_AMERICA': '021',\n",
       "      'US': '840',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['MEDC']},\n",
       "    'callingcode': 1,\n",
       "    'currency': {'alternate_symbols': ['US$'],\n",
       "     'decimal_mark': '.',\n",
       "     'disambiguate_symbol': 'US$',\n",
       "     'html_entity': '$',\n",
       "     'iso_code': 'USD',\n",
       "     'iso_numeric': '840',\n",
       "     'name': 'United States Dollar',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Cent',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': ','},\n",
       "    'flag': '🇺🇸',\n",
       "    'geohash': '9q5cbdmthrfwr4b8t39y',\n",
       "    'qibla': 23.65,\n",
       "    'roadinfo': {'drive_on': 'right',\n",
       "     'road': 'Hilgard Avenue',\n",
       "     'speed_in': 'mph'},\n",
       "    'sun': {'rise': {'apparent': 1679493300,\n",
       "      'astronomical': 1679488320,\n",
       "      'civil': 1679491860,\n",
       "      'nautical': 1679490060},\n",
       "     'set': {'apparent': 1679450760,\n",
       "      'astronomical': 1679455800,\n",
       "      'civil': 1679452260,\n",
       "      'nautical': 1679454000}},\n",
       "    'timezone': {'name': 'America/Los_Angeles',\n",
       "     'now_in_dst': 1,\n",
       "     'offset_sec': -25200,\n",
       "     'offset_string': '-0700',\n",
       "     'short_name': 'PDT'},\n",
       "    'what3words': {'words': 'stir.clean.wrong'},\n",
       "    'wikidata': 'Q174710'},\n",
       "   'bounds': {'northeast': {'lat': 34.0780784, 'lng': -118.4374163},\n",
       "    'southwest': {'lat': 34.0637597, 'lng': -118.455411}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'US',\n",
       "    'ISO_3166-1_alpha-3': 'USA',\n",
       "    'ISO_3166-2': ['US-CA'],\n",
       "    '_category': 'education',\n",
       "    '_type': 'university',\n",
       "    'city': 'Los Angeles',\n",
       "    'continent': 'North America',\n",
       "    'country': 'United States',\n",
       "    'country_code': 'us',\n",
       "    'county': 'Los Angeles County',\n",
       "    'postcode': '90095',\n",
       "    'road': 'Hilgard Avenue',\n",
       "    'state': 'California',\n",
       "    'state_code': 'CA',\n",
       "    'suburb': 'Westwood',\n",
       "    'university': 'University of California, Los Angeles'},\n",
       "   'confidence': 8,\n",
       "   'formatted': 'University of California, Los Angeles, Hilgard Avenue, Los Angeles, CA 90095, United States of America',\n",
       "   'geometry': {'lat': 34.0708777, 'lng': -118.4468507}},\n",
       "  {'annotations': {'DMS': {'lat': \"34° 18' 55.82592'' N\",\n",
       "     'lng': \"118° 12' 34.85160'' W\"},\n",
       "    'FIPS': {'county': '06037', 'state': '06'},\n",
       "    'MGRS': '11SLT8870097802',\n",
       "    'Maidenhead': 'DM04vh45ur',\n",
       "    'Mercator': {'x': -13159041.496, 'y': 4047158.133},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=396479#map=17/34.31551/-118.20968',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/34.31551/-118.20968&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=34.31551&mlon=-118.20968#map=17/34.31551/-118.20968'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'NORTHERN_AMERICA': '021',\n",
       "      'US': '840',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['MEDC']},\n",
       "    'callingcode': 1,\n",
       "    'currency': {'alternate_symbols': ['US$'],\n",
       "     'decimal_mark': '.',\n",
       "     'disambiguate_symbol': 'US$',\n",
       "     'html_entity': '$',\n",
       "     'iso_code': 'USD',\n",
       "     'iso_numeric': '840',\n",
       "     'name': 'United States Dollar',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Cent',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': ','},\n",
       "    'flag': '🇺🇸',\n",
       "    'geohash': '9q5gnnfq6f1mbeh74cgn',\n",
       "    'qibla': 23.83,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'mph'},\n",
       "    'sun': {'rise': {'apparent': 1679493240,\n",
       "      'astronomical': 1679488260,\n",
       "      'civil': 1679491740,\n",
       "      'nautical': 1679490000},\n",
       "     'set': {'apparent': 1679450700,\n",
       "      'astronomical': 1679455740,\n",
       "      'civil': 1679452200,\n",
       "      'nautical': 1679454000}},\n",
       "    'timezone': {'name': 'America/Los_Angeles',\n",
       "     'now_in_dst': 1,\n",
       "     'offset_sec': -25200,\n",
       "     'offset_string': '-0700',\n",
       "     'short_name': 'PDT'},\n",
       "    'what3words': {'words': 'prime.link.tables'},\n",
       "    'wikidata': 'Q104994'},\n",
       "   'bounds': {'northeast': {'lat': 34.8233121, 'lng': -117.64627},\n",
       "    'southwest': {'lat': 32.75004, 'lng': -118.9517221}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'US',\n",
       "    'ISO_3166-1_alpha-3': 'USA',\n",
       "    'ISO_3166-2': ['US-CA'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'county',\n",
       "    'continent': 'North America',\n",
       "    'country': 'United States',\n",
       "    'country_code': 'us',\n",
       "    'county': 'Los Angeles County',\n",
       "    'state': 'California',\n",
       "    'state_code': 'CA'},\n",
       "   'confidence': 1,\n",
       "   'formatted': 'Los Angeles County, California, United States of America',\n",
       "   'geometry': {'lat': 34.3155072, 'lng': -118.209681}},\n",
       "  {'annotations': {'DMS': {'lat': \"9° 23' 24.23004'' N\",\n",
       "     'lng': \"75° 14' 20.12244'' W\"},\n",
       "    'MGRS': '18PVR7376737985',\n",
       "    'Maidenhead': 'FJ29jj13ho',\n",
       "    'Mercator': {'x': -8375558.589, 'y': 1043041.346},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=3487764#map=17/9.39006/-75.23892',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/9.39006/-75.23892&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=9.39006&mlon=-75.23892#map=17/9.39006/-75.23892'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CO': '170',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'SOUTH_AMERICA': '005',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 57,\n",
       "    'currency': {'alternate_symbols': ['COL$'],\n",
       "     'decimal_mark': ',',\n",
       "     'disambiguate_symbol': 'COL$',\n",
       "     'html_entity': '&#36;',\n",
       "     'iso_code': 'COP',\n",
       "     'iso_numeric': '170',\n",
       "     'name': 'Colombian Peso',\n",
       "     'smallest_denomination': 20,\n",
       "     'subunit': 'Centavo',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': '.'},\n",
       "    'flag': '🇨🇴',\n",
       "    'geohash': 'd3dmrvktn4bbczyucq1m',\n",
       "    'qibla': 63.27,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679483100,\n",
       "      'astronomical': 1679478960,\n",
       "      'civil': 1679481840,\n",
       "      'nautical': 1679480400},\n",
       "     'set': {'apparent': 1679526660,\n",
       "      'astronomical': 1679444400,\n",
       "      'civil': 1679527920,\n",
       "      'nautical': 1679529360}},\n",
       "    'timezone': {'name': 'America/Bogota',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': -18000,\n",
       "     'offset_string': '-0500',\n",
       "     'short_name': '-05'},\n",
       "    'what3words': {'words': 'stepfather.spanned.colossus'}},\n",
       "   'bounds': {'northeast': {'lat': 9.4022923, 'lng': -75.2213977},\n",
       "    'southwest': {'lat': 9.3778767, 'lng': -75.2594562}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'CO',\n",
       "    'ISO_3166-1_alpha-3': 'COL',\n",
       "    'ISO_3166-2': ['CO-SUC'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'neighbourhood',\n",
       "    'city_district': 'Los Angeles',\n",
       "    'continent': 'South America',\n",
       "    'country': 'Colombia',\n",
       "    'country_code': 'co',\n",
       "    'state': 'Sucre',\n",
       "    'state_code': 'SUC',\n",
       "    'state_district': 'Montes de María',\n",
       "    'town': 'Los Palmitos'},\n",
       "   'confidence': 7,\n",
       "   'formatted': 'Los Angeles, Los Palmitos, Montes de María, Colombia',\n",
       "   'geometry': {'lat': 9.3900639, 'lng': -75.2389229}},\n",
       "  {'annotations': {'DMS': {'lat': \"37° 28' 14.68380'' S\",\n",
       "     'lng': \"72° 21' 6.06960'' W\"},\n",
       "    'MGRS': '18HYD3419749610',\n",
       "    'Maidenhead': 'FF32tm77ta',\n",
       "    'Mercator': {'x': -8054152.844, 'y': -4478930.466},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=1658515#map=17/-37.47075/-72.35169',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/-37.47075/-72.35169&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=-37.47075&mlon=-72.35169#map=17/-37.47075/-72.35169'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CL': '152',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'SOUTH_AMERICA': '005',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 56,\n",
       "    'currency': {'alternate_symbols': [],\n",
       "     'decimal_mark': ',',\n",
       "     'disambiguate_symbol': 'CLP',\n",
       "     'html_entity': '&#36;',\n",
       "     'iso_code': 'CLP',\n",
       "     'iso_numeric': '152',\n",
       "     'name': 'Chilean Peso',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Peso',\n",
       "     'subunit_to_unit': 1,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': '.'},\n",
       "    'flag': '🇨🇱',\n",
       "    'geohash': '63kdcdej5db8wcbccz46',\n",
       "    'qibla': 84.96,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679482500,\n",
       "      'astronomical': 1679477280,\n",
       "      'civil': 1679480940,\n",
       "      'nautical': 1679479140},\n",
       "     'set': {'apparent': 1679525820,\n",
       "      'astronomical': 1679444640,\n",
       "      'civil': 1679527380,\n",
       "      'nautical': 1679529180}},\n",
       "    'timezone': {'name': 'America/Santiago',\n",
       "     'now_in_dst': 1,\n",
       "     'offset_sec': -10800,\n",
       "     'offset_string': '-0300',\n",
       "     'short_name': '-03'},\n",
       "    'what3words': {'words': 'analysis.possibly.flicked'},\n",
       "    'wikidata': 'Q16910'},\n",
       "   'bounds': {'northeast': {'lat': -37.1785281, 'lng': -72.03901},\n",
       "    'southwest': {'lat': -37.6629358, 'lng': -72.6836424}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'CL',\n",
       "    'ISO_3166-1_alpha-3': 'CHL',\n",
       "    'ISO_3166-2': ['CL-BI'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'city',\n",
       "    'city': 'Los Ángeles',\n",
       "    'continent': 'South America',\n",
       "    'country': 'Chile',\n",
       "    'country_code': 'cl',\n",
       "    'county': 'Provincia de Bío-Bío',\n",
       "    'state': 'Biobío Region'},\n",
       "   'confidence': 1,\n",
       "   'formatted': 'Los Ángeles, Provincia de Bío-Bío, Chile',\n",
       "   'geometry': {'lat': -37.4707455, 'lng': -72.351686}},\n",
       "  {'annotations': {'DMS': {'lat': \"8° 31' 27.00228'' N\",\n",
       "     'lng': \"82° 11' 39.06888'' W\"},\n",
       "    'MGRS': '17PLK6856642449',\n",
       "    'Maidenhead': 'EJ88vm65qt',\n",
       "    'Mercator': {'x': -9149814.905, 'y': 946096.718},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=11025613#map=17/8.52417/-82.19419',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/8.52417/-82.19419&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=8.52417&mlon=-82.19419#map=17/8.52417/-82.19419'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CENTRAL_AMERICA': '013',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'PA': '591',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 507,\n",
       "    'currency': {'alternate_symbols': ['US$'],\n",
       "     'decimal_mark': '.',\n",
       "     'disambiguate_symbol': 'US$',\n",
       "     'html_entity': '$',\n",
       "     'iso_code': 'USD',\n",
       "     'iso_numeric': '840',\n",
       "     'name': 'United States Dollar',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Cent',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': ','},\n",
       "    'flag': '🇵🇦',\n",
       "    'geohash': 'd1t83xu0beuyq9j6xvb0',\n",
       "    'qibla': 61.17,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679484780,\n",
       "      'astronomical': 1679480640,\n",
       "      'civil': 1679483520,\n",
       "      'nautical': 1679482080},\n",
       "     'set': {'apparent': 1679528280,\n",
       "      'astronomical': 1679446080,\n",
       "      'civil': 1679529540,\n",
       "      'nautical': 1679444640}},\n",
       "    'timezone': {'name': 'America/Panama',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': -18000,\n",
       "     'offset_string': '-0500',\n",
       "     'short_name': 'EST'},\n",
       "    'what3words': {'words': 'mimes.unblinking.overnights'},\n",
       "    'wikidata': 'Q20991006'},\n",
       "   'bounds': {'northeast': {'lat': 8.5744293, 'lng': -82.1248326},\n",
       "    'southwest': {'lat': 8.4737289, 'lng': -82.2441543}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'PA',\n",
       "    'ISO_3166-1_alpha-3': 'PAN',\n",
       "    'ISO_3166-2': ['PA-4'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'city',\n",
       "    'city': 'Los Angeles',\n",
       "    'continent': 'North America',\n",
       "    'country': 'Panama',\n",
       "    'country_code': 'pa',\n",
       "    'county': 'Distrito Gualaca',\n",
       "    'state': 'Chiriquí'},\n",
       "   'confidence': 6,\n",
       "   'formatted': 'Los Angeles, Distrito Gualaca, Panama',\n",
       "   'geometry': {'lat': 8.5241673, 'lng': -82.1941858}},\n",
       "  {'annotations': {'DMS': {'lat': \"4° 48' 3.20184'' N\",\n",
       "     'lng': \"75° 41' 29.38776'' W\"},\n",
       "    'MGRS': '18NVL2332030693',\n",
       "    'Maidenhead': 'FJ24dt72af',\n",
       "    'Mercator': {'x': -8425938.857, 'y': 531485.466},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=7752593#map=17/4.80089/-75.69150',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/4.80089/-75.69150&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=4.80089&mlon=-75.69150#map=17/4.80089/-75.69150'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CO': '170',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'SOUTH_AMERICA': '005',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 57,\n",
       "    'currency': {'alternate_symbols': ['COL$'],\n",
       "     'decimal_mark': ',',\n",
       "     'disambiguate_symbol': 'COL$',\n",
       "     'html_entity': '&#36;',\n",
       "     'iso_code': 'COP',\n",
       "     'iso_numeric': '170',\n",
       "     'name': 'Colombian Peso',\n",
       "     'smallest_denomination': 20,\n",
       "     'subunit': 'Centavo',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': '.'},\n",
       "    'flag': '🇨🇴',\n",
       "    'geohash': 'd2f5m9gphq9kqpw9xrk9',\n",
       "    'qibla': 64.68,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679483220,\n",
       "      'astronomical': 1679479080,\n",
       "      'civil': 1679481960,\n",
       "      'nautical': 1679480520},\n",
       "     'set': {'apparent': 1679526720,\n",
       "      'astronomical': 1679444460,\n",
       "      'civil': 1679527980,\n",
       "      'nautical': 1679529420}},\n",
       "    'timezone': {'name': 'America/Bogota',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': -18000,\n",
       "     'offset_string': '-0500',\n",
       "     'short_name': '-05'},\n",
       "    'what3words': {'words': 'unscrew.sourced.exposing'}},\n",
       "   'bounds': {'northeast': {'lat': 4.8050146, 'lng': -75.6898823},\n",
       "    'southwest': {'lat': 4.7967815, 'lng': -75.6939554}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'CO',\n",
       "    'ISO_3166-1_alpha-3': 'COL',\n",
       "    'ISO_3166-2': ['CO-RIS'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'neighbourhood',\n",
       "    'borough': 'Universidad',\n",
       "    'city': 'Perimetro Urbano Pereira',\n",
       "    'continent': 'South America',\n",
       "    'country': 'Colombia',\n",
       "    'country_code': 'co',\n",
       "    'municipality': 'Pereira',\n",
       "    'region': 'RAP Eje Cafetero',\n",
       "    'state': 'Risaralda',\n",
       "    'state_code': 'RIS',\n",
       "    'state_district': 'AMCO, Area Metropolitana Centro Occidente',\n",
       "    'suburb': 'Los Angeles'},\n",
       "   'confidence': 9,\n",
       "   'formatted': 'Los Angeles, Perimetro Urbano Pereira, AMCO, Area Metropolitana Centro Occidente, Colombia',\n",
       "   'geometry': {'lat': 4.8008894, 'lng': -75.6914966}},\n",
       "  {'annotations': {'DMS': {'lat': \"13° 15' 1.24992'' N\",\n",
       "     'lng': \"86° 1' 13.03860'' W\"},\n",
       "    'MGRS': '16PFV0613865028',\n",
       "    'Maidenhead': 'EK63xg70nc',\n",
       "    'Mercator': {'x': -9575734.714, 'y': 1478560.655},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?node=10034935559#map=17/13.25035/-86.02029',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/13.25035/-86.02029&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=13.25035&mlon=-86.02029#map=17/13.25035/-86.02029'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CENTRAL_AMERICA': '013',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'NI': '558',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 505,\n",
       "    'currency': {'alternate_symbols': [],\n",
       "     'decimal_mark': '.',\n",
       "     'disambiguate_symbol': 'NIO$',\n",
       "     'html_entity': '',\n",
       "     'iso_code': 'NIO',\n",
       "     'iso_numeric': '558',\n",
       "     'name': 'Nicaraguan Córdoba',\n",
       "     'smallest_denomination': 5,\n",
       "     'subunit': 'Centavo',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': 'C$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': ','},\n",
       "    'flag': '🇳🇮',\n",
       "    'geohash': 'd46g6s1uvgxzz4z5gwhd',\n",
       "    'qibla': 57.51,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679485680,\n",
       "      'astronomical': 1679481420,\n",
       "      'civil': 1679484420,\n",
       "      'nautical': 1679482920},\n",
       "     'set': {'apparent': 1679529240,\n",
       "      'astronomical': 1679447100,\n",
       "      'civil': 1679444100,\n",
       "      'nautical': 1679445600}},\n",
       "    'timezone': {'name': 'America/Managua',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': -21600,\n",
       "     'offset_string': '-0600',\n",
       "     'short_name': 'CST'},\n",
       "    'what3words': {'words': 'unbolt.ungoverned.unsuited'}},\n",
       "   'bounds': {'northeast': {'lat': 14.2503472, 'lng': -85.0202885},\n",
       "    'southwest': {'lat': 12.2503472, 'lng': -87.0202885}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'NI',\n",
       "    'ISO_3166-1_alpha-3': 'NIC',\n",
       "    'ISO_3166-2': ['NI-JI'],\n",
       "    '_category': 'road',\n",
       "    '_type': 'road',\n",
       "    'continent': 'North America',\n",
       "    'country': 'Nicaragua',\n",
       "    'country_code': 'ni',\n",
       "    'municipality': 'Jinotega (Municipio)',\n",
       "    'place': 'Los Angeles',\n",
       "    'postcode': '65000',\n",
       "    'state': 'Jinotega',\n",
       "    'state_code': 'JI'},\n",
       "   'confidence': 1,\n",
       "   'formatted': 'Los Angeles, Jinotega, Nicaragua',\n",
       "   'geometry': {'lat': 13.2503472, 'lng': -86.0202885}},\n",
       "  {'annotations': {'DMS': {'lat': \"2° 24' 58.35888'' N\",\n",
       "     'lng': \"76° 55' 2.29872'' W\"},\n",
       "    'MGRS': '18NTH8680067215',\n",
       "    'Maidenhead': 'FJ12mj99wv',\n",
       "    'Mercator': {'x': -8562395.248, 'y': 267251.044},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?node=6042263237#map=17/2.41621/-76.91731',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/2.41621/-76.91731&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=2.41621&mlon=-76.91731#map=17/2.41621/-76.91731'},\n",
       "    'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "      'CO': '170',\n",
       "      'LATIN_AMERICA': '419',\n",
       "      'SOUTH_AMERICA': '005',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['LEDC']},\n",
       "    'callingcode': 57,\n",
       "    'currency': {'alternate_symbols': ['COL$'],\n",
       "     'decimal_mark': ',',\n",
       "     'disambiguate_symbol': 'COL$',\n",
       "     'html_entity': '&#36;',\n",
       "     'iso_code': 'COP',\n",
       "     'iso_numeric': '170',\n",
       "     'name': 'Colombian Peso',\n",
       "     'smallest_denomination': 20,\n",
       "     'subunit': 'Centavo',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '$',\n",
       "     'symbol_first': 1,\n",
       "     'thousands_separator': '.'},\n",
       "    'flag': '🇨🇴',\n",
       "    'geohash': 'd23m9xye2yk6c6by1ysp',\n",
       "    'qibla': 65.29,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679483520,\n",
       "      'astronomical': 1679479440,\n",
       "      'civil': 1679482260,\n",
       "      'nautical': 1679480880},\n",
       "     'set': {'apparent': 1679527020,\n",
       "      'astronomical': 1679444700,\n",
       "      'civil': 1679528280,\n",
       "      'nautical': 1679443260}},\n",
       "    'timezone': {'name': 'America/Bogota',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': -18000,\n",
       "     'offset_string': '-0500',\n",
       "     'short_name': '-05'},\n",
       "    'what3words': {'words': 'uncoil.bras.drooped'}},\n",
       "   'bounds': {'northeast': {'lat': 2.4562108, 'lng': -76.8773052},\n",
       "    'southwest': {'lat': 2.3762108, 'lng': -76.9573052}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'CO',\n",
       "    'ISO_3166-1_alpha-3': 'COL',\n",
       "    'ISO_3166-2': ['CO-CAU'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'city',\n",
       "    'continent': 'South America',\n",
       "    'country': 'Colombia',\n",
       "    'country_code': 'co',\n",
       "    'county': 'El Tambo',\n",
       "    'state': 'Cauca',\n",
       "    'state_code': 'CAU',\n",
       "    'state_district': 'Centro',\n",
       "    'town': 'Los Angeles'},\n",
       "   'confidence': 7,\n",
       "   'formatted': 'Los Angeles, El Tambo, Colombia',\n",
       "   'geometry': {'lat': 2.4162108, 'lng': -76.9173052}},\n",
       "  {'annotations': {'DMS': {'lat': \"40° 21' 22.39812'' N\",\n",
       "     'lng': \"3° 41' 58.69968'' W\"},\n",
       "    'MGRS': '30TVK4059067530',\n",
       "    'Maidenhead': 'IN80di65bl',\n",
       "    'Mercator': {'x': -411841.907, 'y': 4890169.008},\n",
       "    'NUTS': {'NUTS0': {'code': 'ES'},\n",
       "     'NUTS1': {'code': 'ES3'},\n",
       "     'NUTS2': {'code': 'ES30'},\n",
       "     'NUTS3': {'code': 'ES300'}},\n",
       "    'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=9235998#map=17/40.35622/-3.69964',\n",
       "     'note_url': 'https://www.openstreetmap.org/note/new#map=17/40.35622/-3.69964&layers=N',\n",
       "     'url': 'https://www.openstreetmap.org/?mlat=40.35622&mlon=-3.69964#map=17/40.35622/-3.69964'},\n",
       "    'UN_M49': {'regions': {'ES': '724',\n",
       "      'EUROPE': '150',\n",
       "      'SOUTHERN_EUROPE': '039',\n",
       "      'WORLD': '001'},\n",
       "     'statistical_groupings': ['MEDC']},\n",
       "    'callingcode': 34,\n",
       "    'currency': {'alternate_symbols': [],\n",
       "     'decimal_mark': ',',\n",
       "     'html_entity': '€',\n",
       "     'iso_code': 'EUR',\n",
       "     'iso_numeric': '978',\n",
       "     'name': 'Euro',\n",
       "     'smallest_denomination': 1,\n",
       "     'subunit': 'Cent',\n",
       "     'subunit_to_unit': 100,\n",
       "     'symbol': '€',\n",
       "     'symbol_first': 0,\n",
       "     'thousands_separator': '.'},\n",
       "    'flag': '🇪🇸',\n",
       "    'geohash': 'ezjmefdh00vr7tye4qmm',\n",
       "    'qibla': 103.91,\n",
       "    'roadinfo': {'drive_on': 'right', 'speed_in': 'km/h'},\n",
       "    'sun': {'rise': {'apparent': 1679465820,\n",
       "      'astronomical': 1679460300,\n",
       "      'civil': 1679464140,\n",
       "      'nautical': 1679462280},\n",
       "     'set': {'apparent': 1679509680,\n",
       "      'astronomical': 1679515140,\n",
       "      'civil': 1679511300,\n",
       "      'nautical': 1679513220}},\n",
       "    'timezone': {'name': 'Europe/Madrid',\n",
       "     'now_in_dst': 0,\n",
       "     'offset_sec': 3600,\n",
       "     'offset_string': '+0100',\n",
       "     'short_name': 'CET'},\n",
       "    'what3words': {'words': 'basher.spooned.clean'},\n",
       "    'wikidata': 'Q390462'},\n",
       "   'bounds': {'northeast': {'lat': 40.3645348, 'lng': -3.6930263},\n",
       "    'southwest': {'lat': 40.3456815, 'lng': -3.7070704}},\n",
       "   'components': {'ISO_3166-1_alpha-2': 'ES',\n",
       "    'ISO_3166-1_alpha-3': 'ESP',\n",
       "    'ISO_3166-2': ['ES-MD'],\n",
       "    '_category': 'place',\n",
       "    '_type': 'neighbourhood',\n",
       "    'city': 'Madrid',\n",
       "    'continent': 'Europe',\n",
       "    'country': 'Spain',\n",
       "    'country_code': 'es',\n",
       "    'county': 'Área metropolitana de Madrid y Corredor del Henares',\n",
       "    'political_union': 'European Union',\n",
       "    'postcode': '28041',\n",
       "    'quarter': 'Los Ángeles',\n",
       "    'state': 'Madrid',\n",
       "    'suburb': 'Villaverde'},\n",
       "   'confidence': 8,\n",
       "   'formatted': '28041 Madrid, Spain',\n",
       "   'geometry': {'lat': 40.3562217, 'lng': -3.6996388}}],\n",
       " 'status': {'code': 200, 'message': 'OK'},\n",
       " 'stay_informed': {'blog': 'https://blog.opencagedata.com',\n",
       "  'mastodon': 'https://en.osm.town/@opencage',\n",
       "  'twitter': 'https://twitter.com/OpenCage'},\n",
       " 'thanks': 'For using an OpenCage API',\n",
       " 'timestamp': {'created_http': 'Wed, 22 Mar 2023 06:11:38 GMT',\n",
       "  'created_unix': 1679465498},\n",
       " 'total_results': 10}"
      ]
     },
     "execution_count": 18,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "j = r.json()\n",
    "j"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "id": "a1a5c543",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "10\n",
      "* Places called \"Los Angeles\":\n",
      "- Los Angeles, California, United States of America\n",
      "- University of California, Los Angeles, Hilgard Avenue, Los Angeles, CA 90095, United States of America\n",
      "- Los Angeles County, California, United States of America\n",
      "- Los Angeles, Los Palmitos, Montes de María, Colombia\n",
      "- Los Ángeles, Provincia de Bío-Bío, Chile\n",
      "- Los Angeles, Distrito Gualaca, Panama\n",
      "- Los Angeles, Perimetro Urbano Pereira, AMCO, Area Metropolitana Centro Occidente, Colombia\n",
      "- Los Angeles, Jinotega, Nicaragua\n",
      "- Los Angeles, El Tambo, Colombia\n",
      "- 28041 Madrid, Spain\n"
     ]
    }
   ],
   "source": [
    "results = j.get('results')\n",
    "print(len(results))\n",
    "\n",
    "places = [ x['formatted'] for x in results]\n",
    "\n",
    "# places = list(map(lambda x : x['formatted'], results))\n",
    "\n",
    "print('* Places called \"Los Angeles\":')\n",
    "for p in places:\n",
    "    print('-', p)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "2acccc44",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "{'annotations': {'DMS': {'lat': \"34° 3' 13.28724'' N\",\n",
       "   'lng': \"118° 14' 33.95760'' W\"},\n",
       "  'FIPS': {'county': '06037', 'state': '06'},\n",
       "  'MGRS': '11SLT8530268805',\n",
       "  'Maidenhead': 'DM04vb02uv',\n",
       "  'Mercator': {'x': -13162724.501, 'y': 4012087.536},\n",
       "  'OSM': {'edit_url': 'https://www.openstreetmap.org/edit?relation=207359#map=17/34.05369/-118.24277',\n",
       "   'note_url': 'https://www.openstreetmap.org/note/new#map=17/34.05369/-118.24277&layers=N',\n",
       "   'url': 'https://www.openstreetmap.org/?mlat=34.05369&mlon=-118.24277#map=17/34.05369/-118.24277'},\n",
       "  'UN_M49': {'regions': {'AMERICAS': '019',\n",
       "    'NORTHERN_AMERICA': '021',\n",
       "    'US': '840',\n",
       "    'WORLD': '001'},\n",
       "   'statistical_groupings': ['MEDC']},\n",
       "  'callingcode': 1,\n",
       "  'currency': {'alternate_symbols': ['US$'],\n",
       "   'decimal_mark': '.',\n",
       "   'disambiguate_symbol': 'US$',\n",
       "   'html_entity': '$',\n",
       "   'iso_code': 'USD',\n",
       "   'iso_numeric': '840',\n",
       "   'name': 'United States Dollar',\n",
       "   'smallest_denomination': 1,\n",
       "   'subunit': 'Cent',\n",
       "   'subunit_to_unit': 100,\n",
       "   'symbol': '$',\n",
       "   'symbol_first': 1,\n",
       "   'thousands_separator': ','},\n",
       "  'flag': '🇺🇸',\n",
       "  'geohash': '9q5ctr61pu56cc11s98x',\n",
       "  'qibla': 23.86,\n",
       "  'roadinfo': {'drive_on': 'right', 'speed_in': 'mph'},\n",
       "  'sun': {'rise': {'apparent': 1679493300,\n",
       "    'astronomical': 1679488260,\n",
       "    'civil': 1679491800,\n",
       "    'nautical': 1679490060},\n",
       "   'set': {'apparent': 1679450700,\n",
       "    'astronomical': 1679455740,\n",
       "    'civil': 1679452200,\n",
       "    'nautical': 1679453940}},\n",
       "  'timezone': {'name': 'America/Los_Angeles',\n",
       "   'now_in_dst': 1,\n",
       "   'offset_sec': -25200,\n",
       "   'offset_string': '-0700',\n",
       "   'short_name': 'PDT'},\n",
       "  'what3words': {'words': 'bless.fork.sober'},\n",
       "  'wikidata': 'Q65'},\n",
       " 'bounds': {'northeast': {'lat': 34.337306, 'lng': -118.1552947},\n",
       "  'southwest': {'lat': 33.659541, 'lng': -118.6681779}},\n",
       " 'components': {'ISO_3166-1_alpha-2': 'US',\n",
       "  'ISO_3166-1_alpha-3': 'USA',\n",
       "  'ISO_3166-2': ['US-CA'],\n",
       "  '_category': 'place',\n",
       "  '_type': 'city',\n",
       "  'city': 'Los Angeles',\n",
       "  'continent': 'North America',\n",
       "  'country': 'United States',\n",
       "  'country_code': 'us',\n",
       "  'county': 'Los Angeles County',\n",
       "  'state': 'California',\n",
       "  'state_code': 'CA'},\n",
       " 'confidence': 1,\n",
       " 'formatted': 'Los Angeles, California, United States of America',\n",
       " 'geometry': {'lat': 34.0536909, 'lng': -118.242766}}"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "la = results[0]\n",
    "la"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "id": "d40f6afd",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'https://www.openstreetmap.org/?mlat=34.05369&mlon=-118.24277#map=17/34.05369/-118.24277'"
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "la_osm_url = la['annotations']['OSM']['url']\n",
    "la_osm_url"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "id": "303d484f",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "lat: 34° 3' 13.28724'' N ;  long: 118° 14' 33.95760'' W\n"
     ]
    }
   ],
   "source": [
    "print('lat:', la['annotations']['DMS']['lat'], ';  long:', la['annotations']['DMS']['lng'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "id": "18cde516",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(34.0536909, -118.242766)"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "la['geometry']['lat'] , la['geometry']['lng']"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "4529a2ab",
   "metadata": {},
   "source": [
    "__Note:__ In practical applications, probably best to use dict.get() and try:/except: for robustness."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "id": "3de479aa",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import webbrowser\n",
    "\n",
    "webbrowser.open(la_osm_url)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "55db6b98",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hello world!\n"
     ]
    }
   ],
   "source": [
    "print('hello world!')"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3 (ipykernel)",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.9.6"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
